{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 1,
   "id": "0c8838bf",
   "metadata": {},
   "outputs": [],
   "source": [
    "import pandas as pd"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "id": "1adf36c0",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "application/vnd.microsoft.datawrangler.viewer.v0+json": {
       "columns": [
        {
         "name": "index",
         "rawType": "int64",
         "type": "integer"
        },
        {
         "name": "questions",
         "rawType": "object",
         "type": "string"
        },
        {
         "name": "option_A",
         "rawType": "object",
         "type": "string"
        },
        {
         "name": "option_B",
         "rawType": "object",
         "type": "string"
        },
        {
         "name": "option_C",
         "rawType": "object",
         "type": "string"
        },
        {
         "name": "option_D",
         "rawType": "object",
         "type": "string"
        },
        {
         "name": "correct_answer",
         "rawType": "object",
         "type": "string"
        },
        {
         "name": "option_E",
         "rawType": "object",
         "type": "string"
        },
        {
         "name": "source_file",
         "rawType": "object",
         "type": "string"
        },
        {
         "name": "source_folder",
         "rawType": "object",
         "type": "string"
        },
        {
         "name": "year",
         "rawType": "int64",
         "type": "integer"
        },
        {
         "name": "question",
         "rawType": "object",
         "type": "string"
        },
        {
         "name": "answer_llm",
         "rawType": "object",
         "type": "string"
        },
        {
         "name": "model_basename",
         "rawType": "object",
         "type": "string"
        }
       ],
       "ref": "5142b019-30ef-46a9-8f34-50a927f60c02",
       "rows": [
        [
         "0",
         "Varón de 65 años con antecedente de hipertensión arterial, acude por cefalea intensa, convulsiones y edema de papila. \nExamen: PA: 190/120 mmHg. ¿Cuál es el medicamento inicial a usar?",
         "Labetalol",
         "Hidralazina",
         "Nitroprusiato",
         "Nitroglicerina",
         "C",
         "Ninguna de las anteriores",
         "Prueba A",
         "Year2025",
         "2025",
         "Varón de 65 años con antecedente de hipertensión arterial, acude por cefalea intensa, convulsiones y edema de papila. \nExamen: PA: 190/120 mmHg. ¿Cuál es el medicamento inicial a usar? A) Labetalol B) Hidralazina C) Nitroprusiato D) Nitroglicerina E) Ninguna de las anteriores",
         "<unused94>thought\n1.  **Analyze the Request:** The user wants me to act as an expert medical assistant trained in Peru and answer a multiple-choice medical question. I need to provide a step-by-step internal thought process, summarize the information, and then output *only* the final letter answer.\n\n2.  **Summarize the Case:**\n    *   Patient: 65-year-old male.\n    *   History: Hypertension (HTN).\n    *   Symptoms: Intense headache, seizures, papilledema.\n    *   Exam Finding: Blood Pressure (BP) = 190/120 mmHg (severely elevated).\n\n3.  **Identify the Condition:** The combination of severe hypertension (190/120 mmHg), headache, seizures, and papilledema strongly suggests a hypertensive emergency, specifically hypertensive encephalopathy. This is a life-threatening condition requiring immediate BP reduction.\n\n4.  **Evaluate the Treatment Options:** The goal is to lower the BP rapidly but controllably to prevent further end-organ damage.\n    *   **A) Labetalol:** An alpha- and beta-blocker. It's commonly used intravenously for hypertensive emergencies. It has a relatively rapid onset and predictable effect, making it a good first-line choice. It's available in Peru.\n    *   **B) Hidralazina:** A direct vasodilator. It can cause rapid BP drops and reflex tachycardia. While used, it's often not the first choice due to less predictable effects compared to labetalol or nicardipine. Available in Peru.\n    *   **C) Nitroprusiato:** A potent arterial and venous vasodilator. It requires continuous infusion and close monitoring (e.g., arterial line) due to the risk of cyanide toxicity with prolonged use or renal impairment. Often reserved for specific situations or when other agents fail. Available in Peru.\n    *   **D) Nitroglicerina:** Primarily a venodilator, also causes some arterial dilation. More commonly used for hypertensive emergencies associated with acute coronary syndrome or acute pulmonary edema. Less effective for hypertensive encephalopathy compared to labetalol or nitroprusiato. Available in Peru.\n    *   **E) Ninguna de las anteriores:** Given that several options are used in hypertensive emergencies, this is unlikely.\n\n5.  **Determine the Best Initial Medication:**\n    *   Hypertensive encephalopathy requires rapid but controlled BP reduction.\n    *   Labetalol is a widely accepted first-line agent for many hypertensive emergencies, including encephalopathy, due to its efficacy, relatively predictable effects, and safety profile (avoiding significant reflex tachycardia).\n    *   Nitroprusiato is also effective but requires more intensive monitoring and has potential toxicity issues.\n    *   Hidralazina and Nitroglicerina are generally considered second-line or for specific indications.\n    *   Considering the clinical presentation (hypertensive encephalopathy) and the available options, Labetalol is a very appropriate *initial* choice.\n\n6.  **Formulate the Final Answer:** Based on the analysis, Labetalol (A) is the most suitable initial medication for this patient presenting with hypertensive encephalopathy.\n\n7.  **Final Check:** Ensure the output format matches the request: internal reasoning (done), summary (done), and *only* the final letter answer.<unused95>Respuesta final:A",
         "medgemma-27b-text-it"
        ],
        [
         "1",
         "Mujer de 32 años asintomática que acude por chequeo. Al examen de mama a la expresión de uno de los pezones sale \nsecreción blanco lechoso. ¿Cuál es el manejo más adecuado?",
         "Solicitar prolactina",
         "Mamografía",
         "Ecografía de mamas",
         "Observación",
         "D",
         "Ninguna de las anteriores",
         "Prueba A",
         "Year2025",
         "2025",
         "Mujer de 32 años asintomática que acude por chequeo. Al examen de mama a la expresión de uno de los pezones sale \nsecreción blanco lechoso. ¿Cuál es el manejo más adecuado? A) Solicitar prolactina B) Mamografía C) Ecografía de mamas D) Observación E) Ninguna de las anteriores",
         "<unused94>thought\n1.  **Analyze the Request:** The user wants me to act as an expert medical assistant trained in Peru and answer a multiple-choice medical question. I need to provide a step-by-step internal thought process, summarize the information, and then give *only* the final letter answer.\n\n2.  **Summarize the Information:**\n    *   Patient: 32-year-old female.\n    *   Presentation: Asymptomatic, routine check-up.\n    *   Finding: Bilateral nipple discharge (implied by \"uno de los pezones\" - likely a typo, should be \"uno de los pezones\" or \"ambos pezones\", but discharge from one nipple is the key finding). The discharge is white and milky (leukorrhea).\n    *   Question: What is the most appropriate management?\n    *   Options:\n        *   A) Solicit prolactin (Order prolactin level)\n        *   B) Mamografía (Mammography)\n        *   C) Ecografía de mamas (Breast ultrasound)\n        *   D) Observación (Observation)\n        *   E) Ninguna de las anteriores (None of the above)\n\n3.  **Evaluate the Options based on the Clinical Scenario:**\n    *   **Patient Profile:** 32 years old. This age is relevant for imaging choices. Mammography is generally less sensitive in younger women due to denser breast tissue. Ultrasound is often preferred as the initial imaging modality in women under 40.\n    *   **Symptom:** Nipple discharge. This is the primary symptom requiring investigation.\n    *   **Discharge Characteristics:** White, milky (leukorrhea). This type of discharge is often physiological, especially in women of reproductive age, potentially related to hormonal fluctuations, pregnancy, lactation, or certain medications. However, it can also be associated with pathological conditions like prolactinoma or other pituitary issues.\n    *   **Asymptomatic:** The patient has no other symptoms (like pain, mass, skin changes).\n    *   **Management Options Analysis:**\n        *   **A) Solicit prolactina:** Milky discharge can be caused by hyperprolactinemia (e.g., due to a prolactinoma). Measuring prolactin is a reasonable step in the workup of milky nipple discharge, especially if it's spontaneous or bilateral.\n        *   **B) Mamografía:** While mammography is a standard breast imaging tool, it's generally not the *first* choice for a 32-year-old with nipple discharge, especially if it's milky and potentially physiological. Ultrasound is usually preferred initially in this age group.\n        *   **C) Ecografía de mamas:** Ultrasound is excellent for evaluating breast tissue in younger women (<40) and can help identify underlying causes of nipple discharge, such as intraductal papillomas or cysts. It's often the initial imaging modality recommended for nipple discharge in this age group.\n        *   **D) Observación:** Given the presence of nipple discharge, even if milky and the patient is asymptomatic, observation alone is generally not the most appropriate *initial* step. Further investigation is usually warranted to rule out underlying pathology.\n        *   **E) Ninguna de las anteriores:** This is unlikely, as options A and C represent standard diagnostic steps.\n\n4.  **Compare A and C:** Both ordering prolactin and performing an ultrasound are reasonable steps. However, the question asks for the *most* appropriate management.\n    *   Milky discharge strongly suggests a hormonal component (like hyperprolactinemia). Therefore, checking prolactin levels (A) is a very direct and relevant investigation.\n    *   Ultrasound (C) is important for evaluating the breast tissue itself to look for structural causes (like papillomas, cysts, or malignancy, although less likely given the milky discharge and age).\n    *   In clinical practice, both might be done. However, given the *specific* characteristic of the discharge (milky), investigating the hormonal cause (prolactin) is often considered a primary step, especially if the discharge is bilateral or spontaneous. If the discharge were bloody, purulent, or unilateral and spontaneous, imaging (ultrasound +/- mammography) would be prioritized. Since it's milky, prolactin is a very strong consideration.\n\n5.  **Refine the Choice:** The discharge is described as \"blanco lechoso\" (white, milky). This is the key feature. Milky discharge is most commonly associated with hormonal causes (hyperprolactinemia, pregnancy, lactation, medications) or sometimes physiological stimulation. While imaging (ultrasound) is important to rule out structural causes, investigating the likely hormonal etiology with a prolactin level is a very appropriate *initial* step, especially in an asymptomatic patient.\n\n6.  **Final Decision:** Based on the milky nature of the discharge in a 32-year-old woman, checking prolactin levels is a highly relevant and appropriate initial step to investigate a common cause. Ultrasound is also important but might follow or be done concurrently. Given the options, ordering prolactin directly addresses the most likely etiology suggested by the discharge type.\n\n7.  **Format the Output:** Provide only the letter of the chosen answer.<unused95>Respuesta final:A",
         "medgemma-27b-text-it"
        ],
        [
         "2",
         "¿Cuál es el sitio más frecuente de implantación del blastocisto?",
         "Fondo uterino",
         "Segmento inferior del útero",
         "Cérvix uterino",
         "Cuerno uterino",
         "A",
         "Ninguna de las anteriores",
         "Prueba A",
         "Year2025",
         "2025",
         "¿Cuál es el sitio más frecuente de implantación del blastocisto? A) Fondo uterino B) Segmento inferior del útero C) Cérvix uterino D) Cuerno uterino E) Ninguna de las anteriores",
         "<unused94>thought\n1.  **Identify the core question:** The question asks for the most common site of blastocyst implantation in the uterus.\n\n2.  **Analyze the options:**\n    *   A) Fondo uterino (Uterine fundus): The top part of the uterus.\n    *   B) Segmento inferior del útero (Lower uterine segment): The lower part of the uterus, near the cervix.\n    *   C) Cérvix uterino (Cervix): The lower, narrow part of the uterus that opens into the vagina.\n    *   D) Cuerno uterino (Uterine horn): The upper lateral parts of the uterus, extending from the fundus.\n    *   E) Ninguna de las anteriores (None of the above).\n\n3.  **Recall/Research knowledge about implantation:** Implantation is the process where the blastocyst attaches to and embeds in the uterine lining (endometrium). This typically occurs around 6-10 days after fertilization. The endometrium is most receptive in the upper part of the uterus.\n\n4.  **Evaluate each option based on knowledge:**\n    *   A) Fondo uterino: This is the upper part of the uterus where the endometrium is generally thickest and most vascularized during the secretory phase, making it a prime location for implantation.\n    *   B) Segmento inferior del útero: This area is less common for implantation. Implantation here can be associated with complications like placenta previa or preterm labor.\n    *   C) Cérvix uterino: Implantation in the cervix is very rare and is called a cervical pregnancy, a dangerous condition.\n    *   D) Cuerno uterino: While implantation can occur here, it's part of the upper uterus, similar to the fundus. The fundus is generally considered the *most* frequent site within the upper uterus.\n    *   E) Ninguna de las anteriores: Since the fundus is a known and common site, this is unlikely.\n\n5.  **Compare the likely options:** The fundus (A) and the uterine horns (D) are both in the upper part of the uterus. However, medical literature consistently cites the posterior wall of the uterine fundus as the most frequent site of implantation.\n\n6.  **Select the best answer:** Based on the common understanding of reproductive physiology, the fundus (fondo uterino) is the most frequent site.\n\n7.  **Format the final answer:** State only the letter corresponding to the chosen answer.<unused95>Respuesta final:A",
         "medgemma-27b-text-it"
        ],
        [
         "3",
         "Varón de 43 años, llevado a urgencias porque sufrió hace 30 minutos impacto de timón en el tórax por accidente de \ntránsito. Presenta disnea intensa, dolor torácico izquierdo, taquipnea. Examen: PA:80/40 mmHg, FC: 100X', FR: 36X'; \ncianosis distal, movimiento paradojal de la pared torácica. RX: múltiples fracturas costales izquierdas. ¿Cuál es la \nconducta más adecuada?",
         "Colocación de catéter central",
         "Ventilación no invasiva",
         "Fijación costal quirúrgica",
         "Intubación orotraqueal",
         "D",
         "Ninguna de las anteriores",
         "Prueba A",
         "Year2025",
         "2025",
         "Varón de 43 años, llevado a urgencias porque sufrió hace 30 minutos impacto de timón en el tórax por accidente de \ntránsito. Presenta disnea intensa, dolor torácico izquierdo, taquipnea. Examen: PA:80/40 mmHg, FC: 100X', FR: 36X'; \ncianosis distal, movimiento paradojal de la pared torácica. RX: múltiples fracturas costales izquierdas. ¿Cuál es la \nconducta más adecuada? A) Colocación de catéter central B) Ventilación no invasiva C) Fijación costal quirúrgica D) Intubación orotraqueal E) Ninguna de las anteriores",
         "<unused94>thought\n1.  **Analyze the Request:** The user wants me to act as an expert medical assistant trained in Peru and answer a multiple-choice medical question. I need to provide a step-by-step internal thought process, summarize the information, and then give *only* the final letter answer.\n\n2.  **Summarize the Case:**\n    *   **Patient:** 43-year-old male.\n    *   **Mechanism:** Blunt chest trauma (steering wheel impact) 30 minutes ago.\n    *   **Symptoms:** Severe dyspnea, left chest pain, tachypnea.\n    *   **Signs:** Hypotension (BP 80/40), tachycardia (HR 100), tachypnea (RR 36), distal cyanosis, paradoxical chest wall movement.\n    *   **Imaging:** Multiple left rib fractures on X-ray.\n\n3.  **Identify the Likely Diagnosis:** The combination of severe blunt chest trauma, respiratory distress (dyspnea, tachypnea, cyanosis), hemodynamic instability (hypotension, tachycardia), and paradoxical chest wall movement strongly suggests a **flail chest** complicated by **respiratory failure** and likely **shock** (hypovolemic or obstructive, possibly tension pneumothorax or cardiac tamponade, though not explicitly stated, the hypotension is concerning). The paradoxical movement is the hallmark of flail chest (multiple adjacent rib fractures in two or more places).\n\n4.  **Evaluate the Options:**\n    *   **A) Colocación de catéter central (Central line placement):** While potentially useful for fluid resuscitation or monitoring, it's not the *most immediate* life-saving intervention for severe respiratory failure and shock due to flail chest. Addressing the airway and breathing is paramount.\n    *   **B) Ventilación no invasiva (Non-invasive ventilation - NIV):** NIV (like CPAP or BiPAP) might be considered in *some* cases of respiratory distress, but in a patient with severe trauma, hemodynamic instability, potential for massive hemothorax/pneumothorax, and likely need for positive pressure ventilation to stabilize the flail segment, NIV is generally contraindicated or insufficient. It doesn't address the underlying mechanical instability or the potential need for controlled ventilation.\n    *   **C) Fijación costal quirúrgica (Surgical rib fixation):** This is a definitive treatment for flail chest but is *not* the immediate emergency management. It's performed later, once the patient is stabilized.\n    *   **D) Intubación orotraqueal (Orotracheal intubation):** This patient has severe respiratory failure (dyspnea, tachypnea, cyanosis) and hemodynamic instability. Intubation and mechanical ventilation are indicated to:\n        *   Secure the airway.\n        *   Provide adequate oxygenation and ventilation.\n        *   Reduce the work of breathing.\n        *   Apply positive end-expiratory pressure (PEEP) to help stabilize the flail segment and improve oxygenation.\n        *   Allow for sedation and analgesia.\n        *   Facilitate resuscitation.\n        This is the most critical immediate step to manage the life-threatening respiratory failure and shock.\n    *   **E) Ninguna de las anteriores (None of the above):** Option D is clearly the most appropriate immediate action.\n\n5.  **Determine the Best Course of Action:** Given the severe respiratory distress, hemodynamic instability, and paradoxical chest movement indicative of flail chest with respiratory failure, immediate airway management and mechanical ventilation via endotracheal intubation are the highest priority.\n\n6.  **Format the Final Answer:** The request asks for *only* the letter of the correct answer after the internal reasoning.\n\n7.  **Final Answer Selection:** The most appropriate immediate action is Intubación orotraqueal. This corresponds to option D.<unused95>Respuesta final:D",
         "medgemma-27b-text-it"
        ],
        [
         "4",
         "Varón de 27 años, acude a consulta por visión doble y caída del párpado derecho. Examen: se evidencia pupila derecha \ndilatada con incapacidad para mover el ojo hacia el lado nasal ¿Cuál es el par craneal comprometido?",
         "VI",
         "I",
         "III",
         "IV",
         "C",
         "Ninguna de las anteriores",
         "Prueba A",
         "Year2025",
         "2025",
         "Varón de 27 años, acude a consulta por visión doble y caída del párpado derecho. Examen: se evidencia pupila derecha \ndilatada con incapacidad para mover el ojo hacia el lado nasal ¿Cuál es el par craneal comprometido? A) VI B) I C) III D) IV E) Ninguna de las anteriores",
         "<unused94>thought\n1.  **Analyze the Request:** The user wants me to act as an expert medical assistant trained in Peru and answer a multiple-choice medical question. I need to provide a step-by-step internal thought process, summarize the information, and then output *only* the final letter answer.\n\n2.  **Summarize the Information:**\n    *   Patient: 27-year-old male.\n    *   Symptoms: Diplopia (visión doble), right ptosis (caída del párpado derecho).\n    *   Exam Findings: Right pupil dilated (pupila derecha dilatada), inability to move the right eye nasally (incapacidad para mover el ojo hacia el lado nasal).\n    *   Question: Which cranial nerve is compromised?\n    *   Options: A) VI (Abducens), B) I (Olfactory), C) III (Oculomotor), D) IV (Trochlear), E) None of the above.\n\n3.  **Step-by-Step Reasoning (Internal):**\n    *   **Ptosis (caída del párpado):** This is primarily controlled by the levator palpebrae superioris muscle, which is innervated by the Oculomotor nerve (CN III).\n    *   **Pupil Dilation (pupila dilatada):** The pupil size is controlled by the iris sphincter (constriction) and dilator (dilation) muscles. The sphincter is innervated by the parasympathetic fibers traveling with the Oculomotor nerve (CN III). Damage to these fibers leads to unopposed sympathetic action, causing dilation (mydriasis).\n    *   **Inability to move the eye nasally (incapacidad para mover el ojo hacia el lado nasal):** This movement (adduction) is controlled by the medial rectus muscle. The medial rectus muscle is innervated by the Oculomotor nerve (CN III).\n    *   **Diplopia (visión doble):** This is a common symptom of eye muscle paralysis or misalignment, consistent with cranial nerve palsies affecting eye movement.\n    *   **Evaluate Options:**\n        *   A) VI (Abducens): Innervates the lateral rectus muscle (abduction - moving the eye laterally/outward). Damage causes inability to abduct the eye. This doesn't match the symptoms.\n        *   B) I (Olfactory): Responsible for smell. Not related to eye movement or pupil function.\n        *   C) III (Oculomotor): Innervates the levator palpebrae superioris (eyelid elevation), most extraocular muscles (superior rectus, inferior rectus, medial rectus, inferior oblique), and carries parasympathetic fibers to the iris sphincter (pupil constriction). Damage typically causes ptosis, pupil dilation, and impaired adduction, elevation, and depression of the eye. This perfectly matches the patient's presentation (ptosis, dilated pupil, inability to adduct).\n        *   D) IV (Trochlear): Innervates the superior oblique muscle (intorsion, depression, abduction). Damage causes difficulty looking down and inward, often resulting in vertical diplopia. This doesn't match the primary symptoms.\n        *   E) None of the above: Option C fits well.\n\n4.  **Conclusion:** The combination of ptosis, dilated pupil, and inability to adduct the eye strongly points to a lesion affecting the Oculomotor nerve (CN III).\n\n5.  **Final Answer Format:** The user requested only the letter of the correct answer.<unused95>Respuesta final:C",
         "medgemma-27b-text-it"
        ],
        [
         "5",
         "Mujer de 58 años con antecedentes de litiasis renal recurrente, presenta fiebre de 39.2 °C, vómitos y dolor lumbar \nizquierdo de 48 horas de evolución. Examen: PA: 90/60 mmHg, FC: 120X', dolor en fosa lumbar izquierda. Leucocitosis. \nTomografía abdomino pélvica: litiasis obstructiva en uréter proximal izquierdo, dilatación del sistema pielocalicial y \nabsceso perinéfrico. ¿Cuál es la intervención inicial más adecuada?",
         "Litotricia extracorpórea y seguimiento con antibióticos",
         "Derivación urinaria urgente con  catéter doble J y nefrostomía percutánea",
         "Antibióticos de amplio espectro y nefrectomía diferida",
         "Drenaje quirúrgico del absceso sin derivación urinaria",
         "B",
         "Ninguna de las anteriores",
         "Prueba A",
         "Year2025",
         "2025",
         "Mujer de 58 años con antecedentes de litiasis renal recurrente, presenta fiebre de 39.2 °C, vómitos y dolor lumbar \nizquierdo de 48 horas de evolución. Examen: PA: 90/60 mmHg, FC: 120X', dolor en fosa lumbar izquierda. Leucocitosis. \nTomografía abdomino pélvica: litiasis obstructiva en uréter proximal izquierdo, dilatación del sistema pielocalicial y \nabsceso perinéfrico. ¿Cuál es la intervención inicial más adecuada? A) Litotricia extracorpórea y seguimiento con antibióticos B) Derivación urinaria urgente con  catéter doble J y nefrostomía percutánea C) Antibióticos de amplio espectro y nefrectomía diferida D) Drenaje quirúrgico del absceso sin derivación urinaria E) Ninguna de las anteriores",
         "<unused94>thought\nLa paciente presenta un cuadro clínico de pielonefritis complicada con absceso perinéfrico y obstrucción urinaria por litiasis en el uréter proximal izquierdo. Los signos vitales (hipotensión, taquicardia) y la fiebre alta sugieren sepsis. La tomografía confirma la obstrucción, la dilatación del sistema pielocalicial y la presencia de un absceso.\n\nLa prioridad en este caso es manejar la sepsis y la obstrucción urinaria. La obstrucción urinaria impide el drenaje de la orina infectada, lo que perpetúa la infección y favorece la formación de abscesos. El absceso perinéfrico requiere drenaje.\n\nAnalicemos las opciones:\nA) Litotricia extracorpórea (LEC) es un tratamiento para la litiasis, pero no es adecuado en un contexto de infección activa y sepsis. Además, no aborda la obstrucción inmediata ni el absceso.\nB) La derivación urinaria urgente (catéter doble J o nefrostomía percutánea) es crucial para aliviar la obstrucción, permitir el drenaje de la orina infectada y facilitar la resolución de la infección y el absceso. El catéter doble J se coloca por vía cistoscópica, mientras que la nefrostomía percutánea se realiza a través de la piel directamente al riñón. Ambas opciones son válidas para la derivación urinaria. El drenaje del absceso también es necesario, pero la derivación urinaria es el paso inicial más importante para controlar la fuente de la infección y la sepsis.\nC) Los antibióticos de amplio espectro son necesarios, pero no son suficientes por sí solos. La nefrectomía (extirpación del riñón) es un tratamiento radical que se considera en casos muy graves o refractarios, pero no es la intervención inicial.\nD) El drenaje quirúrgico del absceso es necesario, pero sin aliviar la obstrucción urinaria, la infección persistirá. La derivación urinaria debe realizarse simultáneamente o antes.\nE) Ninguna de las anteriores no es correcta, ya que la opción B es la más adecuada.\n\nPor lo tanto, la intervención inicial más adecuada es la derivación urinaria urgente para aliviar la obstrucción y permitir el drenaje de la orina infectada, junto con el inicio de antibióticos de amplio espectro. El drenaje del absceso también es necesario, pero la derivación urinaria es el paso inicial prioritario para controlar la sepsis y la infección. La opción B incluye la derivación urinaria urgente.\n\nResumen interno: Paciente con pielonefritis complicada (obstrucción por litiasis, absceso perinéfrico) y signos de sepsis. Prioridad: desobstrucción urinaria y control de la infección.\nOpción A: Inadecuada (LEC no para infección activa).\nOpción B: Adecuada (Derivación urinaria urgente para desobstrucción).\nOpción C: Inadecuada (Nefrectomía no es inicial).\nOpción D: Inadecuada (Drenaje del absceso sin desobstrucción es insuficiente).\nOpción E: Incorrecta.\n\nLa opción más adecuada es la B, que aborda la obstrucción urinaria de forma urgente.<unused95>Respuesta final:B",
         "medgemma-27b-text-it"
        ],
        [
         "6",
         "Preescolar de 4 años, contacto de familiar con TB pulmonar acude a control presentando un resultado de PPD de 12 mm. \nAsintomático. Antecedentes: inmunizaciones completas. Examen físico normal. Rx de tórax sin hallazgos. ¿Cuál es el \ndiagnóstico?",
         "Reacción cruzada a BCG",
         "Infección por Mycobacterium tuberculosis",
         "Enfermedad por Mycobacterium tuberculosis",
         "Exposición a Mycobacterium tuberculosis",
         "B",
         "Ninguna de las anteriores",
         "Prueba A",
         "Year2025",
         "2025",
         "Preescolar de 4 años, contacto de familiar con TB pulmonar acude a control presentando un resultado de PPD de 12 mm. \nAsintomático. Antecedentes: inmunizaciones completas. Examen físico normal. Rx de tórax sin hallazgos. ¿Cuál es el \ndiagnóstico? A) Reacción cruzada a BCG B) Infección por Mycobacterium tuberculosis C) Enfermedad por Mycobacterium tuberculosis D) Exposición a Mycobacterium tuberculosis E) Ninguna de las anteriores",
         "<unused94>thought\n1.  **Analyze the Request:** The user wants me to act as an expert medical assistant trained in Peru and answer a multiple-choice medical question. I need to provide a step-by-step internal thought process, summarize the information, and then give *only* the final letter answer.\n\n2.  **Summarize the Case:**\n    *   Patient: 4-year-old preschooler.\n    *   Exposure: Contact with a family member with pulmonary TB.\n    *   Symptoms: Asymptomatic.\n    *   History: Complete immunizations (implies BCG vaccination, standard in Peru).\n    *   Physical Exam: Normal.\n    *   Chest X-ray (Rx Tórax): No findings.\n    *   PPD Test Result: 12 mm induration.\n\n3.  **Evaluate the PPD Result:**\n    *   A PPD (Purified Protein Derivative) test, also known as the Mantoux test, is used to screen for *Mycobacterium tuberculosis* infection.\n    *   Interpretation depends on risk factors.\n    *   In Peru (and many other countries), BCG vaccination is routine at birth. BCG can cause a false-positive PPD reaction, but typically the induration is smaller (usually <10 mm, though larger reactions can occur).\n    *   However, this child is a *contact* of a person with active pulmonary TB. This significantly increases the risk of infection.\n    *   Interpretation guidelines for PPD in contacts of active TB cases:\n        *   ≥ 5 mm is considered positive.\n        *   ≥ 10 mm is considered positive in individuals with risk factors (like BCG vaccination, recent immigration, IV drug use, etc.).\n        *   ≥ 15 mm is considered positive in individuals with no known risk factors.\n    *   This child has a PPD of 12 mm. Given the *contact* status, this is considered a positive result (≥ 5 mm).\n\n4.  **Analyze the Options:**\n    *   **A) Reacción cruzada a BCG:** While BCG can cause a positive PPD, a 12 mm reaction in a known contact of active TB is more likely due to actual infection than just a BCG reaction, especially since the child is 4 years old (BCG reaction tends to wane over time). Also, the primary concern here is the *exposure* to active TB.\n    *   **B) Infección por Mycobacterium tuberculosis:** A positive PPD indicates that the person's immune system has reacted to TB antigens. This means they have been infected with *M. tuberculosis*. This is also known as Latent TB Infection (LTBI) when the person is asymptomatic and has a normal chest X-ray. This fits the clinical picture perfectly: positive PPD, asymptomatic, normal CXR, known contact.\n    *   **C) Enfermedad por Mycobacterium tuberculosis:** This refers to active TB disease. The child is asymptomatic and has a normal chest X-ray, ruling out active pulmonary disease.\n    *   **D) Exposición a Mycobacterium tuberculosis:** Exposure means the person has been in contact with someone with active TB. While the child *has* been exposed (stated in the case), the positive PPD indicates more than just exposure; it indicates the immune system has responded, meaning *infection* has occurred. Exposure itself doesn't cause a positive PPD.\n    *   **E) Ninguna de las anteriores:** Option B seems to fit well.\n\n5.  **Synthesize and Conclude:** The child is a known contact of active TB. The PPD test is positive (12 mm is significant in a contact). The child is asymptomatic and has a normal chest X-ray. This clinical picture is characteristic of Latent Tuberculosis Infection (LTBI), which falls under the broader category of \"Infección por Mycobacterium tuberculosis\". Option B is the most accurate diagnosis based on the provided information.\n\n6.  **Final Answer Format:** The user requested only the letter of the correct answer.<unused95>Respuesta final:B",
         "medgemma-27b-text-it"
        ],
        [
         "7",
         "Varón de 64 años con diagnóstico de enfermedad pulmonar obstructiva crónica, ingresa a emergencia por \ndescompensación. Examen: FR: 32X'. Laboratorio: pH: 7.24, PaCO2: 62 mmHg, PaO2: 55 mmHg. ¿Qué tipo de receptores \nson los más sensibles a los cambios de CO2?",
         "Quimiorreceptores centrales bulbo raquídeo",
         "Receptores J (yuxtacapilares)",
         "Receptores de estiramiento pulmonar",
         "Quimiorreceptores periféricos en los cuerpos carotídeos y aórticos",
         "A",
         "Ninguna de las anteriores",
         "Prueba A",
         "Year2025",
         "2025",
         "Varón de 64 años con diagnóstico de enfermedad pulmonar obstructiva crónica, ingresa a emergencia por \ndescompensación. Examen: FR: 32X'. Laboratorio: pH: 7.24, PaCO2: 62 mmHg, PaO2: 55 mmHg. ¿Qué tipo de receptores \nson los más sensibles a los cambios de CO2? A) Quimiorreceptores centrales bulbo raquídeo B) Receptores J (yuxtacapilares) C) Receptores de estiramiento pulmonar D) Quimiorreceptores periféricos en los cuerpos carotídeos y aórticos E) Ninguna de las anteriores",
         "<unused94>thought\n1.  **Analyze the Request:** The user wants me to act as an expert medical assistant trained in Peru and answer a multiple-choice medical question. I need to provide a step-by-step internal thought process, summarize the information, and then output *only* the final letter answer.\n\n2.  **Summarize the Case:**\n    *   Patient: 64-year-old male.\n    *   History: COPD.\n    *   Presentation: Emergency department for exacerbation/decompensation.\n    *   Vitals: Respiratory Rate (FR) = 32 breaths/minute (tachypnea).\n    *   Labs (Arterial Blood Gas - ABG):\n        *   pH = 7.24 (acidemia).\n        *   PaCO2 = 62 mmHg (hypercapnia - elevated CO2).\n        *   PaO2 = 55 mmHg (hypoxemia - low O2).\n    *   Question: Which receptors are *most sensitive* to changes in CO2?\n\n3.  **Analyze the Options:**\n    *   A) Quimiorreceptores centrales bulbo raquídeo (Central chemoreceptors in the medulla oblongata): These are located in the brainstem and are highly sensitive to changes in the pH of the cerebrospinal fluid (CSF). CO2 readily crosses the blood-brain barrier, dissolves in the CSF, forms carbonic acid (H2CO3), which dissociates into H+ and HCO3-. The increase in H+ concentration (decrease in pH) in the CSF directly stimulates these receptors. Therefore, they are very sensitive to changes in PaCO2.\n    *   B) Receptores J (yuxtacapilares) (J receptors - juxtacapillary): Located in the alveolar walls near capillaries. They are stimulated by pulmonary congestion, edema, and certain chemicals (like capsaicin). They contribute to rapid, shallow breathing (tachypnea) and bradycardia, often associated with heart failure or pulmonary embolism. They are not primarily sensitive to CO2 changes.\n    *   C) Receptores de estiramiento pulmonar (Pulmonary stretch receptors): Located in the smooth muscle of the airways. They are stimulated by lung inflation and inhibit inspiration (Hering-Breuer reflex). They are sensitive to lung volume, not directly to CO2.\n    *   D) Quimiorreceptores periféricos en los cuerpos carotídeos y aórticos (Peripheral chemoreceptors in carotid and aortic bodies): Located in the carotid bodies (at the bifurcation of the common carotid arteries) and aortic bodies. They are primarily sensitive to *decreases* in PaO2 (hypoxemia) and *increases* in PaCO2 (hypercapnia) and H+ concentration (acidemia). While they *do* respond to CO2, the central chemoreceptors are considered *more* sensitive to changes in PaCO2 because CO2 directly influences the pH of the CSF they monitor.\n    *   E) Ninguna de las anteriores (None of the above).\n\n4.  **Evaluate Sensitivity to CO2:**\n    *   Central chemoreceptors respond *indirectly* to CO2 via changes in CSF pH. They are the primary drivers of ventilation changes in response to hypercapnia.\n    *   Peripheral chemoreceptors respond *directly* to CO2 (and H+), but their response to CO2 is less significant than the central chemoreceptors' response. Their primary role is detecting hypoxemia.\n    *   J receptors and stretch receptors are not primarily sensitive to CO2.\n\n5.  **Determine the *Most* Sensitive:** The question asks for the *most* sensitive receptors to changes in CO2. The central chemoreceptors, due to their direct monitoring of CSF pH changes caused by CO2 diffusion, are considered the most sensitive regulators of ventilation in response to alterations in PaCO2.\n\n6.  **Relate to the Case:** The patient has COPD exacerbation with hypercapnia (PaCO2 = 62 mmHg) and respiratory acidosis (pH = 7.24). This clinical picture highlights the importance of chemoreceptor function in regulating breathing. The central chemoreceptors would be strongly stimulated by the increased CO2 leading to decreased CSF pH.\n\n7.  **Select the Best Answer:** Based on the physiological understanding, the central chemoreceptors (A) are the most sensitive to changes in CO2.\n\n8.  **Format the Output:** Provide only the final letter answer as requested.<unused95>Respuesta final:A",
         "medgemma-27b-text-it"
        ],
        [
         "8",
         "Varón de 38 años, gasfitero, presenta fiebre, escalofríos, cefalea frontal intensa, náusea, vómitos, dolor abdominal \ninespecífico, congestión conjuntival, mialgia intensa y fotofobia. Examen: febril, ictérico, PA: 105/75 mmHg, FC: 68 X', \ncongestión conjuntival y faríngea, sensibilidad muscular, adenomegalia cervical, meningismo y hepatoesplenomegalia. \nCrepitantes en hemitórax derecho. ¿Cuál es el tratamiento indicado?",
         "Gentamicina",
         "Sulfametoxazol",
         "Penicilina",
         "Metronidazol",
         "C",
         "Ninguna de las anteriores",
         "Prueba A",
         "Year2025",
         "2025",
         "Varón de 38 años, gasfitero, presenta fiebre, escalofríos, cefalea frontal intensa, náusea, vómitos, dolor abdominal \ninespecífico, congestión conjuntival, mialgia intensa y fotofobia. Examen: febril, ictérico, PA: 105/75 mmHg, FC: 68 X', \ncongestión conjuntival y faríngea, sensibilidad muscular, adenomegalia cervical, meningismo y hepatoesplenomegalia. \nCrepitantes en hemitórax derecho. ¿Cuál es el tratamiento indicado? A) Gentamicina B) Sulfametoxazol C) Penicilina D) Metronidazol E) Ninguna de las anteriores",
         "<unused94>thought\n1.  **Analyze the Request:** The user wants me to act as an expert medical assistant trained in Peru and answer a multiple-choice medical question. I need to provide a step-by-step internal thought process, summarize the information, and then give *only* the final letter answer.\n\n2.  **Summarize the Case:**\n    *   **Patient:** 38-year-old male, plumber (occupation relevant for exposure).\n    *   **Symptoms:** Fever, chills, severe frontal headache, nausea, vomiting, non-specific abdominal pain, conjunctival congestion, severe myalgia, photophobia.\n    *   **Signs:** Febrile, icteric (jaundice), BP 105/75 mmHg, HR 68 bpm (bradycardia relative to fever?), conjunctival and pharyngeal congestion, muscle tenderness, cervical lymphadenopathy, meningismus (signs of meningeal irritation), hepatosplenomegaly, crackles (crepitantes) in the right hemithorax.\n\n3.  **Differential Diagnosis (based on symptoms and signs):**\n    *   **Leptospirosis:** This fits *very* well. Occupation (plumber - exposure to contaminated water/soil), fever, chills, headache, myalgia (especially calf muscles, though not specified here, severe myalgia is present), conjunctival suffusion (congestion without exudate), jaundice (icteric), abdominal pain, nausea/vomiting, hepatosplenomegaly, meningismus (aseptic meningitis), pulmonary involvement (crackles suggest pulmonary hemorrhage or ARDS - Weil's disease is severe leptospirosis with jaundice and renal failure, but pulmonary involvement can occur). Bradycardia relative to fever can also be seen.\n    *   **Dengue:** Fever, headache, myalgia, rash (not mentioned), conjunctival injection. Jaundice and meningismus are less typical. Hepatosplenomegaly can occur. Pulmonary involvement is rare.\n    *   **Hantavirus:** Fever, myalgia, headache, thrombocytopenia (not mentioned), renal failure (not mentioned), pulmonary syndrome (crackles could fit, but other symptoms less typical).\n    *   **Typhoid Fever (Salmonella Typhi):** Fever, headache, abdominal pain, relative bradycardia, hepatosplenomegaly, sometimes rose spots (not mentioned). Jaundice and severe myalgia/conjunctival suffusion are less common.\n    *   **Viral Hepatitis (A, B, C, E):** Jaundice, fever, abdominal pain, hepatomegaly. Severe myalgia, conjunctival suffusion, meningismus, and pulmonary findings are not typical.\n    *   **Meningitis (Bacterial/Viral):** Headache, fever, meningismus. Jaundice, hepatosplenomegaly, severe myalgia, conjunctival suffusion, and pulmonary findings are less typical for primary meningitis.\n    *   **Malaria:** Fever, chills, headache, myalgia. Jaundice, hepatosplenomegaly can occur. Meningismus and pulmonary findings are less common.\n\n4.  **Evaluate the Best Fit:** Leptospirosis is the strongest diagnosis given the combination of occupational exposure (plumber), fever, severe myalgia, conjunctival suffusion, jaundice, meningismus, and pulmonary findings (crackles). This presentation is highly suggestive of Weil's disease (severe leptospirosis).\n\n5.  **Determine Treatment for Leptospirosis:**\n    *   Mild Leptospirosis: Often treated with doxycycline or amoxicillin.\n    *   Severe Leptospirosis (Weil's disease): Intravenous antibiotics are indicated. Penicillin G is the traditional drug of choice. Ceftriaxone or cefotaxime are also effective alternatives. Doxycycline can also be used intravenously.\n\n6.  **Evaluate the Options:**\n    *   A) Gentamicina: An aminoglycoside, used for gram-negative infections, but not the first-line treatment for leptospirosis.\n    *   B) Sulfametoxazol: A sulfonamide, used for various infections (UTIs, PCP), but not standard for leptospirosis.\n    *   C) Penicilina: Penicillin G is a standard treatment for severe leptospirosis.\n    *   D) Metronidazol: Used for anaerobic infections and protozoal infections (like Giardia, Trichomonas, Amebiasis), not leptospirosis.\n    *   E) Ninguna de las anteriores: Incorrect, as Penicillin is a valid treatment.\n\n7.  **Select the Best Answer:** Based on the likely diagnosis of severe leptospirosis (Weil's disease) and standard treatment guidelines, Penicillin is the most appropriate choice among the options provided.\n\n8.  **Format the Final Answer:** Provide only the letter corresponding to the chosen answer.<unused95>Respuesta final:C",
         "medgemma-27b-text-it"
        ],
        [
         "9",
         "Varón de 46 años, hace una hora sufre impacto de proyectil de arma de fuego en abdomen. Examen: PA: 60/40 mmHg, \nFC: 100X'. Pálido. Tórax: MV normal. Cardiovascular: RC disminuidos de intensidad. Abdomen: distendido, orificio en \nmesogastrio, RHA disminuidos, signo de rebote (+). ¿Cuál es la indicación inmediata?",
         "Laparatomía exploratoria",
         "Laparoscopía diagnóstica",
         "Exploración de la herida",
         "FAST",
         "A",
         "Ninguna de las anteriores",
         "Prueba A",
         "Year2025",
         "2025",
         "Varón de 46 años, hace una hora sufre impacto de proyectil de arma de fuego en abdomen. Examen: PA: 60/40 mmHg, \nFC: 100X'. Pálido. Tórax: MV normal. Cardiovascular: RC disminuidos de intensidad. Abdomen: distendido, orificio en \nmesogastrio, RHA disminuidos, signo de rebote (+). ¿Cuál es la indicación inmediata? A) Laparatomía exploratoria B) Laparoscopía diagnóstica C) Exploración de la herida D) FAST E) Ninguna de las anteriores",
         "<unused94>thought\n1.  **Analyze the Request:** The user wants me to act as an expert medical assistant trained in Peru and answer a multiple-choice medical question. I need to provide a step-by-step internal thought process, summarize the information, and then give *only* the final letter answer.\n\n2.  **Summarize the Case:**\n    *   Patient: 46-year-old male.\n    *   Event: Gunshot wound (GSW) to the abdomen 1 hour ago.\n    *   Vitals: Hypotensive (BP 60/40 mmHg), Tachycardic (HR 100 bpm).\n    *   Physical Exam: Pale, normal breath sounds (MV), diminished heart sounds (RC), distended abdomen, entry wound in mesogastrium, decreased bowel sounds (RHA), positive rebound tenderness (signo de rebote).\n\n3.  **Interpret the Findings:**\n    *   GSW to the abdomen is a penetrating trauma.\n    *   Hypotension (BP 60/40) and tachycardia (HR 100) indicate significant hemodynamic instability, likely due to hemorrhage (shock).\n    *   Pallor supports shock/blood loss.\n    *   Abdominal distension, decreased RHA, and positive rebound tenderness strongly suggest peritonitis, likely from intra-abdominal injury (e.g., bowel perforation, solid organ injury with bleeding).\n    *   The entry wound in the mesogastrium confirms the location of the penetrating injury.\n\n4.  **Evaluate the Options:**\n    *   **A) Laparatomía exploratoria (Exploratory Laparotomy):** This is a major surgical procedure to directly visualize and repair intra-abdominal injuries. Given the penetrating trauma, hemodynamic instability (shock), and signs of peritonitis, this is the standard of care for suspected significant intra-abdominal injury.\n    *   **B) Laparoscopía diagnóstica (Diagnostic Laparoscopy):** While useful in some stable trauma cases, it's generally contraindicated in hemodynamically unstable patients with penetrating abdominal trauma due to the risk of worsening shock, potential for inadequate visualization in a bloody field, and the time required.\n    *   **C) Exploración de la herida (Wound Exploration):** This is typically done for superficial wounds or to determine the depth of a penetrating injury, but it doesn't address the potential *intra-abdominal* damage causing the shock and peritonitis. It's insufficient in this scenario.\n    *   **D) FAST (Focused Assessment with Sonography for Trauma):** FAST is a rapid bedside ultrasound to detect free fluid (usually blood) in the peritoneal cavity, pericardium, or pleural space. While often used in trauma, in a patient with a penetrating abdominal GSW, clear signs of peritonitis, and hemodynamic instability, the need for surgical intervention is already strongly indicated. FAST might confirm hemoperitoneum but wouldn't change the immediate management, which is surgery. Delaying surgery for FAST in this unstable patient with peritonitis is not appropriate.\n    *   **E) Ninguna de las anteriores (None of the above):** Option A is clearly indicated.\n\n5.  **Determine the Best Course of Action:** The patient presents with a penetrating abdominal injury, hemodynamic instability (shock), and signs of peritonitis. This is a surgical emergency requiring immediate exploration to control bleeding and repair injuries. Exploratory laparotomy is the definitive management in this situation.\n\n6.  **Select the Final Answer:** Based on the analysis, Laparatomía exploratoria (A) is the most appropriate immediate indication.\n\n7.  **Format the Output:** Provide only the final letter as requested.<unused95>Respuesta final:A",
         "medgemma-27b-text-it"
        ],
        [
         "10",
         "Varón de 45 años, obeso y con diabetes mellitus no controlada, acude al servicio de urgencias por una gangrena de \nFournier. Examen: PA: 120/60 mmHg, FC: 86X', FR: 24X'. Región anorectal: celulitis con edema y necrosis marcada con \nafectación del esfínter anal externo. ¿Qué tipo de colostomía es la más indicada?",
         "En caño de escopeta",
         "Bocas separadas por piel",
         "En asa derecha",
         "En asa izquierda",
         "D",
         "Ninguna de las anteriores",
         "Prueba A",
         "Year2025",
         "2025",
         "Varón de 45 años, obeso y con diabetes mellitus no controlada, acude al servicio de urgencias por una gangrena de \nFournier. Examen: PA: 120/60 mmHg, FC: 86X', FR: 24X'. Región anorectal: celulitis con edema y necrosis marcada con \nafectación del esfínter anal externo. ¿Qué tipo de colostomía es la más indicada? A) En caño de escopeta B) Bocas separadas por piel C) En asa derecha D) En asa izquierda E) Ninguna de las anteriores",
         "<unused94>thought\n1.  **Analyze the Request:** The user wants me to act as an expert medical assistant trained in Peru and answer a multiple-choice medical question. I need to provide a step-by-step internal thought process (which I won't show in the final output) and then output *only* the letter of the correct answer.\n\n2.  **Summarize the Case:**\n    *   Patient: 45-year-old male.\n    *   Comorbidities: Obesity, uncontrolled diabetes mellitus.\n    *   Presenting Complaint: Fournier's gangrene.\n    *   Vitals: BP 120/60 mmHg, HR 86 bpm, RR 24 breaths/min.\n    *   Physical Exam: Anorectal region shows cellulitis, edema, marked necrosis, and involvement of the external anal sphincter.\n    *   Question: What type of colostomy is most indicated?\n\n3.  **Understand Fournier's Gangrene:** Fournier's gangrene is a necrotizing fasciitis of the perineal, genital, or perianal regions. It's a surgical emergency requiring aggressive debridement and often diversion of fecal and urinary streams to prevent contamination of the wound.\n\n4.  **Understand Colostomy Types:**\n    *   **A) En caño de escopeta (End-to-end/Loop colostomy):** This is typically a loop colostomy, often in the sigmoid or descending colon. It's usually temporary.\n    *   **B) Bocas separadas por piel (Split stoma/Two separate stomas):** This involves creating two separate stomas, often from the sigmoid colon, to divert feces. This is sometimes used for fecal diversion, especially when a single stoma might be difficult or prone to complications.\n    *   **C) En asa derecha (Right loop colostomy):** A loop colostomy created from the ascending colon.\n    *   **D) En asa izquierda (Left loop colostomy):** A loop colostomy created from the descending or sigmoid colon. This is the most common type of temporary colostomy for fecal diversion.\n    *   **E) Ninguna de las anteriores (None of the above):** Implies none of the listed options are appropriate.\n\n5.  **Relate Colostomy to Fournier's Gangrene:** In Fournier's gangrene involving the anorectal region, the primary goal of a colostomy is to divert feces *away* from the infected and necrotic area to allow healing and prevent further contamination. The colostomy should be placed proximal to the affected area.\n\n6.  **Evaluate the Options in Context:**\n    *   The patient has anorectal involvement. A colostomy diverts feces from the rectum and anus.\n    *   The location of the colostomy depends on the extent of the disease and the surgeon's preference, but it needs to be proximal to the perineal wound.\n    *   A loop colostomy (asa) is a common and relatively straightforward method for temporary fecal diversion.\n    *   Options C (right loop) and D (left loop) are both types of loop colostomies.\n    *   Option A (\"en caño de escopeta\") is often used synonymously with loop colostomy in some contexts, but \"asa\" (loop) is more specific.\n    *   Option B (\"bocas separadas por piel\") is less common for standard fecal diversion in this acute setting.\n    *   Given the need for temporary diversion in an emergency setting like Fournier's gangrene, a loop colostomy is the standard approach. Both left and right loop colostomies are possible, but a left-sided loop colostomy (sigmoid or descending colon) is generally preferred because it's technically easier to perform and manage, and the effluent is more formed than from a right-sided one. However, the question asks for the *most indicated* type among the choices. A loop colostomy is definitely indicated.\n\n7.  **Refine the Choice:** The question asks for the *most indicated* type. A loop colostomy is the standard procedure for fecal diversion in Fournier's gangrene involving the perineum. Both \"En asa derecha\" and \"En asa izquierda\" describe loop colostomies. \"En caño de escopeta\" can also refer to a loop colostomy. In Peru, \"colostomía en asa\" (loop colostomy) is the standard term. Both left and right are possible, but left-sided is often preferred. However, the options provided are specific types. A loop colostomy is the general category. Option A (\"En caño de escopeta\") is sometimes used for loop colostomy, but \"asa\" is more precise. Option D (\"En asa izquierda\") is a specific type of loop colostomy commonly used for this purpose. Option C (\"En asa derecha\") is also a loop colostomy but less commonly used for temporary diversion due to more liquid stool. Option B is less standard for this acute situation.\n\n8.  **Consider Peruvian Context:** In Peru, the standard temporary fecal diversion for Fournier's gangrene involving the anorectal area is typically a loop colostomy (colostomía en asa). The left side (sigmoid or descending colon) is often preferred. Therefore, \"En asa izquierda\" (D) represents the most common and often preferred type of loop colostomy for this indication.\n\n9.  **Final Decision:** A loop colostomy is the standard procedure. \"En asa izquierda\" is a specific type of loop colostomy commonly used for this purpose.\n\n10. **Format the Output:** Provide only the letter of the chosen answer.<unused95>Respuesta final:D",
         "medgemma-27b-text-it"
        ],
        [
         "11",
         "Varón de 74 años con EPOC moderado (FEV1 50%), acude por disnea marcada, tos con esputo mucoso y tendencia a \nla somnolencia. Examen: PA: 110/70 mmHg, FC: 92X', FR: 28X'; SatO2: 87%, FiO2: 21%; pulmones: tirajes, roncantes \nbibasales; neurológico: somnoliento y por momentos agitado. Laboratorio: pH: 7.29, PCO2: 55 mmHg, PO2: 62 mmHg. \n¿Cuál es el hallazgo más importante para manejo intrahospitalario?",
         "Acidosis respiratoria",
         "Neumonía atípica",
         "Delirio hiperactivo",
         "Insuficiencia cardíaca",
         "A",
         "Ninguna de las anteriores",
         "Prueba A",
         "Year2025",
         "2025",
         "Varón de 74 años con EPOC moderado (FEV1 50%), acude por disnea marcada, tos con esputo mucoso y tendencia a \nla somnolencia. Examen: PA: 110/70 mmHg, FC: 92X', FR: 28X'; SatO2: 87%, FiO2: 21%; pulmones: tirajes, roncantes \nbibasales; neurológico: somnoliento y por momentos agitado. Laboratorio: pH: 7.29, PCO2: 55 mmHg, PO2: 62 mmHg. \n¿Cuál es el hallazgo más importante para manejo intrahospitalario? A) Acidosis respiratoria B) Neumonía atípica C) Delirio hiperactivo D) Insuficiencia cardíaca E) Ninguna de las anteriores",
         "<unused94>thought\n1.  **Analyze the Request:** The user wants me to act as an expert medical assistant trained in Peru, answer a multiple-choice medical question, and provide only the final letter answer. I need to internally reason through the problem step-by-step but not show the reasoning in the final output.\n\n2.  **Summarize the Case:**\n    *   Patient: 74-year-old male.\n    *   History: Moderate COPD (FEV1 50%).\n    *   Presenting Symptoms: Marked dyspnea, cough with mucous sputum, somnolence.\n    *   Vitals: BP 110/70, HR 92, RR 28, SpO2 87% on room air (FiO2 21%).\n    *   Physical Exam: Respiratory distress (tirajes - retractions), bibasilar rales (roncantes), altered mental status (somnolent, agitated).\n    *   Labs (ABG): pH 7.29 (acidosis), PCO2 55 mmHg (hypercapnia), PO2 62 mmHg (hypoxemia).\n\n3.  **Evaluate the Options:**\n    *   **A) Acidosis respiratoria:** The ABG shows pH < 7.35 (7.29) and PCO2 > 45 mmHg (55 mmHg). This is a classic definition of respiratory acidosis. The patient's clinical presentation (COPD exacerbation, respiratory distress, altered mental status) is consistent with acute respiratory failure leading to respiratory acidosis. This is a critical finding requiring immediate management (e.g., non-invasive ventilation, intubation).\n    *   **B) Neumonía atípica:** While possible in a COPD exacerbation, the presentation (mucous sputum, bibasilar rales) isn't specific for atypical pneumonia. The most striking and immediately life-threatening finding is the severe respiratory acidosis. Pneumonia would be a *potential* cause or complication, but the acidosis itself is the most critical *hallazgo* (finding) for immediate management.\n    *   **C) Delirio hiperactivo:** The patient is somnolent and agitated, which *could* be part of delirium. However, this altered mental status is very likely secondary to the severe hypoxemia and hypercapnia (respiratory acidosis). Addressing the underlying respiratory failure is the priority. Delirium is a consequence, not the primary critical finding driving immediate management in this context.\n    *   **D) Insuficiencia cardíaca:** While COPD patients can have comorbid heart failure, the presentation (mucous sputum, bibasilar rales which could be crackles but described as roncantes, no mention of JVD, edema, or S3 gallop) doesn't strongly point to acute decompensated heart failure as the *primary* issue. The ABG findings are much more indicative of severe respiratory failure.\n    *   **E) Ninguna de las anteriores:** Option A is a very significant and critical finding.\n\n4.  **Determine the Most Important Finding for In-hospital Management:** The patient is in acute respiratory failure with severe respiratory acidosis (pH 7.29, PCO2 55) and hypoxemia (PO2 62, SpO2 87%). This is a life-threatening condition requiring immediate intervention to improve ventilation and oxygenation. The respiratory acidosis is the most direct and critical laboratory finding reflecting the severity of the respiratory failure and guiding immediate management decisions (like initiating NIV or intubation).\n\n5.  **Select the Final Answer:** Based on the analysis, the most important finding for immediate in-hospital management is the respiratory acidosis.\n\n6.  **Format the Output:** Provide only the letter corresponding to the chosen answer.<unused95>Respuesta final:A",
         "medgemma-27b-text-it"
        ],
        [
         "12",
         "Varón de 25 años post laparotomía por apendicitis complicada y peritonitis generalizada; al cuarto día posoperatorio \npresenta distensión abdominal, náusea y vómitos. Examen: abdomen distendido y doloroso, RHA: ausentes, SNG: 1000 \nml de líquido verdoso. Electrolitos normales. ¿Cuál es el diagnóstico más probable?",
         "Perforación intestinal",
         "Obstrucción por bridas",
         "Íleo paralítico",
         "Síndrome de Ogilvie",
         "C",
         "Ninguna de las anteriores",
         "Prueba A",
         "Year2025",
         "2025",
         "Varón de 25 años post laparotomía por apendicitis complicada y peritonitis generalizada; al cuarto día posoperatorio \npresenta distensión abdominal, náusea y vómitos. Examen: abdomen distendido y doloroso, RHA: ausentes, SNG: 1000 \nml de líquido verdoso. Electrolitos normales. ¿Cuál es el diagnóstico más probable? A) Perforación intestinal B) Obstrucción por bridas C) Íleo paralítico D) Síndrome de Ogilvie E) Ninguna de las anteriores",
         "<unused94>thought\n1.  **Analyze the Request:** The user wants me to act as an expert medical assistant trained in Peru and answer a multiple-choice medical question. I need to provide a step-by-step internal thought process, summarize the information, and then give *only* the final letter answer.\n\n2.  **Summarize the Case:**\n    *   Patient: 25-year-old male.\n    *   History: Laparotomy for complicated appendicitis and generalized peritonitis 4 days ago.\n    *   Current Symptoms: Abdominal distension, nausea, vomiting (4th postoperative day).\n    *   Physical Exam: Distended, painful abdomen; absent bowel sounds (RHA ausentes).\n    *   Intervention: Nasogastric tube (SNG) drained 1000 ml of greenish fluid.\n    *   Labs: Normal electrolytes.\n\n3.  **Evaluate the Options:**\n    *   **A) Perforación intestinal (Intestinal Perforation):** While possible post-surgery, it usually presents with signs of peritonitis (rigidity, rebound tenderness) and potentially free air on imaging. The description focuses more on distension and absent bowel sounds, and the fluid is greenish (bilious/gastric content), not necessarily feculent or purulent. Less likely given the specific presentation.\n    *   **B) Obstrucción por bridas (Adhesive Bowel Obstruction):** This is a common cause of bowel obstruction after abdominal surgery. It typically presents with abdominal pain, distension, nausea, vomiting, and constipation/obstipation. Absent bowel sounds can occur. The greenish fluid from the SNG suggests proximal obstruction (stomach/duodenum) or reflux. This fits the clinical picture well, especially given the recent surgery.\n    *   **C) Íleo paralítico (Paralytic Ileus):** This is a functional obstruction where bowel motility ceases, often after surgery or due to inflammation/electrolyte imbalance. It presents with abdominal distension, nausea, vomiting, and absent bowel sounds. Electrolytes are normal here, which makes *pure* paralytic ileus slightly less likely as a primary cause, although it can occur post-op. However, the significant amount of fluid drained via SNG points more towards a mechanical obstruction. Paralytic ileus often involves the entire bowel, leading to distension throughout.\n    *   **D) Síndrome de Ogilvie (Acute Colonic Pseudo-obstruction):** This involves massive colonic dilation without mechanical obstruction, typically in severely ill or hospitalized patients. While the patient is post-op, Ogilvie's usually affects the colon primarily, and the symptoms described (especially the greenish SNG output) are more suggestive of a small bowel issue.\n    *   **E) Ninguna de las anteriores (None of the above):** Given that options B and C are strong possibilities, this is less likely.\n\n4.  **Compare B and C:**\n    *   **Adhesive Obstruction (B):** Common post-op complication. Symptoms match well (distension, N/V, absent RHA). Greenish SNG fluid is consistent with proximal obstruction or reflux.\n    *   **Paralytic Ileus (C):** Also common post-op. Symptoms match (distension, N/V, absent RHA). Normal electrolytes make it slightly less typical but still possible. However, the large volume of SNG drainage often points more towards a mechanical blockage where fluid accumulates proximal to the obstruction.\n\n5.  **Refine the Diagnosis:** The patient had a major abdominal surgery (laparotomy for complicated appendicitis/peritonitis) 4 days ago. This is a classic timeframe for the development of adhesive bowel obstruction. The symptoms (distension, N/V, absent RHA) and the large volume of greenish SNG drainage strongly suggest a mechanical obstruction, most likely due to adhesions. While paralytic ileus is also possible post-op, the significant SNG output favors a mechanical cause like adhesions.\n\n6.  **Select the Best Answer:** Based on the recent major abdominal surgery and the clinical presentation (distension, N/V, absent RHA, large volume greenish SNG output), adhesive bowel obstruction (Obstrucción por bridas) is the most probable diagnosis.\n\n7.  **Format the Final Answer:** Provide only the letter corresponding to the chosen answer.<unused95>Respuesta final:B",
         "medgemma-27b-text-it"
        ],
        [
         "13",
         "Según la norma técnica peruana para el manejo de la anemia en lactantes; si la suspensión del suplemento de hierro es \nmayor a 3 meses, debe...",
         "continuar el tratamiento hasta los dos años.",
         "continuar el tratamiento por 6 meses.",
         "reiniciar la indicación hasta completar el esquema previamente indicado.",
         "iniciar un nuevo esquema, previa evaluación de hemoglobina.",
         "D",
         "Ninguna de las anteriores",
         "Prueba A",
         "Year2025",
         "2025",
         "Según la norma técnica peruana para el manejo de la anemia en lactantes; si la suspensión del suplemento de hierro es \nmayor a 3 meses, debe... A) continuar el tratamiento hasta los dos años. B) continuar el tratamiento por 6 meses. C) reiniciar la indicación hasta completar el esquema previamente indicado. D) iniciar un nuevo esquema, previa evaluación de hemoglobina. E) Ninguna de las anteriores",
         "<unused94>thought\n1.  **Identify the core question:** The question asks about the protocol for managing anemia in infants in Peru according to the national technical standard, specifically when iron supplementation is interrupted for more than 3 months.\n\n2.  **Recall/Access knowledge about Peruvian anemia guidelines:** Access information regarding the Peruvian Ministry of Health (MINSA) guidelines for the prevention and treatment of iron deficiency anemia in children under 5 years old. Key aspects include:\n    *   Universal iron supplementation for infants starting at 6 months.\n    *   Dosage based on age.\n    *   Duration of supplementation (typically until 2 years).\n    *   Management of interruptions in supplementation.\n\n3.  **Analyze the specific scenario:** The scenario involves an interruption of iron supplementation for *more than 3 months*.\n\n4.  **Evaluate the options based on the guidelines:**\n    *   **A) continuar el tratamiento hasta los dos años:** This is the standard duration *if* supplementation is continuous. It doesn't specifically address the interruption.\n    *   **B) continuar el tratamiento por 6 meses:** This is a fixed duration, not necessarily aligned with the standard protocol after an interruption.\n    *   **C) reiniciar la indicación hasta completar el esquema previamente indicado:** This option suggests resuming the original schedule as if the interruption didn't happen. This is a plausible approach to ensure the total duration of supplementation is met.\n    *   **D) iniciar un nuevo esquema, previa evaluación de hemoglobina:** This implies starting over, possibly with a different dose or duration, and requires a hemoglobin check. While evaluation is always important, starting a *new* scheme isn't the standard procedure for a simple interruption. The guidelines usually focus on resuming the original plan.\n    *   **E) Ninguna de las anteriores:** This is possible if none of the other options match the guidelines.\n\n5.  **Consult specific Peruvian guidelines (if necessary/possible):** Search for \"Norma Técnica para el Manejo de la Anemia en Lactantes Perú\" or similar terms. The relevant guideline (often updated, e.g., Resolución Ministerial RM N° 844-2016/MINSA or subsequent updates) typically states that if iron supplementation is interrupted for more than 3 months, the *original* supplementation schedule should be resumed to complete the recommended duration (usually until 2 years).\n\n6.  **Compare options with guideline information:** Option C aligns directly with the standard Peruvian protocol: if supplementation is stopped for >3 months, restart the original schedule to complete the full course.\n\n7.  **Select the best option:** Option C is the most accurate representation of the Peruvian technical standard for this specific situation.\n\n8.  **Format the final answer:** State only the letter of the correct option.<unused95>Respuesta final:C",
         "medgemma-27b-text-it"
        ],
        [
         "14",
         "Varón de 80 años, hace 2 semanas presenta cefalea, náusea, vómito y luego se agrega somnolencia y convulsiones. \nTomografía cerebral signos de atrofia cortical. Punción lumbar: leucocitos 200/µL, hipoglucorraquia y presencia de \nbacilos gram positivos. ¿Cuál es el tratamiento de elección?",
         "Oxacilina",
         "Ceftriaxona",
         "Ampicilina",
         "Aciclovir",
         "C",
         "Ninguna de las anteriores",
         "Prueba A",
         "Year2025",
         "2025",
         "Varón de 80 años, hace 2 semanas presenta cefalea, náusea, vómito y luego se agrega somnolencia y convulsiones. \nTomografía cerebral signos de atrofia cortical. Punción lumbar: leucocitos 200/µL, hipoglucorraquia y presencia de \nbacilos gram positivos. ¿Cuál es el tratamiento de elección? A) Oxacilina B) Ceftriaxona C) Ampicilina D) Aciclovir E) Ninguna de las anteriores",
         "<unused94>thought\n1.  **Analyze the Request:** The user wants me to act as an expert medical assistant trained in Peru and answer a multiple-choice medical question. I need to provide a step-by-step internal thought process, summarize the information, and then output *only* the final letter answer.\n\n2.  **Summarize the Clinical Information:**\n    *   Patient: 80-year-old male.\n    *   Symptoms: Headache, nausea, vomiting (2 weeks duration), followed by somnolence and seizures.\n    *   Imaging: Brain CT shows cortical atrophy (common in elderly, may or may not be related).\n    *   Lumbar Puncture (LP):\n        *   WBC: 200/µL (elevated, normal <5).\n        *   Glucose: Low (hypoglycorrhachia).\n        *   Gram Stain: Gram-positive bacilli.\n\n3.  **Interpret the Findings:**\n    *   The clinical presentation (headache, nausea, vomiting, altered mental status, seizures) suggests meningitis or encephalitis.\n    *   The LP results strongly point towards bacterial meningitis:\n        *   Elevated WBC count (pleocytosis).\n        *   Low glucose (bacteria consume glucose).\n        *   Gram-positive bacilli identified.\n\n4.  **Identify the Likely Pathogen:** Gram-positive bacilli causing meningitis in an elderly patient are most commonly *Listeria monocytogenes*. Other possibilities exist, but *Listeria* is a prime suspect in this age group.\n\n5.  **Determine the Treatment of Choice for the Likely Pathogen:**\n    *   *Listeria monocytogenes* is intrinsically resistant to cephalosporins (like Ceftriaxone).\n    *   *Listeria* is typically susceptible to Ampicillin (often combined with Gentamicin for synergy, especially in severe cases or immunocompromised patients).\n    *   Oxacillin is primarily for *Staphylococcus aureus* (Gram-positive cocci).\n    *   Aciclovir is an antiviral, used for viral encephalitis (like HSV), not bacterial meningitis.\n\n6.  **Evaluate the Options:**\n    *   A) Oxacillin: Incorrect. Targets Staphylococci, not the likely Gram-positive bacilli (*Listeria*).\n    *   B) Ceftriaxona: Incorrect. Standard empiric treatment for many bacterial meningitis pathogens, but *Listeria* is resistant.\n    *   C) Ampicilina: Correct. Standard treatment for *Listeria monocytogenes*.\n    *   D) Aciclovir: Incorrect. Antiviral, not antibacterial.\n    *   E) Ninguna de las anteriores: Incorrect, as Ampicillin is the appropriate choice.\n\n7.  **Formulate the Final Answer:** Based on the analysis, Ampicillin is the treatment of choice for suspected *Listeria monocytogenes* meningitis, which fits the clinical picture and LP findings.\n\n8.  **Final Output Check:** Ensure the output format matches the request: \"Respuesta final:\" followed *only* by the letter.<unused95>Respuesta final:C",
         "medgemma-27b-text-it"
        ],
        [
         "15",
         "Mujer de 21 años, solicita información sobre screening para cáncer de cuello uterino; que no manifiesta sus antecedentes \nsexuales. ¿Cuál es la indicación?",
         "Observación",
         "Test de Cobas",
         "Prueba conjunta",
         "Citología cervical",
         "D",
         "Ninguna de las anteriores",
         "Prueba A",
         "Year2025",
         "2025",
         "Mujer de 21 años, solicita información sobre screening para cáncer de cuello uterino; que no manifiesta sus antecedentes \nsexuales. ¿Cuál es la indicación? A) Observación B) Test de Cobas C) Prueba conjunta D) Citología cervical E) Ninguna de las anteriores",
         "<unused94>thought\n1.  **Identify the core question:** The question asks for the appropriate screening recommendation for cervical cancer in a 21-year-old woman who is not providing her sexual history.\n\n2.  **Analyze the patient profile:**\n    *   Age: 21 years old.\n    *   Reason for visit: Seeking information about cervical cancer screening.\n    *   Key information missing: Sexual history (which is relevant for risk assessment but doesn't negate screening guidelines based on age).\n\n3.  **Recall/Research Peruvian cervical cancer screening guidelines:**\n    *   Peruvian guidelines (based on international standards like WHO, FIGO, and adapted locally) generally recommend starting cervical cancer screening (cytology or HPV testing) at age 25, or earlier if the patient is sexually active.\n    *   However, guidelines often have specific recommendations for the 21-24 age group.\n    *   In many guidelines, including those often followed in Peru, screening *can* start at age 21, but the preferred method and frequency might differ from older age groups.\n    *   Specifically, for ages 21-24, cytology (Pap smear) is often recommended every 3 years. HPV testing is generally recommended starting at age 25 (or 30 in some older guidelines) every 5 years, or co-testing (cytology + HPV) every 5 years starting at age 30.\n    *   The lack of sexual history doesn't change the age-based screening recommendations. Screening is recommended based on age, regardless of sexual activity, although sexual activity is a risk factor.\n\n4.  **Evaluate the options based on guidelines:**\n    *   A) Observación: Incorrect. Screening is recommended based on age.\n    *   B) Test de Cobas: This refers to HPV testing (often using the Cobas HPV test). While HPV testing is used for screening, it's typically recommended starting at age 25 or 30, not usually as the primary method at age 21 in many current guidelines.\n    *   C) Prueba conjunta: This refers to co-testing (cytology + HPV). This is generally recommended starting at age 30, not 21.\n    *   D) Citología cervical: This refers to the Pap smear. This is the standard recommendation for screening in the 21-24 age group in many guidelines, including those often followed in Peru (every 3 years).\n    *   E) Ninguna de las anteriores: Incorrect, as cytology is a valid option.\n\n5.  **Select the best option:** Based on standard screening guidelines for a 21-year-old woman, cytology (Pap smear) is the most appropriate initial screening test.\n\n6.  **Format the final answer:** State only the letter corresponding to the chosen option.<unused95>Respuesta final:D",
         "medgemma-27b-text-it"
        ],
        [
         "16",
         "Primigesta de 32 semanas por ecografía del primer trimestre; acude a control prenatal asintomática. Examen:  AU: 27 \ncm,  SPP: LCI, LCF: 142X´. Ecografía: gestación única activa con ponderado fetal en percentil 2 y doppler fetal normal. \n¿Cuál es el diagnóstico más probable?",
         "Error en la edad gestacional",
         "Restricción en el crecimiento intrauterino",
         "Crecimiento adecuado para la edad gestacional",
         "Pequeño para la edad gestacional",
         "B",
         "Ninguna de las anteriores",
         "Prueba A",
         "Year2025",
         "2025",
         "Primigesta de 32 semanas por ecografía del primer trimestre; acude a control prenatal asintomática. Examen:  AU: 27 \ncm,  SPP: LCI, LCF: 142X´. Ecografía: gestación única activa con ponderado fetal en percentil 2 y doppler fetal normal. \n¿Cuál es el diagnóstico más probable? A) Error en la edad gestacional B) Restricción en el crecimiento intrauterino C) Crecimiento adecuado para la edad gestacional D) Pequeño para la edad gestacional E) Ninguna de las anteriores",
         "<unused94>thought\n1.  **Analyze the Request:** The user wants me to act as an expert medical assistant trained in Peru and answer a multiple-choice medical question. I need to provide a step-by-step internal thought process, summarize the information, and then output *only* the final letter answer.\n\n2.  **Summarize the Information:**\n    *   Patient: Primigesta (first pregnancy).\n    *   Gestational Age (GA): 32 weeks by first-trimester ultrasound (considered the most accurate).\n    *   Presentation: Asymptomatic, routine prenatal control.\n    *   Physical Exam:\n        *   Abdominal Circumference (AU): 27 cm.\n        *   Fetal Heart Rate (FCF): 142 bpm (normal range).\n        *   Fetal Presentation (SPP): Longitudinal, Cephalic (LCI - likely means Longitudinal Cephalic Initial, or similar).\n    *   Ultrasound Findings:\n        *   Single, active pregnancy.\n        *   Fetal weight percentile: 2nd percentile.\n        *   Fetal Doppler: Normal.\n\n3.  **Evaluate the Options:**\n    *   **A) Error in the edad gestacional (Error in gestational age):** The GA is based on a first-trimester ultrasound, which is generally considered reliable. While discrepancies can occur, the ultrasound *also* shows a fetal weight percentile, suggesting the GA is likely correct for the *current* assessment. The discrepancy is in the *size* relative to the GA, not necessarily the GA itself.\n    *   **B) Restricción en el crecimiento intrauterino (Intrauterine Growth Restriction - IUGR):** IUGR is defined as a fetus whose estimated weight is below the 10th percentile for its gestational age. This patient's fetus is at the 2nd percentile. This fits the definition of IUGR.\n    *   **C) Crecimiento adecuado para la edad gestacional (Appropriate for Gestational Age - AGA):** AGA means the fetus is between the 10th and 90th percentiles. This patient's fetus is at the 2nd percentile, so it's not AGA.\n    *   **D) Pequeño para la edad gestacional (Small for Gestational Age - SGA):** SGA is often used interchangeably with IUGR, or sometimes defined as below the 10th percentile. Since the fetus is at the 2nd percentile, it is definitely SGA. IUGR implies a *pathological* process leading to the small size, while SGA is a descriptive term. However, in clinical practice, a fetus at the 2nd percentile is highly suggestive of IUGR, especially when identified at 32 weeks. Given the options, IUGR (B) is a more specific diagnosis describing the likely underlying condition causing the SGA state.\n    *   **E) Ninguna de las anteriores (None of the above):** Options B and D are plausible.\n\n4.  **Compare B and D:** Both IUGR and SGA describe the situation (fetus < 10th percentile). IUGR often implies a pathological cause or potential for adverse outcomes, while SGA is a descriptive term. A fetus at the 2nd percentile is significantly small and warrants further investigation for causes of IUGR. In the context of a medical diagnosis question, IUGR (B) is often considered the more clinically significant diagnosis when a fetus is this small, especially when Doppler is normal (suggesting it's not yet severe compromise but needs monitoring). The term \"Restricción\" (Restriction) implies a process limiting growth.\n\n5.  **Consider the AU:** An AU of 27 cm at 32 weeks is also small. Expected AU at 32 weeks is typically around 28-32 cm. 27 cm is below the expected range, further supporting the finding of a small fetus.\n\n6.  **Final Decision:** The fetus is at the 2nd percentile for weight, which is below the 10th percentile threshold. This defines the condition as either SGA or IUGR. IUGR is a more specific term often used when growth is pathologically restricted. Given the significant deviation (2nd percentile), IUGR is the most likely diagnosis among the choices provided.\n\n7.  **Format the Output:** Provide only the letter of the chosen answer.<unused95>Respuesta final:B",
         "medgemma-27b-text-it"
        ],
        [
         "17",
         "Mujer de 42 años, acude a emergencia por dolor torácico y palpitaciones luego de consumo de cocaína. Examen: PA: \n110/70 mmHg, FC: 135X', FR: 23X', T°: 36.5 °C, SatO2: 97%. ¿Cuál es el diagnóstico más probable?",
         "Taquicardia nodal",
         "Taquicardia supraventricular",
         "Taquicardia sinusal",
         "Taquicardia auricular",
         "C",
         "Ninguna de las anteriores",
         "Prueba A",
         "Year2025",
         "2025",
         "Mujer de 42 años, acude a emergencia por dolor torácico y palpitaciones luego de consumo de cocaína. Examen: PA: \n110/70 mmHg, FC: 135X', FR: 23X', T°: 36.5 °C, SatO2: 97%. ¿Cuál es el diagnóstico más probable? A) Taquicardia nodal B) Taquicardia supraventricular C) Taquicardia sinusal D) Taquicardia auricular E) Ninguna de las anteriores",
         "<unused94>thought\n1.  **Analyze the Request:** The user wants me to act as an expert medical assistant trained in Peru and answer a multiple-choice medical question. I need to provide a step-by-step internal thought process, summarize the information, and then give *only* the final letter answer.\n\n2.  **Summarize the Information:**\n    *   Patient: 42-year-old female.\n    *   Presentation: Emergency department visit.\n    *   Symptoms: Chest pain and palpitations.\n    *   Trigger: Cocaine use.\n    *   Vitals:\n        *   BP: 110/70 mmHg (Normal/Slightly elevated diastolic)\n        *   HR: 135 bpm (Tachycardia)\n        *   RR: 23 breaths/min (Tachypnea)\n        *   Temp: 36.5 °C (Normal)\n        *   SpO2: 97% (Normal)\n    *   Question: Most probable diagnosis among the given options.\n    *   Options:\n        *   A) Nodal tachycardia (AVNRT/AVRT)\n        *   B) Supraventricular tachycardia (SVT) - This is a broad category including A.\n        *   C) Sinus tachycardia\n        *   D) Atrial tachycardia\n        *   E) None of the above\n\n3.  **Internal Reasoning (Step-by-Step):**\n    *   **Identify the core problem:** The patient has tachycardia (HR 135 bpm) associated with chest pain and palpitations after cocaine use.\n    *   **Consider the context:** Cocaine is a potent sympathomimetic drug. It increases catecholamine release (epinephrine, norepinephrine), leading to increased heart rate, blood pressure, and myocardial oxygen demand.\n    *   **Evaluate the options in the context of cocaine use:**\n        *   **Cocaine's effects:** Cocaine can cause various cardiac arrhythmias, including sinus tachycardia, atrial fibrillation/flutter, supraventricular tachycardias (SVT), and ventricular tachycardias/fibrillation. It can also cause coronary artery vasospasm, leading to myocardial ischemia/infarction (explaining the chest pain).\n        *   **Sinus Tachycardia (C):** This is a very common physiological response to stress, pain, anxiety, fever, hypovolemia, and sympathomimetic drugs like cocaine. The heart rate is typically <150 bpm (though can be higher), and the rhythm is regular with normal P waves preceding each QRS complex. Given the cocaine use and associated symptoms, sinus tachycardia is a highly likely initial response.\n        *   **Supraventricular Tachycardia (SVT) (B):** This is a broader category that includes AVNRT, AVRT, atrial tachycardia, and atrial flutter/fibrillation. While cocaine *can* trigger SVTs, sinus tachycardia is often the *first* and most common tachyarrhythmia seen. The question asks for the *most probable* diagnosis.\n        *   **Nodal Tachycardia (A):** This refers specifically to AVNRT or AVRT, types of SVT. Again, possible but perhaps less common as the *initial* presentation compared to sinus tachycardia.\n        *   **Atrial Tachycardia (D):** Another type of SVT. Possible, but sinus tachycardia is more common in this acute setting.\n        *   **Comparing Sinus Tachycardia vs. SVT:** In the context of acute cocaine use causing sympathetic overdrive, sinus tachycardia is the most direct and expected physiological response. While cocaine can precipitate other arrhythmias, sinus tachycardia is often the initial and most frequent finding. The heart rate of 135 bpm is consistent with sinus tachycardia, although it could also be seen in some SVTs. However, without an ECG, differentiating definitively is impossible. But based on probability in this clinical scenario, sinus tachycardia is the most likely *initial* diagnosis.\n    *   **Refine the choice:** The patient's symptoms (palpitations, chest pain) and vital signs (HR 135, RR 23) in the setting of cocaine use strongly suggest sympathetic activation. Sinus tachycardia is the most common cardiac manifestation of this activation. While other arrhythmias are possible, sinus tachycardia is the most probable *initial* diagnosis given the limited information (no ECG).\n    *   **Final Check:** Does sinus tachycardia fit the clinical picture? Yes, cocaine causes sympathetic stimulation, leading to increased heart rate. The rate of 135 bpm is typical for sinus tachycardia in this context. Chest pain could be due to ischemia from increased demand or vasospasm, both exacerbated by tachycardia.\n\n4.  **Select the Final Answer:** Based on the reasoning, Sinus Tachycardia (C) is the most probable diagnosis.\n\n5.  **Format the Output:** Provide only the final letter.<unused95>Respuesta final:C",
         "medgemma-27b-text-it"
        ],
        [
         "18",
         "Tercigesta de 33 semanas, cesareada anterior dos veces; acude por sangrado vaginal indoloro. Examen: AU: 30 cm, \nSPP: LCD, LCF 144X'. Ecografía obstétrica: gestación única activa con ponderado fetal en percentil 60. Placenta cubre \nla totalidad del OCI y presenta ademas lagunas vasculares, adelgazamiento miometrio retroplacentario y vasos puente. \n¿Cuál es el diagnóstico más probable?",
         "Rotura uterina",
         "Espectro de acretismo placentario",
         "Hematoma retroplacentario",
         "Rotura de vasa previa",
         "B",
         "Ninguna de las anteriores",
         "Prueba A",
         "Year2025",
         "2025",
         "Tercigesta de 33 semanas, cesareada anterior dos veces; acude por sangrado vaginal indoloro. Examen: AU: 30 cm, \nSPP: LCD, LCF 144X'. Ecografía obstétrica: gestación única activa con ponderado fetal en percentil 60. Placenta cubre \nla totalidad del OCI y presenta ademas lagunas vasculares, adelgazamiento miometrio retroplacentario y vasos puente. \n¿Cuál es el diagnóstico más probable? A) Rotura uterina B) Espectro de acretismo placentario C) Hematoma retroplacentario D) Rotura de vasa previa E) Ninguna de las anteriores",
         "<unused94>thought\n1.  **Analyze the Request:** The user wants me to act as an expert medical assistant trained in Peru and answer a multiple-choice medical question. I need to provide a step-by-step internal thought process (which I won't output) and then output *only* the final letter answer.\n\n2.  **Summarize the Case Information:**\n    *   Patient: 33 weeks pregnant (tercigesta - third pregnancy).\n    *   History: Two previous cesarean sections.\n    *   Presenting Symptom: Painless vaginal bleeding.\n    *   Physical Exam:\n        *   Abdominal Circumference (AU): 30 cm (consistent with gestational age).\n        *   Fetal Presentation: Longitudinal, Cephalic, Dorsal (LCD).\n        *   Fetal Heart Rate (LCF): 144 bpm (normal range).\n    *   Ultrasound Findings:\n        *   Single, active pregnancy.\n        *   Fetal weight: 60th percentile (appropriate for gestational age).\n        *   Placenta: Covers the entire internal cervical os (complete placenta previa).\n        *   Additional placental findings: Vascular lakes (lagunas vasculares), thinning of the retroplacental myometrium (adelgazamiento miometrio retroplacentario), and bridging vessels (vasos puente).\n\n3.  **Evaluate the Options based on the Summary:**\n\n    *   **A) Rotura uterina (Uterine rupture):** This is a serious complication, often associated with previous uterine surgery (like C-sections). However, it typically presents with *acute abdominal pain*, fetal distress (bradycardia, late decelerations), loss of uterine contour, and often *significant* bleeding (though sometimes concealed). The patient has *painless* bleeding and a normal FHR. While the history of C-sections is a risk factor, the clinical presentation doesn't fit well.\n\n    *   **B) Espectro de acretismo placentario (Placental accretion spectrum):** This refers to abnormal adherence of the placenta to the uterine wall, ranging from increta (invades myometrium) to percreta (penetrates through myometrium). Risk factors include placenta previa and prior uterine surgery (especially C-sections). The ultrasound findings described (thinning of the retroplacental myometrium, vascular lakes, bridging vessels) are *classic signs* suggestive of placenta accreta spectrum (PAS). Painless bleeding is also a common presentation, especially in the third trimester. The combination of placenta previa, prior C-sections, and these specific ultrasound findings strongly points towards PAS.\n\n    *   **C) Hematoma retroplacentario (Retroplacental hematoma):** This is bleeding behind the placenta, often associated with placental abruption. Abruption typically presents with *painful* vaginal bleeding (though it can be painless or concealed), uterine tenderness/rigidity, and potentially fetal distress. The patient has *painless* bleeding, and the ultrasound doesn't describe a hematoma, but rather abnormal placental implantation features.\n\n    *   **D) Rotura de vasa previa (Vasa previa rupture):** This occurs when fetal blood vessels run across or near the internal cervical os, unprotected by placental tissue or the umbilical cord. Rupture typically happens with rupture of membranes or labor and causes *fetal* bleeding, leading to rapid fetal distress (bradycardia, sinusoidal pattern) and potentially fetal demise. While painless bleeding can occur, the primary concern is fetal compromise, and the ultrasound findings described are related to placental implantation, not fetal vessels over the os.\n\n    *   **E) Ninguna de las anteriores (None of the above):** Given the strong correlation between the patient's history (prior C-sections), presentation (painless bleeding), and specific ultrasound findings (placenta previa with signs of abnormal invasion), option B is a very likely diagnosis.\n\n4.  **Synthesize and Select the Best Answer:** The patient has placenta previa (placenta covering the os), a history of two C-sections (major risk factor for PAS), and painless bleeding. Crucially, the ultrasound shows specific features highly suggestive of abnormal placental invasion: thinning of the myometrium, vascular lakes, and bridging vessels. These findings are characteristic of the placenta accreta spectrum. Therefore, option B is the most probable diagnosis.\n\n5.  **Format the Final Output:** Output only the letter corresponding to the chosen answer.<unused95>Respuesta final:B",
         "medgemma-27b-text-it"
        ],
        [
         "19",
         "Mujer de 38 años, acude por cefalea y convulsiones tónico clónicas generalizadas de larga data. Resonancia cerebral \ninforma dos quistes parenquimatosos compatibles con neurocisticercosis. ¿Cuál es el tratamiento de elección?",
         "Albendazol y Praziquantel",
         "Praziquantel",
         "Prednisona",
         "Albendazol",
         "D",
         "Ninguna de las anteriores",
         "Prueba A",
         "Year2025",
         "2025",
         "Mujer de 38 años, acude por cefalea y convulsiones tónico clónicas generalizadas de larga data. Resonancia cerebral \ninforma dos quistes parenquimatosos compatibles con neurocisticercosis. ¿Cuál es el tratamiento de elección? A) Albendazol y Praziquantel B) Praziquantel C) Prednisona D) Albendazol E) Ninguna de las anteriores",
         "<unused94>thought\n1.  **Identify the core problem:** The patient has neurocysticercosis (NCC), confirmed by brain MRI showing parenchymal cysts, presenting with headache and seizures.\n\n2.  **Recall knowledge about NCC treatment:** NCC is caused by the larval stage of *Taenia solium*. Treatment aims to kill the cysts and reduce inflammation.\n\n3.  **Evaluate the options:**\n    *   A) Albendazol and Praziquantel: Both are antihelminthic drugs used for NCC. Combining them might be considered in some protocols, but often one is chosen.\n    *   B) Praziquantel: An effective antihelminthic for NCC, often used as a first-line agent.\n    *   C) Prednisone: A corticosteroid. Used adjunctively in NCC to manage inflammation, especially when cysts are degenerating or causing significant edema, but *not* the primary treatment to kill the parasite.\n    *   D) Albendazol: Another effective antihelminthic for NCC, often considered a first-line agent, potentially with better penetration into the CNS than praziquantel.\n    *   E) Ninguna de las anteriores: Unlikely, as effective treatments exist.\n\n4.  **Compare Albendazol and Praziquantel:** Both are standard treatments. Albendazol is often preferred due to potentially better CNS penetration and efficacy, especially for multiple cysts. Praziquantel is also effective. Guidelines often list both as options.\n\n5.  **Consider the specific presentation:** The patient has *parenchymal* cysts and seizures. This is a common indication for antihelminthic treatment.\n\n6.  **Re-evaluate the options in the context of \"treatment of choice\":** While both Albendazol and Praziquantel are used, Albendazol is frequently cited as the preferred agent or first-line treatment in many guidelines, particularly for parenchymal NCC, due to its efficacy and pharmacokinetic profile. Praziquantel is a valid alternative. Combining them (Option A) is less common as a standard first-line approach compared to using one agent. Prednisone (Option C) is adjunctive, not primary.\n\n7.  **Select the best option:** Given that Albendazol is often considered the preferred first-line agent for parenchymal NCC, Option D seems the most appropriate answer for \"treatment of choice\". While Praziquantel (B) is also a valid treatment, Albendazol is often favored. Option A (combination) is not the standard *initial* choice.\n\n8.  **Final check:** The question asks for the \"treatment of choice\". Albendazol is widely recognized as a primary and often preferred treatment for parenchymal neurocysticercosis.<unused95>Respuesta final:D",
         "medgemma-27b-text-it"
        ],
        [
         "20",
         "Mujer de 19 años, acude por sensación de miedo, sudoración, palpitaciones, dolor torácico y sensación de temor; refiere \nque desde hace más de un mes presenta este episodio y le preocupa mucho. ¿Cuál es el trastorno más probable?",
         "De ansiedad generalizada",
         "De angustia",
         "Obsesivo compulsivo",
         "Fóbico",
         "B",
         "Ninguna de las anteriores",
         "Prueba A",
         "Year2025",
         "2025",
         "Mujer de 19 años, acude por sensación de miedo, sudoración, palpitaciones, dolor torácico y sensación de temor; refiere \nque desde hace más de un mes presenta este episodio y le preocupa mucho. ¿Cuál es el trastorno más probable? A) De ansiedad generalizada B) De angustia C) Obsesivo compulsivo D) Fóbico E) Ninguna de las anteriores",
         "<unused94>thought\n1.  **Analyze the Request:** The user wants me to act as an expert medical assistant trained in Peru and answer a multiple-choice medical question. I need to provide a step-by-step internal thought process, summarize the information, and then output *only* the final letter answer.\n\n2.  **Summarize the Case:**\n    *   Patient: 19-year-old female.\n    *   Symptoms: Fear, sweating, palpitations, chest pain, feeling of dread/doom.\n    *   Duration/Frequency: Episodes occurring for over a month, causing significant worry.\n    *   Key Features: Sudden onset (implied by the constellation of symptoms), intense physical and psychological distress.\n\n3.  **Evaluate the Options:**\n    *   **A) Trastorno de Ansiedad Generalizada (GAD):** Characterized by *excessive, persistent worry* about various things, often accompanied by physical symptoms like restlessness, fatigue, muscle tension, irritability, sleep disturbance. While anxiety is present, the description focuses on *acute, intense episodes* rather than chronic, pervasive worry.\n    *   **B) Trastorno de Angustia (Panic Disorder):** Characterized by *recurrent, unexpected panic attacks*. A panic attack is an abrupt surge of intense fear or discomfort that reaches a peak within minutes, accompanied by physical symptoms (palpitations, sweating, chest pain, shortness of breath, dizziness, etc.) and cognitive symptoms (fear of losing control, fear of dying, derealization/depersonalization). The patient's symptoms (fear, sweating, palpitations, chest pain, dread) strongly match a panic attack. The recurrence over a month and the associated worry also fit the criteria for Panic Disorder.\n    *   **C) Trastorno Obsesivo Compulsivo (OCD):** Characterized by *obsessions* (recurrent, intrusive thoughts, urges, or images) and/or *compulsions* (repetitive behaviors or mental acts performed in response to obsessions or according to rigid rules). The described symptoms don't align with obsessions or compulsions.\n    *   **D) Trastorno Fóbico (Phobic Disorder):** Characterized by *marked fear or anxiety* about a specific object or situation (e.g., heights, spiders, social situations). The fear is out of proportion to the actual danger. While the patient experiences fear, it's not linked to a specific phobic stimulus in the description. The symptoms described are more characteristic of a generalized panic attack.\n    *   **E) Ninguna de las anteriores:** Given the strong match with Panic Disorder, this is unlikely.\n\n4.  **Compare Symptoms to Disorders:** The patient's symptoms (sudden onset, intense fear, sweating, palpitations, chest pain, dread) are classic signs of a panic attack. The fact that these episodes have been recurring for over a month and causing worry points towards a Panic Disorder (Trastorno de Angustia).\n\n5.  **Select the Best Fit:** Trastorno de Angustia (Panic Disorder) is the most likely diagnosis based on the presented symptoms and history.\n\n6.  **Format the Output:** Provide only the final letter answer as requested.<unused95>Respuesta final:B",
         "medgemma-27b-text-it"
        ],
        [
         "21",
         "Primípara de 32 años, Rh negativo; actualmente puérpera de 96 horas de parto vaginal, manifiesta que su hijo es Rh \npositivo y ella no ha recibido inmunoglobulina anti-D durante su embarazo, ni en el puerperio inmediato. ¿Cuál es la \nconducta a seguir?",
         "Diferir inmunoglobulina anti-D hasta el próximo embarazo",
         "Administrar corticoides intramuscular",
         "Solicitar prueba de coombs indirecta",
         "Colocar inmunoglobulina anti-D inmediatamente",
         "D",
         "Ninguna de las anteriores",
         "Prueba A",
         "Year2025",
         "2025",
         "Primípara de 32 años, Rh negativo; actualmente puérpera de 96 horas de parto vaginal, manifiesta que su hijo es Rh \npositivo y ella no ha recibido inmunoglobulina anti-D durante su embarazo, ni en el puerperio inmediato. ¿Cuál es la \nconducta a seguir? A) Diferir inmunoglobulina anti-D hasta el próximo embarazo B) Administrar corticoides intramuscular C) Solicitar prueba de coombs indirecta D) Colocar inmunoglobulina anti-D inmediatamente E) Ninguna de las anteriores",
         "<unused94>thought\n1.  **Identify the core problem:** A Rh-negative mother has delivered a Rh-positive baby. She was not given RhoGAM (anti-D immunoglobulin) during pregnancy or postpartum. This puts her at risk of sensitization.\n\n2.  **Analyze the patient's status:**\n    *   Primipara (first pregnancy).\n    *   32 years old.\n    *   Rh-negative.\n    *   96 hours postpartum (vaginal delivery).\n    *   Baby is Rh-positive.\n    *   No anti-D immunoglobulin given during pregnancy or postpartum.\n\n3.  **Understand the risk:** The mother is exposed to the baby's Rh-positive red blood cells during delivery. Without anti-D immunoglobulin, her immune system can produce anti-D antibodies (sensitization). This sensitization can cause hemolytic disease of the fetus and newborn (HDFN) in *future* pregnancies with Rh-positive fetuses.\n\n4.  **Evaluate the timing:** The standard window for administering anti-D immunoglobulin postpartum to prevent sensitization is within 72 hours of delivery. However, the question states it's 96 hours. While the ideal window has passed, administration *can* still be beneficial, although its effectiveness decreases with time. The key is to prevent or minimize sensitization.\n\n5.  **Assess the options:**\n    *   **A) Diferir inmunoglobulina anti-D hasta el próximo embarazo:** This is incorrect. The goal is to prevent sensitization *now* to protect *future* pregnancies. Delaying treatment increases the risk of sensitization.\n    *   **B) Administrar corticoides intramuscular:** Corticosteroids are used to treat established hemolytic disease in the fetus or newborn, or sometimes in severe maternal autoimmune conditions, but not for preventing Rh sensitization postpartum.\n    *   **C) Solicitar prueba de coombs indirecta:** A Coombs indirect test (indirect antiglobulin test or IAT) detects antibodies in the mother's serum. While it's important to check for sensitization, it doesn't *prevent* it. The immediate need is to prevent sensitization from occurring or worsening. A Coombs test would be done to assess if sensitization *has already occurred*, but the primary action needed is prophylaxis.\n    *   **D) Colocar inmunoglobulina anti-D inmediatamente:** This is the standard treatment to prevent Rh sensitization in an Rh-negative mother exposed to Rh-positive fetal blood. Even though 96 hours is past the ideal 72-hour window, administering anti-D immunoglobulin is still the recommended course of action to minimize the risk of sensitization. Guidelines often state administration is recommended within 28 days postpartum if missed within 72 hours, but immediate administration is still the best approach to reduce risk.\n    *   **E) Ninguna de las anteriores:** Option D is the correct management strategy.\n\n6.  **Synthesize the best course of action:** The mother is at high risk of sensitization. The standard preventative measure is anti-D immunoglobulin. Although the ideal window (72 hours) has passed slightly, administering it as soon as possible (immediately) is still the recommended management to reduce the risk of sensitization.\n\n7.  **Final Answer Selection:** Option D aligns with the standard medical practice for preventing Rh sensitization in this scenario, even with the slight delay.<unused95>Respuesta final:D",
         "medgemma-27b-text-it"
        ],
        [
         "22",
         "Varón de 70 años, acude a consulta, porque hace 8 meses presenta dolor epigástrico constante que no mejora a la \ningesta de alimentos, llenura precoz y melena. Examen: MEN, REH, adenopatía supraclavicular izquierda. Abdomen: se \npalpa masa dolorosa en epigastrio. Laboratorio: Hb: 8 g/dL. ¿Cuál es el diagnóstico más probable?",
         "NM gástrico",
         "Úlcera duodenal",
         "Linfoma gástrico",
         "Tumor de Pancoast",
         "A",
         "Ninguna de las anteriores",
         "Prueba A",
         "Year2025",
         "2025",
         "Varón de 70 años, acude a consulta, porque hace 8 meses presenta dolor epigástrico constante que no mejora a la \ningesta de alimentos, llenura precoz y melena. Examen: MEN, REH, adenopatía supraclavicular izquierda. Abdomen: se \npalpa masa dolorosa en epigastrio. Laboratorio: Hb: 8 g/dL. ¿Cuál es el diagnóstico más probable? A) NM gástrico B) Úlcera duodenal C) Linfoma gástrico D) Tumor de Pancoast E) Ninguna de las anteriores",
         "<unused94>thought\n1.  **Analyze the Request:** The user wants me to act as an expert medical assistant trained in Peru and answer a multiple-choice medical question. I need to provide a step-by-step internal thought process (which I won't show in the final output) and then output *only* the letter of the correct answer, preceded by \"Respuesta final:\".\n\n2.  **Summarize the Patient Information:**\n    *   **Patient:** 70-year-old male.\n    *   **Symptoms:**\n        *   Epigastric pain (constant, 8 months duration, *not* relieved by food).\n        *   Early satiety (llenura precoz).\n        *   Melena (dark, tarry stools, indicating upper GI bleeding).\n    *   **Physical Exam Findings:**\n        *   General: MEN (presumably Mal Estado Nutricional - Malnutrition).\n        *   REH (presumably Reflejo Esofágico Herniado - Hiatal Hernia Reflex, though this is less common terminology; could also mean Reflejo Elicito Hígado - Elicited Liver Reflex, but less likely in this context). Let's assume it's not critical for the primary diagnosis.\n        *   Adenopatía supraclavicular izquierda (Virchow's node - strongly suggests metastatic abdominal malignancy, often gastric).\n        *   Abdomen: Palpable, painful mass in the epigastrium.\n    *   **Laboratory Findings:**\n        *   Hb: 8 g/dL (Anemia, likely due to chronic blood loss from melena).\n\n3.  **Evaluate the Options:**\n    *   **A) NM gástrico (Neoplasia Maligna gástrica - Gastric Malignancy):**\n        *   *Fits:* Age (older adult), chronic epigastric pain (often constant, not relieved by food), early satiety, melena (bleeding), palpable epigastric mass, Virchow's node (metastasis), anemia (chronic blood loss), malnutrition. This aligns very well with the clinical picture of advanced gastric cancer.\n    *   **B) Úlcera duodenal (Duodenal Ulcer):**\n        *   *Doesn't Fit Well:* Pain is typically relieved by food or antacids, not constant and worsening. While melena can occur, the palpable mass, Virchow's node, and early satiety are not typical features of a duodenal ulcer.\n    *   **C) Linfoma gástrico (Gastric Lymphoma):**\n        *   *Fits:* Can present with similar symptoms (pain, bleeding, mass, early satiety, anemia). Can metastasize to supraclavicular nodes.\n        *   *Less Likely than A:* While possible, gastric adenocarcinoma (NM gástrico) is far more common in this age group presenting with these classic signs of advanced disease (Virchow's node, palpable mass, chronic symptoms).\n    *   **D) Tumor de Pancoast (Pancoast Tumor):**\n        *   *Doesn't Fit:* This is a lung tumor (specifically, an apical lung tumor). Symptoms typically involve shoulder/arm pain, Horner's syndrome, and neurological deficits. It does not cause epigastric pain, melena, early satiety, or a palpable epigastric mass. Virchow's node is associated with abdominal malignancies, not typically Pancoast tumors.\n    *   **E) Ninguna de las anteriores (None of the above):**\n        *   *Unlikely:* Option A fits the clinical picture extremely well.\n\n4.  **Compare A and C:** Both gastric malignancy (adenocarcinoma) and gastric lymphoma can present similarly. However, given the patient's age (70 years) and the classic constellation of symptoms including Virchow's node (a hallmark of metastatic gastric cancer), gastric adenocarcinoma (NM gástrico) is statistically much more probable than gastric lymphoma.\n\n5.  **Conclusion:** The clinical presentation (age, chronic epigastric pain not relieved by food, early satiety, melena, palpable epigastric mass, Virchow's node, anemia, malnutrition) is highly suggestive of advanced gastric cancer (Neoplasia Maligna gástrica).\n\n6.  **Final Answer Format:** Select the letter corresponding to the most likely diagnosis.<unused95>Respuesta final:A",
         "medgemma-27b-text-it"
        ],
        [
         "23",
         "Varón de 14 años post amigdalectomizado presenta alteración del gusto. Examen: ageusia en el tercio posterior de la \nlengua, anestesia de la faringe, sequedad oral parcial y dificultad en la deglución. ¿Qué par craneal se encuentra \ncomprometido?",
         "IX",
         "VII",
         "XI",
         "XII",
         "A",
         "Ninguna de las anteriores",
         "Prueba A",
         "Year2025",
         "2025",
         "Varón de 14 años post amigdalectomizado presenta alteración del gusto. Examen: ageusia en el tercio posterior de la \nlengua, anestesia de la faringe, sequedad oral parcial y dificultad en la deglución. ¿Qué par craneal se encuentra \ncomprometido? A) IX B) VII C) XI D) XII E) Ninguna de las anteriores",
         "<unused94>thought\n1.  **Analyze the Request:** The user wants me to act as an expert medical assistant trained in Peru and answer a multiple-choice medical question. I need to provide a step-by-step internal thought process, summarize the information, and then output *only* the final letter answer.\n\n2.  **Summarize the Information:**\n    *   Patient: 14-year-old male.\n    *   History: Post-amigdalectomy (tonsillectomy).\n    *   Symptoms: Altered taste (ageusia in the posterior third of the tongue), anesthesia of the pharynx, partial dry mouth, difficulty swallowing (dysphagia).\n    *   Question: Which cranial nerve is compromised?\n    *   Options: A) IX (Glossopharyngeal), B) VII (Facial), C) XI (Accessory), D) XII (Hypoglossal), E) None.\n\n3.  **Step-by-Step Reasoning (Internal):**\n    *   **Ageusia in the posterior third of the tongue:** Taste sensation is mediated by cranial nerves VII (anterior 2/3) and IX (posterior 1/3). Since the ageusia is specifically in the posterior third, this points strongly towards CN IX.\n    *   **Anesthesia of the pharynx:** The pharyngeal sensory innervation is primarily provided by CN IX (glossopharyngeal nerve).\n    *   **Partial dry mouth (xerostomia):** Salivation is controlled by CN VII (parasympathetic to submandibular and sublingual glands) and CN IX (parasympathetic to parotid gland). While CN VII is the major contributor, CN IX also plays a role, especially in parotid secretion. Anesthesia/damage to CN IX could potentially affect parotid function, contributing to dry mouth.\n    *   **Difficulty swallowing (dysphagia):** Swallowing (deglutition) is a complex process involving multiple cranial nerves. CN IX (glossopharyngeal) is involved in the sensory aspect of the pharyngeal phase and contributes to the motor control of the stylopharyngeus muscle (elevates pharynx). CN X (vagus) is crucial for motor control of pharyngeal and laryngeal muscles. CN XII (hypoglossal) controls tongue movement, important for the oral phase. Given the pharyngeal anesthesia and posterior tongue taste loss, CN IX involvement in the pharyngeal phase of swallowing is highly likely.\n    *   **Post-amigdalectomy context:** The glossopharyngeal nerve (CN IX) runs close to the tonsillar fossa and pharynx. Surgical procedures in this area, like tonsillectomy, carry a risk of injuring CN IX.\n    *   **Evaluate other options:**\n        *   CN VII (Facial): Primarily involved in taste (anterior 2/3), facial expression, salivation (submandibular/sublingual), and lacrimation. The symptoms don't fit CN VII primarily.\n        *   CN XI (Accessory): Primarily motor to sternocleidomastoid and trapezius muscles. Not related to taste, pharyngeal sensation, salivation, or swallowing.\n        *   CN XII (Hypoglossal): Primarily motor to tongue muscles. Damage causes tongue deviation and weakness, affecting the oral phase of swallowing. While dysphagia is present, the other symptoms (posterior taste loss, pharyngeal anesthesia) point away from CN XII as the *primary* nerve involved.\n    *   **Conclusion:** The combination of ageusia in the posterior third of the tongue, pharyngeal anesthesia, potential contribution to dry mouth, and dysphagia, especially in the context of recent pharyngeal surgery (amigdalectomy), strongly implicates the Glossopharyngeal nerve (CN IX).\n\n4.  **Final Answer Selection:** Based on the reasoning, the most likely compromised cranial nerve is CN IX. This corresponds to option A.\n\n5.  **Format the Output:** Provide only the final letter answer as requested.<unused95>Respuesta final:A",
         "medgemma-27b-text-it"
        ],
        [
         "24",
         "Lactante de 9 meses, desde hace 3 días presenta fiebre y vómitos frecuentes. Examen: T°: 39 ºC, piel caliente, poco \nelástica. Laboratorio: leucocitos 20,000/µL, abastonados: 700/µL; examen de orina: nitrito positivo y 100 \nleucocitos/campo. ¿Cuál es la conducta más adecuada?",
         "Hospitalizar para hidratación y antibioticoterapia parenteral",
         "Iniciar hidratación por vía oral e indicar antibioticoterapia oral",
         "Administrar antibioticoterapia parenteral",
         "Realizar ecografía renal para descartar absceso",
         "A",
         "Ninguna de las anteriores",
         "Prueba A",
         "Year2025",
         "2025",
         "Lactante de 9 meses, desde hace 3 días presenta fiebre y vómitos frecuentes. Examen: T°: 39 ºC, piel caliente, poco \nelástica. Laboratorio: leucocitos 20,000/µL, abastonados: 700/µL; examen de orina: nitrito positivo y 100 \nleucocitos/campo. ¿Cuál es la conducta más adecuada? A) Hospitalizar para hidratación y antibioticoterapia parenteral B) Iniciar hidratación por vía oral e indicar antibioticoterapia oral C) Administrar antibioticoterapia parenteral D) Realizar ecografía renal para descartar absceso E) Ninguna de las anteriores",
         "<unused94>thought\n1.  **Analyze the Request:** The user wants me to act as an expert medical assistant trained in Peru and answer a multiple-choice medical question. I need to provide a step-by-step internal thought process, summarize the information, and then give *only* the final letter answer.\n\n2.  **Summarize the Case:**\n    *   Patient: 9-month-old infant.\n    *   Symptoms: Fever (39°C) and frequent vomiting for 3 days.\n    *   Physical Exam: High temperature (39°C), hot skin, poor skin turgor (suggests dehydration).\n    *   Lab Results:\n        *   Leukocytosis (WBC 20,000/µL) with a significant left shift (700 bands/µL) - indicates a bacterial infection.\n        *   Urinalysis: Positive nitrite and 100 WBCs/field - strongly suggests a Urinary Tract Infection (UTI).\n\n3.  **Evaluate the Options:**\n    *   **A) Hospitalizar para hidratación y antibioticoterapia parenteral:** The infant is 9 months old, has a high fever, frequent vomiting (making oral hydration difficult/ineffective), signs of dehydration (poor skin turgor), and lab findings consistent with a significant bacterial infection (UTI). Infants, especially under 1 year, with febrile UTI and signs of dehydration or inability to tolerate oral intake often require hospitalization for IV hydration and parenteral antibiotics. This seems like a very appropriate option.\n    *   **B) Iniciar hidratación por vía oral e indicar antibioticoterapia oral:** While oral hydration and antibiotics are options for *some* UTIs, this infant has frequent vomiting and signs of dehydration. Oral hydration might not be sufficient, and oral antibiotics might not be absorbed well or tolerated due to vomiting. This option seems less appropriate given the clinical picture.\n    *   **C) Administrar antibioticoterapia parenteral:** This addresses the infection but ignores the dehydration and vomiting, which are significant issues. Hydration is crucial. This option is incomplete.\n    *   **D) Realizar ecografía renal para descartar absceso:** An ultrasound might be indicated later, especially if the infant doesn't respond to treatment or has recurrent UTIs, but it's not the *immediate* most appropriate *conducta* (management). The priority is treating the infection and dehydration.\n    *   **E) Ninguna de las anteriores:** Option A seems very appropriate.\n\n4.  **Determine the Best Course of Action:** The infant presents with a febrile UTI, signs of dehydration (poor skin turgor), and vomiting, making oral intake difficult. This clinical picture in a 9-month-old warrants hospitalization for intravenous hydration to correct dehydration and parenteral antibiotics to effectively treat the infection. Option A covers both essential aspects of management.\n\n5.  **Final Answer Formulation:** Based on the analysis, option A is the most appropriate management strategy. The final output should be just the letter 'A'.<unused95>Respuesta final:A",
         "medgemma-27b-text-it"
        ],
        [
         "25",
         "Desde hace tres años, el centro de salud ubicado en el ámbito de una comunidad cuya principal actividad económica es \nla explotación minera, ha incrementado la notificación de casos de menores de diez años con retardo del desarrollo \npsicomotor, irritabilidad, cefalea, vómitos y disgeusia. ¿Qué contaminante ambiental es la causa más probable?",
         "Azufre",
         "Arsénico",
         "Plomo",
         "Níquel",
         "C",
         "Ninguna de las anteriores",
         "Prueba A",
         "Year2025",
         "2025",
         "Desde hace tres años, el centro de salud ubicado en el ámbito de una comunidad cuya principal actividad económica es \nla explotación minera, ha incrementado la notificación de casos de menores de diez años con retardo del desarrollo \npsicomotor, irritabilidad, cefalea, vómitos y disgeusia. ¿Qué contaminante ambiental es la causa más probable? A) Azufre B) Arsénico C) Plomo D) Níquel E) Ninguna de las anteriores",
         "<unused94>thought\n1.  **Analyze the Request:** The user wants me to act as an expert medical assistant trained in Peru and answer a multiple-choice medical question. I need to provide a step-by-step internal thought process, summarize the information, and then output *only* the final letter answer.\n\n2.  **Summarize the Information:**\n    *   **Setting:** Health center in a community with mining as the main economic activity.\n    *   **Timeframe:** Increase in cases over the last three years.\n    *   **Population:** Children under ten years old.\n    *   **Symptoms:** Psychomotor development delay, irritability, headache, vomiting, dysgeusia (altered taste).\n    *   **Question:** Identify the most probable environmental contaminant causing these symptoms.\n    *   **Options:** A) Sulfur, B) Arsenic, C) Lead, D) Nickel, E) None of the above.\n\n3.  **Evaluate Each Option based on Symptoms and Context:**\n    *   **A) Sulfur (Azufre):** Sulfur dioxide (SO2) is a common air pollutant from mining and smelting. It primarily causes respiratory issues (asthma, bronchitis), eye irritation, and acid rain. While it can cause headaches, the constellation of symptoms, especially psychomotor delay and dysgeusia, isn't typical.\n    *   **B) Arsenic (Arsénico):** Arsenic exposure (often through contaminated water or soil in mining areas) can cause various symptoms, including skin lesions, gastrointestinal issues (vomiting), neurological problems (peripheral neuropathy), and developmental issues. While some symptoms overlap (vomiting, potential developmental effects), the specific combination, particularly the prominent psychomotor delay, irritability, and dysgeusia, isn't the *most* classic presentation compared to another option.\n    *   **C) Lead (Plomo):** Lead is a well-known neurotoxin, particularly harmful to developing children. Mining activities (especially smelting and refining) are significant sources of lead pollution. Lead poisoning in children classically presents with:\n        *   **Neurological:** Developmental delay (psychomotor), irritability, behavioral problems, learning difficulties, headaches, seizures (in severe cases).\n        *   **Gastrointestinal:** Abdominal pain, vomiting, constipation.\n        *   **Other:** Anemia, fatigue, loss of appetite.\n        *   **Taste:** Dysgeusia (metallic taste) can occur.\n        This profile matches the described symptoms (psychomotor delay, irritability, headache, vomiting, dysgeusia) very closely, especially in the context of a mining community where lead exposure is plausible.\n    *   **D) Nickel (Níquel):** Nickel exposure (often through inhalation in mining/smelting) can cause respiratory problems (asthma, pneumonitis), skin allergies (contact dermatitis), and potentially cancer with long-term exposure. Neurological symptoms like those described are not typical primary effects of nickel exposure.\n    *   **E) Ninguna de las anteriores:** Given the strong match between lead poisoning symptoms and the clinical picture described, this option is unlikely.\n\n4.  **Compare and Select the Best Fit:** Lead (Plomo) provides the most comprehensive explanation for the combination of symptoms (psychomotor delay, irritability, headache, vomiting, dysgeusia) in young children living in a mining community. The other options are less likely to cause this specific cluster of effects.\n\n5.  **Formulate the Final Answer:** Based on the analysis, Lead (Plomo) is the most probable cause. The corresponding letter is C.\n\n6.  **Final Output Check:** Ensure the output format matches the request: \"Respuesta final:\" followed *only* by the letter.<unused95>Respuesta final:C",
         "medgemma-27b-text-it"
        ],
        [
         "26",
         "Varón de 36 años que acude por astenia, fatigabilidad. Examen: palidez de piel y mucosa. Laboratorio: anemia \nnormocítica, normocrómica, hierro sérico disminuido, saturación de transferrina baja y ferritina aumentada. ¿Cuál es \nel mecanismo fisiopatológico de la anemia?",
         "Disminución de la respuesta eritropoyética",
         "Secuestro de hierro en los macrófagos",
         "Producción inadecuada de transferrina",
         "Aumento de la hepcidina",
         "D",
         "Ninguna de las anteriores",
         "Prueba A",
         "Year2025",
         "2025",
         "Varón de 36 años que acude por astenia, fatigabilidad. Examen: palidez de piel y mucosa. Laboratorio: anemia \nnormocítica, normocrómica, hierro sérico disminuido, saturación de transferrina baja y ferritina aumentada. ¿Cuál es \nel mecanismo fisiopatológico de la anemia? A) Disminución de la respuesta eritropoyética B) Secuestro de hierro en los macrófagos C) Producción inadecuada de transferrina D) Aumento de la hepcidina E) Ninguna de las anteriores",
         "<unused94>thought\n1.  **Analyze the Request:** The user wants me to act as an expert medical assistant trained in Peru and answer a multiple-choice medical question. I need to provide a step-by-step internal thought process, summarize the information, and then output *only* the final letter answer.\n\n2.  **Summarize the Clinical Case:**\n    *   Patient: 36-year-old male.\n    *   Symptoms: Astenia (weakness), fatigability.\n    *   Signs: Pallor of skin and mucous membranes.\n    *   Lab Results:\n        *   Anemia: Normocytic, normochromic.\n        *   Iron studies:\n            *   Serum iron: Decreased.\n            *   Transferrin saturation: Low.\n            *   Ferritin: Increased.\n\n3.  **Identify the Core Problem:** The patient has anemia with specific iron study results: low serum iron, low transferrin saturation, and *high* ferritin. This pattern is characteristic of Anemia of Chronic Disease (ACD), also known as Anemia of Inflammation.\n\n4.  **Evaluate the Options based on ACD Pathophysiology:**\n    *   **A) Disminución de la respuesta eritropoyética (Decreased erythropoietic response):** While ACD can involve some degree of blunted erythropoiesis (often due to inflammatory cytokines suppressing EPO production or action), the *primary* mechanism related to the iron studies presented is iron sequestration. This option isn't the *most* specific or central mechanism explaining the iron profile.\n    *   **B) Secuestro de hierro en los macrófagos (Iron sequestration in macrophages):** In ACD, inflammatory cytokines (like IL-6) stimulate hepcidin production. Hepcidin blocks iron release from macrophages (where iron from recycled RBCs is stored) and reduces iron absorption from the gut. This leads to low serum iron and low transferrin saturation, despite adequate or increased iron stores (reflected by high ferritin). This perfectly matches the patient's lab results.\n    *   **C) Producción inadecuada de transferrina (Inadequate transferrin production):** Transferrin is usually normal or even increased in ACD (as an acute phase reactant), not decreased. This option is incorrect.\n    *   **D) Aumento de la hepcidina (Increased hepcidin):** This is the *key* upstream regulator in ACD that *causes* the iron sequestration described in option B. Increased hepcidin leads to decreased iron availability for erythropoiesis. While true in ACD, option B describes the *direct consequence* of increased hepcidin that explains the specific iron study pattern (low serum iron, low saturation, high ferritin). Option B is a more direct explanation of the *mechanism* leading to the observed iron profile.\n    *   **E) Ninguna de las anteriores (None of the above):** Option B accurately describes the mechanism.\n\n5.  **Compare Options B and D:** Both increased hepcidin (D) and iron sequestration in macrophages (B) are central to ACD. However, the question asks for the *mechanism* explaining the *specific lab findings* (low serum iron, low saturation, high ferritin). The *direct* mechanism causing these findings is the trapping of iron within macrophages, preventing its release into the serum for use in erythropoiesis. Increased hepcidin is the *cause* of this sequestration. Therefore, B is a more direct description of the pathophysiological mechanism responsible for the iron study results presented.\n\n6.  **Final Selection:** Option B best explains the combination of low serum iron, low transferrin saturation, and high ferritin seen in this patient, which is characteristic of Anemia of Chronic Disease/Inflammation.\n\n7.  **Format the Output:** Provide only the final letter.<unused95>Respuesta final:B",
         "medgemma-27b-text-it"
        ],
        [
         "27",
         "Adolescente de 14 años, acude por náusea, vómitos y deposiciones líquidas sin moco sin sangre. Compañeros con \nsíntomas similares tras comer hamburguesa en una excursión. ¿Cuál es el probable agente infeccioso en este caso?",
         "Bacillus cereus",
         "Vibrion cholerae",
         "Staphylococcus aureus",
         "Campylobacter jejuni",
         "C",
         "Ninguna de las anteriores",
         "Prueba A",
         "Year2025",
         "2025",
         "Adolescente de 14 años, acude por náusea, vómitos y deposiciones líquidas sin moco sin sangre. Compañeros con \nsíntomas similares tras comer hamburguesa en una excursión. ¿Cuál es el probable agente infeccioso en este caso? A) Bacillus cereus B) Vibrion cholerae C) Staphylococcus aureus D) Campylobacter jejuni E) Ninguna de las anteriores",
         "<unused94>thought\n1.  **Analyze the Request:** The user wants me to act as an expert medical assistant trained in Peru and answer a multiple-choice medical question. I need to provide a step-by-step internal thought process, summarize the information, and then output *only* the final letter answer.\n\n2.  **Summarize the Case:**\n    *   Patient: 14-year-old adolescent.\n    *   Symptoms: Nausea, vomiting, watery diarrhea (no mucus, no blood).\n    *   Context: Symptoms appeared after eating hamburgers during a school trip.\n    *   Epidemiology: Multiple classmates have similar symptoms.\n    *   Question: Identify the probable infectious agent.\n\n3.  **Evaluate the Options:**\n    *   **A) Bacillus cereus:** Known to cause two types of food poisoning:\n        *   Emetic type: Nausea and vomiting, often associated with fried rice (preformed toxin). Incubation period is short (1-6 hours).\n        *   Diarrheal type: Watery diarrhea and abdominal cramps, often associated with meats, vegetables, sauces (enterotoxin produced in the gut). Incubation period is longer (6-15 hours).\n        *   *Relevance:* Hamburgers (meat) are a potential source. The symptoms (nausea, vomiting, watery diarrhea) fit both types, but the combination and the context of a shared meal (outbreak) are highly suggestive. The short incubation period implied by the outbreak setting fits the emetic type, but the diarrhea points towards the diarrheal type. *Bacillus cereus* is a strong possibility.\n\n    *   **B) Vibrio cholerae:** Causes cholera, characterized by profuse, watery diarrhea (\"rice-water stools\"), vomiting, and rapid dehydration. Usually associated with contaminated water or seafood.\n        *   *Relevance:* While it causes watery diarrhea and vomiting, it's less commonly associated with hamburgers in a typical outbreak setting in Peru (unless the meat was contaminated with contaminated water, which is less likely than other causes). The description doesn't mention the characteristic \"rice-water\" stools. Less likely than *B. cereus*.\n\n    *   **C) Staphylococcus aureus:** Causes food poisoning due to preformed enterotoxins. Symptoms are rapid onset (1-6 hours) and primarily involve nausea, vomiting, abdominal cramps, and sometimes diarrhea. Often associated with contaminated foods handled by infected individuals (e.g., salads, pastries, meats).\n        *   *Relevance:* The rapid onset and prominent nausea/vomiting fit well. Hamburgers can be a source if improperly handled. The outbreak setting is also consistent. *Staphylococcus aureus* is a strong possibility, often presenting with more vomiting than diarrhea compared to *B. cereus* diarrheal type, but the symptoms overlap.\n\n    *   **D) Campylobacter jejuni:** A common cause of bacterial gastroenteritis. Symptoms include diarrhea (often bloody), abdominal pain, fever, nausea, and vomiting. Usually associated with undercooked poultry, unpasteurized milk, or contaminated water. Incubation period is typically 2-5 days.\n        *   *Relevance:* The incubation period is usually longer than suggested by the outbreak scenario. Bloody diarrhea is common, which is explicitly absent here. Less likely.\n\n    *   **E) Ninguna de las anteriores:** Consider this if none of the others fit well.\n\n4.  **Compare Strong Candidates (A and C):**\n    *   *Bacillus cereus* (diarrheal type) fits the watery diarrhea and association with meat.\n    *   *Staphylococcus aureus* fits the rapid onset, nausea, vomiting, and potential association with handled food like hamburgers.\n    *   The symptoms described (nausea, vomiting, *and* watery diarrhea) can be seen with both. However, *B. cereus* is particularly known for causing outbreaks linked to starchy foods (like rice) *and* meats. *S. aureus* is often more strongly associated with vomiting as the primary symptom, though diarrhea can occur. Given the combination of symptoms and the food source (hamburger), *B. cereus* is a very plausible cause, especially considering both its emetic and diarrheal forms can be linked to various foods including meat. *S. aureus* is also plausible.\n\n5.  **Refine the Choice:** The question asks for the *probable* agent. Both *B. cereus* and *S. aureus* are common causes of foodborne outbreaks with these symptoms. *B. cereus* is frequently implicated in outbreaks associated with meat dishes (like hamburgers) and starchy foods, causing either vomiting or diarrhea. *S. aureus* is also common, often linked to foods handled by carriers. Without more specific details (e.g., exact incubation time, predominance of vomiting vs. diarrhea), it's difficult to definitively distinguish. However, *B. cereus* is a classic cause of outbreaks linked to meat products like hamburgers, presenting with either vomiting or diarrhea. Let's re-evaluate the typical presentations. *S. aureus* typically has a very short incubation (1-6 hrs) and prominent vomiting. *B. cereus* emetic type also has a short incubation (1-6 hrs) with vomiting. *B. cereus* diarrheal type has a longer incubation (6-15 hrs) with diarrhea and cramps. The scenario describes an outbreak after a meal, suggesting a relatively short incubation period. The presence of *both* vomiting and watery diarrhea makes *B. cereus* (potentially both types occurring in different individuals or a mixed presentation) a strong candidate, especially given the meat source. *S. aureus* is also very possible. In Peru, both are relevant foodborne pathogens. Considering the classic associations, *B. cereus* is often highlighted in relation to meat outbreaks causing either vomiting or diarrhea.\n\n6.  **Final Decision:** Both A and C are strong contenders. However, *Bacillus cereus* is well-known for causing outbreaks associated with meat dishes (including hamburgers) and can present with either vomiting or diarrhea, fitting the described symptoms and epidemiological context well. *Staphylococcus aureus* is also a possibility, but perhaps slightly less classically associated with this specific combination of symptoms and food source compared to *B. cereus*. Therefore, *Bacillus cereus* seems the most probable answer among the choices.\n\n7.  **Format the Output:** Provide only the letter of the chosen answer.<unused95>Respuesta final:A",
         "medgemma-27b-text-it"
        ],
        [
         "28",
         "Obrero de 30 años llega a emergencia después de haber sido rescatado de incendio; presenta estridor laríngeo, tos y \ndificultad respiratoria. La oximetría muestra SatO2: 90%, pero la gasometría arterial revela una presión parcial de oxígeno \n(PaO2) normal. ¿Cuál es la causa de estos hallazgos?",
         "Reduce la capacidad de hemoglobina para captar oxígeno por modificación en su estructura",
         "Se disuelve pobremente en el plasma sanguíneo reduciendo el oxígeno disuelto",
         "Se une a la hemoglobina formando carboxihemoglobina",
         "Interfiere con la liberación de oxígeno de la hemoglobina a los tejidos",
         "C",
         "Ninguna de las anteriores",
         "Prueba A",
         "Year2025",
         "2025",
         "Obrero de 30 años llega a emergencia después de haber sido rescatado de incendio; presenta estridor laríngeo, tos y \ndificultad respiratoria. La oximetría muestra SatO2: 90%, pero la gasometría arterial revela una presión parcial de oxígeno \n(PaO2) normal. ¿Cuál es la causa de estos hallazgos? A) Reduce la capacidad de hemoglobina para captar oxígeno por modificación en su estructura B) Se disuelve pobremente en el plasma sanguíneo reduciendo el oxígeno disuelto C) Se une a la hemoglobina formando carboxihemoglobina D) Interfiere con la liberación de oxígeno de la hemoglobina a los tejidos E) Ninguna de las anteriores",
         "<unused94>thought\n1.  **Analyze the Request:** The user wants me to act as an expert medical assistant trained in Peru and answer a multiple-choice medical question. I need to provide a step-by-step internal thought process, summarize the information, and then give *only* the final letter answer.\n\n2.  **Summarize the Clinical Scenario:**\n    *   Patient: 30-year-old male construction worker.\n    *   Event: Rescued from a fire.\n    *   Symptoms: Laryngeal stridor, cough, dyspnea (difficulty breathing).\n    *   Signs: SpO2 90% (low), PaO2 normal (normal arterial oxygen tension).\n\n3.  **Identify the Core Problem:** The discrepancy between low SpO2 (pulse oximetry) and normal PaO2 (arterial blood gas). This suggests a problem with how pulse oximetry measures oxygen saturation, rather than a problem with the actual amount of oxygen dissolved in the arterial blood.\n\n4.  **Evaluate the Options in Light of the Problem:**\n    *   **A) Reduce la capacidad de hemoglobina para captar oxígeno por modificación en su estructura:** This describes conditions like methemoglobinemia. Methemoglobinemia *can* cause a discrepancy between SpO2 and PaO2 (SpO2 tends to be falsely low, around 85%, regardless of actual PaO2). This is a plausible cause, especially in the context of smoke inhalation (chemicals can induce methemoglobinemia).\n    *   **B) Se disuelve pobremente en el plasma sanguíneo reduciendo el oxígeno disuelto:** This is incorrect. Oxygen dissolves in plasma, but most is transported bound to hemoglobin. Poor solubility isn't the primary issue here, and it wouldn't explain the SpO2/PaO2 discrepancy.\n    *   **C) Se une a la hemoglobina formando carboxihemoglobina:** This describes carbon monoxide (CO) poisoning, common in fires. CO binds to hemoglobin with much higher affinity than oxygen, forming carboxyhemoglobin (COHb). This *reduces* the oxygen-carrying capacity of hemoglobin. Importantly, standard pulse oximeters often *cannot distinguish* between oxyhemoglobin and carboxyhemoglobin, leading to a *falsely high* SpO2 reading, even when PaO2 might be normal or low and the actual oxygen content is reduced. This contradicts the scenario (SpO2 is *low*).\n    *   **D) Interfiere con la liberación de oxígeno de la hemoglobina a los tejidos:** This describes a left shift in the oxygen-hemoglobin dissociation curve (e.g., alkalosis, CO poisoning). While CO poisoning does this, the primary issue causing the SpO2/PaO2 discrepancy in CO poisoning is the pulse oximeter's inability to detect COHb (leading to falsely *high* SpO2). This option doesn't directly explain the *low* SpO2 with normal PaO2.\n    *   **E) Ninguna de las anteriores:** This is possible if none of the others fit.\n\n5.  **Re-evaluate Options A and C:**\n    *   **CO Poisoning (C):** Causes *falsely high* SpO2 readings on standard pulse oximeters. The scenario has *low* SpO2. So, C is unlikely to be the *primary* explanation for the discrepancy described.\n    *   **Methemoglobinemia (A):** Causes *falsely low* SpO2 readings (typically around 85%) because methemoglobin absorbs light differently than oxyhemoglobin at the wavelengths used by pulse oximeters. The PaO2 (dissolved oxygen) can be normal. This fits the scenario perfectly: low SpO2 (90% is low, though not the classic 85%), normal PaO2, and a plausible cause (smoke inhalation).\n\n6.  **Confirm the Best Fit:** Methemoglobinemia (Option A) is the most likely explanation for a low SpO2 reading despite a normal PaO2 in a patient rescued from a fire. Smoke inhalation contains various chemicals that can oxidize hemoglobin to methemoglobin.\n\n7.  **Final Answer Formulation:** Based on the analysis, Option A is the correct answer. The final output should be just the letter.<unused95>Respuesta final:A",
         "medgemma-27b-text-it"
        ],
        [
         "29",
         "Niño de 10 años, presenta hace 5 días rinorrea acuosa y disfagia, 2 días antes se agrega tos con flema, silbido de \npecho, fiebre e hiporexia. Antecedentes: inmunizaciones completas. Examen: REG, FC: 78 X', FR: 26 X', SatO2: 95%. \nTórax: MV pasa AHT, sibilantes y subcrepitos en AHT, tirajes IC. Laboratorio: Hemograma: leucocitos 12.000/µL; PCR: 5 \nmg/L; procalcitonina ligeramente elevado. ¿Cuál es el agente etiológico más probable?",
         "Streptococcus pneumoniae",
         "Haemophilus influenzae tipo b",
         "Virus sincitial respiratorio",
         "Mycoplasma pneumoniae",
         "D",
         "Ninguna de las anteriores",
         "Prueba A",
         "Year2025",
         "2025",
         "Niño de 10 años, presenta hace 5 días rinorrea acuosa y disfagia, 2 días antes se agrega tos con flema, silbido de \npecho, fiebre e hiporexia. Antecedentes: inmunizaciones completas. Examen: REG, FC: 78 X', FR: 26 X', SatO2: 95%. \nTórax: MV pasa AHT, sibilantes y subcrepitos en AHT, tirajes IC. Laboratorio: Hemograma: leucocitos 12.000/µL; PCR: 5 \nmg/L; procalcitonina ligeramente elevado. ¿Cuál es el agente etiológico más probable? A) Streptococcus pneumoniae B) Haemophilus influenzae tipo b C) Virus sincitial respiratorio D) Mycoplasma pneumoniae E) Ninguna de las anteriores",
         "<unused94>thought\n1.  **Analyze the Request:** The user wants me to act as an expert medical assistant trained in Peru and answer a multiple-choice medical question. I need to provide a step-by-step internal thought process, summarize the information, and then give *only* the final letter answer.\n\n2.  **Summarize the Case:**\n    *   **Patient:** 10-year-old boy.\n    *   **Symptoms:**\n        *   5 days: Watery rhinorrhea, dysphagia.\n        *   2 days ago (total 3 days): Cough with phlegm, wheezing, fever, hyporexia.\n    *   **History:** Complete immunizations.\n    *   **Exam:**\n        *   General: Regular appearance (REG).\n        *   Vitals: HR 78 bpm, RR 26 breaths/min, SpO2 95%.\n        *   Chest: Decreased breath sounds (MV pasa AHT - *Movimiento Vésico Pasado A Hueso* implies decreased air entry), wheezing, subcrepitations (crackles) in the lower lung fields (AHT - *Ápice Hígado Táctil* is likely a typo and should mean *Áreas Hipoauscultación Torácica* or similar, referring to lower lung fields), intercostal retractions (tirajes IC).\n    *   **Labs:**\n        *   CBC: WBC 12,000/µL (mildly elevated).\n        *   PCR: 5 mg/L (elevated, normal < 1 mg/L).\n        *   Procalcitonin: Slightly elevated.\n\n3.  **Analyze the Symptoms and Signs:**\n    *   **Initial phase (rhinorrhea, dysphagia):** Suggests an upper respiratory infection (URI) or viral prodrome.\n    *   **Later phase (cough, phlegm, wheezing, fever, hyporexia, decreased breath sounds, crackles, retractions):** Indicates progression to lower respiratory tract involvement, likely pneumonia or bronchiolitis/bronchitis with significant inflammation. Wheezing points towards airway narrowing.\n    *   **Age (10 years):** This age group is less typical for classic viral bronchiolitis (usually < 2 years) but can still get viral pneumonia or atypical pneumonia.\n    *   **Immunizations:** Complete immunizations make *Haemophilus influenzae* type b (Hib) less likely, although not impossible. *Streptococcus pneumoniae* is still a common cause of bacterial pneumonia, even with vaccination (vaccine doesn't cover all serotypes).\n    *   **Vitals:** RR is slightly elevated for age (normal ~18-25), SpO2 is borderline low but acceptable.\n    *   **Labs:**\n        *   WBC 12,000: Mild leukocytosis, non-specific, can be seen in both viral and bacterial infections.\n        *   PCR 5 mg/L: Significantly elevated, strongly suggests a bacterial infection.\n        *   Procalcitonin slightly elevated: Also points towards a bacterial component, though less specific than PCR.\n\n4.  **Evaluate the Options:**\n    *   **A) Streptococcus pneumoniae:** A very common cause of bacterial pneumonia in children. Fits with fever, cough, crackles, leukocytosis, elevated PCR, and elevated procalcitonin.\n    *   **B) Haemophilus influenzae tipo b:** Less likely due to complete immunizations. Non-typeable *H. influenzae* is still possible but less common than *S. pneumoniae* in this age group for pneumonia.\n    *   **C) Virus sincitial respiratorio (RSV):** A common cause of bronchiolitis and pneumonia, especially in younger children (<2 years). While possible in a 10-year-old, the significantly elevated PCR and procalcitonin make a primary viral etiology less likely, although viral infections can predispose to bacterial superinfection. RSV typically causes more wheezing and less consolidation than suggested here, and PCR levels are usually not this high in uncomplicated RSV.\n    *   **D) Mycoplasma pneumoniae:** A common cause of \"atypical\" pneumonia in school-aged children and adolescents. Often presents with gradual onset, cough, wheezing, headache, malaise. Fever can be present. Lab findings can be variable, sometimes with mild leukocytosis. PCR and procalcitonin *can* be elevated but are often less dramatically so than in typical bacterial pneumonia. The presentation (initial URI symptoms followed by lower respiratory symptoms) and age fit well with *Mycoplasma*. However, the *degree* of PCR elevation (5 mg/L) is quite high and more typical of pyogenic bacteria like *S. pneumoniae*.\n    *   **E) Ninguna de las anteriores:** Possible if none of the others fit well.\n\n5.  **Compare Likely Candidates (A vs. D):**\n    *   *S. pneumoniae* (A): Classic bacterial pneumonia presentation. High PCR and procalcitonin strongly support this.\n    *   *Mycoplasma pneumoniae* (D): Atypical pneumonia presentation. Age and initial symptoms fit. Wheezing is common. However, the very high PCR (5 mg/L) is less typical for *Mycoplasma* and more suggestive of a typical bacterial pathogen like *S. pneumoniae*.\n\n6.  **Conclusion:** The clinical picture (fever, productive cough, crackles, retractions) combined with the laboratory findings (leukocytosis, significantly elevated PCR, elevated procalcitonin) strongly points towards a typical bacterial pneumonia. Among the given options, *Streptococcus pneumoniae* is the most common cause of typical bacterial pneumonia in this age group and best fits the overall picture, especially the high inflammatory markers (PCR, procalcitonin). While *Mycoplasma* is common in this age group, the high PCR makes *S. pneumoniae* more probable. RSV is less likely given the age and high bacterial markers. Hib is unlikely due to vaccination.\n\n7.  **Final Answer Selection:** Based on the analysis, *Streptococcus pneumoniae* (A) is the most likely etiological agent.<unused95>Respuesta final:A",
         "medgemma-27b-text-it"
        ],
        [
         "30",
         "Varón de 75 años, procedente de una residencia de ancianos presenta sepsis de origen urinario. Hemocultivos y \nurocultivo muestran E. coli productora de betalactamasas de espectro ampliado; antibiograma pendiente. ¿Cuál es el \nantibiótico mejor indicado?",
         "Aztreonam",
         "Ertapenem",
         "Cefotaxima",
         "Ceftriaxona",
         "B",
         "Ninguna de las anteriores",
         "Prueba A",
         "Year2025",
         "2025",
         "Varón de 75 años, procedente de una residencia de ancianos presenta sepsis de origen urinario. Hemocultivos y \nurocultivo muestran E. coli productora de betalactamasas de espectro ampliado; antibiograma pendiente. ¿Cuál es el \nantibiótico mejor indicado? A) Aztreonam B) Ertapenem C) Cefotaxima D) Ceftriaxona E) Ninguna de las anteriores",
         "<unused94>thought\n1.  **Analyze the Request:** The user wants me to act as an expert medical assistant trained in Peru and answer a multiple-choice medical question. I need to provide a step-by-step internal thought process, summarize the information, and then give *only* the final letter answer.\n\n2.  **Summarize the Information:**\n    *   Patient: 75-year-old male from a nursing home.\n    *   Condition: Sepsis of urinary origin.\n    *   Microbiology: *E. coli* producing Extended-Spectrum Beta-Lactamases (ESBL).\n    *   Antibiotic Susceptibility: Pending (so empirical treatment is needed).\n    *   Question: Best antibiotic choice.\n    *   Options: A) Aztreonam, B) Ertapenem, C) Cefotaxime, D) Ceftriaxone, E) None of the above.\n\n3.  **Evaluate the Options based on ESBL *E. coli*:**\n    *   ESBLs confer resistance to most penicillins, cephalosporins (including 1st, 2nd, and 3rd generation), and aztreonam.\n    *   **A) Aztreonam:** Monobactam. ESBLs typically confer resistance to aztreonam. *Not a good choice.*\n    *   **B) Ertapenem:** Carbapenem. Carbapenems (like ertapenem, meropenem, imipenem) are generally the drugs of choice for serious infections caused by ESBL-producing organisms. Ertapenem has good activity against *E. coli* and is often used for UTIs and intra-abdominal infections. *A strong candidate.*\n    *   **C) Cefotaxime:** Third-generation cephalosporin. ESBLs hydrolyze and confer resistance to cefotaxime. *Not a good choice.*\n    *   **D) Ceftriaxone:** Third-generation cephalosporin. ESBLs hydrolyze and confer resistance to ceftriaxone. *Not a good choice.*\n    *   **E) Ninguna de las anteriores:** Since Ertapenem (a carbapenem) is a standard treatment for ESBL infections, this option is unlikely unless Ertapenem is contraindicated or unavailable, which isn't stated.\n\n4.  **Consider the Clinical Context (Sepsis):** Sepsis is a severe condition requiring broad-spectrum and effective antibiotics. Carbapenems are often preferred for serious ESBL infections like sepsis.\n\n5.  **Consider Peruvian Guidelines/Context (Implicit):** While not explicitly stated, carbapenems are generally recommended for ESBL infections in most international and likely Peruvian guidelines for severe infections.\n\n6.  **Refine the Choice:** Ertapenem is a carbapenem, the class of antibiotics generally recommended for treating serious infections caused by ESBL-producing organisms like *E. coli*. Aztreonam, cefotaxime, and ceftriaxone are typically ineffective due to ESBL production.\n\n7.  **Final Answer Selection:** Based on the analysis, Ertapenem (B) is the most appropriate choice among the given options for empirical treatment of sepsis caused by ESBL-producing *E. coli*.\n\n8.  **Format the Output:** Follow the instructions: internal summary (done above), step-by-step reasoning (done above), and then *only* the final letter.<unused95>Respuesta final:B",
         "medgemma-27b-text-it"
        ],
        [
         "31",
         "Varón de 40 años, hace un día con dolor en región inguinal izquierda después de levantar objeto pesado. Examen: MEG. \nAbdomen: globuloso, RHA disminuidos; a nivel del pliegue de la ingle aumento de volumen por tumoración 2x2 cm, \nindurada, no reductible y con signos de flogosis. Rx abdomen simple de pie: múltiples niveles hidroaéreos. ¿Cuál es el \ndiagnóstico?",
         "Hernia de Spiegel estrangulada",
         "Hernia crural encarcelada",
         "Hernia inguinal estrangulada",
         "Íleo adinámico",
         "C",
         "Ninguna de las anteriores",
         "Prueba A",
         "Year2025",
         "2025",
         "Varón de 40 años, hace un día con dolor en región inguinal izquierda después de levantar objeto pesado. Examen: MEG. \nAbdomen: globuloso, RHA disminuidos; a nivel del pliegue de la ingle aumento de volumen por tumoración 2x2 cm, \nindurada, no reductible y con signos de flogosis. Rx abdomen simple de pie: múltiples niveles hidroaéreos. ¿Cuál es el \ndiagnóstico? A) Hernia de Spiegel estrangulada B) Hernia crural encarcelada C) Hernia inguinal estrangulada D) Íleo adinámico E) Ninguna de las anteriores",
         "<unused94>thought\n1.  **Analyze the Request:** The user wants me to act as an expert medical assistant trained in Peru and answer a multiple-choice medical question. I need to provide a step-by-step internal thought process, summarize the information, and then give *only* the final letter answer.\n\n2.  **Summarize the Case:**\n    *   **Patient:** 40-year-old male.\n    *   **Presenting Complaint:** Left inguinal pain for 1 day after heavy lifting.\n    *   **Physical Exam:**\n        *   Abdomen: Globulous (distended), decreased bowel sounds (RHA disminuidos).\n        *   Left Inguinal Region: 2x2 cm mass, hard (indurada), non-reducible, signs of inflammation (flogosis).\n    *   **Imaging:** Abdominal X-ray (standing): Multiple air-fluid levels (niveles hidroaéreos).\n\n3.  **Analyze the Findings:**\n    *   **Inguinal Mass:** The presence of a non-reducible, indurated mass with signs of inflammation in the inguinal region strongly suggests a hernia that has become complicated.\n    *   **Abdominal Distension & Decreased Bowel Sounds:** These findings point towards an intestinal obstruction or ileus.\n    *   **Multiple Air-Fluid Levels on X-ray:** This is a classic sign of intestinal obstruction.\n    *   **History:** Pain onset after heavy lifting is a common trigger for hernia development or complications.\n    *   **Location:** The mass is specifically in the *inguinal* region.\n\n4.  **Evaluate the Options:**\n    *   **A) Hernia de Spiegel estrangulada:** A Spigelian hernia occurs lateral to the rectus abdominis muscle, usually below the umbilicus. The mass is described in the *inguinal* region, making this less likely.\n    *   **B) Hernia crural encarcelada:** A femoral (crural) hernia occurs below the inguinal ligament. While possible, the description \"pliegue de la ingle\" (inguinal fold) usually implies an inguinal hernia, which is much more common in men. Also, \"encarcelada\" (incarcerated) means trapped but not necessarily strangulated (compromised blood supply). The signs of inflammation (flogosis) and induration suggest strangulation.\n    *   **C) Hernia inguinal estrangulada:** An inguinal hernia occurs in the inguinal canal. The location (inguinal region), the non-reducible nature, the induration, the signs of inflammation (flogosis), and the signs of intestinal obstruction (abdominal distension, decreased bowel sounds, air-fluid levels) are all highly consistent with a strangulated inguinal hernia. The strangulation leads to ischemia, inflammation, and potentially bowel obstruction.\n    *   **D) Íleo adinámico:** Paralytic ileus involves decreased or absent bowel motility without a mechanical obstruction. While the patient has decreased bowel sounds and abdominal distension, the presence of a distinct, inflamed, non-reducible inguinal mass and air-fluid levels strongly points towards a mechanical obstruction caused by a strangulated hernia, rather than a primary ileus.\n    *   **E) Ninguna de las anteriores:** Option C fits the clinical picture well.\n\n5.  **Synthesize and Conclude:** The patient presents with classic signs and symptoms of a strangulated inguinal hernia: a non-reducible, tender, inflamed mass in the inguinal region, coupled with signs of intestinal obstruction (abdominal distension, decreased bowel sounds, air-fluid levels on X-ray). The history of heavy lifting is a typical precipitating factor.\n\n6.  **Final Answer Selection:** Based on the analysis, option C is the most likely diagnosis.\n\n7.  **Format the Output:** Follow the instructions: provide only the final letter.<unused95>Respuesta final:C",
         "medgemma-27b-text-it"
        ],
        [
         "32",
         "Multigesta de 40 semanas, acude por dolor tipo contracción. Examen: AU: 31cm, SPP: LCI, LCF 144 X´. Tacto \nvaginal: dilatación: 9 cm, B: 100%, AP +1, membranas rotas con liquido claro, se palpa presentación cara mento anterior. \n¿Cuál es la conducta más adecuada?",
         "Programar cesárea de emergencia",
         "Usar vacuum de salida",
         "Convertir a presentación occipucio",
         "Dejar evolucionar parto vaginal",
         "D",
         "Ninguna de las anteriores",
         "Prueba A",
         "Year2025",
         "2025",
         "Multigesta de 40 semanas, acude por dolor tipo contracción. Examen: AU: 31cm, SPP: LCI, LCF 144 X´. Tacto \nvaginal: dilatación: 9 cm, B: 100%, AP +1, membranas rotas con liquido claro, se palpa presentación cara mento anterior. \n¿Cuál es la conducta más adecuada? A) Programar cesárea de emergencia B) Usar vacuum de salida C) Convertir a presentación occipucio D) Dejar evolucionar parto vaginal E) Ninguna de las anteriores",
         "<unused94>thought\n1.  **Analyze the Request:** The user wants me to act as an expert medical assistant trained in Peru and answer a multiple-choice medical question. I need to provide a step-by-step internal thought process, summarize the information, and then give *only* the final letter answer.\n\n2.  **Summarize the Clinical Scenario:**\n    *   Patient: Multigesta (has had previous pregnancies).\n    *   Gestational Age: 40 weeks (term).\n    *   Presenting Complaint: Contraction-like pain.\n    *   Abdominal Exam:\n        *   AU (Abdominal Circumference): 31 cm (This seems low for 40 weeks, but focus on the other findings).\n        *   SPP (Single Point Percussion): LCI (Left Iliac Crest), LCF (Left Coronary Fetus) 144 bpm (Normal fetal heart rate).\n    *   Vaginal Exam:\n        *   Dilatation: 9 cm (Almost fully dilated).\n        *   B (Bladder): 100% (Full bladder - needs emptying).\n        *   AP (Anterior Position): +1 (Presenting part is +1 station, meaning it's low in the pelvis but not yet on the pelvic floor).\n        *   Membranes: Ruptured with clear fluid.\n        *   Presentation: Face mento-anterior (Face presentation, chin pointing anteriorly).\n\n3.  **Evaluate the Options based on the Summary:**\n    *   **A) Programar cesárea de emergencia:** Is there an immediate threat to mother or baby requiring emergency C-section? The fetal heart rate is normal (144 bpm). The mother is almost fully dilated (9 cm). Face presentation *can* be an indication for C-section, but *mento-anterior* is generally considered favorable for vaginal delivery, especially when the head is well-flexed (though flexion isn't explicitly stated, it's implied by the progression to 9 cm dilation). There's no mention of fetal distress or failure to progress *despite* adequate contractions (which are implied by the pain and dilation). So, an *emergency* C-section isn't immediately indicated based *solely* on this information.\n    *   **B) Usar vacuum de salida:** Vacuum extraction is typically used when the head is engaged and visible at the introitus (station +3 or +4) and there's a need to expedite delivery (e.g., maternal exhaustion, fetal distress). The presenting part is only at +1 station. Vacuum is contraindicated for face presentation.\n    *   **C) Convertir a presentación occipucio:** This is not possible. The presentation is already established. Attempting to manipulate the fetus at this stage (9 cm dilation, +1 station) is dangerous and unlikely to succeed.\n    *   **D) Dejar evolucionar parto vaginal:** The patient is at 9 cm dilation, membranes are ruptured, the fetal heart rate is normal, and the presentation is face mento-anterior, which *can* deliver vaginally. The presenting part is at +1 station. The main issue is the full bladder (B: 100%), which needs to be emptied (e.g., via catheterization) to allow descent. Assuming adequate contractions continue and the bladder is emptied, vaginal delivery is the most likely and appropriate course. Face mento-anterior presentations often rotate spontaneously to occiput anterior or deliver directly in the face presentation.\n    *   **E) Ninguna de las anteriores:** Option D seems appropriate.\n\n4.  **Refine the Choice:** The key factors are:\n    *   Term pregnancy (40 weeks).\n    *   Advanced labor (9 cm dilation).\n    *   Normal fetal heart rate (144 bpm).\n    *   Favorable face presentation (mento-anterior).\n    *   Presenting part low (+1 station).\n    *   Ruptured membranes.\n    *   *Need to empty the bladder.*\n\n    Given these factors, especially the mento-anterior presentation and advanced dilation with a normal FHR, allowing labor to progress vaginally (after emptying the bladder) is the standard and most appropriate management. Cesarean section is reserved for complications like fetal distress, failure to progress, or a mento-posterior presentation. Vacuum is inappropriate for face presentation and the station. Conversion is impossible.\n\n5.  **Final Answer Selection:** Option D aligns best with the clinical picture and standard obstetric management.<unused95>Respuesta final:D",
         "medgemma-27b-text-it"
        ],
        [
         "33",
         "Mujer de 45 años usuaria crónica de AINES por osteoartritis, acude por hematemesis y melena activa. Examen: PA: 80/50 \nmmHg, FC: 112 X', FR: 22 X'. Palidez marcada de piel y mucosas. Luego de administrar el bolo de omeprazol se decide \ncontinuar con infusión del mismo medicamento. ¿Cuál es la velocidad de infusión del omeprazol en mg/h?",
         "8",
         "6",
         "4",
         "10",
         "A",
         "Ninguna de las anteriores",
         "Prueba A",
         "Year2025",
         "2025",
         "Mujer de 45 años usuaria crónica de AINES por osteoartritis, acude por hematemesis y melena activa. Examen: PA: 80/50 \nmmHg, FC: 112 X', FR: 22 X'. Palidez marcada de piel y mucosas. Luego de administrar el bolo de omeprazol se decide \ncontinuar con infusión del mismo medicamento. ¿Cuál es la velocidad de infusión del omeprazol en mg/h? A) 8 B) 6 C) 4 D) 10 E) Ninguna de las anteriores",
         "<unused94>thought\n1.  **Identify the core question:** The question asks for the infusion rate of omeprazole in mg/h for a patient with upper GI bleeding (hematemesis, melena) and hemodynamic instability (hypotension, tachycardia) who is a chronic NSAID user.\n\n2.  **Analyze the patient's condition:**\n    *   45-year-old female.\n    *   Chronic NSAID use (risk factor for peptic ulcer disease and bleeding).\n    *   Symptoms: Hematemesis (vomiting blood) and melena (black, tarry stools) - indicate upper GI bleeding.\n    *   Signs: Hypotension (PA 80/50 mmHg), tachycardia (FC 112 X'), tachypnea (FR 22 X'), pallor - indicate significant blood loss and hemodynamic instability (shock).\n    *   Initial treatment: IV bolus of omeprazole.\n    *   Next step: Continuous IV infusion of omeprazole.\n\n3.  **Recall/Research standard protocols for managing upper GI bleeding:**\n    *   Upper GI bleeding, especially with hemodynamic instability, is a medical emergency.\n    *   Initial management includes resuscitation (fluids, blood transfusion if needed), endoscopic evaluation, and pharmacotherapy.\n    *   Proton pump inhibitors (PPIs) like omeprazole are crucial. They reduce gastric acid secretion, promote clot stability, and decrease rebleeding risk.\n    *   Standard protocols often involve an initial IV bolus followed by a continuous infusion.\n\n4.  **Focus on the omeprazole infusion rate:**\n    *   What is the standard IV infusion rate for omeprazole in the context of acute upper GI bleeding?\n    *   Common protocols (e.g., based on guidelines from gastroenterology societies, hospital formularies) recommend a specific infusion rate.\n    *   Search for standard IV omeprazole infusion rates for acute upper GI bleed.\n    *   Sources (like UpToDate, hospital protocols, pharmacology references) typically state the standard IV infusion rate for omeprazole in acute upper GI bleeding is 4 mg/h.\n    *   The initial bolus is usually 80 mg IV over 20-30 minutes.\n    *   The continuous infusion is then typically 4 mg/h for 72 hours after the bolus, followed by oral therapy.\n\n5.  **Compare the standard rate with the options:**\n    *   A) 8 mg/h\n    *   B) 6 mg/h\n    *   C) 4 mg/h\n    *   D) 10 mg/h\n    *   E) Ninguna de las anteriores\n\n6.  **Select the correct option:** The standard infusion rate is 4 mg/h, which matches option C.\n\n7.  **Format the final answer:** The instruction requires only the letter of the correct option.<unused95>Respuesta final:C",
         "medgemma-27b-text-it"
        ],
        [
         "34",
         "¿Cuál es la hormona responsable de aumentar la producción hepática de glucosa durante un ayuno prolongado de 24 \nhoras?",
         "Glucagon",
         "Insulina",
         "Leptina",
         "Somatostatina",
         "A",
         "Ninguna de las anteriores",
         "Prueba A",
         "Year2025",
         "2025",
         "¿Cuál es la hormona responsable de aumentar la producción hepática de glucosa durante un ayuno prolongado de 24 \nhoras? A) Glucagon B) Insulina C) Leptina D) Somatostatina E) Ninguna de las anteriores",
         "<unused94>thought\n1.  **Analyze the question:** The question asks for the hormone responsible for increasing hepatic glucose production during a prolonged fast (24 hours). This implies a state of low blood glucose and the body's response to maintain it.\n\n2.  **Recall relevant physiology:**\n    *   **Fasting state:** During fasting, blood glucose levels decrease.\n    *   **Hepatic glucose production:** The liver produces glucose primarily through glycogenolysis (breakdown of stored glycogen) and gluconeogenesis (synthesis of glucose from non-carbohydrate precursors).\n    *   **Hormonal regulation of glucose:** Several hormones regulate blood glucose.\n        *   **Insulin:** Secreted by pancreatic beta cells in response to high blood glucose. It *decreases* hepatic glucose production and promotes glucose uptake by tissues.\n        *   **Glucagon:** Secreted by pancreatic alpha cells in response to low blood glucose. It *increases* hepatic glucose production (glycogenolysis and gluconeogenesis).\n        *   **Leptin:** Secreted by adipose tissue. Primarily involved in appetite regulation and energy balance. It generally *inhibits* hepatic glucose production.\n        *   **Somatostatin:** Secreted by pancreatic delta cells, hypothalamus, etc. It has inhibitory effects on various hormones, including insulin and glucagon, but its primary role in *increasing* hepatic glucose production during fasting is not established. It tends to *decrease* both insulin and glucagon secretion.\n        *   **Other hormones:** Cortisol and growth hormone also increase hepatic glucose production during prolonged fasting, but glucagon is the primary counter-regulatory hormone released immediately in response to falling glucose levels.\n\n3.  **Evaluate the options:**\n    *   **A) Glucagon:** This hormone is secreted when blood glucose is low (like during fasting) and directly stimulates the liver to produce glucose. This fits the description.\n    *   **B) Insulin:** This hormone is secreted when blood glucose is high and *inhibits* hepatic glucose production. This is the opposite of what's needed during fasting.\n    *   **C) Leptin:** This hormone is related to satiety and energy stores. It generally *inhibits* glucose production.\n    *   **D) Somatostatin:** This hormone generally inhibits hormone secretion, including both insulin and glucagon. It doesn't directly stimulate hepatic glucose production in this context.\n    *   **E) Ninguna de las anteriores:** Since Glucagon (A) is a strong candidate, this option is unlikely.\n\n4.  **Confirm the best fit:** Glucagon is the principal hormone that counteracts the effects of insulin and raises blood glucose levels by stimulating hepatic glucose production (glycogenolysis and gluconeogenesis) during fasting. A 24-hour fast is a significant period where glucagon's role becomes prominent.\n\n5.  **Formulate the final answer:** Based on the analysis, Glucagon is the correct hormone. The corresponding option is A.<unused95>Respuesta final:A",
         "medgemma-27b-text-it"
        ],
        [
         "35",
         "Mujer de 47 años, hipertensa mal controlada, acude por que hace 20 minutos presenta dolor precordial opresivo con \nirradiación a brazo izquierdo. EKG muestra supradesnivel del ST en todas las derivadas precordiales. En un escenario \nideal. ¿Cuál es el tratamiento de elección?",
         "Oxigenoterapia",
         "Fibrinolisis",
         "Doble antiagregación",
         "Intervención coronaria",
         "D",
         "Ninguna de las anteriores",
         "Prueba A",
         "Year2025",
         "2025",
         "Mujer de 47 años, hipertensa mal controlada, acude por que hace 20 minutos presenta dolor precordial opresivo con \nirradiación a brazo izquierdo. EKG muestra supradesnivel del ST en todas las derivadas precordiales. En un escenario \nideal. ¿Cuál es el tratamiento de elección? A) Oxigenoterapia B) Fibrinolisis C) Doble antiagregación D) Intervención coronaria E) Ninguna de las anteriores",
         "<unused94>thought\n1.  **Analyze the Request:** The user wants me to act as an expert medical assistant trained in Peru and answer a multiple-choice medical question. I need to provide a step-by-step internal thought process, summarize the information, and then give *only* the final letter answer.\n\n2.  **Summarize the Case:**\n    *   Patient: 47-year-old female.\n    *   History: Poorly controlled hypertension.\n    *   Presentation: Acute onset (20 minutes ago) of oppressive precordial chest pain radiating to the left arm.\n    *   EKG Findings: ST-segment elevation in all precordial leads (V1-V6).\n    *   Scenario: Ideal setting.\n    *   Question: What is the treatment of choice?\n\n3.  **Interpret the Findings:**\n    *   The symptoms (acute chest pain, radiation) are classic for acute myocardial infarction (AMI).\n    *   The EKG findings (ST elevation in V1-V6) indicate an extensive anterior ST-segment elevation myocardial infarction (STEMI).\n    *   The patient is relatively young (47 years old).\n    *   The scenario is \"ideal,\" implying access to optimal resources.\n\n4.  **Evaluate the Options:**\n    *   **A) Oxigenoterapia (Oxygen therapy):** Important supportive care for AMI, especially if hypoxic, but not the definitive *treatment* to restore coronary flow.\n    *   **B) Fibrinolisis (Fibrinolysis):** A reperfusion strategy used when primary PCI is not readily available within the recommended timeframe (e.g., <90-120 minutes). It dissolves the clot causing the occlusion.\n    *   **C) Doble antiagregación (Dual antiplatelet therapy):** Crucial part of AMI management (aspirin + P2Y12 inhibitor), but it prevents further clot formation/extension, it doesn't actively dissolve the existing occlusive thrombus or mechanically open the artery.\n    *   **D) Intervención coronaria (Coronary intervention):** Refers to primary percutaneous coronary intervention (PCI), specifically angioplasty with or without stenting. This is the preferred method for reperfusion in STEMI when available promptly in an ideal setting, as it directly opens the occluded artery.\n    *   **E) Ninguna de las anteriores (None of the above):** Unlikely, as there are established treatments.\n\n5.  **Determine the Best Choice (Ideal Scenario):**\n    *   The patient has a STEMI.\n    *   The goal in STEMI is rapid reperfusion to salvage myocardium.\n    *   Primary PCI (coronary intervention) is the gold standard and preferred reperfusion strategy for STEMI when it can be performed in a timely manner (door-to-balloon time <90 minutes in a PCI-capable hospital, or <120 minutes if transfer is needed).\n    *   The question specifies an \"ideal scenario,\" which strongly implies access to timely primary PCI.\n    *   Fibrinolysis is an alternative if PCI is delayed.\n    *   Oxygen and dual antiplatelet therapy are essential adjuncts but not the primary reperfusion strategy.\n\n6.  **Formulate the Final Answer:** Based on the analysis, coronary intervention (primary PCI) is the treatment of choice in an ideal setting for STEMI. This corresponds to option D.\n\n7.  **Final Check:** Ensure the output format matches the request (internal reasoning, then *only* the letter).<unused95>Respuesta final:D",
         "medgemma-27b-text-it"
        ],
        [
         "36",
         "Mujer de 32 años que presenta ataxia y temblor de manos. Antecedente: epilepsia tratada con fármaco que aumenta los \nniveles de GABA e inhibe los canales de calcio tipo T. Examen: petequias. Laboratorio: hiperamonemia. ¿Qué \nmedicamento se ha utilizado?",
         "Etosuximida",
         "Gabapentina",
         "Fenitoína",
         "Valproato",
         "D",
         "Ninguna de las anteriores",
         "Prueba A",
         "Year2025",
         "2025",
         "Mujer de 32 años que presenta ataxia y temblor de manos. Antecedente: epilepsia tratada con fármaco que aumenta los \nniveles de GABA e inhibe los canales de calcio tipo T. Examen: petequias. Laboratorio: hiperamonemia. ¿Qué \nmedicamento se ha utilizado? A) Etosuximida B) Gabapentina C) Fenitoína D) Valproato E) Ninguna de las anteriores",
         "<unused94>thought\n1.  **Analyze the Request:** The user wants me to act as an expert medical assistant trained in Peru and answer a multiple-choice medical question. I need to provide a step-by-step internal thought process, summarize the information, and then output *only* the final letter answer.\n\n2.  **Summarize the Information:**\n    *   Patient: 32-year-old female.\n    *   Symptoms: Ataxia, hand tremor, petechiae.\n    *   History: Epilepsy.\n    *   Medication: A drug that increases GABA levels and inhibits T-type calcium channels.\n    *   Lab finding: Hyperammonemia.\n    *   Question: Identify the medication used.\n    *   Options: A) Ethosuximide, B) Gabapentin, C) Phenytoin, D) Valproate, E) None of the above.\n\n3.  **Evaluate Each Option based on the Information:**\n\n    *   **A) Ethosuximide:**\n        *   Mechanism: Primarily inhibits T-type calcium channels.\n        *   Use: Primarily for absence seizures.\n        *   Side effects: GI upset, CNS effects (drowsiness, headache), rarely blood dyscrasias, *not* typically associated with hyperammonemia or significant GABA increase.\n        *   Match: Partially matches mechanism (T-type Ca++ channels), but doesn't fit the GABA increase, hyperammonemia, or petechiae well.\n\n    *   **B) Gabapentin:**\n        *   Mechanism: Binds to alpha-2-delta subunit of voltage-gated calcium channels. *Not* a primary GABA agonist or inhibitor of T-type calcium channels in the way described.\n        *   Use: Epilepsy (adjunctive), neuropathic pain.\n        *   Side effects: Drowsiness, dizziness, ataxia. *Not* typically associated with hyperammonemia or petechiae.\n        *   Match: Doesn't fit the described mechanism or the hyperammonemia/petechiae.\n\n    *   **C) Phenytoin:**\n        *   Mechanism: Blocks voltage-gated sodium channels.\n        *   Use: Focal and generalized tonic-clonic seizures.\n        *   Side effects: Gingival hyperplasia, hirsutism, ataxia, nystagmus, rash (including Stevens-Johnson), blood dyscrasias (rarely). *Not* associated with GABA increase, T-type Ca++ inhibition, or hyperammonemia.\n        *   Match: Doesn't fit the described mechanism or the hyperammonemia.\n\n    *   **D) Valproate (Valproic Acid):**\n        *   Mechanism: Multiple mechanisms - increases GABA levels (inhibits GABA transaminase, increases GABA synthesis), blocks voltage-gated sodium channels, and inhibits T-type calcium channels.\n        *   Use: Broad-spectrum anti-epileptic (absence, myoclonic, tonic-clonic, focal).\n        *   Side effects: Hepatotoxicity, pancreatitis, *hyperammonemia*, thrombocytopenia (leading to petechiae/bruising), weight gain, hair loss, tremor, ataxia.\n        *   Match: Fits *all* the key pieces of information:\n            *   Mechanism: Increases GABA, inhibits T-type Ca++ channels.\n            *   Symptoms/Signs: Ataxia, tremor (common side effects), petechiae (due to thrombocytopenia).\n            *   Lab: Hyperammonemia (known side effect).\n            *   History: Epilepsy (common indication).\n\n    *   **E) None of the above:** Since Valproate fits well, this is unlikely.\n\n4.  **Synthesize and Conclude:** Valproate is the only drug among the options that matches the described mechanism of action (increasing GABA and inhibiting T-type calcium channels) and the clinical presentation (ataxia, tremor, petechiae) and laboratory finding (hyperammonemia).\n\n5.  **Format the Output:** Provide only the final letter answer as requested.<unused95>Respuesta final:D",
         "medgemma-27b-text-it"
        ],
        [
         "37",
         "Varón de 39 años, obeso, acude por anorexia, constipación, poliuria y dolores oseos difusos. Examen: PA: 130/80 mmHg, \nFC: 84X'. Laboratorio: calcio: 11.6 mg/dL. ¿Cuál es el diagnóstico presuntivo?",
         "Consumo de tiazidas",
         "Hiperparatiroidismo primario",
         "Neoplasia metastásica",
         "Hiperparatoridismo secundario",
         "B",
         "Ninguna de las anteriores",
         "Prueba A",
         "Year2025",
         "2025",
         "Varón de 39 años, obeso, acude por anorexia, constipación, poliuria y dolores oseos difusos. Examen: PA: 130/80 mmHg, \nFC: 84X'. Laboratorio: calcio: 11.6 mg/dL. ¿Cuál es el diagnóstico presuntivo? A) Consumo de tiazidas B) Hiperparatiroidismo primario C) Neoplasia metastásica D) Hiperparatoridismo secundario E) Ninguna de las anteriores",
         "<unused94>thought\n1.  **Analyze the Request:** The user wants me to act as an expert medical assistant trained in Peru and answer a multiple-choice medical question. I need to provide a step-by-step internal thought process, summarize the information, and then output *only* the final letter answer.\n\n2.  **Summarize the Case:**\n    *   Patient: 39-year-old male.\n    *   Relevant History: Obese.\n    *   Symptoms: Anorexia, constipation, polyuria, diffuse bone pain.\n    *   Vitals: BP 130/80 mmHg, HR 84 bpm (within normal limits, slightly elevated BP but not severely hypertensive).\n    *   Lab Result: Calcium 11.6 mg/dL (Normal range typically ~8.5-10.2 mg/dL, so this is elevated - hypercalcemia).\n\n3.  **Analyze the Symptoms and Lab Result:**\n    *   **Hypercalcemia (Ca 11.6 mg/dL):** This is the key finding.\n    *   **Symptoms related to hypercalcemia:**\n        *   Anorexia (loss of appetite)\n        *   Constipation\n        *   Polyuria (due to nephrogenic diabetes insipidus caused by hypercalcemia)\n        *   Bone pain (can be caused by hypercalcemia itself or underlying bone disease)\n    *   **Other factors:** Obesity is noted but doesn't directly point to a specific cause of hypercalcemia in this context. Age (39) is relatively young for some causes but possible for others.\n\n4.  **Evaluate the Options:**\n    *   **A) Consumo de tiazidas (Thiazide use):** Thiazide diuretics can cause mild hypercalcemia by increasing renal calcium reabsorption. However, they usually don't cause such significant symptoms like diffuse bone pain, and the calcium level might not be this high. The patient's history doesn't mention thiazide use. Less likely to be the primary cause given the constellation of symptoms.\n    *   **B) Hiperparatiroidismo primario (Primary hyperparathyroidism):** This is a common cause of hypercalcemia, especially in adults. It's caused by excessive PTH secretion (usually from a parathyroid adenoma). Symptoms often include \"stones, bones, abdominal groans, thrones, and psychiatric overtones.\" The patient's symptoms (bone pain, constipation, polyuria - \"thrones\", anorexia - \"groans\") fit well. Hypercalcemia is the hallmark. This is a strong possibility.\n    *   **C) Neoplasia metastásica (Metastatic neoplasia):** Malignancy is another major cause of hypercalcemia, often more severe and rapid in onset than primary hyperparathyroidism. Bone metastases (e.g., from breast, lung, prostate cancer) can cause bone pain and hypercalcemia through osteolysis or secretion of PTHrP (parathyroid hormone-related peptide). While possible, primary hyperparathyroidism is statistically more common as a cause of hypercalcemia in an outpatient setting with these symptoms. The age (39) makes widespread metastases slightly less common than primary hyperparathyroidism, although not impossible.\n    *   **D) Hiperparatiroidismo secundario (Secondary hyperparathyroidism):** This occurs in response to chronic hypocalcemia (e.g., chronic kidney disease, vitamin D deficiency). PTH levels are high, but *calcium levels are typically low or normal*, not high. This option is inconsistent with the patient's hypercalcemia.\n    *   **E) Ninguna de las anteriores (None of the above):** Given that primary hyperparathyroidism (B) fits the clinical picture well, this is less likely.\n\n5.  **Compare Strongest Options (B vs. C):**\n    *   Primary hyperparathyroidism (B) is the most common cause of hypercalcemia in the outpatient setting. The symptoms (bone pain, constipation, polyuria, anorexia) are classic, albeit non-specific, for hypercalcemia and fit well with this diagnosis.\n    *   Metastatic neoplasia (C) is a significant cause, especially in hospitalized patients or those with known cancer. While possible, the presentation is very typical for primary hyperparathyroidism. Without more information suggesting malignancy (e.g., weight loss, history of cancer), primary hyperparathyroidism is the more likely *presumptive* diagnosis.\n\n6.  **Conclusion:** Based on the classic symptoms of hypercalcemia (anorexia, constipation, polyuria) combined with bone pain and a significantly elevated calcium level (11.6 mg/dL) in a 39-year-old male, primary hyperparathyroidism is the most likely presumptive diagnosis among the choices provided.\n\n7.  **Final Answer Format:** Select the letter corresponding to the chosen diagnosis.<unused95>Respuesta final:B",
         "medgemma-27b-text-it"
        ],
        [
         "38",
         "En pacientes con acromegalia secundarios a adenomas que secretan GH. ¿Cuál es el tratamiento inicial?",
         "Pegvisomant",
         "Cabergolina",
         "Octeótride",
         "Ablación quirúrgica",
         "D",
         "Ninguna de las anteriores",
         "Prueba A",
         "Year2025",
         "2025",
         "En pacientes con acromegalia secundarios a adenomas que secretan GH. ¿Cuál es el tratamiento inicial? A) Pegvisomant B) Cabergolina C) Octeótride D) Ablación quirúrgica E) Ninguna de las anteriores",
         "<unused94>thought\n1.  **Identify the core question:** The question asks for the *initial* treatment for acromegaly caused by GH-secreting pituitary adenomas.\n\n2.  **Analyze the condition:** Acromegaly is caused by excessive Growth Hormone (GH), usually from a pituitary adenoma. The goal of treatment is to normalize GH and IGF-1 levels and reduce tumor size if possible.\n\n3.  **Evaluate the options:**\n    *   **A) Pegvisomant:** This is a GH receptor antagonist. It blocks the action of GH but doesn't reduce tumor size. It's typically used when surgery or somatostatin analogs fail or are contraindicated. Not usually the *initial* treatment.\n    *   **B) Cabergolina:** This is a dopamine agonist. It can sometimes lower GH levels, especially in tumors that co-secrete prolactin, but it's not the primary or most effective treatment for pure GH-secreting adenomas. Not the standard *initial* treatment.\n    *   **C) Octeótride:** This is a somatostatin analog. It inhibits GH secretion from the pituitary adenoma and can also reduce tumor size in some cases. It's a common medical treatment option.\n    *   **D) Ablación quirúrgica (Surgical ablation/Transsphenoidal surgery):** This is the removal of the pituitary adenoma. It's considered the *first-line* and most definitive treatment for most patients with GH-secreting adenomas, aiming to cure the disease by removing the source of excess GH.\n    *   **E) Ninguna de las anteriores (None of the above):** Given that surgery is a standard initial treatment, this is unlikely.\n\n4.  **Determine the *initial* treatment:** Standard medical guidelines (including those relevant in Peru, which generally follow international standards) recommend transsphenoidal surgery as the primary and initial treatment for most patients with acromegaly due to pituitary adenomas. Medical therapy (like somatostatin analogs or pegvisomant) is usually reserved for patients who are not surgical candidates, have residual disease after surgery, or cannot tolerate surgery.\n\n5.  **Select the best option:** Based on the standard of care, surgical ablation (transsphenoidal surgery) is the preferred initial treatment.\n\n6.  **Format the answer:** The final answer should be just the letter corresponding to the chosen option.<unused95>Respuesta final:D",
         "medgemma-27b-text-it"
        ],
        [
         "39",
         "Primigesta de 41 semanas, acude a control prenatal por que aún no ha iniciado trabajo de parto. Examen: PA: 100/60 \nmmHg, FC: 72 X', AU: 32 cm, SPP: LCI, LCF: 132 X'. Tacto vaginal: D: 0 B: 50% AP -2. Ecografía: ponderado fetal 3700 \ng y oligohidramnios. Test no estresante normal. ¿Cuál es la conducta más adecuada?",
         "Inducción de trabajo de parto",
         "Cesárea a las 42 semanas",
         "Vigilancia fetal cada 72 horas",
         "Cesárea de emergencia",
         "A",
         "Ninguna de las anteriores",
         "Prueba A",
         "Year2025",
         "2025",
         "Primigesta de 41 semanas, acude a control prenatal por que aún no ha iniciado trabajo de parto. Examen: PA: 100/60 \nmmHg, FC: 72 X', AU: 32 cm, SPP: LCI, LCF: 132 X'. Tacto vaginal: D: 0 B: 50% AP -2. Ecografía: ponderado fetal 3700 \ng y oligohidramnios. Test no estresante normal. ¿Cuál es la conducta más adecuada? A) Inducción de trabajo de parto B) Cesárea a las 42 semanas C) Vigilancia fetal cada 72 horas D) Cesárea de emergencia E) Ninguna de las anteriores",
         "<unused94>thought\n1.  **Analyze the Request:** The user wants me to act as an expert medical assistant trained in Peru and answer a multiple-choice medical question. I need to provide a step-by-step internal thought process, summarize the information, and then give *only* the final letter answer.\n\n2.  **Summarize the Patient Information:**\n    *   Patient: Primigesta (first pregnancy).\n    *   Gestational Age: 41 weeks (post-term).\n    *   Reason for visit: No labor onset.\n    *   Vitals: BP 100/60 mmHg (normal), HR 72 bpm (normal).\n    *   Abdominal Exam: AU 32 cm (appropriate for GA), Fetal Presentation: Longitudinal, Cephalic, Fetal Heart Rate (FHR): 132 bpm (normal range).\n    *   Vaginal Exam: Dilation 0 cm, Effacement 50%, Station -2 (unfavorable cervix).\n    *   Ultrasound: Estimated Fetal Weight (EFW) 3700 g (macrosomia risk), Oligohydramnios (low amniotic fluid).\n    *   Non-Stress Test (NST): Normal (reassuring fetal status *at this moment*).\n\n3.  **Identify the Key Issues:**\n    *   **Post-term pregnancy (41 weeks):** Increased risk of placental insufficiency, macrosomia, meconium aspiration, stillbirth.\n    *   **Oligohydramnios:** Associated with placental insufficiency and increased risk of fetal compromise.\n    *   **Macrosomia (EFW 3700g):** Increased risk of shoulder dystocia, birth trauma, C-section.\n    *   **Unfavorable cervix (0/50%/-2):** Induction might be less successful or take longer.\n    *   **Normal NST:** Reassuring *currently*, but doesn't negate the risks associated with post-term pregnancy and oligohydramnios.\n\n4.  **Evaluate the Options:**\n    *   **A) Inducción de trabajo de parto (Induction of labor):** This is a standard management option for post-term pregnancies (typically recommended at 41-42 weeks). Given the oligohydramnios and potential macrosomia, delivery is indicated. Induction is a reasonable first step, although the unfavorable cervix might make it challenging. However, the risks of continuing the pregnancy (placental insufficiency, fetal compromise) outweigh the risks of induction in this scenario.\n    *   **B) Cesárea a las 42 semanas (Cesarean section at 42 weeks):** Waiting until 42 weeks increases the risks significantly, especially with oligohydramnios. This is not the most appropriate immediate action.\n    *   **C) Vigilancia fetal cada 72 horas (Fetal surveillance every 72 hours):** While fetal surveillance (like NSTs, biophysical profiles) is important, it's not sufficient management for a post-term pregnancy with oligohydramnios. The risks are too high to simply wait and monitor every 72 hours. More frequent monitoring (e.g., daily or every other day) and consideration for delivery are needed.\n    *   **D) Cesárea de emergencia (Emergency Cesarean section):** There is no indication for an *emergency* C-section *right now*. The NST is normal, and there are no signs of acute fetal distress or maternal compromise. Induction is usually attempted first unless there are contraindications or fetal distress.\n    *   **E) Ninguna de las anteriores (None of the above):** Option A (Induction) is a standard and appropriate management strategy in this situation.\n\n5.  **Determine the Most Appropriate Conduct:** The patient is post-term (41 weeks) with oligohydramnios and a macrosomic fetus. These factors increase the risk of adverse outcomes if the pregnancy continues. Although the NST is currently normal and the cervix is unfavorable, the risks associated with continuing the pregnancy outweigh the risks of attempting induction. Induction of labor is the standard management for post-term pregnancies, especially when complicated by oligohydramnios. While the unfavorable cervix might necessitate cervical ripening agents or a higher chance of C-section if induction fails, it remains the most appropriate initial step.\n\n6.  **Final Answer Selection:** Based on the analysis, induction of labor (Option A) is the most appropriate management strategy.<unused95>Respuesta final:A",
         "medgemma-27b-text-it"
        ],
        [
         "40",
         "Mujer de 30 años que durante una apendicectomía se encuentra una tumoración de menos de 2 cm en la punta del \napéndice. No se observa muestra de extensión abdominal extraapendicular. ¿Cuál es la conducta indicada?",
         "Colectomía ascendente",
         "Ileostomía",
         "Hemicolectomía derecha",
         "Apendicectomía",
         "D",
         "Ninguna de las anteriores",
         "Prueba A",
         "Year2025",
         "2025",
         "Mujer de 30 años que durante una apendicectomía se encuentra una tumoración de menos de 2 cm en la punta del \napéndice. No se observa muestra de extensión abdominal extraapendicular. ¿Cuál es la conducta indicada? A) Colectomía ascendente B) Ileostomía C) Hemicolectomía derecha D) Apendicectomía E) Ninguna de las anteriores",
         "<unused94>thought\n1.  **Analyze the question:** A 30-year-old woman undergoes an appendectomy. A tumor < 2 cm is found at the tip of the appendix. No extra-appendiceal spread is seen. The question asks for the indicated management.\n\n2.  **Identify the key information:**\n    *   Age: 30 years old (young adult)\n    *   Procedure: Appendectomy\n    *   Finding: Tumor < 2 cm at the tip of the appendix\n    *   Extent: No extra-appendiceal spread observed (implies localized disease)\n    *   Goal: Determine the appropriate management.\n\n3.  **Evaluate the options:**\n    *   A) Colectomía ascendente (Ascending colectomy): This is a major surgery involving removal of the cecum, ascending colon, and part of the transverse colon. It's typically reserved for larger tumors or those involving the cecum/ascending colon. Given the small size (< 2 cm) and location limited to the appendix tip with no spread, this seems excessive.\n    *   B) Ileostomía (Ileostomy): This is a surgical procedure creating an opening (stoma) from the ileum to the outside of the body. It's usually done for conditions affecting the colon or rectum, requiring temporary or permanent diversion of stool. It's not a primary treatment for a localized appendiceal tumor.\n    *   C) Hemicolectomía derecha (Right hemicolectomy): This involves removing the cecum, ascending colon, hepatic flexure, and the terminal ileum. It's a standard procedure for cecal or ascending colon cancers, or sometimes for appendiceal cancers with significant involvement or spread. Similar to ascending colectomy, it seems too extensive for a small, localized tumor at the appendix tip.\n    *   D) Apendicectomía (Appendectomy): The patient is already undergoing an appendectomy. If the tumor is small (< 2 cm), located at the tip, and confined to the appendix (no extra-appendiceal spread), a simple appendectomy might be sufficient treatment, especially for certain types of appendiceal tumors like carcinoid tumors of this size.\n    *   E) Ninguna de las anteriores (None of the above): This would be correct if none of the other options are appropriate.\n\n4.  **Consider the pathology:** The description suggests a possible appendiceal neuroendocrine tumor (carcinoid) or potentially a low-grade appendiceal mucinous neoplasm (LAMN) or adenocarcinoma.\n    *   For carcinoid tumors < 1 cm confined to the appendix, simple appendectomy is generally considered curative.\n    *   For carcinoid tumors between 1 and 2 cm, the risk of nodal metastasis increases, and a right hemicolectomy might be considered, especially if there are high-risk features (e.g., invasion of the mesoappendix, positive margins). However, the question states \"no se observa muestra de extensión abdominal extraapendicular,\" which implies the tumor is confined.\n    *   For LAMN or adenocarcinoma, even if small, a right hemicolectomy is often recommended due to the risk of spread and the potential for mucin production.\n\n5.  **Re-evaluate based on typical guidelines (Peruvian context implied, but general principles apply):**\n    *   A tumor < 2 cm at the *tip* of the appendix with *no* extra-appendiceal spread.\n    *   If it's a carcinoid: < 1 cm -> appendectomy. 1-2 cm -> appendectomy *or* right hemicolectomy depending on risk factors (invasion, margins, etc.). Since no spread is noted and it's at the tip, appendectomy is a strong possibility, especially if it's < 1 cm. Even if it's 1-2 cm, appendectomy *can* be considered if margins are clear and no high-risk features are present.\n    *   If it's LAMN or adenocarcinoma: Right hemicolectomy is usually preferred even for small tumors due to the risk of peritoneal spread.\n\n6.  **Critically assess the options again:**\n    *   A, C (Colectomía ascendente, Hemicolectomía derecha): These are major resections. While potentially indicated for certain appendiceal cancers (especially adenocarcinoma or high-risk carcinoids), they might be overtreatment for a small (<2cm), localized tumor at the tip, particularly if it's a low-grade carcinoid.\n    *   B (Ileostomía): Irrelevant for primary treatment.\n    *   D (Apendicectomía): The patient is already having this. If the tumor is small and confined (as described), this *might* be sufficient, especially for carcinoids < 1 cm or even 1-2 cm without adverse features. Given the options, and the description of a small tumor confined to the tip, appendectomy is the *least* invasive option that could potentially be curative in some scenarios (e.g., carcinoid < 1 cm). If the tumor is 1-2 cm, the decision between appendectomy and right hemicolectomy is more complex and depends on histology and risk factors not provided. However, *among the given choices*, appendectomy is the most plausible *initial* or *sufficient* procedure described. The question asks for the *indicated* conduct *given the findings during the appendectomy*. The finding is a small tumor confined to the tip. The most immediate and potentially sufficient procedure *based solely on the information given* is the appendectomy itself. If further pathology suggested a need for wider resection, that would be a subsequent decision, but the *indicated* conduct *at that moment* based on the intraoperative finding is to complete the appendectomy.\n\n7.  **Refine the choice:** The question describes a finding *during* an appendectomy. The tumor is small (<2cm) and localized to the tip without apparent spread. While a right hemicolectomy is often standard for appendiceal adenocarcinoma or high-risk carcinoids, a simple appendectomy is curative for carcinoids <1cm and can be considered for 1-2cm carcinoids without high-risk features. Given the limited information and the options, the appendectomy already in progress is the most appropriate *initial* step and potentially curative procedure based on the description. The other options represent more extensive surgery that might not be necessary based *only* on the intraoperative findings described.\n\n8.  **Final check:** The tumor is small (<2cm), at the tip, and no spread is seen. Appendectomy is the procedure being performed. For certain tumor types (like carcinoid <1cm), appendectomy alone is sufficient. Even for 1-2cm carcinoids, appendectomy might be considered if margins are clear and no high-risk features are present. Therefore, completing the appendectomy is the most reasonable immediate action based on the provided information.<unused95>Respuesta final:D",
         "medgemma-27b-text-it"
        ],
        [
         "41",
         "Varón de 18 años sufre caída sobre su hombro izquierdo, acude por limitación en la movilidad del miembro superior \nizquierdo. Examen: hombro en aducción, brazo en rotación interna y codo extendido. ¿Dónde se localiza la lesión?",
         "Tronco inferior del plexo braquial",
         "Nervio cubital y braquial cutáneo medial",
         "Tronco superior del plexo braquial",
         "Tronco medio del plexo braquial",
         "C",
         "Ninguna de las anteriores",
         "Prueba A",
         "Year2025",
         "2025",
         "Varón de 18 años sufre caída sobre su hombro izquierdo, acude por limitación en la movilidad del miembro superior \nizquierdo. Examen: hombro en aducción, brazo en rotación interna y codo extendido. ¿Dónde se localiza la lesión? A) Tronco inferior del plexo braquial B) Nervio cubital y braquial cutáneo medial C) Tronco superior del plexo braquial D) Tronco medio del plexo braquial E) Ninguna de las anteriores",
         "<unused94>thought\n1.  **Analyze the Request:** The user wants me to act as an expert medical assistant trained in Peru and answer a multiple-choice medical question. I need to provide a step-by-step internal thought process, summarize the information, and then output *only* the final letter answer.\n\n2.  **Summarize the Information:**\n    *   Patient: 18-year-old male.\n    *   Mechanism: Fall onto the left shoulder.\n    *   Symptom: Limited mobility of the left upper limb.\n    *   Physical Exam Findings:\n        *   Shoulder: Adducted.\n        *   Arm: Internally rotated.\n        *   Elbow: Extended.\n    *   Question: Location of the lesion causing these findings.\n    *   Options:\n        *   A) Lower trunk of the brachial plexus\n        *   B) Ulnar and medial brachial cutaneous nerves\n        *   C) Upper trunk of the brachial plexus\n        *   D) Middle trunk of the brachial plexus\n        *   E) None of the above\n\n3.  **Internal Step-by-Step Reasoning:**\n    *   **Identify the clinical presentation:** The described posture (shoulder adducted, arm internally rotated, elbow extended) is characteristic of a specific type of brachial plexus injury. This posture is often called the \"waiter's tip\" position.\n    *   **Relate the posture to muscle function:**\n        *   Shoulder adduction implies weakness/paralysis of shoulder abductors (deltoid, supraspinatus).\n        *   Arm internal rotation implies weakness/paralysis of external rotators (infraspinatus, teres minor).\n        *   Elbow extension implies weakness/paralysis of elbow flexors (biceps, brachialis, brachioradialis).\n    *   **Identify the nerves involved:**\n        *   Deltoid (abduction): Axillary nerve (C5, C6).\n        *   Supraspinatus (abduction initiation): Suprascapular nerve (C5, C6).\n        *   Infraspinatus (external rotation): Suprascapular nerve (C5, C6).\n        *   Teres minor (external rotation): Axillary nerve (C5, C6).\n        *   Biceps (elbow flexion, forearm supination): Musculocutaneous nerve (C5, C6, C7).\n        *   Brachialis (elbow flexion): Musculocutaneous nerve (C5, C6, T1).\n        *   Brachioradialis (elbow flexion): Radial nerve (C5, C6, C7).\n    *   **Determine the origin of these nerves:**\n        *   Axillary nerve: Posterior cord (C5, C6).\n        *   Suprascapular nerve: Upper trunk (C5, C6).\n        *   Musculocutaneous nerve: Lateral cord (C5, C6, C7).\n        *   Radial nerve: Posterior cord (C5, C6, C7, C8, T1).\n    *   **Identify the common origin:** The nerves supplying the muscles responsible for the observed weakness (deltoid, supraspinatus, infraspinatus, teres minor, biceps, brachialis, brachioradialis) primarily originate from the C5 and C6 nerve roots. These roots form the *upper trunk* of the brachial plexus.\n    *   **Consider the mechanism:** A fall onto the shoulder can stretch the brachial plexus, particularly the upper trunk, as it passes over the first rib or through the thoracic outlet. This is a common mechanism for Erb's palsy (upper trunk injury).\n    *   **Evaluate the options:**\n        *   A) Lower trunk (C8, T1): Primarily affects intrinsic hand muscles and forearm flexors/pronators. Not consistent with the presentation.\n        *   B) Ulnar and medial brachial cutaneous nerves: Ulnar nerve (C8, T1) affects intrinsic hand muscles, flexor carpi ulnaris, medial half of flexor digitorum profundus. Medial brachial cutaneous nerve (C8, T1) is sensory. Not consistent.\n        *   C) Upper trunk (C5, C6): Affects muscles innervated by C5/C6, leading to the \"waiter's tip\" posture. Consistent with the presentation.\n        *   D) Middle trunk (C7): Primarily affects triceps, wrist/finger extensors. Not consistent.\n        *   E) None of the above: Option C is consistent.\n    *   **Conclusion:** The clinical presentation strongly suggests an injury to the upper trunk of the brachial plexus (Erb's palsy).\n\n4.  **Format the Final Answer:** Output only the letter corresponding to the correct option.<unused95>Respuesta final:C",
         "medgemma-27b-text-it"
        ],
        [
         "42",
         "En el sistema de cuantificación POP-Q para prolapso genital. ¿Qué significa cuando el punto D se omite?",
         "Dificultad para cuantificar",
         "Prolapso genital total",
         "Hay presencia de incontinencia",
         "No hay cérvix",
         "D",
         "Ninguna de las anteriores",
         "Prueba A",
         "Year2025",
         "2025",
         "En el sistema de cuantificación POP-Q para prolapso genital. ¿Qué significa cuando el punto D se omite? A) Dificultad para cuantificar B) Prolapso genital total C) Hay presencia de incontinencia D) No hay cérvix E) Ninguna de las anteriores",
         "<unused94>thought\n1.  **Analyze the Request:** The user wants me to act as a medical assistant expert trained in Peru and answer a multiple-choice question about the POP-Q system for pelvic organ prolapse. I need to provide a step-by-step internal thought process, summarize the information, and then give *only* the final letter answer.\n\n2.  **Understand the POP-Q System:** The POP-Q (Pelvic Organ Prolapse Quantification) system is a standardized method for describing and quantifying pelvic organ prolapse. It uses specific anatomical points measured relative to the hymenal ring (or vaginal opening if the hymen is absent). The points are:\n    *   A: Anterior vaginal wall (cystocele)\n    *   B: Vesicourethral pivot point\n    *   C: Urethral meatus\n    *   D: Posterior vaginal wall (rectocele)\n    *   E: Perineal body\n    *   F: Popliteal fossa (used for rectal prolapse)\n    *   Ba: Bladder neck\n    *   Bb: Urethral meatus (at rest)\n    *   Bc: Urethral meatus (straining)\n    *   Bp: Vesicourethral pivot point (straining)\n    *   Qa: Anterior vaginal wall (straining)\n    *   Qb: Vesicourethral pivot point (straining)\n    *   Qc: Urethral meatus (straining)\n    *   Qd: Posterior vaginal wall (straining)\n    *   Qe: Perineal body (straining)\n    *   Sf: Rectal axis (straining)\n\n3.  **Focus on Point D:** Point D specifically refers to the *posterior vaginal wall* (rectocele). It's measured from the hymenal ring to the most distal point of the posterior vaginal wall.\n\n4.  **Interpret \"Point D is omitted\":** If point D is omitted, it means the posterior vaginal wall cannot be measured in its usual way. Why might this happen?\n    *   The posterior wall is completely prolapsed *beyond* the hymenal ring, making the measurement impossible or meaningless in the standard way.\n    *   The posterior wall is *absent* or significantly altered, preventing measurement.\n    *   The *cervix* has prolapsed completely, obscuring the posterior vaginal wall. This is a common reason for omitting D. When the cervix prolapses completely (Stage III or IV prolapse, specifically uterine prolapse), it descends below the hymenal ring, making the measurement of the posterior vaginal wall (D) impossible or irrelevant as the primary prolapse is uterine.\n\n5.  **Evaluate the Options:**\n    *   A) Dificultad para cuantificar: This is too general. Omitting D *is* a difficulty, but the question asks for the *specific meaning* of the omission in the context of POP-Q.\n    *   B) Prolapso genital total: This is a possible outcome of severe prolapse, but omitting D doesn't *automatically* mean total prolapse. It could be just a complete uterine prolapse obscuring D.\n    *   C) Hay presencia de incontinencia: Incontinence is related to pelvic floor function but is not directly indicated by omitting point D.\n    *   D) No hay cérvix: This is incorrect. The omission of D often happens *because* the cervix is present and has prolapsed completely, obscuring the posterior wall. If there were no cervix (e.g., post-hysterectomy), point D would still be measurable (representing the rectocele).\n    *   E) Ninguna de las anteriores: Let's re-evaluate. The most common reason for omitting D is a complete uterine prolapse where the cervix descends below the hymen, making the posterior vaginal wall measurement impossible or irrelevant. None of the options perfectly capture this specific scenario. Option D is definitively wrong. Option A is too vague. Option B might occur, but isn't the direct meaning of omitting D. Option C is unrelated.\n\n6.  **Refine Understanding of Omitting D:** According to POP-Q guidelines (e.g., ACOG Practice Bulletin No. 200), point D is omitted when the cervix is completely prolapsed (below the hymen). The reason is that the measurement of the posterior vaginal wall is no longer relevant or possible in the standard way when the uterus/cervix is the primary prolapsing organ obscuring the view.\n\n7.  **Re-evaluate Options based on Refined Understanding:**\n    *   A) Dificultad para cuantificar: Still too general.\n    *   B) Prolapso genital total: Possible consequence, but not the *meaning* of omitting D.\n    *   C) Hay presencia de incontinencia: Unrelated.\n    *   D) No hay cérvix: Incorrect. Omitting D is often *because* the cervix is present and prolapsed.\n    *   E) Ninguna de las anteriores: This seems the most likely correct answer, as none of the other options accurately describe the specific clinical situation (complete uterine prolapse obscuring the posterior vaginal wall) that leads to omitting point D in the POP-Q system.\n\n8.  **Final Check:** The standard interpretation of omitting D in POP-Q is due to complete uterine prolapse where the cervix descends below the hymenal ring. None of the provided options (A, B, C, D) accurately state this reason. Therefore, E is the correct choice.<unused95>Respuesta final:E",
         "medgemma-27b-text-it"
        ],
        [
         "43",
         "Mujer de 65 años, diabética con ERC en terapia dialítica hace 4 años, desde hace un mes presenta dorsalgia y fiebre; en \nla última semana se agrega debilidad en miembros inferiores y dificultad para la micción. ¿Cuál es el diagnóstico más \nprobable?",
         "Metástasis ósea",
         "Osteomielitis vertebral",
         "Espóndiloartrosis",
         "Paraparesia espástica",
         "B",
         "Ninguna de las anteriores",
         "Prueba A",
         "Year2025",
         "2025",
         "Mujer de 65 años, diabética con ERC en terapia dialítica hace 4 años, desde hace un mes presenta dorsalgia y fiebre; en \nla última semana se agrega debilidad en miembros inferiores y dificultad para la micción. ¿Cuál es el diagnóstico más \nprobable? A) Metástasis ósea B) Osteomielitis vertebral C) Espóndiloartrosis D) Paraparesia espástica E) Ninguna de las anteriores",
         "<unused94>thought\nLa usuaria quiere que actúe como un asistente médico experto con entrenamiento en Perú y responda una pregunta de opción múltiple sobre un caso clínico.\n\n**Resumen del caso:**\n*   **Paciente:** Mujer de 65 años.\n*   **Antecedentes:** Diabetes Mellitus, Enfermedad Renal Crónica (ERC) en diálisis hace 4 años.\n*   **Síntomas:**\n    *   Dorsalgia (dolor de espalda) y fiebre desde hace 1 mes.\n    *   Debilidad en miembros inferiores y dificultad para la micción desde hace 1 semana.\n\n**Análisis de las opciones:**\n\n*   **A) Metástasis ósea:** Posible en una paciente de 65 años, pero la fiebre y la rápida progresión de síntomas neurológicos (debilidad, dificultad para micción) en una semana no son tan típicos, aunque pueden ocurrir con compresión medular. No hay información sobre un cáncer primario.\n*   **B) Osteomielitis vertebral:** La fiebre y el dolor de espalda son consistentes. La ERC y la diabetes son factores de riesgo. La compresión medular por un absceso epidural asociado a osteomielitis vertebral podría explicar la debilidad en miembros inferiores y la dificultad para la micción (síndrome de cauda equina o compresión medular). Esta opción encaja bien con el cuadro clínico completo.\n*   **C) Espóndiloartrosis:** Es común en esta edad, causa dorsalgia, pero no explica la fiebre, la debilidad en miembros inferiores ni la dificultad para la micción.\n*   **D) Paraparesia espástica:** Es un síntoma (debilidad en miembros inferiores), no un diagnóstico etiológico. La causa de la paraparesia necesita ser determinada.\n*   **E) Ninguna de las anteriores:** Dado que la osteomielitis vertebral con posible compresión medular parece una explicación plausible, esta opción es menos probable.\n\n**Razonamiento:**\nLa combinación de fiebre, dolor de espalda (dorsalgia) en un paciente con diabetes y ERC en diálisis, junto con el desarrollo rápido de síntomas neurológicos como debilidad en miembros inferiores y disfunción urinaria (dificultad para la micción), sugiere fuertemente una infección vertebral con posible extensión a estructuras adyacentes causando compresión medular o del cono medular/cauda equina. La osteomielitis vertebral, especialmente con formación de absceso epidural, es una causa importante de estos síntomas en pacientes inmunocomprometidos o con comorbilidades como la diabetes y la ERC. Las metástasis óseas son menos probables sin un antecedente de cáncer y la fiebre no es un síntoma primario. La espóndiloartrosis no explica la fiebre ni los síntomas neurológicos agudos. La paraparesia espástica es un hallazgo, no la causa subyacente.\n\n**Conclusión:** La osteomielitis vertebral con posible compresión medular es el diagnóstico más probable que integra todos los síntomas y factores de riesgo de la paciente.\n\n**Respuesta final:** B<unused95>Respuesta final:B",
         "medgemma-27b-text-it"
        ],
        [
         "44",
         "Mujer de 75 años es trasladada al servicio de emergencia, porque desde hace 4 días presenta dolor abdominal a \npredominio de fosa iliaca izquierda, vómitos, alza térmica y rectorragia. Antecedente: estreñimiento crónico. Examen: \npálida, PA: 90/60 mmHg, FC: 100X', FR: 30X'. Abdomen: distendido, RHA (-); a la palpación dolor abdominal generalizado, \nrebote(+); TR: dedo de guante con sangre. ¿Cuál es el diagnóstico más probable?",
         "Colitis infecciosa",
         "Apendicitis aguda",
         "Diverticulitis aguda",
         "Enfermedad de Crohn",
         "C",
         "Ninguna de las anteriores",
         "Prueba A",
         "Year2025",
         "2025",
         "Mujer de 75 años es trasladada al servicio de emergencia, porque desde hace 4 días presenta dolor abdominal a \npredominio de fosa iliaca izquierda, vómitos, alza térmica y rectorragia. Antecedente: estreñimiento crónico. Examen: \npálida, PA: 90/60 mmHg, FC: 100X', FR: 30X'. Abdomen: distendido, RHA (-); a la palpación dolor abdominal generalizado, \nrebote(+); TR: dedo de guante con sangre. ¿Cuál es el diagnóstico más probable? A) Colitis infecciosa B) Apendicitis aguda C) Diverticulitis aguda D) Enfermedad de Crohn E) Ninguna de las anteriores",
         "<unused94>thought\n1.  **Analyze the Request:** The user wants me to act as an expert medical assistant trained in Peru and answer a multiple-choice medical question. I need to provide a step-by-step internal thought process (which I won't show in the final output) and then output *only* the letter of the correct answer, preceded by \"Respuesta final:\".\n\n2.  **Summarize the Case Information:**\n    *   **Patient:** 75-year-old female.\n    *   **Presenting Complaint:** 4 days of abdominal pain (predominantly left iliac fossa), vomiting, fever, rectal bleeding.\n    *   **History:** Chronic constipation.\n    *   **Examination Findings:**\n        *   Pale.\n        *   Hypotension (BP 90/60 mmHg).\n        *   Tachycardia (HR 100 bpm).\n        *   Tachypnea (RR 30 breaths/min).\n        *   Abdomen: Distended, absent bowel sounds (RHA -), generalized tenderness, rebound tenderness (+).\n        *   Rectal Exam (TR): Blood on glove.\n\n3.  **Evaluate the Options:**\n    *   **A) Colitis infecciosa (Infectious Colitis):** Can cause abdominal pain, fever, and sometimes rectal bleeding. However, the pain is often more diffuse or lower abdominal, and the localized left iliac fossa pain, combined with the patient's age and history of chronic constipation, makes other diagnoses more likely. The signs of peritonitis (rebound tenderness, absent bowel sounds) are less typical for uncomplicated infectious colitis.\n    *   **B) Apendicitis aguda (Acute Appendicitis):** Typically presents with periumbilical pain migrating to the right iliac fossa. While atypical presentations exist, the predominant *left* iliac fossa pain makes this diagnosis highly unlikely.\n    *   **C) Diverticulitis aguda (Acute Diverticulitis):** This is inflammation/infection of diverticula, most commonly in the sigmoid colon (left iliac fossa). It classically presents with left lower quadrant pain, fever, and changes in bowel habits (constipation or diarrhea). Complications can include perforation, abscess, obstruction, and bleeding. The patient's age (elderly), history of chronic constipation (risk factor for diverticulosis), location of pain (left iliac fossa), fever, vomiting, and signs of peritonitis (distension, absent bowel sounds, rebound tenderness) are highly suggestive of complicated diverticulitis (e.g., perforation with peritonitis). The rectal bleeding could be from diverticular bleeding (common) or related to the inflammation/perforation. This fits the clinical picture well.\n    *   **D) Enfermedad de Crohn (Crohn's Disease):** This is a chronic inflammatory bowel disease. While it can cause abdominal pain, fever, and sometimes bleeding, it usually presents more insidiously or with recurrent flares. Acute presentation with signs of peritonitis like this is less typical, especially as a first presentation in a 75-year-old. Crohn's often affects the terminal ileum (right lower quadrant) or perianal area, although it can affect any part of the GI tract. The acute, severe presentation with peritonitis points away from Crohn's as the *most likely* diagnosis in this scenario.\n    *   **E) Ninguna de las anteriores (None of the above):** Given that diverticulitis fits the clinical picture very well, this option is less likely.\n\n4.  **Synthesize and Conclude:** The patient is elderly with chronic constipation, presenting with acute left iliac fossa pain, fever, vomiting, rectal bleeding, and signs of peritonitis (distension, absent bowel sounds, rebound tenderness). This constellation of symptoms and signs is most characteristic of acute diverticulitis, likely complicated (e.g., perforation leading to peritonitis).\n\n5.  **Format the Final Answer:** The request requires only \"Respuesta final:\" followed by the letter. The most likely diagnosis is Diverticulitis aguda, which corresponds to option C.<unused95>Respuesta final:C",
         "medgemma-27b-text-it"
        ],
        [
         "45",
         "¿Qué sustancia facilita la absorción de hierro a nivel intestinal?",
         "Polifenoles",
         "Calcio",
         "Fructosa",
         "Oxalatos",
         "C",
         "Ninguna de las anteriores",
         "Prueba A",
         "Year2025",
         "2025",
         "¿Qué sustancia facilita la absorción de hierro a nivel intestinal? A) Polifenoles B) Calcio C) Fructosa D) Oxalatos E) Ninguna de las anteriores",
         "<unused94>thought\n1.  **Analyze the question:** The question asks which substance *facilitates* (enhances) iron absorption in the intestine.\n\n2.  **Evaluate the options:**\n    *   **A) Polifenoles:** These are found in tea, coffee, and some fruits/vegetables. They are known to *inhibit* iron absorption by forming complexes with iron. So, this is incorrect.\n    *   **B) Calcio:** Calcium competes with iron for absorption pathways in the intestine. High calcium intake can *inhibit* iron absorption. So, this is incorrect.\n    *   **C) Fructosa:** Fructose is a sugar. While some studies suggest certain sugars might slightly influence iron absorption, it's not a primary facilitator. Vitamin C (ascorbic acid) is the most well-known enhancer. Fructose itself isn't typically listed as a major facilitator.\n    *   **D) Oxalatos:** Oxalates, found in spinach, rhubarb, etc., bind to iron and *inhibit* its absorption. So, this is incorrect.\n    *   **E) Ninguna de las anteriores:** Since options A, B, and D are known inhibitors, and C is not a primary facilitator, this option becomes plausible. The most significant facilitator of non-heme iron absorption is Vitamin C (ascorbic acid), which is not listed.\n\n3.  **Confirm knowledge:** Recall or look up factors affecting iron absorption. Key enhancers include Vitamin C (ascorbic acid) and meat/fish/poultry factors (for heme iron). Key inhibitors include phytates, polyphenols (tannins), calcium, oxalates, and certain medications (e.g., antacids).\n\n4.  **Re-evaluate options based on confirmation:**\n    *   Polyphenols: Inhibitor.\n    *   Calcium: Inhibitor.\n    *   Fructosa: Not a primary facilitator.\n    *   Oxalates: Inhibitor.\n    *   None of the above: Correct, as the major facilitator (Vitamin C) is missing, and the listed options are either inhibitors or not significant facilitators.\n\n5.  **Formulate the final answer:** Based on the analysis, none of the listed substances (Polifenoles, Calcio, Fructosa, Oxalatos) facilitate iron absorption; in fact, A, B, and D inhibit it. Therefore, the correct answer is E.<unused95>Respuesta final:E",
         "medgemma-27b-text-it"
        ],
        [
         "46",
         "Con el objetivo de disminuir la incidencia de embarazo en adolescentes la Dirección Regional de Salud implementa un \nplan de comunicación educativa dirigido a los escolares de secundaria de su ámbito. ¿Qué tipo de intervención sanitaria \nse está implementando?",
         "Rehabilitación",
         "Prevención",
         "Promoción",
         "Recuperación",
         "C",
         "Ninguna de las anteriores",
         "Prueba A",
         "Year2025",
         "2025",
         "Con el objetivo de disminuir la incidencia de embarazo en adolescentes la Dirección Regional de Salud implementa un \nplan de comunicación educativa dirigido a los escolares de secundaria de su ámbito. ¿Qué tipo de intervención sanitaria \nse está implementando? A) Rehabilitación B) Prevención C) Promoción D) Recuperación E) Ninguna de las anteriores",
         "<unused94>thought\n1.  **Analyze the question:** The question asks to classify a health intervention implemented by a Regional Health Directorate in Peru. The intervention is an educational communication plan aimed at secondary school students to reduce teenage pregnancy.\n\n2.  **Identify the key elements:**\n    *   **Goal:** Decrease the incidence of teenage pregnancy.\n    *   **Target population:** Secondary school students.\n    *   **Method:** Educational communication plan.\n    *   **Context:** Implemented by a health authority (Dirección Regional de Salud).\n\n3.  **Define the options:**\n    *   **A) Rehabilitación (Rehabilitation):** Actions aimed at restoring function or reducing disability after a disease or injury has occurred. Focuses on recovery from an existing condition.\n    *   **B) Prevención (Prevention):** Actions aimed at reducing the risk of disease or injury *before* it occurs. Includes primary (preventing onset), secondary (early detection/intervention), and tertiary (reducing complications).\n    *   **C) Promoción (Promotion):** Actions aimed at enabling people to increase control over and improve their health. Focuses on health education, lifestyle changes, and creating supportive environments *before* disease occurs. Often overlaps with primary prevention but emphasizes empowerment and positive health.\n    *   **D) Recuperación (Recovery):** Similar to rehabilitation, focusing on regaining health or function after illness or injury.\n    *   **E) Ninguna de las anteriores (None of the above):** If none of the other options fit.\n\n4.  **Evaluate the intervention against the definitions:**\n    *   The intervention aims to *decrease the incidence* of teenage pregnancy. This means it's trying to stop it from happening in the first place.\n    *   It targets a population *before* they experience the outcome (teenage pregnancy).\n    *   It uses *education* to influence behavior and knowledge.\n    *   This aligns strongly with the concept of **prevention**, specifically primary prevention, as it aims to prevent the initial occurrence of the unwanted outcome (pregnancy).\n    *   It also has elements of **promotion**, as it involves health education to empower students to make informed decisions about their health. However, the primary goal stated (\"disminuir la incidencia\") points more directly towards prevention.\n    *   Rehabilitation and Recovery are clearly incorrect as they deal with conditions that have already occurred.\n\n5.  **Distinguish between Prevention and Promotion:** While related, prevention often focuses on specific risk reduction (e.g., vaccination, screening), while promotion is broader, focusing on overall health enhancement and empowerment through education and lifestyle changes. In this case, the intervention is specifically targeted at reducing the *incidence* of a particular negative outcome (teenage pregnancy) through education. This fits the definition of prevention, particularly primary prevention. While it *promotes* health by educating, the *objective* stated is prevention. In public health classification, interventions aimed at reducing the *incidence* of a specific health problem are typically categorized under prevention.\n\n6.  **Select the best fit:** Based on the goal of reducing the *incidence* of teenage pregnancy before it occurs, \"Prevención\" (Prevention) is the most accurate classification.\n\n7.  **Final Answer Formulation:** The question asks for the type of health intervention. The intervention aims to reduce the incidence of teenage pregnancy through education. This is a classic example of primary prevention. Therefore, the correct option is B.<unused95>Respuesta final:B",
         "medgemma-27b-text-it"
        ],
        [
         "47",
         "Mujer de 32 años, acude por dolor en fosa iliaca derecha desde hace tres días que se ha ido intensificando. Antecedentes \nde hidrosonografía hace 10 días. Examen: T°: 37 °C, FC: 80X'. Tacto vaginal: dolor a la movilización de cérvix, se \nevidencia flujo vaginal con mal olor. Eco TV útero de 7 cm, presencia de líquido en fondo de saco. ¿Cuál es el manejo \nmás adecuado?",
         "Clindamicina + gentamicina",
         "Doxiciclina + ceftriaxona + metronidazol",
         "Doxiciclina + azitromicina",
         "Ceftriaxona + doxiciclina + gentamicina",
         "B",
         "Ninguna de las anteriores",
         "Prueba A",
         "Year2025",
         "2025",
         "Mujer de 32 años, acude por dolor en fosa iliaca derecha desde hace tres días que se ha ido intensificando. Antecedentes \nde hidrosonografía hace 10 días. Examen: T°: 37 °C, FC: 80X'. Tacto vaginal: dolor a la movilización de cérvix, se \nevidencia flujo vaginal con mal olor. Eco TV útero de 7 cm, presencia de líquido en fondo de saco. ¿Cuál es el manejo \nmás adecuado? A) Clindamicina + gentamicina B) Doxiciclina + ceftriaxona + metronidazol C) Doxiciclina + azitromicina D) Ceftriaxona + doxiciclina + gentamicina E) Ninguna de las anteriores",
         "<unused94>thought\n1.  **Analyze the Request:** The user wants me to act as an expert medical assistant trained in Peru and answer a multiple-choice medical question. I need to provide a step-by-step internal thought process, summarize the information, and then give *only* the final letter answer.\n\n2.  **Summarize the Case:**\n    *   **Patient:** 32-year-old female.\n    *   **Presenting Complaint:** Right iliac fossa pain, worsening over 3 days.\n    *   **Relevant History:** Hysterosalpingography (HSG) 10 days ago.\n    *   **Vitals:** Temp 37°C (afebrile), HR 80 bpm (normal).\n    *   **Physical Exam:**\n        *   Vaginal exam: Cervical motion tenderness (CMT).\n        *   Vaginal discharge: Malodorous.\n    *   **Imaging (Transvaginal Ultrasound - TVUS):**\n        *   Uterus: 7 cm (enlarged, normal is ~5-7 cm, but could be within range or slightly enlarged).\n        *   Pouch of Douglas (cul-de-sac): Free fluid.\n\n3.  **Differential Diagnosis based on Symptoms/Signs:**\n    *   **Pelvic Inflammatory Disease (PID):** Right iliac fossa pain, CMT, malodorous discharge, free fluid in the pouch of Douglas. The recent HSG is a significant risk factor (instrumentation can introduce infection). The enlarged uterus could be related to endometritis (part of PID).\n    *   **Appendicitis:** Right iliac fossa pain. However, CMT and malodorous discharge are less typical. Fever is often present but not always.\n    *   **Ectopic Pregnancy:** Right iliac fossa pain, free fluid. However, CMT is less specific, and malodorous discharge is not typical. A pregnancy test would be crucial (not mentioned, but assumed negative or ruled out given the context of PID treatment options).\n    *   **Ovarian Cyst Rupture/Torsion:** Right iliac fossa pain, free fluid. CMT and malodorous discharge are less typical.\n    *   **Endometritis:** Pain, enlarged uterus, free fluid. Often associated with PID.\n    *   **Tubo-ovarian Abscess (TOA):** A complication of PID. Presents with severe pain, often fever, and a palpable mass (not mentioned here).\n\n4.  **Most Likely Diagnosis:** Given the combination of right iliac fossa pain, CMT, malodorous discharge, free fluid, and the recent HSG (a known risk factor for ascending infection), Pelvic Inflammatory Disease (PID) is the most likely diagnosis. The enlarged uterus suggests possible endometritis.\n\n5.  **Evaluate Treatment Options for PID (based on Peruvian/International Guidelines - CDC/WHO):**\n    *   PID is typically polymicrobial, involving *Neisseria gonorrhoeae*, *Chlamydia trachomatis*, anaerobes, and Gram-negative rods.\n    *   Treatment needs to cover these organisms.\n    *   **Outpatient Regimens (for mild-moderate PID):**\n        *   Ceftriaxone (covers *N. gonorrhoeae*) + Doxycycline (covers *C. trachomatis*) +/- Metronidazole (covers anaerobes).\n        *   Cefoxitin or Cefotetan (covers *N. gonorrhoeae*, *C. trachomatis*, and anaerobes) OR Other parenteral 3rd-gen cephalosporin + Doxycycline +/- Metronidazole.\n        *   Azithromycin can sometimes substitute for Doxycycline.\n    *   **Inpatient Regimens (for severe PID, TOA, pregnancy, failure of outpatient therapy):**\n        *   Cefotetan or Cefoxitin PLUS Doxycycline.\n        *   Clindamycin PLUS Gentamicin.\n        *   Ampicillin-Sulbactam PLUS Doxycycline.\n\n6.  **Analyze the Provided Options:**\n    *   **A) Clindamicina + gentamicina:** This is a standard *inpatient* regimen for PID, particularly if TOA is suspected or if there's concern for resistant organisms or allergy to cephalosporins. It covers anaerobes, Gram-negatives, and some Gram-positives.\n    *   **B) Doxiciclina + ceftriaxona + metronidazol:** This is a comprehensive *outpatient* regimen covering *N. gonorrhoeae* (ceftriaxone), *C. trachomatis* (doxycycline), and anaerobes (metronidazole). This is a very common and appropriate regimen for PID.\n    *   **C) Doxiciclina + azitromicina:** This covers *C. trachomatis* (both) and some other atypical organisms. It lacks reliable coverage for *N. gonorrhoeae* and anaerobes. Not a standard PID regimen.\n    *   **D) Ceftriaxona + doxiciclina + gentamicina:** Ceftriaxone + Doxycycline is a standard outpatient regimen. Adding Gentamicin is usually reserved for inpatient, more severe cases or specific situations (like suspected *Pseudomonas* or resistant Gram-negatives), often in combination with Clindamycin. This combination isn't a typical first-line outpatient regimen.\n    *   **E) Ninguna de las anteriores:** Unlikely, as several options represent standard PID treatments.\n\n7.  **Select the Best Option:**\n    *   The patient presents with symptoms suggestive of PID (pain, CMT, discharge, free fluid) following a procedure known to increase risk (HSG).\n    *   The patient is afebrile and hemodynamically stable (T 37°C, FC 80), suggesting mild-to-moderate PID suitable for outpatient management, although the worsening pain and free fluid warrant careful consideration.\n    *   Option B (Doxycycline + Ceftriaxone + Metronidazole) provides broad coverage for the most common pathogens in PID (*N. gonorrhoeae*, *C. trachomatis*, anaerobes) and is a standard outpatient regimen.\n    *   Option A (Clindamycin + Gentamicin) is typically reserved for inpatient management or more severe cases. While potentially effective, it's usually not the first choice for uncomplicated outpatient PID.\n    *   Option D adds Gentamicin to a standard outpatient regimen, which isn't standard practice for initial outpatient treatment.\n    *   Option C lacks adequate coverage for *N. gonorrhoeae* and anaerobes.\n\n8.  **Conclusion:** Option B represents the most appropriate and comprehensive outpatient antibiotic regimen for suspected PID in this clinical scenario, covering the likely pathogens.\n\n9.  **Final Answer Format:** Provide only the letter.<unused95>Respuesta final:B",
         "medgemma-27b-text-it"
        ],
        [
         "48",
         "Varón de 32 años, ingresa por pérdida de conciencia de forma brusca acompañado de movimientos tónico clónicos \ngeneralizados; esposo refiere que desde hace 2 días no duerme por problemas familiares y estrés y que nunca ha tenido \nun cuadro similar. Examen: post ictal. Boca: signos de mordedura de lengua. ¿Cuál es la indicación?",
         "Fenitoina",
         "Conducta expectante",
         "Fenobarbital",
         "Valproato de sodio",
         "B",
         "Ninguna de las anteriores",
         "Prueba A",
         "Year2025",
         "2025",
         "Varón de 32 años, ingresa por pérdida de conciencia de forma brusca acompañado de movimientos tónico clónicos \ngeneralizados; esposo refiere que desde hace 2 días no duerme por problemas familiares y estrés y que nunca ha tenido \nun cuadro similar. Examen: post ictal. Boca: signos de mordedura de lengua. ¿Cuál es la indicación? A) Fenitoina B) Conducta expectante C) Fenobarbital D) Valproato de sodio E) Ninguna de las anteriores",
         "<unused94>thought\n1.  **Analyze the Request:** The user wants me to act as an expert medical assistant trained in Peru and answer a multiple-choice medical question. I need to provide a step-by-step internal thought process, summarize the information, and then output *only* the final letter answer.\n\n2.  **Summarize the Case:**\n    *   Patient: 32-year-old male.\n    *   Presentation: Sudden loss of consciousness with generalized tonic-clonic movements.\n    *   History: 2 days of sleep deprivation due to family problems/stress. No prior similar episodes.\n    *   Exam: Post-ictal state. Signs of tongue biting.\n    *   Question: What is the indication (treatment)?\n\n3.  **Identify the Likely Diagnosis:** The clinical presentation (sudden loss of consciousness, generalized tonic-clonic movements, post-ictal state, tongue biting) is highly suggestive of a generalized tonic-clonic seizure (GTCS). The history of sleep deprivation and stress are known triggers for seizures, especially in someone with a potential underlying predisposition or in the context of a first-time seizure. This is likely a *first unprovoked seizure* (although triggered by stress/sleep deprivation, it's the first episode).\n\n4.  **Evaluate the Treatment Options:**\n    *   **A) Fenitoina:** An anticonvulsant commonly used for generalized tonic-clonic seizures and focal seizures. It's a reasonable option for managing seizures.\n    *   **B) Conducta expectante:** This means observation without immediate treatment. While sometimes considered after a *single* unprovoked seizure, especially if the cause is clearly identified and reversible (like here, potentially stress/sleep deprivation), the severity (tonic-clonic, tongue biting) and the potential risk of recurrence often warrant treatment, particularly in the acute setting after a first seizure. However, the question asks for the *indication* (treatment), implying what should be done *now* or shortly after.\n    *   **C) Fenobarbital:** Another anticonvulsant, often used for neonatal seizures or status epilepticus, but less commonly as a first-line agent for a new-onset seizure in an adult compared to others due to side effects (sedation).\n    *   **D) Valproato de sodio:** A broad-spectrum anticonvulsant effective for various seizure types, including generalized tonic-clonic seizures. It's a common first-line option.\n    *   **E) Ninguna de las anteriores:** This is possible if none of the other options are appropriate.\n\n5.  **Determine the Best Indication/Treatment:**\n    *   The patient has had a first generalized tonic-clonic seizure.\n    *   Standard practice after a first unprovoked seizure often involves initiating anticonvulsant therapy to reduce the risk of recurrence, although the decision is individualized based on risk factors (e.g., structural brain lesion, EEG findings, patient preference).\n    *   Given the options, Fenitoina (A) and Valproato de sodio (D) are both appropriate first-line treatments for generalized tonic-clonic seizures.\n    *   Fenobarbital (C) is less commonly used first-line in adults for this presentation.\n    *   Conducta expectante (B) might be considered *long-term* after a single seizure if risk factors are low, but immediate management often involves addressing the acute event and considering prophylaxis. The question asks for the \"indicación,\" which usually implies treatment.\n    *   Between Fenitoina and Valproato, both are valid. However, Fenitoina is a very classic and widely used drug for GTCS. In the context of a multiple-choice question without further differentiating factors, Fenitoina is a strong candidate. Valproato is also a strong candidate.\n    *   Let's re-read the question: \"Cuál es la indicación?\". This implies what treatment is indicated *for this condition* (first GTCS). Both A and D are indicated. Is there a reason to prefer one? Not strongly based on the limited info. However, Fenitoina is a very common choice for GTCS.\n    *   Consider the context of Peru. Both drugs are available and used.\n    *   Let's assume the question is asking for a standard, appropriate treatment for a first GTCS. Both A and D fit. Is there any subtle clue? The presentation is classic GTCS.\n    *   If forced to choose one standard first-line agent for GTCS presented in this way, Fenitoina is a very common and appropriate choice. Valproate is also appropriate, especially if other seizure types were suspected or if the patient was female of childbearing potential (though not relevant here).\n    *   Let's stick with Fenitoina as a highly representative and correct answer for treating a first GTCS.\n\n6.  **Final Answer Selection:** Based on the analysis, Fenitoina (A) is a standard and appropriate indication for treating a first generalized tonic-clonic seizure.<unused95>Respuesta final:A",
         "medgemma-27b-text-it"
        ],
        [
         "49",
         "Primigesta de 37 semanas, sin controles prenatales, acude por presentar dolor tipo contracción esporádico. Examen: AU: \n32 cm, SPP: LCI, LCF: 150 X'; Tacto vaginal: D: 0 B: 30% AP: -4. Laboratorio: VIH + y carga viral en 2000 copias/mL. \n¿Cuál es la conducta más adecuada para la vía de parto?",
         "Parto vaginal espontaneo",
         "Cesárea programada",
         "Inducción a las 39 semanas",
         "Parto instrumentado",
         "B",
         "Ninguna de las anteriores",
         "Prueba A",
         "Year2025",
         "2025",
         "Primigesta de 37 semanas, sin controles prenatales, acude por presentar dolor tipo contracción esporádico. Examen: AU: \n32 cm, SPP: LCI, LCF: 150 X'; Tacto vaginal: D: 0 B: 30% AP: -4. Laboratorio: VIH + y carga viral en 2000 copias/mL. \n¿Cuál es la conducta más adecuada para la vía de parto? A) Parto vaginal espontaneo B) Cesárea programada C) Inducción a las 39 semanas D) Parto instrumentado E) Ninguna de las anteriores",
         "<unused94>thought\n1.  **Analyze the Request:** The user wants me to act as an expert medical assistant trained in Peru and answer a multiple-choice medical question. I need to provide a step-by-step internal thought process, summarize the information, and then give *only* the final letter answer.\n\n2.  **Summarize the Case:**\n    *   Patient: Primigesta (first pregnancy).\n    *   Gestational Age: 37 weeks.\n    *   Prenatal Care: None.\n    *   Presenting Symptom: Sporadic contraction-like pain.\n    *   Physical Exam:\n        *   Abdominal Circumference (AU): 32 cm (This seems small for 37 weeks, suggesting possible IUGR or inaccurate dating, but not the primary driver for delivery mode).\n        *   Fetal Presentation (SPP): Longitudinal Cephalic Presentation (LCI).\n        *   Fetal Heart Rate (LCF): 150 bpm (Normal range).\n        *   Vaginal Exam:\n            *   Dilation (D): 0 cm (No dilation).\n            *   Effacement (B): 30% (Some effacement).\n            *   Station (AP): -4 (High station, fetal head is far from the pelvis).\n    *   Laboratory:\n        *   HIV Positive (+).\n        *   Viral Load: 2000 copies/mL (This is a significant viral load).\n\n3.  **Identify the Core Question:** What is the most appropriate mode of delivery for this patient?\n\n4.  **Evaluate the Options based on the Summary:**\n    *   **A) Parto vaginal espontaneo (Spontaneous Vaginal Delivery):** This is generally preferred if no contraindications exist. However, the patient is HIV positive with a significant viral load (2000 copies/mL).\n    *   **B) Cesárea programada (Scheduled Cesarean Section):** Cesarean section is often recommended for HIV-positive pregnant women with a high viral load (typically >1000 copies/mL) near the time of delivery to minimize the risk of vertical transmission to the baby during labor and vaginal delivery. The patient is at 37 weeks, which is near term.\n    *   **C) Inducción a las 39 semanas (Induction at 39 weeks):** Induction might be considered if there were other indications, but the primary concern here is the HIV status and viral load. Delaying delivery to 39 weeks might increase the risk of transmission if the viral load remains high. Also, the patient is already 37 weeks and presenting with symptoms.\n    *   **D) Parto instrumentado (Instrumental Delivery):** This is a type of vaginal delivery (forceps or vacuum) and carries the same risks of vertical transmission as a spontaneous vaginal delivery in this context. It's not the primary mode of delivery planned *before* labor.\n    *   **E) Ninguna de las anteriores (None of the above):** Given the options, one of them is likely appropriate.\n\n5.  **Apply Medical Knowledge (Peruvian Context/General Guidelines):**\n    *   **HIV and Vertical Transmission:** The primary goal is to prevent mother-to-child transmission (MTCT) of HIV.\n    *   **Viral Load Threshold:** A viral load > 1000 copies/mL near delivery significantly increases the risk of MTCT during vaginal delivery.\n    *   **Recommended Management:** For HIV-positive pregnant women with a viral load > 1000 copies/mL at or near term (36-38 weeks), a scheduled cesarean section is generally recommended to reduce MTCT risk, provided the mother is on antiretroviral therapy (ART). Although the case doesn't explicitly state she's on ART, the high viral load suggests either she's not on ART, not adherent, or the ART is not effective. Regardless, the high viral load is the key factor.\n    *   **Gestational Age:** 37 weeks is considered early term. Delivery is often recommended between 38 and 39 weeks for HIV-positive women on effective ART with suppressed viral load, but with a high viral load, delivery might be considered sooner, and cesarean is the preferred mode.\n    *   **Other Factors:** The patient has no dilation, some effacement, and a high station, indicating she is not in active labor. The AU of 32 cm is noted but doesn't change the management regarding the mode of delivery based on HIV status.\n\n6.  **Synthesize and Choose the Best Option:** The patient is HIV positive with a high viral load (2000 copies/mL) at 37 weeks gestation. Standard guidelines recommend a scheduled cesarean section in this situation to minimize the risk of vertical HIV transmission.\n\n7.  **Final Answer Formulation:** Based on the analysis, option B is the most appropriate management. The final output should be just the letter.<unused95>Respuesta final:B",
         "medgemma-27b-text-it"
        ]
       ],
       "shape": {
        "columns": 13,
        "rows": 8380
       }
      },
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>questions</th>\n",
       "      <th>option_A</th>\n",
       "      <th>option_B</th>\n",
       "      <th>option_C</th>\n",
       "      <th>option_D</th>\n",
       "      <th>correct_answer</th>\n",
       "      <th>option_E</th>\n",
       "      <th>source_file</th>\n",
       "      <th>source_folder</th>\n",
       "      <th>year</th>\n",
       "      <th>question</th>\n",
       "      <th>answer_llm</th>\n",
       "      <th>model_basename</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Varón de 65 años con antecedente de hipertensi...</td>\n",
       "      <td>Labetalol</td>\n",
       "      <td>Hidralazina</td>\n",
       "      <td>Nitroprusiato</td>\n",
       "      <td>Nitroglicerina</td>\n",
       "      <td>C</td>\n",
       "      <td>Ninguna de las anteriores</td>\n",
       "      <td>Prueba A</td>\n",
       "      <td>Year2025</td>\n",
       "      <td>2025</td>\n",
       "      <td>Varón de 65 años con antecedente de hipertensi...</td>\n",
       "      <td>&lt;unused94&gt;thought\\n1.  **Analyze the Request:*...</td>\n",
       "      <td>medgemma-27b-text-it</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Mujer de 32 años asintomática que acude por ch...</td>\n",
       "      <td>Solicitar prolactina</td>\n",
       "      <td>Mamografía</td>\n",
       "      <td>Ecografía de mamas</td>\n",
       "      <td>Observación</td>\n",
       "      <td>D</td>\n",
       "      <td>Ninguna de las anteriores</td>\n",
       "      <td>Prueba A</td>\n",
       "      <td>Year2025</td>\n",
       "      <td>2025</td>\n",
       "      <td>Mujer de 32 años asintomática que acude por ch...</td>\n",
       "      <td>&lt;unused94&gt;thought\\n1.  **Analyze the Request:*...</td>\n",
       "      <td>medgemma-27b-text-it</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>¿Cuál es el sitio más frecuente de implantació...</td>\n",
       "      <td>Fondo uterino</td>\n",
       "      <td>Segmento inferior del útero</td>\n",
       "      <td>Cérvix uterino</td>\n",
       "      <td>Cuerno uterino</td>\n",
       "      <td>A</td>\n",
       "      <td>Ninguna de las anteriores</td>\n",
       "      <td>Prueba A</td>\n",
       "      <td>Year2025</td>\n",
       "      <td>2025</td>\n",
       "      <td>¿Cuál es el sitio más frecuente de implantació...</td>\n",
       "      <td>&lt;unused94&gt;thought\\n1.  **Identify the core que...</td>\n",
       "      <td>medgemma-27b-text-it</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>Varón de 43 años, llevado a urgencias porque s...</td>\n",
       "      <td>Colocación de catéter central</td>\n",
       "      <td>Ventilación no invasiva</td>\n",
       "      <td>Fijación costal quirúrgica</td>\n",
       "      <td>Intubación orotraqueal</td>\n",
       "      <td>D</td>\n",
       "      <td>Ninguna de las anteriores</td>\n",
       "      <td>Prueba A</td>\n",
       "      <td>Year2025</td>\n",
       "      <td>2025</td>\n",
       "      <td>Varón de 43 años, llevado a urgencias porque s...</td>\n",
       "      <td>&lt;unused94&gt;thought\\n1.  **Analyze the Request:*...</td>\n",
       "      <td>medgemma-27b-text-it</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>Varón de 27 años, acude a consulta por visión ...</td>\n",
       "      <td>VI</td>\n",
       "      <td>I</td>\n",
       "      <td>III</td>\n",
       "      <td>IV</td>\n",
       "      <td>C</td>\n",
       "      <td>Ninguna de las anteriores</td>\n",
       "      <td>Prueba A</td>\n",
       "      <td>Year2025</td>\n",
       "      <td>2025</td>\n",
       "      <td>Varón de 27 años, acude a consulta por visión ...</td>\n",
       "      <td>&lt;unused94&gt;thought\\n1.  **Analyze the Request:*...</td>\n",
       "      <td>medgemma-27b-text-it</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8375</th>\n",
       "      <td>Gestante de 20 años con 10 semanas de embarazo...</td>\n",
       "      <td>Epigastralgia</td>\n",
       "      <td>Meteorismo</td>\n",
       "      <td>Pérdida de peso menor al 5%</td>\n",
       "      <td>Presencia de aliento fétido</td>\n",
       "      <td>E</td>\n",
       "      <td>Alteraciones hidroelectrolíticas</td>\n",
       "      <td>Ginecología y Obstetricia</td>\n",
       "      <td>Year2020</td>\n",
       "      <td>2020</td>\n",
       "      <td>Gestante de 20 años con 10 semanas de embarazo...</td>\n",
       "      <td>&lt;unused94&gt;thought\\n1.  **Analyze the Request:*...</td>\n",
       "      <td>medgemma-27b-text-it</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8376</th>\n",
       "      <td>Mujer de 40 años ha tenido 4 partos eutócicos,...</td>\n",
       "      <td>Mola hidatidiforme</td>\n",
       "      <td>Hematometra</td>\n",
       "      <td>Tumor anexial</td>\n",
       "      <td>Miomatosis uterina</td>\n",
       "      <td>A</td>\n",
       "      <td>Embarazo gemelar</td>\n",
       "      <td>Ginecología y Obstetricia</td>\n",
       "      <td>Year2020</td>\n",
       "      <td>2020</td>\n",
       "      <td>Mujer de 40 años ha tenido 4 partos eutócicos,...</td>\n",
       "      <td>&lt;unused94&gt;thought\\nLa usuaria quiere que actúe...</td>\n",
       "      <td>medgemma-27b-text-it</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8377</th>\n",
       "      <td>Mujer de 40 años, refiere menstruaciones regul...</td>\n",
       "      <td>Biopsia en sacabocado y curetaje cervical</td>\n",
       "      <td>Histerectomía inmediata y extirpación de</td>\n",
       "      <td>Repetir el frotis de Papanicolaou y control a los</td>\n",
       "      <td>Colposcopía con biopsia</td>\n",
       "      <td>D</td>\n",
       "      <td>Dilatación y legrado fraccionado</td>\n",
       "      <td>Ginecología y Obstetricia</td>\n",
       "      <td>Year2020</td>\n",
       "      <td>2020</td>\n",
       "      <td>Mujer de 40 años, refiere menstruaciones regul...</td>\n",
       "      <td>&lt;unused94&gt;thought\\n1.  **Analyze the Request:*...</td>\n",
       "      <td>medgemma-27b-text-it</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8378</th>\n",
       "      <td>De los siguientes exámenes o procedimientos, ¿...</td>\n",
       "      <td>Eco transvaginal</td>\n",
       "      <td>Eco doppler transvaginal</td>\n",
       "      <td>Cultivo de secreción vaginal</td>\n",
       "      <td>Histeroscopía</td>\n",
       "      <td>E</td>\n",
       "      <td>Laparoscopia</td>\n",
       "      <td>Ginecología y Obstetricia</td>\n",
       "      <td>Year2020</td>\n",
       "      <td>2020</td>\n",
       "      <td>De los siguientes exámenes o procedimientos, ¿...</td>\n",
       "      <td>&lt;unused94&gt;thought\\n1.  **Analyze the question:...</td>\n",
       "      <td>medgemma-27b-text-it</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8379</th>\n",
       "      <td>Si usted fuera el encargado de determinar que ...</td>\n",
       "      <td>Bloqueo tubárico</td>\n",
       "      <td>DIU</td>\n",
       "      <td>Preservativo</td>\n",
       "      <td>Diafragma</td>\n",
       "      <td>E</td>\n",
       "      <td>Vasectomía</td>\n",
       "      <td>Ginecología y Obstetricia</td>\n",
       "      <td>Year2020</td>\n",
       "      <td>2020</td>\n",
       "      <td>Si usted fuera el encargado de determinar que ...</td>\n",
       "      <td>&lt;unused94&gt;thought\\n1.  **Analyze the Request:*...</td>\n",
       "      <td>medgemma-27b-text-it</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>8380 rows × 13 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "                                              questions  \\\n",
       "0     Varón de 65 años con antecedente de hipertensi...   \n",
       "1     Mujer de 32 años asintomática que acude por ch...   \n",
       "2     ¿Cuál es el sitio más frecuente de implantació...   \n",
       "3     Varón de 43 años, llevado a urgencias porque s...   \n",
       "4     Varón de 27 años, acude a consulta por visión ...   \n",
       "...                                                 ...   \n",
       "8375  Gestante de 20 años con 10 semanas de embarazo...   \n",
       "8376  Mujer de 40 años ha tenido 4 partos eutócicos,...   \n",
       "8377  Mujer de 40 años, refiere menstruaciones regul...   \n",
       "8378  De los siguientes exámenes o procedimientos, ¿...   \n",
       "8379  Si usted fuera el encargado de determinar que ...   \n",
       "\n",
       "                                       option_A  \\\n",
       "0                                     Labetalol   \n",
       "1                          Solicitar prolactina   \n",
       "2                                 Fondo uterino   \n",
       "3                 Colocación de catéter central   \n",
       "4                                            VI   \n",
       "...                                         ...   \n",
       "8375                              Epigastralgia   \n",
       "8376                         Mola hidatidiforme   \n",
       "8377  Biopsia en sacabocado y curetaje cervical   \n",
       "8378                           Eco transvaginal   \n",
       "8379                           Bloqueo tubárico   \n",
       "\n",
       "                                      option_B  \\\n",
       "0                                  Hidralazina   \n",
       "1                                   Mamografía   \n",
       "2                  Segmento inferior del útero   \n",
       "3                      Ventilación no invasiva   \n",
       "4                                            I   \n",
       "...                                        ...   \n",
       "8375                                Meteorismo   \n",
       "8376                               Hematometra   \n",
       "8377  Histerectomía inmediata y extirpación de   \n",
       "8378                  Eco doppler transvaginal   \n",
       "8379                                       DIU   \n",
       "\n",
       "                                               option_C  \\\n",
       "0                                         Nitroprusiato   \n",
       "1                                    Ecografía de mamas   \n",
       "2                                        Cérvix uterino   \n",
       "3                            Fijación costal quirúrgica   \n",
       "4                                                   III   \n",
       "...                                                 ...   \n",
       "8375                        Pérdida de peso menor al 5%   \n",
       "8376                                      Tumor anexial   \n",
       "8377  Repetir el frotis de Papanicolaou y control a los   \n",
       "8378                       Cultivo de secreción vaginal   \n",
       "8379                                       Preservativo   \n",
       "\n",
       "                         option_D correct_answer  \\\n",
       "0                  Nitroglicerina              C   \n",
       "1                     Observación              D   \n",
       "2                  Cuerno uterino              A   \n",
       "3          Intubación orotraqueal              D   \n",
       "4                              IV              C   \n",
       "...                           ...            ...   \n",
       "8375  Presencia de aliento fétido              E   \n",
       "8376           Miomatosis uterina              A   \n",
       "8377      Colposcopía con biopsia              D   \n",
       "8378                Histeroscopía              E   \n",
       "8379                    Diafragma              E   \n",
       "\n",
       "                              option_E                 source_file  \\\n",
       "0            Ninguna de las anteriores                    Prueba A   \n",
       "1            Ninguna de las anteriores                    Prueba A   \n",
       "2            Ninguna de las anteriores                    Prueba A   \n",
       "3            Ninguna de las anteriores                    Prueba A   \n",
       "4            Ninguna de las anteriores                    Prueba A   \n",
       "...                                ...                         ...   \n",
       "8375  Alteraciones hidroelectrolíticas  Ginecología y Obstetricia   \n",
       "8376                  Embarazo gemelar  Ginecología y Obstetricia   \n",
       "8377  Dilatación y legrado fraccionado  Ginecología y Obstetricia   \n",
       "8378                      Laparoscopia  Ginecología y Obstetricia   \n",
       "8379                        Vasectomía  Ginecología y Obstetricia   \n",
       "\n",
       "     source_folder  year                                           question  \\\n",
       "0         Year2025  2025  Varón de 65 años con antecedente de hipertensi...   \n",
       "1         Year2025  2025  Mujer de 32 años asintomática que acude por ch...   \n",
       "2         Year2025  2025  ¿Cuál es el sitio más frecuente de implantació...   \n",
       "3         Year2025  2025  Varón de 43 años, llevado a urgencias porque s...   \n",
       "4         Year2025  2025  Varón de 27 años, acude a consulta por visión ...   \n",
       "...            ...   ...                                                ...   \n",
       "8375      Year2020  2020  Gestante de 20 años con 10 semanas de embarazo...   \n",
       "8376      Year2020  2020  Mujer de 40 años ha tenido 4 partos eutócicos,...   \n",
       "8377      Year2020  2020  Mujer de 40 años, refiere menstruaciones regul...   \n",
       "8378      Year2020  2020  De los siguientes exámenes o procedimientos, ¿...   \n",
       "8379      Year2020  2020  Si usted fuera el encargado de determinar que ...   \n",
       "\n",
       "                                             answer_llm        model_basename  \n",
       "0     <unused94>thought\\n1.  **Analyze the Request:*...  medgemma-27b-text-it  \n",
       "1     <unused94>thought\\n1.  **Analyze the Request:*...  medgemma-27b-text-it  \n",
       "2     <unused94>thought\\n1.  **Identify the core que...  medgemma-27b-text-it  \n",
       "3     <unused94>thought\\n1.  **Analyze the Request:*...  medgemma-27b-text-it  \n",
       "4     <unused94>thought\\n1.  **Analyze the Request:*...  medgemma-27b-text-it  \n",
       "...                                                 ...                   ...  \n",
       "8375  <unused94>thought\\n1.  **Analyze the Request:*...  medgemma-27b-text-it  \n",
       "8376  <unused94>thought\\nLa usuaria quiere que actúe...  medgemma-27b-text-it  \n",
       "8377  <unused94>thought\\n1.  **Analyze the Request:*...  medgemma-27b-text-it  \n",
       "8378  <unused94>thought\\n1.  **Analyze the question:...  medgemma-27b-text-it  \n",
       "8379  <unused94>thought\\n1.  **Analyze the Request:*...  medgemma-27b-text-it  \n",
       "\n",
       "[8380 rows x 13 columns]"
      ]
     },
     "execution_count": 2,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df = pd.read_pickle('/Users/rodrigocarrillo/Documents/Natural Language Processing Projects/Examen Residentado Peru/02.LLMs Results/06.medgemma-27b-text-it/combined_exam_dataset_medgemma-27b-text-it.pickle')\n",
    "df"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "id": "7aefe9c2",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "application/vnd.microsoft.datawrangler.viewer.v0+json": {
       "columns": [
        {
         "name": "index",
         "rawType": "int64",
         "type": "integer"
        },
        {
         "name": "questions",
         "rawType": "object",
         "type": "string"
        },
        {
         "name": "option_A",
         "rawType": "object",
         "type": "string"
        },
        {
         "name": "option_B",
         "rawType": "object",
         "type": "string"
        },
        {
         "name": "option_C",
         "rawType": "object",
         "type": "string"
        },
        {
         "name": "option_D",
         "rawType": "object",
         "type": "string"
        },
        {
         "name": "correct_answer",
         "rawType": "object",
         "type": "string"
        },
        {
         "name": "option_E",
         "rawType": "object",
         "type": "string"
        },
        {
         "name": "source_file",
         "rawType": "object",
         "type": "string"
        },
        {
         "name": "source_folder",
         "rawType": "object",
         "type": "string"
        },
        {
         "name": "year",
         "rawType": "int64",
         "type": "integer"
        },
        {
         "name": "question",
         "rawType": "object",
         "type": "string"
        },
        {
         "name": "answer_llm",
         "rawType": "object",
         "type": "string"
        },
        {
         "name": "model_basename",
         "rawType": "object",
         "type": "string"
        },
        {
         "name": "letra_respuesta",
         "rawType": "object",
         "type": "unknown"
        }
       ],
       "ref": "a77e6457-5629-4a55-bef7-83e87ad096db",
       "rows": [
        [
         "0",
         "Varón de 65 años con antecedente de hipertensión arterial, acude por cefalea intensa, convulsiones y edema de papila. \nExamen: PA: 190/120 mmHg. ¿Cuál es el medicamento inicial a usar?",
         "Labetalol",
         "Hidralazina",
         "Nitroprusiato",
         "Nitroglicerina",
         "C",
         "Ninguna de las anteriores",
         "Prueba A",
         "Year2025",
         "2025",
         "Varón de 65 años con antecedente de hipertensión arterial, acude por cefalea intensa, convulsiones y edema de papila. \nExamen: PA: 190/120 mmHg. ¿Cuál es el medicamento inicial a usar? A) Labetalol B) Hidralazina C) Nitroprusiato D) Nitroglicerina E) Ninguna de las anteriores",
         "<unused94>thought\n1.  **Analyze the Request:** The user wants me to act as an expert medical assistant trained in Peru and answer a multiple-choice medical question. I need to provide a step-by-step internal thought process, summarize the information, and then output *only* the final letter answer.\n\n2.  **Summarize the Case:**\n    *   Patient: 65-year-old male.\n    *   History: Hypertension (HTN).\n    *   Symptoms: Intense headache, seizures, papilledema.\n    *   Exam Finding: Blood Pressure (BP) = 190/120 mmHg (severely elevated).\n\n3.  **Identify the Condition:** The combination of severe hypertension (190/120 mmHg), headache, seizures, and papilledema strongly suggests a hypertensive emergency, specifically hypertensive encephalopathy. This is a life-threatening condition requiring immediate BP reduction.\n\n4.  **Evaluate the Treatment Options:** The goal is to lower the BP rapidly but controllably to prevent further end-organ damage.\n    *   **A) Labetalol:** An alpha- and beta-blocker. It's commonly used intravenously for hypertensive emergencies. It has a relatively rapid onset and predictable effect, making it a good first-line choice. It's available in Peru.\n    *   **B) Hidralazina:** A direct vasodilator. It can cause rapid BP drops and reflex tachycardia. While used, it's often not the first choice due to less predictable effects compared to labetalol or nicardipine. Available in Peru.\n    *   **C) Nitroprusiato:** A potent arterial and venous vasodilator. It requires continuous infusion and close monitoring (e.g., arterial line) due to the risk of cyanide toxicity with prolonged use or renal impairment. Often reserved for specific situations or when other agents fail. Available in Peru.\n    *   **D) Nitroglicerina:** Primarily a venodilator, also causes some arterial dilation. More commonly used for hypertensive emergencies associated with acute coronary syndrome or acute pulmonary edema. Less effective for hypertensive encephalopathy compared to labetalol or nitroprusiato. Available in Peru.\n    *   **E) Ninguna de las anteriores:** Given that several options are used in hypertensive emergencies, this is unlikely.\n\n5.  **Determine the Best Initial Medication:**\n    *   Hypertensive encephalopathy requires rapid but controlled BP reduction.\n    *   Labetalol is a widely accepted first-line agent for many hypertensive emergencies, including encephalopathy, due to its efficacy, relatively predictable effects, and safety profile (avoiding significant reflex tachycardia).\n    *   Nitroprusiato is also effective but requires more intensive monitoring and has potential toxicity issues.\n    *   Hidralazina and Nitroglicerina are generally considered second-line or for specific indications.\n    *   Considering the clinical presentation (hypertensive encephalopathy) and the available options, Labetalol is a very appropriate *initial* choice.\n\n6.  **Formulate the Final Answer:** Based on the analysis, Labetalol (A) is the most suitable initial medication for this patient presenting with hypertensive encephalopathy.\n\n7.  **Final Check:** Ensure the output format matches the request: internal reasoning (done), summary (done), and *only* the final letter answer.<unused95>Respuesta final:A",
         "medgemma-27b-text-it",
         "A"
        ],
        [
         "1",
         "Mujer de 32 años asintomática que acude por chequeo. Al examen de mama a la expresión de uno de los pezones sale \nsecreción blanco lechoso. ¿Cuál es el manejo más adecuado?",
         "Solicitar prolactina",
         "Mamografía",
         "Ecografía de mamas",
         "Observación",
         "D",
         "Ninguna de las anteriores",
         "Prueba A",
         "Year2025",
         "2025",
         "Mujer de 32 años asintomática que acude por chequeo. Al examen de mama a la expresión de uno de los pezones sale \nsecreción blanco lechoso. ¿Cuál es el manejo más adecuado? A) Solicitar prolactina B) Mamografía C) Ecografía de mamas D) Observación E) Ninguna de las anteriores",
         "<unused94>thought\n1.  **Analyze the Request:** The user wants me to act as an expert medical assistant trained in Peru and answer a multiple-choice medical question. I need to provide a step-by-step internal thought process, summarize the information, and then give *only* the final letter answer.\n\n2.  **Summarize the Information:**\n    *   Patient: 32-year-old female.\n    *   Presentation: Asymptomatic, routine check-up.\n    *   Finding: Bilateral nipple discharge (implied by \"uno de los pezones\" - likely a typo, should be \"uno de los pezones\" or \"ambos pezones\", but discharge from one nipple is the key finding). The discharge is white and milky (leukorrhea).\n    *   Question: What is the most appropriate management?\n    *   Options:\n        *   A) Solicit prolactin (Order prolactin level)\n        *   B) Mamografía (Mammography)\n        *   C) Ecografía de mamas (Breast ultrasound)\n        *   D) Observación (Observation)\n        *   E) Ninguna de las anteriores (None of the above)\n\n3.  **Evaluate the Options based on the Clinical Scenario:**\n    *   **Patient Profile:** 32 years old. This age is relevant for imaging choices. Mammography is generally less sensitive in younger women due to denser breast tissue. Ultrasound is often preferred as the initial imaging modality in women under 40.\n    *   **Symptom:** Nipple discharge. This is the primary symptom requiring investigation.\n    *   **Discharge Characteristics:** White, milky (leukorrhea). This type of discharge is often physiological, especially in women of reproductive age, potentially related to hormonal fluctuations, pregnancy, lactation, or certain medications. However, it can also be associated with pathological conditions like prolactinoma or other pituitary issues.\n    *   **Asymptomatic:** The patient has no other symptoms (like pain, mass, skin changes).\n    *   **Management Options Analysis:**\n        *   **A) Solicit prolactina:** Milky discharge can be caused by hyperprolactinemia (e.g., due to a prolactinoma). Measuring prolactin is a reasonable step in the workup of milky nipple discharge, especially if it's spontaneous or bilateral.\n        *   **B) Mamografía:** While mammography is a standard breast imaging tool, it's generally not the *first* choice for a 32-year-old with nipple discharge, especially if it's milky and potentially physiological. Ultrasound is usually preferred initially in this age group.\n        *   **C) Ecografía de mamas:** Ultrasound is excellent for evaluating breast tissue in younger women (<40) and can help identify underlying causes of nipple discharge, such as intraductal papillomas or cysts. It's often the initial imaging modality recommended for nipple discharge in this age group.\n        *   **D) Observación:** Given the presence of nipple discharge, even if milky and the patient is asymptomatic, observation alone is generally not the most appropriate *initial* step. Further investigation is usually warranted to rule out underlying pathology.\n        *   **E) Ninguna de las anteriores:** This is unlikely, as options A and C represent standard diagnostic steps.\n\n4.  **Compare A and C:** Both ordering prolactin and performing an ultrasound are reasonable steps. However, the question asks for the *most* appropriate management.\n    *   Milky discharge strongly suggests a hormonal component (like hyperprolactinemia). Therefore, checking prolactin levels (A) is a very direct and relevant investigation.\n    *   Ultrasound (C) is important for evaluating the breast tissue itself to look for structural causes (like papillomas, cysts, or malignancy, although less likely given the milky discharge and age).\n    *   In clinical practice, both might be done. However, given the *specific* characteristic of the discharge (milky), investigating the hormonal cause (prolactin) is often considered a primary step, especially if the discharge is bilateral or spontaneous. If the discharge were bloody, purulent, or unilateral and spontaneous, imaging (ultrasound +/- mammography) would be prioritized. Since it's milky, prolactin is a very strong consideration.\n\n5.  **Refine the Choice:** The discharge is described as \"blanco lechoso\" (white, milky). This is the key feature. Milky discharge is most commonly associated with hormonal causes (hyperprolactinemia, pregnancy, lactation, medications) or sometimes physiological stimulation. While imaging (ultrasound) is important to rule out structural causes, investigating the likely hormonal etiology with a prolactin level is a very appropriate *initial* step, especially in an asymptomatic patient.\n\n6.  **Final Decision:** Based on the milky nature of the discharge in a 32-year-old woman, checking prolactin levels is a highly relevant and appropriate initial step to investigate a common cause. Ultrasound is also important but might follow or be done concurrently. Given the options, ordering prolactin directly addresses the most likely etiology suggested by the discharge type.\n\n7.  **Format the Output:** Provide only the letter of the chosen answer.<unused95>Respuesta final:A",
         "medgemma-27b-text-it",
         "A"
        ],
        [
         "2",
         "¿Cuál es el sitio más frecuente de implantación del blastocisto?",
         "Fondo uterino",
         "Segmento inferior del útero",
         "Cérvix uterino",
         "Cuerno uterino",
         "A",
         "Ninguna de las anteriores",
         "Prueba A",
         "Year2025",
         "2025",
         "¿Cuál es el sitio más frecuente de implantación del blastocisto? A) Fondo uterino B) Segmento inferior del útero C) Cérvix uterino D) Cuerno uterino E) Ninguna de las anteriores",
         "<unused94>thought\n1.  **Identify the core question:** The question asks for the most common site of blastocyst implantation in the uterus.\n\n2.  **Analyze the options:**\n    *   A) Fondo uterino (Uterine fundus): The top part of the uterus.\n    *   B) Segmento inferior del útero (Lower uterine segment): The lower part of the uterus, near the cervix.\n    *   C) Cérvix uterino (Cervix): The lower, narrow part of the uterus that opens into the vagina.\n    *   D) Cuerno uterino (Uterine horn): The upper lateral parts of the uterus, extending from the fundus.\n    *   E) Ninguna de las anteriores (None of the above).\n\n3.  **Recall/Research knowledge about implantation:** Implantation is the process where the blastocyst attaches to and embeds in the uterine lining (endometrium). This typically occurs around 6-10 days after fertilization. The endometrium is most receptive in the upper part of the uterus.\n\n4.  **Evaluate each option based on knowledge:**\n    *   A) Fondo uterino: This is the upper part of the uterus where the endometrium is generally thickest and most vascularized during the secretory phase, making it a prime location for implantation.\n    *   B) Segmento inferior del útero: This area is less common for implantation. Implantation here can be associated with complications like placenta previa or preterm labor.\n    *   C) Cérvix uterino: Implantation in the cervix is very rare and is called a cervical pregnancy, a dangerous condition.\n    *   D) Cuerno uterino: While implantation can occur here, it's part of the upper uterus, similar to the fundus. The fundus is generally considered the *most* frequent site within the upper uterus.\n    *   E) Ninguna de las anteriores: Since the fundus is a known and common site, this is unlikely.\n\n5.  **Compare the likely options:** The fundus (A) and the uterine horns (D) are both in the upper part of the uterus. However, medical literature consistently cites the posterior wall of the uterine fundus as the most frequent site of implantation.\n\n6.  **Select the best answer:** Based on the common understanding of reproductive physiology, the fundus (fondo uterino) is the most frequent site.\n\n7.  **Format the final answer:** State only the letter corresponding to the chosen answer.<unused95>Respuesta final:A",
         "medgemma-27b-text-it",
         "A"
        ],
        [
         "3",
         "Varón de 43 años, llevado a urgencias porque sufrió hace 30 minutos impacto de timón en el tórax por accidente de \ntránsito. Presenta disnea intensa, dolor torácico izquierdo, taquipnea. Examen: PA:80/40 mmHg, FC: 100X', FR: 36X'; \ncianosis distal, movimiento paradojal de la pared torácica. RX: múltiples fracturas costales izquierdas. ¿Cuál es la \nconducta más adecuada?",
         "Colocación de catéter central",
         "Ventilación no invasiva",
         "Fijación costal quirúrgica",
         "Intubación orotraqueal",
         "D",
         "Ninguna de las anteriores",
         "Prueba A",
         "Year2025",
         "2025",
         "Varón de 43 años, llevado a urgencias porque sufrió hace 30 minutos impacto de timón en el tórax por accidente de \ntránsito. Presenta disnea intensa, dolor torácico izquierdo, taquipnea. Examen: PA:80/40 mmHg, FC: 100X', FR: 36X'; \ncianosis distal, movimiento paradojal de la pared torácica. RX: múltiples fracturas costales izquierdas. ¿Cuál es la \nconducta más adecuada? A) Colocación de catéter central B) Ventilación no invasiva C) Fijación costal quirúrgica D) Intubación orotraqueal E) Ninguna de las anteriores",
         "<unused94>thought\n1.  **Analyze the Request:** The user wants me to act as an expert medical assistant trained in Peru and answer a multiple-choice medical question. I need to provide a step-by-step internal thought process, summarize the information, and then give *only* the final letter answer.\n\n2.  **Summarize the Case:**\n    *   **Patient:** 43-year-old male.\n    *   **Mechanism:** Blunt chest trauma (steering wheel impact) 30 minutes ago.\n    *   **Symptoms:** Severe dyspnea, left chest pain, tachypnea.\n    *   **Signs:** Hypotension (BP 80/40), tachycardia (HR 100), tachypnea (RR 36), distal cyanosis, paradoxical chest wall movement.\n    *   **Imaging:** Multiple left rib fractures on X-ray.\n\n3.  **Identify the Likely Diagnosis:** The combination of severe blunt chest trauma, respiratory distress (dyspnea, tachypnea, cyanosis), hemodynamic instability (hypotension, tachycardia), and paradoxical chest wall movement strongly suggests a **flail chest** complicated by **respiratory failure** and likely **shock** (hypovolemic or obstructive, possibly tension pneumothorax or cardiac tamponade, though not explicitly stated, the hypotension is concerning). The paradoxical movement is the hallmark of flail chest (multiple adjacent rib fractures in two or more places).\n\n4.  **Evaluate the Options:**\n    *   **A) Colocación de catéter central (Central line placement):** While potentially useful for fluid resuscitation or monitoring, it's not the *most immediate* life-saving intervention for severe respiratory failure and shock due to flail chest. Addressing the airway and breathing is paramount.\n    *   **B) Ventilación no invasiva (Non-invasive ventilation - NIV):** NIV (like CPAP or BiPAP) might be considered in *some* cases of respiratory distress, but in a patient with severe trauma, hemodynamic instability, potential for massive hemothorax/pneumothorax, and likely need for positive pressure ventilation to stabilize the flail segment, NIV is generally contraindicated or insufficient. It doesn't address the underlying mechanical instability or the potential need for controlled ventilation.\n    *   **C) Fijación costal quirúrgica (Surgical rib fixation):** This is a definitive treatment for flail chest but is *not* the immediate emergency management. It's performed later, once the patient is stabilized.\n    *   **D) Intubación orotraqueal (Orotracheal intubation):** This patient has severe respiratory failure (dyspnea, tachypnea, cyanosis) and hemodynamic instability. Intubation and mechanical ventilation are indicated to:\n        *   Secure the airway.\n        *   Provide adequate oxygenation and ventilation.\n        *   Reduce the work of breathing.\n        *   Apply positive end-expiratory pressure (PEEP) to help stabilize the flail segment and improve oxygenation.\n        *   Allow for sedation and analgesia.\n        *   Facilitate resuscitation.\n        This is the most critical immediate step to manage the life-threatening respiratory failure and shock.\n    *   **E) Ninguna de las anteriores (None of the above):** Option D is clearly the most appropriate immediate action.\n\n5.  **Determine the Best Course of Action:** Given the severe respiratory distress, hemodynamic instability, and paradoxical chest movement indicative of flail chest with respiratory failure, immediate airway management and mechanical ventilation via endotracheal intubation are the highest priority.\n\n6.  **Format the Final Answer:** The request asks for *only* the letter of the correct answer after the internal reasoning.\n\n7.  **Final Answer Selection:** The most appropriate immediate action is Intubación orotraqueal. This corresponds to option D.<unused95>Respuesta final:D",
         "medgemma-27b-text-it",
         "D"
        ],
        [
         "4",
         "Varón de 27 años, acude a consulta por visión doble y caída del párpado derecho. Examen: se evidencia pupila derecha \ndilatada con incapacidad para mover el ojo hacia el lado nasal ¿Cuál es el par craneal comprometido?",
         "VI",
         "I",
         "III",
         "IV",
         "C",
         "Ninguna de las anteriores",
         "Prueba A",
         "Year2025",
         "2025",
         "Varón de 27 años, acude a consulta por visión doble y caída del párpado derecho. Examen: se evidencia pupila derecha \ndilatada con incapacidad para mover el ojo hacia el lado nasal ¿Cuál es el par craneal comprometido? A) VI B) I C) III D) IV E) Ninguna de las anteriores",
         "<unused94>thought\n1.  **Analyze the Request:** The user wants me to act as an expert medical assistant trained in Peru and answer a multiple-choice medical question. I need to provide a step-by-step internal thought process, summarize the information, and then output *only* the final letter answer.\n\n2.  **Summarize the Information:**\n    *   Patient: 27-year-old male.\n    *   Symptoms: Diplopia (visión doble), right ptosis (caída del párpado derecho).\n    *   Exam Findings: Right pupil dilated (pupila derecha dilatada), inability to move the right eye nasally (incapacidad para mover el ojo hacia el lado nasal).\n    *   Question: Which cranial nerve is compromised?\n    *   Options: A) VI (Abducens), B) I (Olfactory), C) III (Oculomotor), D) IV (Trochlear), E) None of the above.\n\n3.  **Step-by-Step Reasoning (Internal):**\n    *   **Ptosis (caída del párpado):** This is primarily controlled by the levator palpebrae superioris muscle, which is innervated by the Oculomotor nerve (CN III).\n    *   **Pupil Dilation (pupila dilatada):** The pupil size is controlled by the iris sphincter (constriction) and dilator (dilation) muscles. The sphincter is innervated by the parasympathetic fibers traveling with the Oculomotor nerve (CN III). Damage to these fibers leads to unopposed sympathetic action, causing dilation (mydriasis).\n    *   **Inability to move the eye nasally (incapacidad para mover el ojo hacia el lado nasal):** This movement (adduction) is controlled by the medial rectus muscle. The medial rectus muscle is innervated by the Oculomotor nerve (CN III).\n    *   **Diplopia (visión doble):** This is a common symptom of eye muscle paralysis or misalignment, consistent with cranial nerve palsies affecting eye movement.\n    *   **Evaluate Options:**\n        *   A) VI (Abducens): Innervates the lateral rectus muscle (abduction - moving the eye laterally/outward). Damage causes inability to abduct the eye. This doesn't match the symptoms.\n        *   B) I (Olfactory): Responsible for smell. Not related to eye movement or pupil function.\n        *   C) III (Oculomotor): Innervates the levator palpebrae superioris (eyelid elevation), most extraocular muscles (superior rectus, inferior rectus, medial rectus, inferior oblique), and carries parasympathetic fibers to the iris sphincter (pupil constriction). Damage typically causes ptosis, pupil dilation, and impaired adduction, elevation, and depression of the eye. This perfectly matches the patient's presentation (ptosis, dilated pupil, inability to adduct).\n        *   D) IV (Trochlear): Innervates the superior oblique muscle (intorsion, depression, abduction). Damage causes difficulty looking down and inward, often resulting in vertical diplopia. This doesn't match the primary symptoms.\n        *   E) None of the above: Option C fits well.\n\n4.  **Conclusion:** The combination of ptosis, dilated pupil, and inability to adduct the eye strongly points to a lesion affecting the Oculomotor nerve (CN III).\n\n5.  **Final Answer Format:** The user requested only the letter of the correct answer.<unused95>Respuesta final:C",
         "medgemma-27b-text-it",
         "C"
        ],
        [
         "5",
         "Mujer de 58 años con antecedentes de litiasis renal recurrente, presenta fiebre de 39.2 °C, vómitos y dolor lumbar \nizquierdo de 48 horas de evolución. Examen: PA: 90/60 mmHg, FC: 120X', dolor en fosa lumbar izquierda. Leucocitosis. \nTomografía abdomino pélvica: litiasis obstructiva en uréter proximal izquierdo, dilatación del sistema pielocalicial y \nabsceso perinéfrico. ¿Cuál es la intervención inicial más adecuada?",
         "Litotricia extracorpórea y seguimiento con antibióticos",
         "Derivación urinaria urgente con  catéter doble J y nefrostomía percutánea",
         "Antibióticos de amplio espectro y nefrectomía diferida",
         "Drenaje quirúrgico del absceso sin derivación urinaria",
         "B",
         "Ninguna de las anteriores",
         "Prueba A",
         "Year2025",
         "2025",
         "Mujer de 58 años con antecedentes de litiasis renal recurrente, presenta fiebre de 39.2 °C, vómitos y dolor lumbar \nizquierdo de 48 horas de evolución. Examen: PA: 90/60 mmHg, FC: 120X', dolor en fosa lumbar izquierda. Leucocitosis. \nTomografía abdomino pélvica: litiasis obstructiva en uréter proximal izquierdo, dilatación del sistema pielocalicial y \nabsceso perinéfrico. ¿Cuál es la intervención inicial más adecuada? A) Litotricia extracorpórea y seguimiento con antibióticos B) Derivación urinaria urgente con  catéter doble J y nefrostomía percutánea C) Antibióticos de amplio espectro y nefrectomía diferida D) Drenaje quirúrgico del absceso sin derivación urinaria E) Ninguna de las anteriores",
         "<unused94>thought\nLa paciente presenta un cuadro clínico de pielonefritis complicada con absceso perinéfrico y obstrucción urinaria por litiasis en el uréter proximal izquierdo. Los signos vitales (hipotensión, taquicardia) y la fiebre alta sugieren sepsis. La tomografía confirma la obstrucción, la dilatación del sistema pielocalicial y la presencia de un absceso.\n\nLa prioridad en este caso es manejar la sepsis y la obstrucción urinaria. La obstrucción urinaria impide el drenaje de la orina infectada, lo que perpetúa la infección y favorece la formación de abscesos. El absceso perinéfrico requiere drenaje.\n\nAnalicemos las opciones:\nA) Litotricia extracorpórea (LEC) es un tratamiento para la litiasis, pero no es adecuado en un contexto de infección activa y sepsis. Además, no aborda la obstrucción inmediata ni el absceso.\nB) La derivación urinaria urgente (catéter doble J o nefrostomía percutánea) es crucial para aliviar la obstrucción, permitir el drenaje de la orina infectada y facilitar la resolución de la infección y el absceso. El catéter doble J se coloca por vía cistoscópica, mientras que la nefrostomía percutánea se realiza a través de la piel directamente al riñón. Ambas opciones son válidas para la derivación urinaria. El drenaje del absceso también es necesario, pero la derivación urinaria es el paso inicial más importante para controlar la fuente de la infección y la sepsis.\nC) Los antibióticos de amplio espectro son necesarios, pero no son suficientes por sí solos. La nefrectomía (extirpación del riñón) es un tratamiento radical que se considera en casos muy graves o refractarios, pero no es la intervención inicial.\nD) El drenaje quirúrgico del absceso es necesario, pero sin aliviar la obstrucción urinaria, la infección persistirá. La derivación urinaria debe realizarse simultáneamente o antes.\nE) Ninguna de las anteriores no es correcta, ya que la opción B es la más adecuada.\n\nPor lo tanto, la intervención inicial más adecuada es la derivación urinaria urgente para aliviar la obstrucción y permitir el drenaje de la orina infectada, junto con el inicio de antibióticos de amplio espectro. El drenaje del absceso también es necesario, pero la derivación urinaria es el paso inicial prioritario para controlar la sepsis y la infección. La opción B incluye la derivación urinaria urgente.\n\nResumen interno: Paciente con pielonefritis complicada (obstrucción por litiasis, absceso perinéfrico) y signos de sepsis. Prioridad: desobstrucción urinaria y control de la infección.\nOpción A: Inadecuada (LEC no para infección activa).\nOpción B: Adecuada (Derivación urinaria urgente para desobstrucción).\nOpción C: Inadecuada (Nefrectomía no es inicial).\nOpción D: Inadecuada (Drenaje del absceso sin desobstrucción es insuficiente).\nOpción E: Incorrecta.\n\nLa opción más adecuada es la B, que aborda la obstrucción urinaria de forma urgente.<unused95>Respuesta final:B",
         "medgemma-27b-text-it",
         "B"
        ],
        [
         "6",
         "Preescolar de 4 años, contacto de familiar con TB pulmonar acude a control presentando un resultado de PPD de 12 mm. \nAsintomático. Antecedentes: inmunizaciones completas. Examen físico normal. Rx de tórax sin hallazgos. ¿Cuál es el \ndiagnóstico?",
         "Reacción cruzada a BCG",
         "Infección por Mycobacterium tuberculosis",
         "Enfermedad por Mycobacterium tuberculosis",
         "Exposición a Mycobacterium tuberculosis",
         "B",
         "Ninguna de las anteriores",
         "Prueba A",
         "Year2025",
         "2025",
         "Preescolar de 4 años, contacto de familiar con TB pulmonar acude a control presentando un resultado de PPD de 12 mm. \nAsintomático. Antecedentes: inmunizaciones completas. Examen físico normal. Rx de tórax sin hallazgos. ¿Cuál es el \ndiagnóstico? A) Reacción cruzada a BCG B) Infección por Mycobacterium tuberculosis C) Enfermedad por Mycobacterium tuberculosis D) Exposición a Mycobacterium tuberculosis E) Ninguna de las anteriores",
         "<unused94>thought\n1.  **Analyze the Request:** The user wants me to act as an expert medical assistant trained in Peru and answer a multiple-choice medical question. I need to provide a step-by-step internal thought process, summarize the information, and then give *only* the final letter answer.\n\n2.  **Summarize the Case:**\n    *   Patient: 4-year-old preschooler.\n    *   Exposure: Contact with a family member with pulmonary TB.\n    *   Symptoms: Asymptomatic.\n    *   History: Complete immunizations (implies BCG vaccination, standard in Peru).\n    *   Physical Exam: Normal.\n    *   Chest X-ray (Rx Tórax): No findings.\n    *   PPD Test Result: 12 mm induration.\n\n3.  **Evaluate the PPD Result:**\n    *   A PPD (Purified Protein Derivative) test, also known as the Mantoux test, is used to screen for *Mycobacterium tuberculosis* infection.\n    *   Interpretation depends on risk factors.\n    *   In Peru (and many other countries), BCG vaccination is routine at birth. BCG can cause a false-positive PPD reaction, but typically the induration is smaller (usually <10 mm, though larger reactions can occur).\n    *   However, this child is a *contact* of a person with active pulmonary TB. This significantly increases the risk of infection.\n    *   Interpretation guidelines for PPD in contacts of active TB cases:\n        *   ≥ 5 mm is considered positive.\n        *   ≥ 10 mm is considered positive in individuals with risk factors (like BCG vaccination, recent immigration, IV drug use, etc.).\n        *   ≥ 15 mm is considered positive in individuals with no known risk factors.\n    *   This child has a PPD of 12 mm. Given the *contact* status, this is considered a positive result (≥ 5 mm).\n\n4.  **Analyze the Options:**\n    *   **A) Reacción cruzada a BCG:** While BCG can cause a positive PPD, a 12 mm reaction in a known contact of active TB is more likely due to actual infection than just a BCG reaction, especially since the child is 4 years old (BCG reaction tends to wane over time). Also, the primary concern here is the *exposure* to active TB.\n    *   **B) Infección por Mycobacterium tuberculosis:** A positive PPD indicates that the person's immune system has reacted to TB antigens. This means they have been infected with *M. tuberculosis*. This is also known as Latent TB Infection (LTBI) when the person is asymptomatic and has a normal chest X-ray. This fits the clinical picture perfectly: positive PPD, asymptomatic, normal CXR, known contact.\n    *   **C) Enfermedad por Mycobacterium tuberculosis:** This refers to active TB disease. The child is asymptomatic and has a normal chest X-ray, ruling out active pulmonary disease.\n    *   **D) Exposición a Mycobacterium tuberculosis:** Exposure means the person has been in contact with someone with active TB. While the child *has* been exposed (stated in the case), the positive PPD indicates more than just exposure; it indicates the immune system has responded, meaning *infection* has occurred. Exposure itself doesn't cause a positive PPD.\n    *   **E) Ninguna de las anteriores:** Option B seems to fit well.\n\n5.  **Synthesize and Conclude:** The child is a known contact of active TB. The PPD test is positive (12 mm is significant in a contact). The child is asymptomatic and has a normal chest X-ray. This clinical picture is characteristic of Latent Tuberculosis Infection (LTBI), which falls under the broader category of \"Infección por Mycobacterium tuberculosis\". Option B is the most accurate diagnosis based on the provided information.\n\n6.  **Final Answer Format:** The user requested only the letter of the correct answer.<unused95>Respuesta final:B",
         "medgemma-27b-text-it",
         "B"
        ],
        [
         "7",
         "Varón de 64 años con diagnóstico de enfermedad pulmonar obstructiva crónica, ingresa a emergencia por \ndescompensación. Examen: FR: 32X'. Laboratorio: pH: 7.24, PaCO2: 62 mmHg, PaO2: 55 mmHg. ¿Qué tipo de receptores \nson los más sensibles a los cambios de CO2?",
         "Quimiorreceptores centrales bulbo raquídeo",
         "Receptores J (yuxtacapilares)",
         "Receptores de estiramiento pulmonar",
         "Quimiorreceptores periféricos en los cuerpos carotídeos y aórticos",
         "A",
         "Ninguna de las anteriores",
         "Prueba A",
         "Year2025",
         "2025",
         "Varón de 64 años con diagnóstico de enfermedad pulmonar obstructiva crónica, ingresa a emergencia por \ndescompensación. Examen: FR: 32X'. Laboratorio: pH: 7.24, PaCO2: 62 mmHg, PaO2: 55 mmHg. ¿Qué tipo de receptores \nson los más sensibles a los cambios de CO2? A) Quimiorreceptores centrales bulbo raquídeo B) Receptores J (yuxtacapilares) C) Receptores de estiramiento pulmonar D) Quimiorreceptores periféricos en los cuerpos carotídeos y aórticos E) Ninguna de las anteriores",
         "<unused94>thought\n1.  **Analyze the Request:** The user wants me to act as an expert medical assistant trained in Peru and answer a multiple-choice medical question. I need to provide a step-by-step internal thought process, summarize the information, and then output *only* the final letter answer.\n\n2.  **Summarize the Case:**\n    *   Patient: 64-year-old male.\n    *   History: COPD.\n    *   Presentation: Emergency department for exacerbation/decompensation.\n    *   Vitals: Respiratory Rate (FR) = 32 breaths/minute (tachypnea).\n    *   Labs (Arterial Blood Gas - ABG):\n        *   pH = 7.24 (acidemia).\n        *   PaCO2 = 62 mmHg (hypercapnia - elevated CO2).\n        *   PaO2 = 55 mmHg (hypoxemia - low O2).\n    *   Question: Which receptors are *most sensitive* to changes in CO2?\n\n3.  **Analyze the Options:**\n    *   A) Quimiorreceptores centrales bulbo raquídeo (Central chemoreceptors in the medulla oblongata): These are located in the brainstem and are highly sensitive to changes in the pH of the cerebrospinal fluid (CSF). CO2 readily crosses the blood-brain barrier, dissolves in the CSF, forms carbonic acid (H2CO3), which dissociates into H+ and HCO3-. The increase in H+ concentration (decrease in pH) in the CSF directly stimulates these receptors. Therefore, they are very sensitive to changes in PaCO2.\n    *   B) Receptores J (yuxtacapilares) (J receptors - juxtacapillary): Located in the alveolar walls near capillaries. They are stimulated by pulmonary congestion, edema, and certain chemicals (like capsaicin). They contribute to rapid, shallow breathing (tachypnea) and bradycardia, often associated with heart failure or pulmonary embolism. They are not primarily sensitive to CO2 changes.\n    *   C) Receptores de estiramiento pulmonar (Pulmonary stretch receptors): Located in the smooth muscle of the airways. They are stimulated by lung inflation and inhibit inspiration (Hering-Breuer reflex). They are sensitive to lung volume, not directly to CO2.\n    *   D) Quimiorreceptores periféricos en los cuerpos carotídeos y aórticos (Peripheral chemoreceptors in carotid and aortic bodies): Located in the carotid bodies (at the bifurcation of the common carotid arteries) and aortic bodies. They are primarily sensitive to *decreases* in PaO2 (hypoxemia) and *increases* in PaCO2 (hypercapnia) and H+ concentration (acidemia). While they *do* respond to CO2, the central chemoreceptors are considered *more* sensitive to changes in PaCO2 because CO2 directly influences the pH of the CSF they monitor.\n    *   E) Ninguna de las anteriores (None of the above).\n\n4.  **Evaluate Sensitivity to CO2:**\n    *   Central chemoreceptors respond *indirectly* to CO2 via changes in CSF pH. They are the primary drivers of ventilation changes in response to hypercapnia.\n    *   Peripheral chemoreceptors respond *directly* to CO2 (and H+), but their response to CO2 is less significant than the central chemoreceptors' response. Their primary role is detecting hypoxemia.\n    *   J receptors and stretch receptors are not primarily sensitive to CO2.\n\n5.  **Determine the *Most* Sensitive:** The question asks for the *most* sensitive receptors to changes in CO2. The central chemoreceptors, due to their direct monitoring of CSF pH changes caused by CO2 diffusion, are considered the most sensitive regulators of ventilation in response to alterations in PaCO2.\n\n6.  **Relate to the Case:** The patient has COPD exacerbation with hypercapnia (PaCO2 = 62 mmHg) and respiratory acidosis (pH = 7.24). This clinical picture highlights the importance of chemoreceptor function in regulating breathing. The central chemoreceptors would be strongly stimulated by the increased CO2 leading to decreased CSF pH.\n\n7.  **Select the Best Answer:** Based on the physiological understanding, the central chemoreceptors (A) are the most sensitive to changes in CO2.\n\n8.  **Format the Output:** Provide only the final letter answer as requested.<unused95>Respuesta final:A",
         "medgemma-27b-text-it",
         "A"
        ],
        [
         "8",
         "Varón de 38 años, gasfitero, presenta fiebre, escalofríos, cefalea frontal intensa, náusea, vómitos, dolor abdominal \ninespecífico, congestión conjuntival, mialgia intensa y fotofobia. Examen: febril, ictérico, PA: 105/75 mmHg, FC: 68 X', \ncongestión conjuntival y faríngea, sensibilidad muscular, adenomegalia cervical, meningismo y hepatoesplenomegalia. \nCrepitantes en hemitórax derecho. ¿Cuál es el tratamiento indicado?",
         "Gentamicina",
         "Sulfametoxazol",
         "Penicilina",
         "Metronidazol",
         "C",
         "Ninguna de las anteriores",
         "Prueba A",
         "Year2025",
         "2025",
         "Varón de 38 años, gasfitero, presenta fiebre, escalofríos, cefalea frontal intensa, náusea, vómitos, dolor abdominal \ninespecífico, congestión conjuntival, mialgia intensa y fotofobia. Examen: febril, ictérico, PA: 105/75 mmHg, FC: 68 X', \ncongestión conjuntival y faríngea, sensibilidad muscular, adenomegalia cervical, meningismo y hepatoesplenomegalia. \nCrepitantes en hemitórax derecho. ¿Cuál es el tratamiento indicado? A) Gentamicina B) Sulfametoxazol C) Penicilina D) Metronidazol E) Ninguna de las anteriores",
         "<unused94>thought\n1.  **Analyze the Request:** The user wants me to act as an expert medical assistant trained in Peru and answer a multiple-choice medical question. I need to provide a step-by-step internal thought process, summarize the information, and then give *only* the final letter answer.\n\n2.  **Summarize the Case:**\n    *   **Patient:** 38-year-old male, plumber (occupation relevant for exposure).\n    *   **Symptoms:** Fever, chills, severe frontal headache, nausea, vomiting, non-specific abdominal pain, conjunctival congestion, severe myalgia, photophobia.\n    *   **Signs:** Febrile, icteric (jaundice), BP 105/75 mmHg, HR 68 bpm (bradycardia relative to fever?), conjunctival and pharyngeal congestion, muscle tenderness, cervical lymphadenopathy, meningismus (signs of meningeal irritation), hepatosplenomegaly, crackles (crepitantes) in the right hemithorax.\n\n3.  **Differential Diagnosis (based on symptoms and signs):**\n    *   **Leptospirosis:** This fits *very* well. Occupation (plumber - exposure to contaminated water/soil), fever, chills, headache, myalgia (especially calf muscles, though not specified here, severe myalgia is present), conjunctival suffusion (congestion without exudate), jaundice (icteric), abdominal pain, nausea/vomiting, hepatosplenomegaly, meningismus (aseptic meningitis), pulmonary involvement (crackles suggest pulmonary hemorrhage or ARDS - Weil's disease is severe leptospirosis with jaundice and renal failure, but pulmonary involvement can occur). Bradycardia relative to fever can also be seen.\n    *   **Dengue:** Fever, headache, myalgia, rash (not mentioned), conjunctival injection. Jaundice and meningismus are less typical. Hepatosplenomegaly can occur. Pulmonary involvement is rare.\n    *   **Hantavirus:** Fever, myalgia, headache, thrombocytopenia (not mentioned), renal failure (not mentioned), pulmonary syndrome (crackles could fit, but other symptoms less typical).\n    *   **Typhoid Fever (Salmonella Typhi):** Fever, headache, abdominal pain, relative bradycardia, hepatosplenomegaly, sometimes rose spots (not mentioned). Jaundice and severe myalgia/conjunctival suffusion are less common.\n    *   **Viral Hepatitis (A, B, C, E):** Jaundice, fever, abdominal pain, hepatomegaly. Severe myalgia, conjunctival suffusion, meningismus, and pulmonary findings are not typical.\n    *   **Meningitis (Bacterial/Viral):** Headache, fever, meningismus. Jaundice, hepatosplenomegaly, severe myalgia, conjunctival suffusion, and pulmonary findings are less typical for primary meningitis.\n    *   **Malaria:** Fever, chills, headache, myalgia. Jaundice, hepatosplenomegaly can occur. Meningismus and pulmonary findings are less common.\n\n4.  **Evaluate the Best Fit:** Leptospirosis is the strongest diagnosis given the combination of occupational exposure (plumber), fever, severe myalgia, conjunctival suffusion, jaundice, meningismus, and pulmonary findings (crackles). This presentation is highly suggestive of Weil's disease (severe leptospirosis).\n\n5.  **Determine Treatment for Leptospirosis:**\n    *   Mild Leptospirosis: Often treated with doxycycline or amoxicillin.\n    *   Severe Leptospirosis (Weil's disease): Intravenous antibiotics are indicated. Penicillin G is the traditional drug of choice. Ceftriaxone or cefotaxime are also effective alternatives. Doxycycline can also be used intravenously.\n\n6.  **Evaluate the Options:**\n    *   A) Gentamicina: An aminoglycoside, used for gram-negative infections, but not the first-line treatment for leptospirosis.\n    *   B) Sulfametoxazol: A sulfonamide, used for various infections (UTIs, PCP), but not standard for leptospirosis.\n    *   C) Penicilina: Penicillin G is a standard treatment for severe leptospirosis.\n    *   D) Metronidazol: Used for anaerobic infections and protozoal infections (like Giardia, Trichomonas, Amebiasis), not leptospirosis.\n    *   E) Ninguna de las anteriores: Incorrect, as Penicillin is a valid treatment.\n\n7.  **Select the Best Answer:** Based on the likely diagnosis of severe leptospirosis (Weil's disease) and standard treatment guidelines, Penicillin is the most appropriate choice among the options provided.\n\n8.  **Format the Final Answer:** Provide only the letter corresponding to the chosen answer.<unused95>Respuesta final:C",
         "medgemma-27b-text-it",
         "C"
        ],
        [
         "9",
         "Varón de 46 años, hace una hora sufre impacto de proyectil de arma de fuego en abdomen. Examen: PA: 60/40 mmHg, \nFC: 100X'. Pálido. Tórax: MV normal. Cardiovascular: RC disminuidos de intensidad. Abdomen: distendido, orificio en \nmesogastrio, RHA disminuidos, signo de rebote (+). ¿Cuál es la indicación inmediata?",
         "Laparatomía exploratoria",
         "Laparoscopía diagnóstica",
         "Exploración de la herida",
         "FAST",
         "A",
         "Ninguna de las anteriores",
         "Prueba A",
         "Year2025",
         "2025",
         "Varón de 46 años, hace una hora sufre impacto de proyectil de arma de fuego en abdomen. Examen: PA: 60/40 mmHg, \nFC: 100X'. Pálido. Tórax: MV normal. Cardiovascular: RC disminuidos de intensidad. Abdomen: distendido, orificio en \nmesogastrio, RHA disminuidos, signo de rebote (+). ¿Cuál es la indicación inmediata? A) Laparatomía exploratoria B) Laparoscopía diagnóstica C) Exploración de la herida D) FAST E) Ninguna de las anteriores",
         "<unused94>thought\n1.  **Analyze the Request:** The user wants me to act as an expert medical assistant trained in Peru and answer a multiple-choice medical question. I need to provide a step-by-step internal thought process, summarize the information, and then give *only* the final letter answer.\n\n2.  **Summarize the Case:**\n    *   Patient: 46-year-old male.\n    *   Event: Gunshot wound (GSW) to the abdomen 1 hour ago.\n    *   Vitals: Hypotensive (BP 60/40 mmHg), Tachycardic (HR 100 bpm).\n    *   Physical Exam: Pale, normal breath sounds (MV), diminished heart sounds (RC), distended abdomen, entry wound in mesogastrium, decreased bowel sounds (RHA), positive rebound tenderness (signo de rebote).\n\n3.  **Interpret the Findings:**\n    *   GSW to the abdomen is a penetrating trauma.\n    *   Hypotension (BP 60/40) and tachycardia (HR 100) indicate significant hemodynamic instability, likely due to hemorrhage (shock).\n    *   Pallor supports shock/blood loss.\n    *   Abdominal distension, decreased RHA, and positive rebound tenderness strongly suggest peritonitis, likely from intra-abdominal injury (e.g., bowel perforation, solid organ injury with bleeding).\n    *   The entry wound in the mesogastrium confirms the location of the penetrating injury.\n\n4.  **Evaluate the Options:**\n    *   **A) Laparatomía exploratoria (Exploratory Laparotomy):** This is a major surgical procedure to directly visualize and repair intra-abdominal injuries. Given the penetrating trauma, hemodynamic instability (shock), and signs of peritonitis, this is the standard of care for suspected significant intra-abdominal injury.\n    *   **B) Laparoscopía diagnóstica (Diagnostic Laparoscopy):** While useful in some stable trauma cases, it's generally contraindicated in hemodynamically unstable patients with penetrating abdominal trauma due to the risk of worsening shock, potential for inadequate visualization in a bloody field, and the time required.\n    *   **C) Exploración de la herida (Wound Exploration):** This is typically done for superficial wounds or to determine the depth of a penetrating injury, but it doesn't address the potential *intra-abdominal* damage causing the shock and peritonitis. It's insufficient in this scenario.\n    *   **D) FAST (Focused Assessment with Sonography for Trauma):** FAST is a rapid bedside ultrasound to detect free fluid (usually blood) in the peritoneal cavity, pericardium, or pleural space. While often used in trauma, in a patient with a penetrating abdominal GSW, clear signs of peritonitis, and hemodynamic instability, the need for surgical intervention is already strongly indicated. FAST might confirm hemoperitoneum but wouldn't change the immediate management, which is surgery. Delaying surgery for FAST in this unstable patient with peritonitis is not appropriate.\n    *   **E) Ninguna de las anteriores (None of the above):** Option A is clearly indicated.\n\n5.  **Determine the Best Course of Action:** The patient presents with a penetrating abdominal injury, hemodynamic instability (shock), and signs of peritonitis. This is a surgical emergency requiring immediate exploration to control bleeding and repair injuries. Exploratory laparotomy is the definitive management in this situation.\n\n6.  **Select the Final Answer:** Based on the analysis, Laparatomía exploratoria (A) is the most appropriate immediate indication.\n\n7.  **Format the Output:** Provide only the final letter as requested.<unused95>Respuesta final:A",
         "medgemma-27b-text-it",
         "A"
        ],
        [
         "10",
         "Varón de 45 años, obeso y con diabetes mellitus no controlada, acude al servicio de urgencias por una gangrena de \nFournier. Examen: PA: 120/60 mmHg, FC: 86X', FR: 24X'. Región anorectal: celulitis con edema y necrosis marcada con \nafectación del esfínter anal externo. ¿Qué tipo de colostomía es la más indicada?",
         "En caño de escopeta",
         "Bocas separadas por piel",
         "En asa derecha",
         "En asa izquierda",
         "D",
         "Ninguna de las anteriores",
         "Prueba A",
         "Year2025",
         "2025",
         "Varón de 45 años, obeso y con diabetes mellitus no controlada, acude al servicio de urgencias por una gangrena de \nFournier. Examen: PA: 120/60 mmHg, FC: 86X', FR: 24X'. Región anorectal: celulitis con edema y necrosis marcada con \nafectación del esfínter anal externo. ¿Qué tipo de colostomía es la más indicada? A) En caño de escopeta B) Bocas separadas por piel C) En asa derecha D) En asa izquierda E) Ninguna de las anteriores",
         "<unused94>thought\n1.  **Analyze the Request:** The user wants me to act as an expert medical assistant trained in Peru and answer a multiple-choice medical question. I need to provide a step-by-step internal thought process (which I won't show in the final output) and then output *only* the letter of the correct answer.\n\n2.  **Summarize the Case:**\n    *   Patient: 45-year-old male.\n    *   Comorbidities: Obesity, uncontrolled diabetes mellitus.\n    *   Presenting Complaint: Fournier's gangrene.\n    *   Vitals: BP 120/60 mmHg, HR 86 bpm, RR 24 breaths/min.\n    *   Physical Exam: Anorectal region shows cellulitis, edema, marked necrosis, and involvement of the external anal sphincter.\n    *   Question: What type of colostomy is most indicated?\n\n3.  **Understand Fournier's Gangrene:** Fournier's gangrene is a necrotizing fasciitis of the perineal, genital, or perianal regions. It's a surgical emergency requiring aggressive debridement and often diversion of fecal and urinary streams to prevent contamination of the wound.\n\n4.  **Understand Colostomy Types:**\n    *   **A) En caño de escopeta (End-to-end/Loop colostomy):** This is typically a loop colostomy, often in the sigmoid or descending colon. It's usually temporary.\n    *   **B) Bocas separadas por piel (Split stoma/Two separate stomas):** This involves creating two separate stomas, often from the sigmoid colon, to divert feces. This is sometimes used for fecal diversion, especially when a single stoma might be difficult or prone to complications.\n    *   **C) En asa derecha (Right loop colostomy):** A loop colostomy created from the ascending colon.\n    *   **D) En asa izquierda (Left loop colostomy):** A loop colostomy created from the descending or sigmoid colon. This is the most common type of temporary colostomy for fecal diversion.\n    *   **E) Ninguna de las anteriores (None of the above):** Implies none of the listed options are appropriate.\n\n5.  **Relate Colostomy to Fournier's Gangrene:** In Fournier's gangrene involving the anorectal region, the primary goal of a colostomy is to divert feces *away* from the infected and necrotic area to allow healing and prevent further contamination. The colostomy should be placed proximal to the affected area.\n\n6.  **Evaluate the Options in Context:**\n    *   The patient has anorectal involvement. A colostomy diverts feces from the rectum and anus.\n    *   The location of the colostomy depends on the extent of the disease and the surgeon's preference, but it needs to be proximal to the perineal wound.\n    *   A loop colostomy (asa) is a common and relatively straightforward method for temporary fecal diversion.\n    *   Options C (right loop) and D (left loop) are both types of loop colostomies.\n    *   Option A (\"en caño de escopeta\") is often used synonymously with loop colostomy in some contexts, but \"asa\" (loop) is more specific.\n    *   Option B (\"bocas separadas por piel\") is less common for standard fecal diversion in this acute setting.\n    *   Given the need for temporary diversion in an emergency setting like Fournier's gangrene, a loop colostomy is the standard approach. Both left and right loop colostomies are possible, but a left-sided loop colostomy (sigmoid or descending colon) is generally preferred because it's technically easier to perform and manage, and the effluent is more formed than from a right-sided one. However, the question asks for the *most indicated* type among the choices. A loop colostomy is definitely indicated.\n\n7.  **Refine the Choice:** The question asks for the *most indicated* type. A loop colostomy is the standard procedure for fecal diversion in Fournier's gangrene involving the perineum. Both \"En asa derecha\" and \"En asa izquierda\" describe loop colostomies. \"En caño de escopeta\" can also refer to a loop colostomy. In Peru, \"colostomía en asa\" (loop colostomy) is the standard term. Both left and right are possible, but left-sided is often preferred. However, the options provided are specific types. A loop colostomy is the general category. Option A (\"En caño de escopeta\") is sometimes used for loop colostomy, but \"asa\" is more precise. Option D (\"En asa izquierda\") is a specific type of loop colostomy commonly used for this purpose. Option C (\"En asa derecha\") is also a loop colostomy but less commonly used for temporary diversion due to more liquid stool. Option B is less standard for this acute situation.\n\n8.  **Consider Peruvian Context:** In Peru, the standard temporary fecal diversion for Fournier's gangrene involving the anorectal area is typically a loop colostomy (colostomía en asa). The left side (sigmoid or descending colon) is often preferred. Therefore, \"En asa izquierda\" (D) represents the most common and often preferred type of loop colostomy for this indication.\n\n9.  **Final Decision:** A loop colostomy is the standard procedure. \"En asa izquierda\" is a specific type of loop colostomy commonly used for this purpose.\n\n10. **Format the Output:** Provide only the letter of the chosen answer.<unused95>Respuesta final:D",
         "medgemma-27b-text-it",
         "D"
        ],
        [
         "11",
         "Varón de 74 años con EPOC moderado (FEV1 50%), acude por disnea marcada, tos con esputo mucoso y tendencia a \nla somnolencia. Examen: PA: 110/70 mmHg, FC: 92X', FR: 28X'; SatO2: 87%, FiO2: 21%; pulmones: tirajes, roncantes \nbibasales; neurológico: somnoliento y por momentos agitado. Laboratorio: pH: 7.29, PCO2: 55 mmHg, PO2: 62 mmHg. \n¿Cuál es el hallazgo más importante para manejo intrahospitalario?",
         "Acidosis respiratoria",
         "Neumonía atípica",
         "Delirio hiperactivo",
         "Insuficiencia cardíaca",
         "A",
         "Ninguna de las anteriores",
         "Prueba A",
         "Year2025",
         "2025",
         "Varón de 74 años con EPOC moderado (FEV1 50%), acude por disnea marcada, tos con esputo mucoso y tendencia a \nla somnolencia. Examen: PA: 110/70 mmHg, FC: 92X', FR: 28X'; SatO2: 87%, FiO2: 21%; pulmones: tirajes, roncantes \nbibasales; neurológico: somnoliento y por momentos agitado. Laboratorio: pH: 7.29, PCO2: 55 mmHg, PO2: 62 mmHg. \n¿Cuál es el hallazgo más importante para manejo intrahospitalario? A) Acidosis respiratoria B) Neumonía atípica C) Delirio hiperactivo D) Insuficiencia cardíaca E) Ninguna de las anteriores",
         "<unused94>thought\n1.  **Analyze the Request:** The user wants me to act as an expert medical assistant trained in Peru, answer a multiple-choice medical question, and provide only the final letter answer. I need to internally reason through the problem step-by-step but not show the reasoning in the final output.\n\n2.  **Summarize the Case:**\n    *   Patient: 74-year-old male.\n    *   History: Moderate COPD (FEV1 50%).\n    *   Presenting Symptoms: Marked dyspnea, cough with mucous sputum, somnolence.\n    *   Vitals: BP 110/70, HR 92, RR 28, SpO2 87% on room air (FiO2 21%).\n    *   Physical Exam: Respiratory distress (tirajes - retractions), bibasilar rales (roncantes), altered mental status (somnolent, agitated).\n    *   Labs (ABG): pH 7.29 (acidosis), PCO2 55 mmHg (hypercapnia), PO2 62 mmHg (hypoxemia).\n\n3.  **Evaluate the Options:**\n    *   **A) Acidosis respiratoria:** The ABG shows pH < 7.35 (7.29) and PCO2 > 45 mmHg (55 mmHg). This is a classic definition of respiratory acidosis. The patient's clinical presentation (COPD exacerbation, respiratory distress, altered mental status) is consistent with acute respiratory failure leading to respiratory acidosis. This is a critical finding requiring immediate management (e.g., non-invasive ventilation, intubation).\n    *   **B) Neumonía atípica:** While possible in a COPD exacerbation, the presentation (mucous sputum, bibasilar rales) isn't specific for atypical pneumonia. The most striking and immediately life-threatening finding is the severe respiratory acidosis. Pneumonia would be a *potential* cause or complication, but the acidosis itself is the most critical *hallazgo* (finding) for immediate management.\n    *   **C) Delirio hiperactivo:** The patient is somnolent and agitated, which *could* be part of delirium. However, this altered mental status is very likely secondary to the severe hypoxemia and hypercapnia (respiratory acidosis). Addressing the underlying respiratory failure is the priority. Delirium is a consequence, not the primary critical finding driving immediate management in this context.\n    *   **D) Insuficiencia cardíaca:** While COPD patients can have comorbid heart failure, the presentation (mucous sputum, bibasilar rales which could be crackles but described as roncantes, no mention of JVD, edema, or S3 gallop) doesn't strongly point to acute decompensated heart failure as the *primary* issue. The ABG findings are much more indicative of severe respiratory failure.\n    *   **E) Ninguna de las anteriores:** Option A is a very significant and critical finding.\n\n4.  **Determine the Most Important Finding for In-hospital Management:** The patient is in acute respiratory failure with severe respiratory acidosis (pH 7.29, PCO2 55) and hypoxemia (PO2 62, SpO2 87%). This is a life-threatening condition requiring immediate intervention to improve ventilation and oxygenation. The respiratory acidosis is the most direct and critical laboratory finding reflecting the severity of the respiratory failure and guiding immediate management decisions (like initiating NIV or intubation).\n\n5.  **Select the Final Answer:** Based on the analysis, the most important finding for immediate in-hospital management is the respiratory acidosis.\n\n6.  **Format the Output:** Provide only the letter corresponding to the chosen answer.<unused95>Respuesta final:A",
         "medgemma-27b-text-it",
         "A"
        ],
        [
         "12",
         "Varón de 25 años post laparotomía por apendicitis complicada y peritonitis generalizada; al cuarto día posoperatorio \npresenta distensión abdominal, náusea y vómitos. Examen: abdomen distendido y doloroso, RHA: ausentes, SNG: 1000 \nml de líquido verdoso. Electrolitos normales. ¿Cuál es el diagnóstico más probable?",
         "Perforación intestinal",
         "Obstrucción por bridas",
         "Íleo paralítico",
         "Síndrome de Ogilvie",
         "C",
         "Ninguna de las anteriores",
         "Prueba A",
         "Year2025",
         "2025",
         "Varón de 25 años post laparotomía por apendicitis complicada y peritonitis generalizada; al cuarto día posoperatorio \npresenta distensión abdominal, náusea y vómitos. Examen: abdomen distendido y doloroso, RHA: ausentes, SNG: 1000 \nml de líquido verdoso. Electrolitos normales. ¿Cuál es el diagnóstico más probable? A) Perforación intestinal B) Obstrucción por bridas C) Íleo paralítico D) Síndrome de Ogilvie E) Ninguna de las anteriores",
         "<unused94>thought\n1.  **Analyze the Request:** The user wants me to act as an expert medical assistant trained in Peru and answer a multiple-choice medical question. I need to provide a step-by-step internal thought process, summarize the information, and then give *only* the final letter answer.\n\n2.  **Summarize the Case:**\n    *   Patient: 25-year-old male.\n    *   History: Laparotomy for complicated appendicitis and generalized peritonitis 4 days ago.\n    *   Current Symptoms: Abdominal distension, nausea, vomiting (4th postoperative day).\n    *   Physical Exam: Distended, painful abdomen; absent bowel sounds (RHA ausentes).\n    *   Intervention: Nasogastric tube (SNG) drained 1000 ml of greenish fluid.\n    *   Labs: Normal electrolytes.\n\n3.  **Evaluate the Options:**\n    *   **A) Perforación intestinal (Intestinal Perforation):** While possible post-surgery, it usually presents with signs of peritonitis (rigidity, rebound tenderness) and potentially free air on imaging. The description focuses more on distension and absent bowel sounds, and the fluid is greenish (bilious/gastric content), not necessarily feculent or purulent. Less likely given the specific presentation.\n    *   **B) Obstrucción por bridas (Adhesive Bowel Obstruction):** This is a common cause of bowel obstruction after abdominal surgery. It typically presents with abdominal pain, distension, nausea, vomiting, and constipation/obstipation. Absent bowel sounds can occur. The greenish fluid from the SNG suggests proximal obstruction (stomach/duodenum) or reflux. This fits the clinical picture well, especially given the recent surgery.\n    *   **C) Íleo paralítico (Paralytic Ileus):** This is a functional obstruction where bowel motility ceases, often after surgery or due to inflammation/electrolyte imbalance. It presents with abdominal distension, nausea, vomiting, and absent bowel sounds. Electrolytes are normal here, which makes *pure* paralytic ileus slightly less likely as a primary cause, although it can occur post-op. However, the significant amount of fluid drained via SNG points more towards a mechanical obstruction. Paralytic ileus often involves the entire bowel, leading to distension throughout.\n    *   **D) Síndrome de Ogilvie (Acute Colonic Pseudo-obstruction):** This involves massive colonic dilation without mechanical obstruction, typically in severely ill or hospitalized patients. While the patient is post-op, Ogilvie's usually affects the colon primarily, and the symptoms described (especially the greenish SNG output) are more suggestive of a small bowel issue.\n    *   **E) Ninguna de las anteriores (None of the above):** Given that options B and C are strong possibilities, this is less likely.\n\n4.  **Compare B and C:**\n    *   **Adhesive Obstruction (B):** Common post-op complication. Symptoms match well (distension, N/V, absent RHA). Greenish SNG fluid is consistent with proximal obstruction or reflux.\n    *   **Paralytic Ileus (C):** Also common post-op. Symptoms match (distension, N/V, absent RHA). Normal electrolytes make it slightly less typical but still possible. However, the large volume of SNG drainage often points more towards a mechanical blockage where fluid accumulates proximal to the obstruction.\n\n5.  **Refine the Diagnosis:** The patient had a major abdominal surgery (laparotomy for complicated appendicitis/peritonitis) 4 days ago. This is a classic timeframe for the development of adhesive bowel obstruction. The symptoms (distension, N/V, absent RHA) and the large volume of greenish SNG drainage strongly suggest a mechanical obstruction, most likely due to adhesions. While paralytic ileus is also possible post-op, the significant SNG output favors a mechanical cause like adhesions.\n\n6.  **Select the Best Answer:** Based on the recent major abdominal surgery and the clinical presentation (distension, N/V, absent RHA, large volume greenish SNG output), adhesive bowel obstruction (Obstrucción por bridas) is the most probable diagnosis.\n\n7.  **Format the Final Answer:** Provide only the letter corresponding to the chosen answer.<unused95>Respuesta final:B",
         "medgemma-27b-text-it",
         "B"
        ],
        [
         "13",
         "Según la norma técnica peruana para el manejo de la anemia en lactantes; si la suspensión del suplemento de hierro es \nmayor a 3 meses, debe...",
         "continuar el tratamiento hasta los dos años.",
         "continuar el tratamiento por 6 meses.",
         "reiniciar la indicación hasta completar el esquema previamente indicado.",
         "iniciar un nuevo esquema, previa evaluación de hemoglobina.",
         "D",
         "Ninguna de las anteriores",
         "Prueba A",
         "Year2025",
         "2025",
         "Según la norma técnica peruana para el manejo de la anemia en lactantes; si la suspensión del suplemento de hierro es \nmayor a 3 meses, debe... A) continuar el tratamiento hasta los dos años. B) continuar el tratamiento por 6 meses. C) reiniciar la indicación hasta completar el esquema previamente indicado. D) iniciar un nuevo esquema, previa evaluación de hemoglobina. E) Ninguna de las anteriores",
         "<unused94>thought\n1.  **Identify the core question:** The question asks about the protocol for managing anemia in infants in Peru according to the national technical standard, specifically when iron supplementation is interrupted for more than 3 months.\n\n2.  **Recall/Access knowledge about Peruvian anemia guidelines:** Access information regarding the Peruvian Ministry of Health (MINSA) guidelines for the prevention and treatment of iron deficiency anemia in children under 5 years old. Key aspects include:\n    *   Universal iron supplementation for infants starting at 6 months.\n    *   Dosage based on age.\n    *   Duration of supplementation (typically until 2 years).\n    *   Management of interruptions in supplementation.\n\n3.  **Analyze the specific scenario:** The scenario involves an interruption of iron supplementation for *more than 3 months*.\n\n4.  **Evaluate the options based on the guidelines:**\n    *   **A) continuar el tratamiento hasta los dos años:** This is the standard duration *if* supplementation is continuous. It doesn't specifically address the interruption.\n    *   **B) continuar el tratamiento por 6 meses:** This is a fixed duration, not necessarily aligned with the standard protocol after an interruption.\n    *   **C) reiniciar la indicación hasta completar el esquema previamente indicado:** This option suggests resuming the original schedule as if the interruption didn't happen. This is a plausible approach to ensure the total duration of supplementation is met.\n    *   **D) iniciar un nuevo esquema, previa evaluación de hemoglobina:** This implies starting over, possibly with a different dose or duration, and requires a hemoglobin check. While evaluation is always important, starting a *new* scheme isn't the standard procedure for a simple interruption. The guidelines usually focus on resuming the original plan.\n    *   **E) Ninguna de las anteriores:** This is possible if none of the other options match the guidelines.\n\n5.  **Consult specific Peruvian guidelines (if necessary/possible):** Search for \"Norma Técnica para el Manejo de la Anemia en Lactantes Perú\" or similar terms. The relevant guideline (often updated, e.g., Resolución Ministerial RM N° 844-2016/MINSA or subsequent updates) typically states that if iron supplementation is interrupted for more than 3 months, the *original* supplementation schedule should be resumed to complete the recommended duration (usually until 2 years).\n\n6.  **Compare options with guideline information:** Option C aligns directly with the standard Peruvian protocol: if supplementation is stopped for >3 months, restart the original schedule to complete the full course.\n\n7.  **Select the best option:** Option C is the most accurate representation of the Peruvian technical standard for this specific situation.\n\n8.  **Format the final answer:** State only the letter of the correct option.<unused95>Respuesta final:C",
         "medgemma-27b-text-it",
         "C"
        ],
        [
         "14",
         "Varón de 80 años, hace 2 semanas presenta cefalea, náusea, vómito y luego se agrega somnolencia y convulsiones. \nTomografía cerebral signos de atrofia cortical. Punción lumbar: leucocitos 200/µL, hipoglucorraquia y presencia de \nbacilos gram positivos. ¿Cuál es el tratamiento de elección?",
         "Oxacilina",
         "Ceftriaxona",
         "Ampicilina",
         "Aciclovir",
         "C",
         "Ninguna de las anteriores",
         "Prueba A",
         "Year2025",
         "2025",
         "Varón de 80 años, hace 2 semanas presenta cefalea, náusea, vómito y luego se agrega somnolencia y convulsiones. \nTomografía cerebral signos de atrofia cortical. Punción lumbar: leucocitos 200/µL, hipoglucorraquia y presencia de \nbacilos gram positivos. ¿Cuál es el tratamiento de elección? A) Oxacilina B) Ceftriaxona C) Ampicilina D) Aciclovir E) Ninguna de las anteriores",
         "<unused94>thought\n1.  **Analyze the Request:** The user wants me to act as an expert medical assistant trained in Peru and answer a multiple-choice medical question. I need to provide a step-by-step internal thought process, summarize the information, and then output *only* the final letter answer.\n\n2.  **Summarize the Clinical Information:**\n    *   Patient: 80-year-old male.\n    *   Symptoms: Headache, nausea, vomiting (2 weeks duration), followed by somnolence and seizures.\n    *   Imaging: Brain CT shows cortical atrophy (common in elderly, may or may not be related).\n    *   Lumbar Puncture (LP):\n        *   WBC: 200/µL (elevated, normal <5).\n        *   Glucose: Low (hypoglycorrhachia).\n        *   Gram Stain: Gram-positive bacilli.\n\n3.  **Interpret the Findings:**\n    *   The clinical presentation (headache, nausea, vomiting, altered mental status, seizures) suggests meningitis or encephalitis.\n    *   The LP results strongly point towards bacterial meningitis:\n        *   Elevated WBC count (pleocytosis).\n        *   Low glucose (bacteria consume glucose).\n        *   Gram-positive bacilli identified.\n\n4.  **Identify the Likely Pathogen:** Gram-positive bacilli causing meningitis in an elderly patient are most commonly *Listeria monocytogenes*. Other possibilities exist, but *Listeria* is a prime suspect in this age group.\n\n5.  **Determine the Treatment of Choice for the Likely Pathogen:**\n    *   *Listeria monocytogenes* is intrinsically resistant to cephalosporins (like Ceftriaxone).\n    *   *Listeria* is typically susceptible to Ampicillin (often combined with Gentamicin for synergy, especially in severe cases or immunocompromised patients).\n    *   Oxacillin is primarily for *Staphylococcus aureus* (Gram-positive cocci).\n    *   Aciclovir is an antiviral, used for viral encephalitis (like HSV), not bacterial meningitis.\n\n6.  **Evaluate the Options:**\n    *   A) Oxacillin: Incorrect. Targets Staphylococci, not the likely Gram-positive bacilli (*Listeria*).\n    *   B) Ceftriaxona: Incorrect. Standard empiric treatment for many bacterial meningitis pathogens, but *Listeria* is resistant.\n    *   C) Ampicilina: Correct. Standard treatment for *Listeria monocytogenes*.\n    *   D) Aciclovir: Incorrect. Antiviral, not antibacterial.\n    *   E) Ninguna de las anteriores: Incorrect, as Ampicillin is the appropriate choice.\n\n7.  **Formulate the Final Answer:** Based on the analysis, Ampicillin is the treatment of choice for suspected *Listeria monocytogenes* meningitis, which fits the clinical picture and LP findings.\n\n8.  **Final Output Check:** Ensure the output format matches the request: \"Respuesta final:\" followed *only* by the letter.<unused95>Respuesta final:C",
         "medgemma-27b-text-it",
         "C"
        ],
        [
         "15",
         "Mujer de 21 años, solicita información sobre screening para cáncer de cuello uterino; que no manifiesta sus antecedentes \nsexuales. ¿Cuál es la indicación?",
         "Observación",
         "Test de Cobas",
         "Prueba conjunta",
         "Citología cervical",
         "D",
         "Ninguna de las anteriores",
         "Prueba A",
         "Year2025",
         "2025",
         "Mujer de 21 años, solicita información sobre screening para cáncer de cuello uterino; que no manifiesta sus antecedentes \nsexuales. ¿Cuál es la indicación? A) Observación B) Test de Cobas C) Prueba conjunta D) Citología cervical E) Ninguna de las anteriores",
         "<unused94>thought\n1.  **Identify the core question:** The question asks for the appropriate screening recommendation for cervical cancer in a 21-year-old woman who is not providing her sexual history.\n\n2.  **Analyze the patient profile:**\n    *   Age: 21 years old.\n    *   Reason for visit: Seeking information about cervical cancer screening.\n    *   Key information missing: Sexual history (which is relevant for risk assessment but doesn't negate screening guidelines based on age).\n\n3.  **Recall/Research Peruvian cervical cancer screening guidelines:**\n    *   Peruvian guidelines (based on international standards like WHO, FIGO, and adapted locally) generally recommend starting cervical cancer screening (cytology or HPV testing) at age 25, or earlier if the patient is sexually active.\n    *   However, guidelines often have specific recommendations for the 21-24 age group.\n    *   In many guidelines, including those often followed in Peru, screening *can* start at age 21, but the preferred method and frequency might differ from older age groups.\n    *   Specifically, for ages 21-24, cytology (Pap smear) is often recommended every 3 years. HPV testing is generally recommended starting at age 25 (or 30 in some older guidelines) every 5 years, or co-testing (cytology + HPV) every 5 years starting at age 30.\n    *   The lack of sexual history doesn't change the age-based screening recommendations. Screening is recommended based on age, regardless of sexual activity, although sexual activity is a risk factor.\n\n4.  **Evaluate the options based on guidelines:**\n    *   A) Observación: Incorrect. Screening is recommended based on age.\n    *   B) Test de Cobas: This refers to HPV testing (often using the Cobas HPV test). While HPV testing is used for screening, it's typically recommended starting at age 25 or 30, not usually as the primary method at age 21 in many current guidelines.\n    *   C) Prueba conjunta: This refers to co-testing (cytology + HPV). This is generally recommended starting at age 30, not 21.\n    *   D) Citología cervical: This refers to the Pap smear. This is the standard recommendation for screening in the 21-24 age group in many guidelines, including those often followed in Peru (every 3 years).\n    *   E) Ninguna de las anteriores: Incorrect, as cytology is a valid option.\n\n5.  **Select the best option:** Based on standard screening guidelines for a 21-year-old woman, cytology (Pap smear) is the most appropriate initial screening test.\n\n6.  **Format the final answer:** State only the letter corresponding to the chosen option.<unused95>Respuesta final:D",
         "medgemma-27b-text-it",
         "D"
        ],
        [
         "16",
         "Primigesta de 32 semanas por ecografía del primer trimestre; acude a control prenatal asintomática. Examen:  AU: 27 \ncm,  SPP: LCI, LCF: 142X´. Ecografía: gestación única activa con ponderado fetal en percentil 2 y doppler fetal normal. \n¿Cuál es el diagnóstico más probable?",
         "Error en la edad gestacional",
         "Restricción en el crecimiento intrauterino",
         "Crecimiento adecuado para la edad gestacional",
         "Pequeño para la edad gestacional",
         "B",
         "Ninguna de las anteriores",
         "Prueba A",
         "Year2025",
         "2025",
         "Primigesta de 32 semanas por ecografía del primer trimestre; acude a control prenatal asintomática. Examen:  AU: 27 \ncm,  SPP: LCI, LCF: 142X´. Ecografía: gestación única activa con ponderado fetal en percentil 2 y doppler fetal normal. \n¿Cuál es el diagnóstico más probable? A) Error en la edad gestacional B) Restricción en el crecimiento intrauterino C) Crecimiento adecuado para la edad gestacional D) Pequeño para la edad gestacional E) Ninguna de las anteriores",
         "<unused94>thought\n1.  **Analyze the Request:** The user wants me to act as an expert medical assistant trained in Peru and answer a multiple-choice medical question. I need to provide a step-by-step internal thought process, summarize the information, and then output *only* the final letter answer.\n\n2.  **Summarize the Information:**\n    *   Patient: Primigesta (first pregnancy).\n    *   Gestational Age (GA): 32 weeks by first-trimester ultrasound (considered the most accurate).\n    *   Presentation: Asymptomatic, routine prenatal control.\n    *   Physical Exam:\n        *   Abdominal Circumference (AU): 27 cm.\n        *   Fetal Heart Rate (FCF): 142 bpm (normal range).\n        *   Fetal Presentation (SPP): Longitudinal, Cephalic (LCI - likely means Longitudinal Cephalic Initial, or similar).\n    *   Ultrasound Findings:\n        *   Single, active pregnancy.\n        *   Fetal weight percentile: 2nd percentile.\n        *   Fetal Doppler: Normal.\n\n3.  **Evaluate the Options:**\n    *   **A) Error in the edad gestacional (Error in gestational age):** The GA is based on a first-trimester ultrasound, which is generally considered reliable. While discrepancies can occur, the ultrasound *also* shows a fetal weight percentile, suggesting the GA is likely correct for the *current* assessment. The discrepancy is in the *size* relative to the GA, not necessarily the GA itself.\n    *   **B) Restricción en el crecimiento intrauterino (Intrauterine Growth Restriction - IUGR):** IUGR is defined as a fetus whose estimated weight is below the 10th percentile for its gestational age. This patient's fetus is at the 2nd percentile. This fits the definition of IUGR.\n    *   **C) Crecimiento adecuado para la edad gestacional (Appropriate for Gestational Age - AGA):** AGA means the fetus is between the 10th and 90th percentiles. This patient's fetus is at the 2nd percentile, so it's not AGA.\n    *   **D) Pequeño para la edad gestacional (Small for Gestational Age - SGA):** SGA is often used interchangeably with IUGR, or sometimes defined as below the 10th percentile. Since the fetus is at the 2nd percentile, it is definitely SGA. IUGR implies a *pathological* process leading to the small size, while SGA is a descriptive term. However, in clinical practice, a fetus at the 2nd percentile is highly suggestive of IUGR, especially when identified at 32 weeks. Given the options, IUGR (B) is a more specific diagnosis describing the likely underlying condition causing the SGA state.\n    *   **E) Ninguna de las anteriores (None of the above):** Options B and D are plausible.\n\n4.  **Compare B and D:** Both IUGR and SGA describe the situation (fetus < 10th percentile). IUGR often implies a pathological cause or potential for adverse outcomes, while SGA is a descriptive term. A fetus at the 2nd percentile is significantly small and warrants further investigation for causes of IUGR. In the context of a medical diagnosis question, IUGR (B) is often considered the more clinically significant diagnosis when a fetus is this small, especially when Doppler is normal (suggesting it's not yet severe compromise but needs monitoring). The term \"Restricción\" (Restriction) implies a process limiting growth.\n\n5.  **Consider the AU:** An AU of 27 cm at 32 weeks is also small. Expected AU at 32 weeks is typically around 28-32 cm. 27 cm is below the expected range, further supporting the finding of a small fetus.\n\n6.  **Final Decision:** The fetus is at the 2nd percentile for weight, which is below the 10th percentile threshold. This defines the condition as either SGA or IUGR. IUGR is a more specific term often used when growth is pathologically restricted. Given the significant deviation (2nd percentile), IUGR is the most likely diagnosis among the choices provided.\n\n7.  **Format the Output:** Provide only the letter of the chosen answer.<unused95>Respuesta final:B",
         "medgemma-27b-text-it",
         "B"
        ],
        [
         "17",
         "Mujer de 42 años, acude a emergencia por dolor torácico y palpitaciones luego de consumo de cocaína. Examen: PA: \n110/70 mmHg, FC: 135X', FR: 23X', T°: 36.5 °C, SatO2: 97%. ¿Cuál es el diagnóstico más probable?",
         "Taquicardia nodal",
         "Taquicardia supraventricular",
         "Taquicardia sinusal",
         "Taquicardia auricular",
         "C",
         "Ninguna de las anteriores",
         "Prueba A",
         "Year2025",
         "2025",
         "Mujer de 42 años, acude a emergencia por dolor torácico y palpitaciones luego de consumo de cocaína. Examen: PA: \n110/70 mmHg, FC: 135X', FR: 23X', T°: 36.5 °C, SatO2: 97%. ¿Cuál es el diagnóstico más probable? A) Taquicardia nodal B) Taquicardia supraventricular C) Taquicardia sinusal D) Taquicardia auricular E) Ninguna de las anteriores",
         "<unused94>thought\n1.  **Analyze the Request:** The user wants me to act as an expert medical assistant trained in Peru and answer a multiple-choice medical question. I need to provide a step-by-step internal thought process, summarize the information, and then give *only* the final letter answer.\n\n2.  **Summarize the Information:**\n    *   Patient: 42-year-old female.\n    *   Presentation: Emergency department visit.\n    *   Symptoms: Chest pain and palpitations.\n    *   Trigger: Cocaine use.\n    *   Vitals:\n        *   BP: 110/70 mmHg (Normal/Slightly elevated diastolic)\n        *   HR: 135 bpm (Tachycardia)\n        *   RR: 23 breaths/min (Tachypnea)\n        *   Temp: 36.5 °C (Normal)\n        *   SpO2: 97% (Normal)\n    *   Question: Most probable diagnosis among the given options.\n    *   Options:\n        *   A) Nodal tachycardia (AVNRT/AVRT)\n        *   B) Supraventricular tachycardia (SVT) - This is a broad category including A.\n        *   C) Sinus tachycardia\n        *   D) Atrial tachycardia\n        *   E) None of the above\n\n3.  **Internal Reasoning (Step-by-Step):**\n    *   **Identify the core problem:** The patient has tachycardia (HR 135 bpm) associated with chest pain and palpitations after cocaine use.\n    *   **Consider the context:** Cocaine is a potent sympathomimetic drug. It increases catecholamine release (epinephrine, norepinephrine), leading to increased heart rate, blood pressure, and myocardial oxygen demand.\n    *   **Evaluate the options in the context of cocaine use:**\n        *   **Cocaine's effects:** Cocaine can cause various cardiac arrhythmias, including sinus tachycardia, atrial fibrillation/flutter, supraventricular tachycardias (SVT), and ventricular tachycardias/fibrillation. It can also cause coronary artery vasospasm, leading to myocardial ischemia/infarction (explaining the chest pain).\n        *   **Sinus Tachycardia (C):** This is a very common physiological response to stress, pain, anxiety, fever, hypovolemia, and sympathomimetic drugs like cocaine. The heart rate is typically <150 bpm (though can be higher), and the rhythm is regular with normal P waves preceding each QRS complex. Given the cocaine use and associated symptoms, sinus tachycardia is a highly likely initial response.\n        *   **Supraventricular Tachycardia (SVT) (B):** This is a broader category that includes AVNRT, AVRT, atrial tachycardia, and atrial flutter/fibrillation. While cocaine *can* trigger SVTs, sinus tachycardia is often the *first* and most common tachyarrhythmia seen. The question asks for the *most probable* diagnosis.\n        *   **Nodal Tachycardia (A):** This refers specifically to AVNRT or AVRT, types of SVT. Again, possible but perhaps less common as the *initial* presentation compared to sinus tachycardia.\n        *   **Atrial Tachycardia (D):** Another type of SVT. Possible, but sinus tachycardia is more common in this acute setting.\n        *   **Comparing Sinus Tachycardia vs. SVT:** In the context of acute cocaine use causing sympathetic overdrive, sinus tachycardia is the most direct and expected physiological response. While cocaine can precipitate other arrhythmias, sinus tachycardia is often the initial and most frequent finding. The heart rate of 135 bpm is consistent with sinus tachycardia, although it could also be seen in some SVTs. However, without an ECG, differentiating definitively is impossible. But based on probability in this clinical scenario, sinus tachycardia is the most likely *initial* diagnosis.\n    *   **Refine the choice:** The patient's symptoms (palpitations, chest pain) and vital signs (HR 135, RR 23) in the setting of cocaine use strongly suggest sympathetic activation. Sinus tachycardia is the most common cardiac manifestation of this activation. While other arrhythmias are possible, sinus tachycardia is the most probable *initial* diagnosis given the limited information (no ECG).\n    *   **Final Check:** Does sinus tachycardia fit the clinical picture? Yes, cocaine causes sympathetic stimulation, leading to increased heart rate. The rate of 135 bpm is typical for sinus tachycardia in this context. Chest pain could be due to ischemia from increased demand or vasospasm, both exacerbated by tachycardia.\n\n4.  **Select the Final Answer:** Based on the reasoning, Sinus Tachycardia (C) is the most probable diagnosis.\n\n5.  **Format the Output:** Provide only the final letter.<unused95>Respuesta final:C",
         "medgemma-27b-text-it",
         "C"
        ],
        [
         "18",
         "Tercigesta de 33 semanas, cesareada anterior dos veces; acude por sangrado vaginal indoloro. Examen: AU: 30 cm, \nSPP: LCD, LCF 144X'. Ecografía obstétrica: gestación única activa con ponderado fetal en percentil 60. Placenta cubre \nla totalidad del OCI y presenta ademas lagunas vasculares, adelgazamiento miometrio retroplacentario y vasos puente. \n¿Cuál es el diagnóstico más probable?",
         "Rotura uterina",
         "Espectro de acretismo placentario",
         "Hematoma retroplacentario",
         "Rotura de vasa previa",
         "B",
         "Ninguna de las anteriores",
         "Prueba A",
         "Year2025",
         "2025",
         "Tercigesta de 33 semanas, cesareada anterior dos veces; acude por sangrado vaginal indoloro. Examen: AU: 30 cm, \nSPP: LCD, LCF 144X'. Ecografía obstétrica: gestación única activa con ponderado fetal en percentil 60. Placenta cubre \nla totalidad del OCI y presenta ademas lagunas vasculares, adelgazamiento miometrio retroplacentario y vasos puente. \n¿Cuál es el diagnóstico más probable? A) Rotura uterina B) Espectro de acretismo placentario C) Hematoma retroplacentario D) Rotura de vasa previa E) Ninguna de las anteriores",
         "<unused94>thought\n1.  **Analyze the Request:** The user wants me to act as an expert medical assistant trained in Peru and answer a multiple-choice medical question. I need to provide a step-by-step internal thought process (which I won't output) and then output *only* the final letter answer.\n\n2.  **Summarize the Case Information:**\n    *   Patient: 33 weeks pregnant (tercigesta - third pregnancy).\n    *   History: Two previous cesarean sections.\n    *   Presenting Symptom: Painless vaginal bleeding.\n    *   Physical Exam:\n        *   Abdominal Circumference (AU): 30 cm (consistent with gestational age).\n        *   Fetal Presentation: Longitudinal, Cephalic, Dorsal (LCD).\n        *   Fetal Heart Rate (LCF): 144 bpm (normal range).\n    *   Ultrasound Findings:\n        *   Single, active pregnancy.\n        *   Fetal weight: 60th percentile (appropriate for gestational age).\n        *   Placenta: Covers the entire internal cervical os (complete placenta previa).\n        *   Additional placental findings: Vascular lakes (lagunas vasculares), thinning of the retroplacental myometrium (adelgazamiento miometrio retroplacentario), and bridging vessels (vasos puente).\n\n3.  **Evaluate the Options based on the Summary:**\n\n    *   **A) Rotura uterina (Uterine rupture):** This is a serious complication, often associated with previous uterine surgery (like C-sections). However, it typically presents with *acute abdominal pain*, fetal distress (bradycardia, late decelerations), loss of uterine contour, and often *significant* bleeding (though sometimes concealed). The patient has *painless* bleeding and a normal FHR. While the history of C-sections is a risk factor, the clinical presentation doesn't fit well.\n\n    *   **B) Espectro de acretismo placentario (Placental accretion spectrum):** This refers to abnormal adherence of the placenta to the uterine wall, ranging from increta (invades myometrium) to percreta (penetrates through myometrium). Risk factors include placenta previa and prior uterine surgery (especially C-sections). The ultrasound findings described (thinning of the retroplacental myometrium, vascular lakes, bridging vessels) are *classic signs* suggestive of placenta accreta spectrum (PAS). Painless bleeding is also a common presentation, especially in the third trimester. The combination of placenta previa, prior C-sections, and these specific ultrasound findings strongly points towards PAS.\n\n    *   **C) Hematoma retroplacentario (Retroplacental hematoma):** This is bleeding behind the placenta, often associated with placental abruption. Abruption typically presents with *painful* vaginal bleeding (though it can be painless or concealed), uterine tenderness/rigidity, and potentially fetal distress. The patient has *painless* bleeding, and the ultrasound doesn't describe a hematoma, but rather abnormal placental implantation features.\n\n    *   **D) Rotura de vasa previa (Vasa previa rupture):** This occurs when fetal blood vessels run across or near the internal cervical os, unprotected by placental tissue or the umbilical cord. Rupture typically happens with rupture of membranes or labor and causes *fetal* bleeding, leading to rapid fetal distress (bradycardia, sinusoidal pattern) and potentially fetal demise. While painless bleeding can occur, the primary concern is fetal compromise, and the ultrasound findings described are related to placental implantation, not fetal vessels over the os.\n\n    *   **E) Ninguna de las anteriores (None of the above):** Given the strong correlation between the patient's history (prior C-sections), presentation (painless bleeding), and specific ultrasound findings (placenta previa with signs of abnormal invasion), option B is a very likely diagnosis.\n\n4.  **Synthesize and Select the Best Answer:** The patient has placenta previa (placenta covering the os), a history of two C-sections (major risk factor for PAS), and painless bleeding. Crucially, the ultrasound shows specific features highly suggestive of abnormal placental invasion: thinning of the myometrium, vascular lakes, and bridging vessels. These findings are characteristic of the placenta accreta spectrum. Therefore, option B is the most probable diagnosis.\n\n5.  **Format the Final Output:** Output only the letter corresponding to the chosen answer.<unused95>Respuesta final:B",
         "medgemma-27b-text-it",
         "B"
        ],
        [
         "19",
         "Mujer de 38 años, acude por cefalea y convulsiones tónico clónicas generalizadas de larga data. Resonancia cerebral \ninforma dos quistes parenquimatosos compatibles con neurocisticercosis. ¿Cuál es el tratamiento de elección?",
         "Albendazol y Praziquantel",
         "Praziquantel",
         "Prednisona",
         "Albendazol",
         "D",
         "Ninguna de las anteriores",
         "Prueba A",
         "Year2025",
         "2025",
         "Mujer de 38 años, acude por cefalea y convulsiones tónico clónicas generalizadas de larga data. Resonancia cerebral \ninforma dos quistes parenquimatosos compatibles con neurocisticercosis. ¿Cuál es el tratamiento de elección? A) Albendazol y Praziquantel B) Praziquantel C) Prednisona D) Albendazol E) Ninguna de las anteriores",
         "<unused94>thought\n1.  **Identify the core problem:** The patient has neurocysticercosis (NCC), confirmed by brain MRI showing parenchymal cysts, presenting with headache and seizures.\n\n2.  **Recall knowledge about NCC treatment:** NCC is caused by the larval stage of *Taenia solium*. Treatment aims to kill the cysts and reduce inflammation.\n\n3.  **Evaluate the options:**\n    *   A) Albendazol and Praziquantel: Both are antihelminthic drugs used for NCC. Combining them might be considered in some protocols, but often one is chosen.\n    *   B) Praziquantel: An effective antihelminthic for NCC, often used as a first-line agent.\n    *   C) Prednisone: A corticosteroid. Used adjunctively in NCC to manage inflammation, especially when cysts are degenerating or causing significant edema, but *not* the primary treatment to kill the parasite.\n    *   D) Albendazol: Another effective antihelminthic for NCC, often considered a first-line agent, potentially with better penetration into the CNS than praziquantel.\n    *   E) Ninguna de las anteriores: Unlikely, as effective treatments exist.\n\n4.  **Compare Albendazol and Praziquantel:** Both are standard treatments. Albendazol is often preferred due to potentially better CNS penetration and efficacy, especially for multiple cysts. Praziquantel is also effective. Guidelines often list both as options.\n\n5.  **Consider the specific presentation:** The patient has *parenchymal* cysts and seizures. This is a common indication for antihelminthic treatment.\n\n6.  **Re-evaluate the options in the context of \"treatment of choice\":** While both Albendazol and Praziquantel are used, Albendazol is frequently cited as the preferred agent or first-line treatment in many guidelines, particularly for parenchymal NCC, due to its efficacy and pharmacokinetic profile. Praziquantel is a valid alternative. Combining them (Option A) is less common as a standard first-line approach compared to using one agent. Prednisone (Option C) is adjunctive, not primary.\n\n7.  **Select the best option:** Given that Albendazol is often considered the preferred first-line agent for parenchymal NCC, Option D seems the most appropriate answer for \"treatment of choice\". While Praziquantel (B) is also a valid treatment, Albendazol is often favored. Option A (combination) is not the standard *initial* choice.\n\n8.  **Final check:** The question asks for the \"treatment of choice\". Albendazol is widely recognized as a primary and often preferred treatment for parenchymal neurocysticercosis.<unused95>Respuesta final:D",
         "medgemma-27b-text-it",
         "D"
        ],
        [
         "20",
         "Mujer de 19 años, acude por sensación de miedo, sudoración, palpitaciones, dolor torácico y sensación de temor; refiere \nque desde hace más de un mes presenta este episodio y le preocupa mucho. ¿Cuál es el trastorno más probable?",
         "De ansiedad generalizada",
         "De angustia",
         "Obsesivo compulsivo",
         "Fóbico",
         "B",
         "Ninguna de las anteriores",
         "Prueba A",
         "Year2025",
         "2025",
         "Mujer de 19 años, acude por sensación de miedo, sudoración, palpitaciones, dolor torácico y sensación de temor; refiere \nque desde hace más de un mes presenta este episodio y le preocupa mucho. ¿Cuál es el trastorno más probable? A) De ansiedad generalizada B) De angustia C) Obsesivo compulsivo D) Fóbico E) Ninguna de las anteriores",
         "<unused94>thought\n1.  **Analyze the Request:** The user wants me to act as an expert medical assistant trained in Peru and answer a multiple-choice medical question. I need to provide a step-by-step internal thought process, summarize the information, and then output *only* the final letter answer.\n\n2.  **Summarize the Case:**\n    *   Patient: 19-year-old female.\n    *   Symptoms: Fear, sweating, palpitations, chest pain, feeling of dread/doom.\n    *   Duration/Frequency: Episodes occurring for over a month, causing significant worry.\n    *   Key Features: Sudden onset (implied by the constellation of symptoms), intense physical and psychological distress.\n\n3.  **Evaluate the Options:**\n    *   **A) Trastorno de Ansiedad Generalizada (GAD):** Characterized by *excessive, persistent worry* about various things, often accompanied by physical symptoms like restlessness, fatigue, muscle tension, irritability, sleep disturbance. While anxiety is present, the description focuses on *acute, intense episodes* rather than chronic, pervasive worry.\n    *   **B) Trastorno de Angustia (Panic Disorder):** Characterized by *recurrent, unexpected panic attacks*. A panic attack is an abrupt surge of intense fear or discomfort that reaches a peak within minutes, accompanied by physical symptoms (palpitations, sweating, chest pain, shortness of breath, dizziness, etc.) and cognitive symptoms (fear of losing control, fear of dying, derealization/depersonalization). The patient's symptoms (fear, sweating, palpitations, chest pain, dread) strongly match a panic attack. The recurrence over a month and the associated worry also fit the criteria for Panic Disorder.\n    *   **C) Trastorno Obsesivo Compulsivo (OCD):** Characterized by *obsessions* (recurrent, intrusive thoughts, urges, or images) and/or *compulsions* (repetitive behaviors or mental acts performed in response to obsessions or according to rigid rules). The described symptoms don't align with obsessions or compulsions.\n    *   **D) Trastorno Fóbico (Phobic Disorder):** Characterized by *marked fear or anxiety* about a specific object or situation (e.g., heights, spiders, social situations). The fear is out of proportion to the actual danger. While the patient experiences fear, it's not linked to a specific phobic stimulus in the description. The symptoms described are more characteristic of a generalized panic attack.\n    *   **E) Ninguna de las anteriores:** Given the strong match with Panic Disorder, this is unlikely.\n\n4.  **Compare Symptoms to Disorders:** The patient's symptoms (sudden onset, intense fear, sweating, palpitations, chest pain, dread) are classic signs of a panic attack. The fact that these episodes have been recurring for over a month and causing worry points towards a Panic Disorder (Trastorno de Angustia).\n\n5.  **Select the Best Fit:** Trastorno de Angustia (Panic Disorder) is the most likely diagnosis based on the presented symptoms and history.\n\n6.  **Format the Output:** Provide only the final letter answer as requested.<unused95>Respuesta final:B",
         "medgemma-27b-text-it",
         "B"
        ],
        [
         "21",
         "Primípara de 32 años, Rh negativo; actualmente puérpera de 96 horas de parto vaginal, manifiesta que su hijo es Rh \npositivo y ella no ha recibido inmunoglobulina anti-D durante su embarazo, ni en el puerperio inmediato. ¿Cuál es la \nconducta a seguir?",
         "Diferir inmunoglobulina anti-D hasta el próximo embarazo",
         "Administrar corticoides intramuscular",
         "Solicitar prueba de coombs indirecta",
         "Colocar inmunoglobulina anti-D inmediatamente",
         "D",
         "Ninguna de las anteriores",
         "Prueba A",
         "Year2025",
         "2025",
         "Primípara de 32 años, Rh negativo; actualmente puérpera de 96 horas de parto vaginal, manifiesta que su hijo es Rh \npositivo y ella no ha recibido inmunoglobulina anti-D durante su embarazo, ni en el puerperio inmediato. ¿Cuál es la \nconducta a seguir? A) Diferir inmunoglobulina anti-D hasta el próximo embarazo B) Administrar corticoides intramuscular C) Solicitar prueba de coombs indirecta D) Colocar inmunoglobulina anti-D inmediatamente E) Ninguna de las anteriores",
         "<unused94>thought\n1.  **Identify the core problem:** A Rh-negative mother has delivered a Rh-positive baby. She was not given RhoGAM (anti-D immunoglobulin) during pregnancy or postpartum. This puts her at risk of sensitization.\n\n2.  **Analyze the patient's status:**\n    *   Primipara (first pregnancy).\n    *   32 years old.\n    *   Rh-negative.\n    *   96 hours postpartum (vaginal delivery).\n    *   Baby is Rh-positive.\n    *   No anti-D immunoglobulin given during pregnancy or postpartum.\n\n3.  **Understand the risk:** The mother is exposed to the baby's Rh-positive red blood cells during delivery. Without anti-D immunoglobulin, her immune system can produce anti-D antibodies (sensitization). This sensitization can cause hemolytic disease of the fetus and newborn (HDFN) in *future* pregnancies with Rh-positive fetuses.\n\n4.  **Evaluate the timing:** The standard window for administering anti-D immunoglobulin postpartum to prevent sensitization is within 72 hours of delivery. However, the question states it's 96 hours. While the ideal window has passed, administration *can* still be beneficial, although its effectiveness decreases with time. The key is to prevent or minimize sensitization.\n\n5.  **Assess the options:**\n    *   **A) Diferir inmunoglobulina anti-D hasta el próximo embarazo:** This is incorrect. The goal is to prevent sensitization *now* to protect *future* pregnancies. Delaying treatment increases the risk of sensitization.\n    *   **B) Administrar corticoides intramuscular:** Corticosteroids are used to treat established hemolytic disease in the fetus or newborn, or sometimes in severe maternal autoimmune conditions, but not for preventing Rh sensitization postpartum.\n    *   **C) Solicitar prueba de coombs indirecta:** A Coombs indirect test (indirect antiglobulin test or IAT) detects antibodies in the mother's serum. While it's important to check for sensitization, it doesn't *prevent* it. The immediate need is to prevent sensitization from occurring or worsening. A Coombs test would be done to assess if sensitization *has already occurred*, but the primary action needed is prophylaxis.\n    *   **D) Colocar inmunoglobulina anti-D inmediatamente:** This is the standard treatment to prevent Rh sensitization in an Rh-negative mother exposed to Rh-positive fetal blood. Even though 96 hours is past the ideal 72-hour window, administering anti-D immunoglobulin is still the recommended course of action to minimize the risk of sensitization. Guidelines often state administration is recommended within 28 days postpartum if missed within 72 hours, but immediate administration is still the best approach to reduce risk.\n    *   **E) Ninguna de las anteriores:** Option D is the correct management strategy.\n\n6.  **Synthesize the best course of action:** The mother is at high risk of sensitization. The standard preventative measure is anti-D immunoglobulin. Although the ideal window (72 hours) has passed slightly, administering it as soon as possible (immediately) is still the recommended management to reduce the risk of sensitization.\n\n7.  **Final Answer Selection:** Option D aligns with the standard medical practice for preventing Rh sensitization in this scenario, even with the slight delay.<unused95>Respuesta final:D",
         "medgemma-27b-text-it",
         "D"
        ],
        [
         "22",
         "Varón de 70 años, acude a consulta, porque hace 8 meses presenta dolor epigástrico constante que no mejora a la \ningesta de alimentos, llenura precoz y melena. Examen: MEN, REH, adenopatía supraclavicular izquierda. Abdomen: se \npalpa masa dolorosa en epigastrio. Laboratorio: Hb: 8 g/dL. ¿Cuál es el diagnóstico más probable?",
         "NM gástrico",
         "Úlcera duodenal",
         "Linfoma gástrico",
         "Tumor de Pancoast",
         "A",
         "Ninguna de las anteriores",
         "Prueba A",
         "Year2025",
         "2025",
         "Varón de 70 años, acude a consulta, porque hace 8 meses presenta dolor epigástrico constante que no mejora a la \ningesta de alimentos, llenura precoz y melena. Examen: MEN, REH, adenopatía supraclavicular izquierda. Abdomen: se \npalpa masa dolorosa en epigastrio. Laboratorio: Hb: 8 g/dL. ¿Cuál es el diagnóstico más probable? A) NM gástrico B) Úlcera duodenal C) Linfoma gástrico D) Tumor de Pancoast E) Ninguna de las anteriores",
         "<unused94>thought\n1.  **Analyze the Request:** The user wants me to act as an expert medical assistant trained in Peru and answer a multiple-choice medical question. I need to provide a step-by-step internal thought process (which I won't show in the final output) and then output *only* the letter of the correct answer, preceded by \"Respuesta final:\".\n\n2.  **Summarize the Patient Information:**\n    *   **Patient:** 70-year-old male.\n    *   **Symptoms:**\n        *   Epigastric pain (constant, 8 months duration, *not* relieved by food).\n        *   Early satiety (llenura precoz).\n        *   Melena (dark, tarry stools, indicating upper GI bleeding).\n    *   **Physical Exam Findings:**\n        *   General: MEN (presumably Mal Estado Nutricional - Malnutrition).\n        *   REH (presumably Reflejo Esofágico Herniado - Hiatal Hernia Reflex, though this is less common terminology; could also mean Reflejo Elicito Hígado - Elicited Liver Reflex, but less likely in this context). Let's assume it's not critical for the primary diagnosis.\n        *   Adenopatía supraclavicular izquierda (Virchow's node - strongly suggests metastatic abdominal malignancy, often gastric).\n        *   Abdomen: Palpable, painful mass in the epigastrium.\n    *   **Laboratory Findings:**\n        *   Hb: 8 g/dL (Anemia, likely due to chronic blood loss from melena).\n\n3.  **Evaluate the Options:**\n    *   **A) NM gástrico (Neoplasia Maligna gástrica - Gastric Malignancy):**\n        *   *Fits:* Age (older adult), chronic epigastric pain (often constant, not relieved by food), early satiety, melena (bleeding), palpable epigastric mass, Virchow's node (metastasis), anemia (chronic blood loss), malnutrition. This aligns very well with the clinical picture of advanced gastric cancer.\n    *   **B) Úlcera duodenal (Duodenal Ulcer):**\n        *   *Doesn't Fit Well:* Pain is typically relieved by food or antacids, not constant and worsening. While melena can occur, the palpable mass, Virchow's node, and early satiety are not typical features of a duodenal ulcer.\n    *   **C) Linfoma gástrico (Gastric Lymphoma):**\n        *   *Fits:* Can present with similar symptoms (pain, bleeding, mass, early satiety, anemia). Can metastasize to supraclavicular nodes.\n        *   *Less Likely than A:* While possible, gastric adenocarcinoma (NM gástrico) is far more common in this age group presenting with these classic signs of advanced disease (Virchow's node, palpable mass, chronic symptoms).\n    *   **D) Tumor de Pancoast (Pancoast Tumor):**\n        *   *Doesn't Fit:* This is a lung tumor (specifically, an apical lung tumor). Symptoms typically involve shoulder/arm pain, Horner's syndrome, and neurological deficits. It does not cause epigastric pain, melena, early satiety, or a palpable epigastric mass. Virchow's node is associated with abdominal malignancies, not typically Pancoast tumors.\n    *   **E) Ninguna de las anteriores (None of the above):**\n        *   *Unlikely:* Option A fits the clinical picture extremely well.\n\n4.  **Compare A and C:** Both gastric malignancy (adenocarcinoma) and gastric lymphoma can present similarly. However, given the patient's age (70 years) and the classic constellation of symptoms including Virchow's node (a hallmark of metastatic gastric cancer), gastric adenocarcinoma (NM gástrico) is statistically much more probable than gastric lymphoma.\n\n5.  **Conclusion:** The clinical presentation (age, chronic epigastric pain not relieved by food, early satiety, melena, palpable epigastric mass, Virchow's node, anemia, malnutrition) is highly suggestive of advanced gastric cancer (Neoplasia Maligna gástrica).\n\n6.  **Final Answer Format:** Select the letter corresponding to the most likely diagnosis.<unused95>Respuesta final:A",
         "medgemma-27b-text-it",
         "A"
        ],
        [
         "23",
         "Varón de 14 años post amigdalectomizado presenta alteración del gusto. Examen: ageusia en el tercio posterior de la \nlengua, anestesia de la faringe, sequedad oral parcial y dificultad en la deglución. ¿Qué par craneal se encuentra \ncomprometido?",
         "IX",
         "VII",
         "XI",
         "XII",
         "A",
         "Ninguna de las anteriores",
         "Prueba A",
         "Year2025",
         "2025",
         "Varón de 14 años post amigdalectomizado presenta alteración del gusto. Examen: ageusia en el tercio posterior de la \nlengua, anestesia de la faringe, sequedad oral parcial y dificultad en la deglución. ¿Qué par craneal se encuentra \ncomprometido? A) IX B) VII C) XI D) XII E) Ninguna de las anteriores",
         "<unused94>thought\n1.  **Analyze the Request:** The user wants me to act as an expert medical assistant trained in Peru and answer a multiple-choice medical question. I need to provide a step-by-step internal thought process, summarize the information, and then output *only* the final letter answer.\n\n2.  **Summarize the Information:**\n    *   Patient: 14-year-old male.\n    *   History: Post-amigdalectomy (tonsillectomy).\n    *   Symptoms: Altered taste (ageusia in the posterior third of the tongue), anesthesia of the pharynx, partial dry mouth, difficulty swallowing (dysphagia).\n    *   Question: Which cranial nerve is compromised?\n    *   Options: A) IX (Glossopharyngeal), B) VII (Facial), C) XI (Accessory), D) XII (Hypoglossal), E) None.\n\n3.  **Step-by-Step Reasoning (Internal):**\n    *   **Ageusia in the posterior third of the tongue:** Taste sensation is mediated by cranial nerves VII (anterior 2/3) and IX (posterior 1/3). Since the ageusia is specifically in the posterior third, this points strongly towards CN IX.\n    *   **Anesthesia of the pharynx:** The pharyngeal sensory innervation is primarily provided by CN IX (glossopharyngeal nerve).\n    *   **Partial dry mouth (xerostomia):** Salivation is controlled by CN VII (parasympathetic to submandibular and sublingual glands) and CN IX (parasympathetic to parotid gland). While CN VII is the major contributor, CN IX also plays a role, especially in parotid secretion. Anesthesia/damage to CN IX could potentially affect parotid function, contributing to dry mouth.\n    *   **Difficulty swallowing (dysphagia):** Swallowing (deglutition) is a complex process involving multiple cranial nerves. CN IX (glossopharyngeal) is involved in the sensory aspect of the pharyngeal phase and contributes to the motor control of the stylopharyngeus muscle (elevates pharynx). CN X (vagus) is crucial for motor control of pharyngeal and laryngeal muscles. CN XII (hypoglossal) controls tongue movement, important for the oral phase. Given the pharyngeal anesthesia and posterior tongue taste loss, CN IX involvement in the pharyngeal phase of swallowing is highly likely.\n    *   **Post-amigdalectomy context:** The glossopharyngeal nerve (CN IX) runs close to the tonsillar fossa and pharynx. Surgical procedures in this area, like tonsillectomy, carry a risk of injuring CN IX.\n    *   **Evaluate other options:**\n        *   CN VII (Facial): Primarily involved in taste (anterior 2/3), facial expression, salivation (submandibular/sublingual), and lacrimation. The symptoms don't fit CN VII primarily.\n        *   CN XI (Accessory): Primarily motor to sternocleidomastoid and trapezius muscles. Not related to taste, pharyngeal sensation, salivation, or swallowing.\n        *   CN XII (Hypoglossal): Primarily motor to tongue muscles. Damage causes tongue deviation and weakness, affecting the oral phase of swallowing. While dysphagia is present, the other symptoms (posterior taste loss, pharyngeal anesthesia) point away from CN XII as the *primary* nerve involved.\n    *   **Conclusion:** The combination of ageusia in the posterior third of the tongue, pharyngeal anesthesia, potential contribution to dry mouth, and dysphagia, especially in the context of recent pharyngeal surgery (amigdalectomy), strongly implicates the Glossopharyngeal nerve (CN IX).\n\n4.  **Final Answer Selection:** Based on the reasoning, the most likely compromised cranial nerve is CN IX. This corresponds to option A.\n\n5.  **Format the Output:** Provide only the final letter answer as requested.<unused95>Respuesta final:A",
         "medgemma-27b-text-it",
         "A"
        ],
        [
         "24",
         "Lactante de 9 meses, desde hace 3 días presenta fiebre y vómitos frecuentes. Examen: T°: 39 ºC, piel caliente, poco \nelástica. Laboratorio: leucocitos 20,000/µL, abastonados: 700/µL; examen de orina: nitrito positivo y 100 \nleucocitos/campo. ¿Cuál es la conducta más adecuada?",
         "Hospitalizar para hidratación y antibioticoterapia parenteral",
         "Iniciar hidratación por vía oral e indicar antibioticoterapia oral",
         "Administrar antibioticoterapia parenteral",
         "Realizar ecografía renal para descartar absceso",
         "A",
         "Ninguna de las anteriores",
         "Prueba A",
         "Year2025",
         "2025",
         "Lactante de 9 meses, desde hace 3 días presenta fiebre y vómitos frecuentes. Examen: T°: 39 ºC, piel caliente, poco \nelástica. Laboratorio: leucocitos 20,000/µL, abastonados: 700/µL; examen de orina: nitrito positivo y 100 \nleucocitos/campo. ¿Cuál es la conducta más adecuada? A) Hospitalizar para hidratación y antibioticoterapia parenteral B) Iniciar hidratación por vía oral e indicar antibioticoterapia oral C) Administrar antibioticoterapia parenteral D) Realizar ecografía renal para descartar absceso E) Ninguna de las anteriores",
         "<unused94>thought\n1.  **Analyze the Request:** The user wants me to act as an expert medical assistant trained in Peru and answer a multiple-choice medical question. I need to provide a step-by-step internal thought process, summarize the information, and then give *only* the final letter answer.\n\n2.  **Summarize the Case:**\n    *   Patient: 9-month-old infant.\n    *   Symptoms: Fever (39°C) and frequent vomiting for 3 days.\n    *   Physical Exam: High temperature (39°C), hot skin, poor skin turgor (suggests dehydration).\n    *   Lab Results:\n        *   Leukocytosis (WBC 20,000/µL) with a significant left shift (700 bands/µL) - indicates a bacterial infection.\n        *   Urinalysis: Positive nitrite and 100 WBCs/field - strongly suggests a Urinary Tract Infection (UTI).\n\n3.  **Evaluate the Options:**\n    *   **A) Hospitalizar para hidratación y antibioticoterapia parenteral:** The infant is 9 months old, has a high fever, frequent vomiting (making oral hydration difficult/ineffective), signs of dehydration (poor skin turgor), and lab findings consistent with a significant bacterial infection (UTI). Infants, especially under 1 year, with febrile UTI and signs of dehydration or inability to tolerate oral intake often require hospitalization for IV hydration and parenteral antibiotics. This seems like a very appropriate option.\n    *   **B) Iniciar hidratación por vía oral e indicar antibioticoterapia oral:** While oral hydration and antibiotics are options for *some* UTIs, this infant has frequent vomiting and signs of dehydration. Oral hydration might not be sufficient, and oral antibiotics might not be absorbed well or tolerated due to vomiting. This option seems less appropriate given the clinical picture.\n    *   **C) Administrar antibioticoterapia parenteral:** This addresses the infection but ignores the dehydration and vomiting, which are significant issues. Hydration is crucial. This option is incomplete.\n    *   **D) Realizar ecografía renal para descartar absceso:** An ultrasound might be indicated later, especially if the infant doesn't respond to treatment or has recurrent UTIs, but it's not the *immediate* most appropriate *conducta* (management). The priority is treating the infection and dehydration.\n    *   **E) Ninguna de las anteriores:** Option A seems very appropriate.\n\n4.  **Determine the Best Course of Action:** The infant presents with a febrile UTI, signs of dehydration (poor skin turgor), and vomiting, making oral intake difficult. This clinical picture in a 9-month-old warrants hospitalization for intravenous hydration to correct dehydration and parenteral antibiotics to effectively treat the infection. Option A covers both essential aspects of management.\n\n5.  **Final Answer Formulation:** Based on the analysis, option A is the most appropriate management strategy. The final output should be just the letter 'A'.<unused95>Respuesta final:A",
         "medgemma-27b-text-it",
         "A"
        ],
        [
         "25",
         "Desde hace tres años, el centro de salud ubicado en el ámbito de una comunidad cuya principal actividad económica es \nla explotación minera, ha incrementado la notificación de casos de menores de diez años con retardo del desarrollo \npsicomotor, irritabilidad, cefalea, vómitos y disgeusia. ¿Qué contaminante ambiental es la causa más probable?",
         "Azufre",
         "Arsénico",
         "Plomo",
         "Níquel",
         "C",
         "Ninguna de las anteriores",
         "Prueba A",
         "Year2025",
         "2025",
         "Desde hace tres años, el centro de salud ubicado en el ámbito de una comunidad cuya principal actividad económica es \nla explotación minera, ha incrementado la notificación de casos de menores de diez años con retardo del desarrollo \npsicomotor, irritabilidad, cefalea, vómitos y disgeusia. ¿Qué contaminante ambiental es la causa más probable? A) Azufre B) Arsénico C) Plomo D) Níquel E) Ninguna de las anteriores",
         "<unused94>thought\n1.  **Analyze the Request:** The user wants me to act as an expert medical assistant trained in Peru and answer a multiple-choice medical question. I need to provide a step-by-step internal thought process, summarize the information, and then output *only* the final letter answer.\n\n2.  **Summarize the Information:**\n    *   **Setting:** Health center in a community with mining as the main economic activity.\n    *   **Timeframe:** Increase in cases over the last three years.\n    *   **Population:** Children under ten years old.\n    *   **Symptoms:** Psychomotor development delay, irritability, headache, vomiting, dysgeusia (altered taste).\n    *   **Question:** Identify the most probable environmental contaminant causing these symptoms.\n    *   **Options:** A) Sulfur, B) Arsenic, C) Lead, D) Nickel, E) None of the above.\n\n3.  **Evaluate Each Option based on Symptoms and Context:**\n    *   **A) Sulfur (Azufre):** Sulfur dioxide (SO2) is a common air pollutant from mining and smelting. It primarily causes respiratory issues (asthma, bronchitis), eye irritation, and acid rain. While it can cause headaches, the constellation of symptoms, especially psychomotor delay and dysgeusia, isn't typical.\n    *   **B) Arsenic (Arsénico):** Arsenic exposure (often through contaminated water or soil in mining areas) can cause various symptoms, including skin lesions, gastrointestinal issues (vomiting), neurological problems (peripheral neuropathy), and developmental issues. While some symptoms overlap (vomiting, potential developmental effects), the specific combination, particularly the prominent psychomotor delay, irritability, and dysgeusia, isn't the *most* classic presentation compared to another option.\n    *   **C) Lead (Plomo):** Lead is a well-known neurotoxin, particularly harmful to developing children. Mining activities (especially smelting and refining) are significant sources of lead pollution. Lead poisoning in children classically presents with:\n        *   **Neurological:** Developmental delay (psychomotor), irritability, behavioral problems, learning difficulties, headaches, seizures (in severe cases).\n        *   **Gastrointestinal:** Abdominal pain, vomiting, constipation.\n        *   **Other:** Anemia, fatigue, loss of appetite.\n        *   **Taste:** Dysgeusia (metallic taste) can occur.\n        This profile matches the described symptoms (psychomotor delay, irritability, headache, vomiting, dysgeusia) very closely, especially in the context of a mining community where lead exposure is plausible.\n    *   **D) Nickel (Níquel):** Nickel exposure (often through inhalation in mining/smelting) can cause respiratory problems (asthma, pneumonitis), skin allergies (contact dermatitis), and potentially cancer with long-term exposure. Neurological symptoms like those described are not typical primary effects of nickel exposure.\n    *   **E) Ninguna de las anteriores:** Given the strong match between lead poisoning symptoms and the clinical picture described, this option is unlikely.\n\n4.  **Compare and Select the Best Fit:** Lead (Plomo) provides the most comprehensive explanation for the combination of symptoms (psychomotor delay, irritability, headache, vomiting, dysgeusia) in young children living in a mining community. The other options are less likely to cause this specific cluster of effects.\n\n5.  **Formulate the Final Answer:** Based on the analysis, Lead (Plomo) is the most probable cause. The corresponding letter is C.\n\n6.  **Final Output Check:** Ensure the output format matches the request: \"Respuesta final:\" followed *only* by the letter.<unused95>Respuesta final:C",
         "medgemma-27b-text-it",
         "C"
        ],
        [
         "26",
         "Varón de 36 años que acude por astenia, fatigabilidad. Examen: palidez de piel y mucosa. Laboratorio: anemia \nnormocítica, normocrómica, hierro sérico disminuido, saturación de transferrina baja y ferritina aumentada. ¿Cuál es \nel mecanismo fisiopatológico de la anemia?",
         "Disminución de la respuesta eritropoyética",
         "Secuestro de hierro en los macrófagos",
         "Producción inadecuada de transferrina",
         "Aumento de la hepcidina",
         "D",
         "Ninguna de las anteriores",
         "Prueba A",
         "Year2025",
         "2025",
         "Varón de 36 años que acude por astenia, fatigabilidad. Examen: palidez de piel y mucosa. Laboratorio: anemia \nnormocítica, normocrómica, hierro sérico disminuido, saturación de transferrina baja y ferritina aumentada. ¿Cuál es \nel mecanismo fisiopatológico de la anemia? A) Disminución de la respuesta eritropoyética B) Secuestro de hierro en los macrófagos C) Producción inadecuada de transferrina D) Aumento de la hepcidina E) Ninguna de las anteriores",
         "<unused94>thought\n1.  **Analyze the Request:** The user wants me to act as an expert medical assistant trained in Peru and answer a multiple-choice medical question. I need to provide a step-by-step internal thought process, summarize the information, and then output *only* the final letter answer.\n\n2.  **Summarize the Clinical Case:**\n    *   Patient: 36-year-old male.\n    *   Symptoms: Astenia (weakness), fatigability.\n    *   Signs: Pallor of skin and mucous membranes.\n    *   Lab Results:\n        *   Anemia: Normocytic, normochromic.\n        *   Iron studies:\n            *   Serum iron: Decreased.\n            *   Transferrin saturation: Low.\n            *   Ferritin: Increased.\n\n3.  **Identify the Core Problem:** The patient has anemia with specific iron study results: low serum iron, low transferrin saturation, and *high* ferritin. This pattern is characteristic of Anemia of Chronic Disease (ACD), also known as Anemia of Inflammation.\n\n4.  **Evaluate the Options based on ACD Pathophysiology:**\n    *   **A) Disminución de la respuesta eritropoyética (Decreased erythropoietic response):** While ACD can involve some degree of blunted erythropoiesis (often due to inflammatory cytokines suppressing EPO production or action), the *primary* mechanism related to the iron studies presented is iron sequestration. This option isn't the *most* specific or central mechanism explaining the iron profile.\n    *   **B) Secuestro de hierro en los macrófagos (Iron sequestration in macrophages):** In ACD, inflammatory cytokines (like IL-6) stimulate hepcidin production. Hepcidin blocks iron release from macrophages (where iron from recycled RBCs is stored) and reduces iron absorption from the gut. This leads to low serum iron and low transferrin saturation, despite adequate or increased iron stores (reflected by high ferritin). This perfectly matches the patient's lab results.\n    *   **C) Producción inadecuada de transferrina (Inadequate transferrin production):** Transferrin is usually normal or even increased in ACD (as an acute phase reactant), not decreased. This option is incorrect.\n    *   **D) Aumento de la hepcidina (Increased hepcidin):** This is the *key* upstream regulator in ACD that *causes* the iron sequestration described in option B. Increased hepcidin leads to decreased iron availability for erythropoiesis. While true in ACD, option B describes the *direct consequence* of increased hepcidin that explains the specific iron study pattern (low serum iron, low saturation, high ferritin). Option B is a more direct explanation of the *mechanism* leading to the observed iron profile.\n    *   **E) Ninguna de las anteriores (None of the above):** Option B accurately describes the mechanism.\n\n5.  **Compare Options B and D:** Both increased hepcidin (D) and iron sequestration in macrophages (B) are central to ACD. However, the question asks for the *mechanism* explaining the *specific lab findings* (low serum iron, low saturation, high ferritin). The *direct* mechanism causing these findings is the trapping of iron within macrophages, preventing its release into the serum for use in erythropoiesis. Increased hepcidin is the *cause* of this sequestration. Therefore, B is a more direct description of the pathophysiological mechanism responsible for the iron study results presented.\n\n6.  **Final Selection:** Option B best explains the combination of low serum iron, low transferrin saturation, and high ferritin seen in this patient, which is characteristic of Anemia of Chronic Disease/Inflammation.\n\n7.  **Format the Output:** Provide only the final letter.<unused95>Respuesta final:B",
         "medgemma-27b-text-it",
         "B"
        ],
        [
         "27",
         "Adolescente de 14 años, acude por náusea, vómitos y deposiciones líquidas sin moco sin sangre. Compañeros con \nsíntomas similares tras comer hamburguesa en una excursión. ¿Cuál es el probable agente infeccioso en este caso?",
         "Bacillus cereus",
         "Vibrion cholerae",
         "Staphylococcus aureus",
         "Campylobacter jejuni",
         "C",
         "Ninguna de las anteriores",
         "Prueba A",
         "Year2025",
         "2025",
         "Adolescente de 14 años, acude por náusea, vómitos y deposiciones líquidas sin moco sin sangre. Compañeros con \nsíntomas similares tras comer hamburguesa en una excursión. ¿Cuál es el probable agente infeccioso en este caso? A) Bacillus cereus B) Vibrion cholerae C) Staphylococcus aureus D) Campylobacter jejuni E) Ninguna de las anteriores",
         "<unused94>thought\n1.  **Analyze the Request:** The user wants me to act as an expert medical assistant trained in Peru and answer a multiple-choice medical question. I need to provide a step-by-step internal thought process, summarize the information, and then output *only* the final letter answer.\n\n2.  **Summarize the Case:**\n    *   Patient: 14-year-old adolescent.\n    *   Symptoms: Nausea, vomiting, watery diarrhea (no mucus, no blood).\n    *   Context: Symptoms appeared after eating hamburgers during a school trip.\n    *   Epidemiology: Multiple classmates have similar symptoms.\n    *   Question: Identify the probable infectious agent.\n\n3.  **Evaluate the Options:**\n    *   **A) Bacillus cereus:** Known to cause two types of food poisoning:\n        *   Emetic type: Nausea and vomiting, often associated with fried rice (preformed toxin). Incubation period is short (1-6 hours).\n        *   Diarrheal type: Watery diarrhea and abdominal cramps, often associated with meats, vegetables, sauces (enterotoxin produced in the gut). Incubation period is longer (6-15 hours).\n        *   *Relevance:* Hamburgers (meat) are a potential source. The symptoms (nausea, vomiting, watery diarrhea) fit both types, but the combination and the context of a shared meal (outbreak) are highly suggestive. The short incubation period implied by the outbreak setting fits the emetic type, but the diarrhea points towards the diarrheal type. *Bacillus cereus* is a strong possibility.\n\n    *   **B) Vibrio cholerae:** Causes cholera, characterized by profuse, watery diarrhea (\"rice-water stools\"), vomiting, and rapid dehydration. Usually associated with contaminated water or seafood.\n        *   *Relevance:* While it causes watery diarrhea and vomiting, it's less commonly associated with hamburgers in a typical outbreak setting in Peru (unless the meat was contaminated with contaminated water, which is less likely than other causes). The description doesn't mention the characteristic \"rice-water\" stools. Less likely than *B. cereus*.\n\n    *   **C) Staphylococcus aureus:** Causes food poisoning due to preformed enterotoxins. Symptoms are rapid onset (1-6 hours) and primarily involve nausea, vomiting, abdominal cramps, and sometimes diarrhea. Often associated with contaminated foods handled by infected individuals (e.g., salads, pastries, meats).\n        *   *Relevance:* The rapid onset and prominent nausea/vomiting fit well. Hamburgers can be a source if improperly handled. The outbreak setting is also consistent. *Staphylococcus aureus* is a strong possibility, often presenting with more vomiting than diarrhea compared to *B. cereus* diarrheal type, but the symptoms overlap.\n\n    *   **D) Campylobacter jejuni:** A common cause of bacterial gastroenteritis. Symptoms include diarrhea (often bloody), abdominal pain, fever, nausea, and vomiting. Usually associated with undercooked poultry, unpasteurized milk, or contaminated water. Incubation period is typically 2-5 days.\n        *   *Relevance:* The incubation period is usually longer than suggested by the outbreak scenario. Bloody diarrhea is common, which is explicitly absent here. Less likely.\n\n    *   **E) Ninguna de las anteriores:** Consider this if none of the others fit well.\n\n4.  **Compare Strong Candidates (A and C):**\n    *   *Bacillus cereus* (diarrheal type) fits the watery diarrhea and association with meat.\n    *   *Staphylococcus aureus* fits the rapid onset, nausea, vomiting, and potential association with handled food like hamburgers.\n    *   The symptoms described (nausea, vomiting, *and* watery diarrhea) can be seen with both. However, *B. cereus* is particularly known for causing outbreaks linked to starchy foods (like rice) *and* meats. *S. aureus* is often more strongly associated with vomiting as the primary symptom, though diarrhea can occur. Given the combination of symptoms and the food source (hamburger), *B. cereus* is a very plausible cause, especially considering both its emetic and diarrheal forms can be linked to various foods including meat. *S. aureus* is also plausible.\n\n5.  **Refine the Choice:** The question asks for the *probable* agent. Both *B. cereus* and *S. aureus* are common causes of foodborne outbreaks with these symptoms. *B. cereus* is frequently implicated in outbreaks associated with meat dishes (like hamburgers) and starchy foods, causing either vomiting or diarrhea. *S. aureus* is also common, often linked to foods handled by carriers. Without more specific details (e.g., exact incubation time, predominance of vomiting vs. diarrhea), it's difficult to definitively distinguish. However, *B. cereus* is a classic cause of outbreaks linked to meat products like hamburgers, presenting with either vomiting or diarrhea. Let's re-evaluate the typical presentations. *S. aureus* typically has a very short incubation (1-6 hrs) and prominent vomiting. *B. cereus* emetic type also has a short incubation (1-6 hrs) with vomiting. *B. cereus* diarrheal type has a longer incubation (6-15 hrs) with diarrhea and cramps. The scenario describes an outbreak after a meal, suggesting a relatively short incubation period. The presence of *both* vomiting and watery diarrhea makes *B. cereus* (potentially both types occurring in different individuals or a mixed presentation) a strong candidate, especially given the meat source. *S. aureus* is also very possible. In Peru, both are relevant foodborne pathogens. Considering the classic associations, *B. cereus* is often highlighted in relation to meat outbreaks causing either vomiting or diarrhea.\n\n6.  **Final Decision:** Both A and C are strong contenders. However, *Bacillus cereus* is well-known for causing outbreaks associated with meat dishes (including hamburgers) and can present with either vomiting or diarrhea, fitting the described symptoms and epidemiological context well. *Staphylococcus aureus* is also a possibility, but perhaps slightly less classically associated with this specific combination of symptoms and food source compared to *B. cereus*. Therefore, *Bacillus cereus* seems the most probable answer among the choices.\n\n7.  **Format the Output:** Provide only the letter of the chosen answer.<unused95>Respuesta final:A",
         "medgemma-27b-text-it",
         "A"
        ],
        [
         "28",
         "Obrero de 30 años llega a emergencia después de haber sido rescatado de incendio; presenta estridor laríngeo, tos y \ndificultad respiratoria. La oximetría muestra SatO2: 90%, pero la gasometría arterial revela una presión parcial de oxígeno \n(PaO2) normal. ¿Cuál es la causa de estos hallazgos?",
         "Reduce la capacidad de hemoglobina para captar oxígeno por modificación en su estructura",
         "Se disuelve pobremente en el plasma sanguíneo reduciendo el oxígeno disuelto",
         "Se une a la hemoglobina formando carboxihemoglobina",
         "Interfiere con la liberación de oxígeno de la hemoglobina a los tejidos",
         "C",
         "Ninguna de las anteriores",
         "Prueba A",
         "Year2025",
         "2025",
         "Obrero de 30 años llega a emergencia después de haber sido rescatado de incendio; presenta estridor laríngeo, tos y \ndificultad respiratoria. La oximetría muestra SatO2: 90%, pero la gasometría arterial revela una presión parcial de oxígeno \n(PaO2) normal. ¿Cuál es la causa de estos hallazgos? A) Reduce la capacidad de hemoglobina para captar oxígeno por modificación en su estructura B) Se disuelve pobremente en el plasma sanguíneo reduciendo el oxígeno disuelto C) Se une a la hemoglobina formando carboxihemoglobina D) Interfiere con la liberación de oxígeno de la hemoglobina a los tejidos E) Ninguna de las anteriores",
         "<unused94>thought\n1.  **Analyze the Request:** The user wants me to act as an expert medical assistant trained in Peru and answer a multiple-choice medical question. I need to provide a step-by-step internal thought process, summarize the information, and then give *only* the final letter answer.\n\n2.  **Summarize the Clinical Scenario:**\n    *   Patient: 30-year-old male construction worker.\n    *   Event: Rescued from a fire.\n    *   Symptoms: Laryngeal stridor, cough, dyspnea (difficulty breathing).\n    *   Signs: SpO2 90% (low), PaO2 normal (normal arterial oxygen tension).\n\n3.  **Identify the Core Problem:** The discrepancy between low SpO2 (pulse oximetry) and normal PaO2 (arterial blood gas). This suggests a problem with how pulse oximetry measures oxygen saturation, rather than a problem with the actual amount of oxygen dissolved in the arterial blood.\n\n4.  **Evaluate the Options in Light of the Problem:**\n    *   **A) Reduce la capacidad de hemoglobina para captar oxígeno por modificación en su estructura:** This describes conditions like methemoglobinemia. Methemoglobinemia *can* cause a discrepancy between SpO2 and PaO2 (SpO2 tends to be falsely low, around 85%, regardless of actual PaO2). This is a plausible cause, especially in the context of smoke inhalation (chemicals can induce methemoglobinemia).\n    *   **B) Se disuelve pobremente en el plasma sanguíneo reduciendo el oxígeno disuelto:** This is incorrect. Oxygen dissolves in plasma, but most is transported bound to hemoglobin. Poor solubility isn't the primary issue here, and it wouldn't explain the SpO2/PaO2 discrepancy.\n    *   **C) Se une a la hemoglobina formando carboxihemoglobina:** This describes carbon monoxide (CO) poisoning, common in fires. CO binds to hemoglobin with much higher affinity than oxygen, forming carboxyhemoglobin (COHb). This *reduces* the oxygen-carrying capacity of hemoglobin. Importantly, standard pulse oximeters often *cannot distinguish* between oxyhemoglobin and carboxyhemoglobin, leading to a *falsely high* SpO2 reading, even when PaO2 might be normal or low and the actual oxygen content is reduced. This contradicts the scenario (SpO2 is *low*).\n    *   **D) Interfiere con la liberación de oxígeno de la hemoglobina a los tejidos:** This describes a left shift in the oxygen-hemoglobin dissociation curve (e.g., alkalosis, CO poisoning). While CO poisoning does this, the primary issue causing the SpO2/PaO2 discrepancy in CO poisoning is the pulse oximeter's inability to detect COHb (leading to falsely *high* SpO2). This option doesn't directly explain the *low* SpO2 with normal PaO2.\n    *   **E) Ninguna de las anteriores:** This is possible if none of the others fit.\n\n5.  **Re-evaluate Options A and C:**\n    *   **CO Poisoning (C):** Causes *falsely high* SpO2 readings on standard pulse oximeters. The scenario has *low* SpO2. So, C is unlikely to be the *primary* explanation for the discrepancy described.\n    *   **Methemoglobinemia (A):** Causes *falsely low* SpO2 readings (typically around 85%) because methemoglobin absorbs light differently than oxyhemoglobin at the wavelengths used by pulse oximeters. The PaO2 (dissolved oxygen) can be normal. This fits the scenario perfectly: low SpO2 (90% is low, though not the classic 85%), normal PaO2, and a plausible cause (smoke inhalation).\n\n6.  **Confirm the Best Fit:** Methemoglobinemia (Option A) is the most likely explanation for a low SpO2 reading despite a normal PaO2 in a patient rescued from a fire. Smoke inhalation contains various chemicals that can oxidize hemoglobin to methemoglobin.\n\n7.  **Final Answer Formulation:** Based on the analysis, Option A is the correct answer. The final output should be just the letter.<unused95>Respuesta final:A",
         "medgemma-27b-text-it",
         "A"
        ],
        [
         "29",
         "Niño de 10 años, presenta hace 5 días rinorrea acuosa y disfagia, 2 días antes se agrega tos con flema, silbido de \npecho, fiebre e hiporexia. Antecedentes: inmunizaciones completas. Examen: REG, FC: 78 X', FR: 26 X', SatO2: 95%. \nTórax: MV pasa AHT, sibilantes y subcrepitos en AHT, tirajes IC. Laboratorio: Hemograma: leucocitos 12.000/µL; PCR: 5 \nmg/L; procalcitonina ligeramente elevado. ¿Cuál es el agente etiológico más probable?",
         "Streptococcus pneumoniae",
         "Haemophilus influenzae tipo b",
         "Virus sincitial respiratorio",
         "Mycoplasma pneumoniae",
         "D",
         "Ninguna de las anteriores",
         "Prueba A",
         "Year2025",
         "2025",
         "Niño de 10 años, presenta hace 5 días rinorrea acuosa y disfagia, 2 días antes se agrega tos con flema, silbido de \npecho, fiebre e hiporexia. Antecedentes: inmunizaciones completas. Examen: REG, FC: 78 X', FR: 26 X', SatO2: 95%. \nTórax: MV pasa AHT, sibilantes y subcrepitos en AHT, tirajes IC. Laboratorio: Hemograma: leucocitos 12.000/µL; PCR: 5 \nmg/L; procalcitonina ligeramente elevado. ¿Cuál es el agente etiológico más probable? A) Streptococcus pneumoniae B) Haemophilus influenzae tipo b C) Virus sincitial respiratorio D) Mycoplasma pneumoniae E) Ninguna de las anteriores",
         "<unused94>thought\n1.  **Analyze the Request:** The user wants me to act as an expert medical assistant trained in Peru and answer a multiple-choice medical question. I need to provide a step-by-step internal thought process, summarize the information, and then give *only* the final letter answer.\n\n2.  **Summarize the Case:**\n    *   **Patient:** 10-year-old boy.\n    *   **Symptoms:**\n        *   5 days: Watery rhinorrhea, dysphagia.\n        *   2 days ago (total 3 days): Cough with phlegm, wheezing, fever, hyporexia.\n    *   **History:** Complete immunizations.\n    *   **Exam:**\n        *   General: Regular appearance (REG).\n        *   Vitals: HR 78 bpm, RR 26 breaths/min, SpO2 95%.\n        *   Chest: Decreased breath sounds (MV pasa AHT - *Movimiento Vésico Pasado A Hueso* implies decreased air entry), wheezing, subcrepitations (crackles) in the lower lung fields (AHT - *Ápice Hígado Táctil* is likely a typo and should mean *Áreas Hipoauscultación Torácica* or similar, referring to lower lung fields), intercostal retractions (tirajes IC).\n    *   **Labs:**\n        *   CBC: WBC 12,000/µL (mildly elevated).\n        *   PCR: 5 mg/L (elevated, normal < 1 mg/L).\n        *   Procalcitonin: Slightly elevated.\n\n3.  **Analyze the Symptoms and Signs:**\n    *   **Initial phase (rhinorrhea, dysphagia):** Suggests an upper respiratory infection (URI) or viral prodrome.\n    *   **Later phase (cough, phlegm, wheezing, fever, hyporexia, decreased breath sounds, crackles, retractions):** Indicates progression to lower respiratory tract involvement, likely pneumonia or bronchiolitis/bronchitis with significant inflammation. Wheezing points towards airway narrowing.\n    *   **Age (10 years):** This age group is less typical for classic viral bronchiolitis (usually < 2 years) but can still get viral pneumonia or atypical pneumonia.\n    *   **Immunizations:** Complete immunizations make *Haemophilus influenzae* type b (Hib) less likely, although not impossible. *Streptococcus pneumoniae* is still a common cause of bacterial pneumonia, even with vaccination (vaccine doesn't cover all serotypes).\n    *   **Vitals:** RR is slightly elevated for age (normal ~18-25), SpO2 is borderline low but acceptable.\n    *   **Labs:**\n        *   WBC 12,000: Mild leukocytosis, non-specific, can be seen in both viral and bacterial infections.\n        *   PCR 5 mg/L: Significantly elevated, strongly suggests a bacterial infection.\n        *   Procalcitonin slightly elevated: Also points towards a bacterial component, though less specific than PCR.\n\n4.  **Evaluate the Options:**\n    *   **A) Streptococcus pneumoniae:** A very common cause of bacterial pneumonia in children. Fits with fever, cough, crackles, leukocytosis, elevated PCR, and elevated procalcitonin.\n    *   **B) Haemophilus influenzae tipo b:** Less likely due to complete immunizations. Non-typeable *H. influenzae* is still possible but less common than *S. pneumoniae* in this age group for pneumonia.\n    *   **C) Virus sincitial respiratorio (RSV):** A common cause of bronchiolitis and pneumonia, especially in younger children (<2 years). While possible in a 10-year-old, the significantly elevated PCR and procalcitonin make a primary viral etiology less likely, although viral infections can predispose to bacterial superinfection. RSV typically causes more wheezing and less consolidation than suggested here, and PCR levels are usually not this high in uncomplicated RSV.\n    *   **D) Mycoplasma pneumoniae:** A common cause of \"atypical\" pneumonia in school-aged children and adolescents. Often presents with gradual onset, cough, wheezing, headache, malaise. Fever can be present. Lab findings can be variable, sometimes with mild leukocytosis. PCR and procalcitonin *can* be elevated but are often less dramatically so than in typical bacterial pneumonia. The presentation (initial URI symptoms followed by lower respiratory symptoms) and age fit well with *Mycoplasma*. However, the *degree* of PCR elevation (5 mg/L) is quite high and more typical of pyogenic bacteria like *S. pneumoniae*.\n    *   **E) Ninguna de las anteriores:** Possible if none of the others fit well.\n\n5.  **Compare Likely Candidates (A vs. D):**\n    *   *S. pneumoniae* (A): Classic bacterial pneumonia presentation. High PCR and procalcitonin strongly support this.\n    *   *Mycoplasma pneumoniae* (D): Atypical pneumonia presentation. Age and initial symptoms fit. Wheezing is common. However, the very high PCR (5 mg/L) is less typical for *Mycoplasma* and more suggestive of a typical bacterial pathogen like *S. pneumoniae*.\n\n6.  **Conclusion:** The clinical picture (fever, productive cough, crackles, retractions) combined with the laboratory findings (leukocytosis, significantly elevated PCR, elevated procalcitonin) strongly points towards a typical bacterial pneumonia. Among the given options, *Streptococcus pneumoniae* is the most common cause of typical bacterial pneumonia in this age group and best fits the overall picture, especially the high inflammatory markers (PCR, procalcitonin). While *Mycoplasma* is common in this age group, the high PCR makes *S. pneumoniae* more probable. RSV is less likely given the age and high bacterial markers. Hib is unlikely due to vaccination.\n\n7.  **Final Answer Selection:** Based on the analysis, *Streptococcus pneumoniae* (A) is the most likely etiological agent.<unused95>Respuesta final:A",
         "medgemma-27b-text-it",
         "A"
        ],
        [
         "30",
         "Varón de 75 años, procedente de una residencia de ancianos presenta sepsis de origen urinario. Hemocultivos y \nurocultivo muestran E. coli productora de betalactamasas de espectro ampliado; antibiograma pendiente. ¿Cuál es el \nantibiótico mejor indicado?",
         "Aztreonam",
         "Ertapenem",
         "Cefotaxima",
         "Ceftriaxona",
         "B",
         "Ninguna de las anteriores",
         "Prueba A",
         "Year2025",
         "2025",
         "Varón de 75 años, procedente de una residencia de ancianos presenta sepsis de origen urinario. Hemocultivos y \nurocultivo muestran E. coli productora de betalactamasas de espectro ampliado; antibiograma pendiente. ¿Cuál es el \nantibiótico mejor indicado? A) Aztreonam B) Ertapenem C) Cefotaxima D) Ceftriaxona E) Ninguna de las anteriores",
         "<unused94>thought\n1.  **Analyze the Request:** The user wants me to act as an expert medical assistant trained in Peru and answer a multiple-choice medical question. I need to provide a step-by-step internal thought process, summarize the information, and then give *only* the final letter answer.\n\n2.  **Summarize the Information:**\n    *   Patient: 75-year-old male from a nursing home.\n    *   Condition: Sepsis of urinary origin.\n    *   Microbiology: *E. coli* producing Extended-Spectrum Beta-Lactamases (ESBL).\n    *   Antibiotic Susceptibility: Pending (so empirical treatment is needed).\n    *   Question: Best antibiotic choice.\n    *   Options: A) Aztreonam, B) Ertapenem, C) Cefotaxime, D) Ceftriaxone, E) None of the above.\n\n3.  **Evaluate the Options based on ESBL *E. coli*:**\n    *   ESBLs confer resistance to most penicillins, cephalosporins (including 1st, 2nd, and 3rd generation), and aztreonam.\n    *   **A) Aztreonam:** Monobactam. ESBLs typically confer resistance to aztreonam. *Not a good choice.*\n    *   **B) Ertapenem:** Carbapenem. Carbapenems (like ertapenem, meropenem, imipenem) are generally the drugs of choice for serious infections caused by ESBL-producing organisms. Ertapenem has good activity against *E. coli* and is often used for UTIs and intra-abdominal infections. *A strong candidate.*\n    *   **C) Cefotaxime:** Third-generation cephalosporin. ESBLs hydrolyze and confer resistance to cefotaxime. *Not a good choice.*\n    *   **D) Ceftriaxone:** Third-generation cephalosporin. ESBLs hydrolyze and confer resistance to ceftriaxone. *Not a good choice.*\n    *   **E) Ninguna de las anteriores:** Since Ertapenem (a carbapenem) is a standard treatment for ESBL infections, this option is unlikely unless Ertapenem is contraindicated or unavailable, which isn't stated.\n\n4.  **Consider the Clinical Context (Sepsis):** Sepsis is a severe condition requiring broad-spectrum and effective antibiotics. Carbapenems are often preferred for serious ESBL infections like sepsis.\n\n5.  **Consider Peruvian Guidelines/Context (Implicit):** While not explicitly stated, carbapenems are generally recommended for ESBL infections in most international and likely Peruvian guidelines for severe infections.\n\n6.  **Refine the Choice:** Ertapenem is a carbapenem, the class of antibiotics generally recommended for treating serious infections caused by ESBL-producing organisms like *E. coli*. Aztreonam, cefotaxime, and ceftriaxone are typically ineffective due to ESBL production.\n\n7.  **Final Answer Selection:** Based on the analysis, Ertapenem (B) is the most appropriate choice among the given options for empirical treatment of sepsis caused by ESBL-producing *E. coli*.\n\n8.  **Format the Output:** Follow the instructions: internal summary (done above), step-by-step reasoning (done above), and then *only* the final letter.<unused95>Respuesta final:B",
         "medgemma-27b-text-it",
         "B"
        ],
        [
         "31",
         "Varón de 40 años, hace un día con dolor en región inguinal izquierda después de levantar objeto pesado. Examen: MEG. \nAbdomen: globuloso, RHA disminuidos; a nivel del pliegue de la ingle aumento de volumen por tumoración 2x2 cm, \nindurada, no reductible y con signos de flogosis. Rx abdomen simple de pie: múltiples niveles hidroaéreos. ¿Cuál es el \ndiagnóstico?",
         "Hernia de Spiegel estrangulada",
         "Hernia crural encarcelada",
         "Hernia inguinal estrangulada",
         "Íleo adinámico",
         "C",
         "Ninguna de las anteriores",
         "Prueba A",
         "Year2025",
         "2025",
         "Varón de 40 años, hace un día con dolor en región inguinal izquierda después de levantar objeto pesado. Examen: MEG. \nAbdomen: globuloso, RHA disminuidos; a nivel del pliegue de la ingle aumento de volumen por tumoración 2x2 cm, \nindurada, no reductible y con signos de flogosis. Rx abdomen simple de pie: múltiples niveles hidroaéreos. ¿Cuál es el \ndiagnóstico? A) Hernia de Spiegel estrangulada B) Hernia crural encarcelada C) Hernia inguinal estrangulada D) Íleo adinámico E) Ninguna de las anteriores",
         "<unused94>thought\n1.  **Analyze the Request:** The user wants me to act as an expert medical assistant trained in Peru and answer a multiple-choice medical question. I need to provide a step-by-step internal thought process, summarize the information, and then give *only* the final letter answer.\n\n2.  **Summarize the Case:**\n    *   **Patient:** 40-year-old male.\n    *   **Presenting Complaint:** Left inguinal pain for 1 day after heavy lifting.\n    *   **Physical Exam:**\n        *   Abdomen: Globulous (distended), decreased bowel sounds (RHA disminuidos).\n        *   Left Inguinal Region: 2x2 cm mass, hard (indurada), non-reducible, signs of inflammation (flogosis).\n    *   **Imaging:** Abdominal X-ray (standing): Multiple air-fluid levels (niveles hidroaéreos).\n\n3.  **Analyze the Findings:**\n    *   **Inguinal Mass:** The presence of a non-reducible, indurated mass with signs of inflammation in the inguinal region strongly suggests a hernia that has become complicated.\n    *   **Abdominal Distension & Decreased Bowel Sounds:** These findings point towards an intestinal obstruction or ileus.\n    *   **Multiple Air-Fluid Levels on X-ray:** This is a classic sign of intestinal obstruction.\n    *   **History:** Pain onset after heavy lifting is a common trigger for hernia development or complications.\n    *   **Location:** The mass is specifically in the *inguinal* region.\n\n4.  **Evaluate the Options:**\n    *   **A) Hernia de Spiegel estrangulada:** A Spigelian hernia occurs lateral to the rectus abdominis muscle, usually below the umbilicus. The mass is described in the *inguinal* region, making this less likely.\n    *   **B) Hernia crural encarcelada:** A femoral (crural) hernia occurs below the inguinal ligament. While possible, the description \"pliegue de la ingle\" (inguinal fold) usually implies an inguinal hernia, which is much more common in men. Also, \"encarcelada\" (incarcerated) means trapped but not necessarily strangulated (compromised blood supply). The signs of inflammation (flogosis) and induration suggest strangulation.\n    *   **C) Hernia inguinal estrangulada:** An inguinal hernia occurs in the inguinal canal. The location (inguinal region), the non-reducible nature, the induration, the signs of inflammation (flogosis), and the signs of intestinal obstruction (abdominal distension, decreased bowel sounds, air-fluid levels) are all highly consistent with a strangulated inguinal hernia. The strangulation leads to ischemia, inflammation, and potentially bowel obstruction.\n    *   **D) Íleo adinámico:** Paralytic ileus involves decreased or absent bowel motility without a mechanical obstruction. While the patient has decreased bowel sounds and abdominal distension, the presence of a distinct, inflamed, non-reducible inguinal mass and air-fluid levels strongly points towards a mechanical obstruction caused by a strangulated hernia, rather than a primary ileus.\n    *   **E) Ninguna de las anteriores:** Option C fits the clinical picture well.\n\n5.  **Synthesize and Conclude:** The patient presents with classic signs and symptoms of a strangulated inguinal hernia: a non-reducible, tender, inflamed mass in the inguinal region, coupled with signs of intestinal obstruction (abdominal distension, decreased bowel sounds, air-fluid levels on X-ray). The history of heavy lifting is a typical precipitating factor.\n\n6.  **Final Answer Selection:** Based on the analysis, option C is the most likely diagnosis.\n\n7.  **Format the Output:** Follow the instructions: provide only the final letter.<unused95>Respuesta final:C",
         "medgemma-27b-text-it",
         "C"
        ],
        [
         "32",
         "Multigesta de 40 semanas, acude por dolor tipo contracción. Examen: AU: 31cm, SPP: LCI, LCF 144 X´. Tacto \nvaginal: dilatación: 9 cm, B: 100%, AP +1, membranas rotas con liquido claro, se palpa presentación cara mento anterior. \n¿Cuál es la conducta más adecuada?",
         "Programar cesárea de emergencia",
         "Usar vacuum de salida",
         "Convertir a presentación occipucio",
         "Dejar evolucionar parto vaginal",
         "D",
         "Ninguna de las anteriores",
         "Prueba A",
         "Year2025",
         "2025",
         "Multigesta de 40 semanas, acude por dolor tipo contracción. Examen: AU: 31cm, SPP: LCI, LCF 144 X´. Tacto \nvaginal: dilatación: 9 cm, B: 100%, AP +1, membranas rotas con liquido claro, se palpa presentación cara mento anterior. \n¿Cuál es la conducta más adecuada? A) Programar cesárea de emergencia B) Usar vacuum de salida C) Convertir a presentación occipucio D) Dejar evolucionar parto vaginal E) Ninguna de las anteriores",
         "<unused94>thought\n1.  **Analyze the Request:** The user wants me to act as an expert medical assistant trained in Peru and answer a multiple-choice medical question. I need to provide a step-by-step internal thought process, summarize the information, and then give *only* the final letter answer.\n\n2.  **Summarize the Clinical Scenario:**\n    *   Patient: Multigesta (has had previous pregnancies).\n    *   Gestational Age: 40 weeks (term).\n    *   Presenting Complaint: Contraction-like pain.\n    *   Abdominal Exam:\n        *   AU (Abdominal Circumference): 31 cm (This seems low for 40 weeks, but focus on the other findings).\n        *   SPP (Single Point Percussion): LCI (Left Iliac Crest), LCF (Left Coronary Fetus) 144 bpm (Normal fetal heart rate).\n    *   Vaginal Exam:\n        *   Dilatation: 9 cm (Almost fully dilated).\n        *   B (Bladder): 100% (Full bladder - needs emptying).\n        *   AP (Anterior Position): +1 (Presenting part is +1 station, meaning it's low in the pelvis but not yet on the pelvic floor).\n        *   Membranes: Ruptured with clear fluid.\n        *   Presentation: Face mento-anterior (Face presentation, chin pointing anteriorly).\n\n3.  **Evaluate the Options based on the Summary:**\n    *   **A) Programar cesárea de emergencia:** Is there an immediate threat to mother or baby requiring emergency C-section? The fetal heart rate is normal (144 bpm). The mother is almost fully dilated (9 cm). Face presentation *can* be an indication for C-section, but *mento-anterior* is generally considered favorable for vaginal delivery, especially when the head is well-flexed (though flexion isn't explicitly stated, it's implied by the progression to 9 cm dilation). There's no mention of fetal distress or failure to progress *despite* adequate contractions (which are implied by the pain and dilation). So, an *emergency* C-section isn't immediately indicated based *solely* on this information.\n    *   **B) Usar vacuum de salida:** Vacuum extraction is typically used when the head is engaged and visible at the introitus (station +3 or +4) and there's a need to expedite delivery (e.g., maternal exhaustion, fetal distress). The presenting part is only at +1 station. Vacuum is contraindicated for face presentation.\n    *   **C) Convertir a presentación occipucio:** This is not possible. The presentation is already established. Attempting to manipulate the fetus at this stage (9 cm dilation, +1 station) is dangerous and unlikely to succeed.\n    *   **D) Dejar evolucionar parto vaginal:** The patient is at 9 cm dilation, membranes are ruptured, the fetal heart rate is normal, and the presentation is face mento-anterior, which *can* deliver vaginally. The presenting part is at +1 station. The main issue is the full bladder (B: 100%), which needs to be emptied (e.g., via catheterization) to allow descent. Assuming adequate contractions continue and the bladder is emptied, vaginal delivery is the most likely and appropriate course. Face mento-anterior presentations often rotate spontaneously to occiput anterior or deliver directly in the face presentation.\n    *   **E) Ninguna de las anteriores:** Option D seems appropriate.\n\n4.  **Refine the Choice:** The key factors are:\n    *   Term pregnancy (40 weeks).\n    *   Advanced labor (9 cm dilation).\n    *   Normal fetal heart rate (144 bpm).\n    *   Favorable face presentation (mento-anterior).\n    *   Presenting part low (+1 station).\n    *   Ruptured membranes.\n    *   *Need to empty the bladder.*\n\n    Given these factors, especially the mento-anterior presentation and advanced dilation with a normal FHR, allowing labor to progress vaginally (after emptying the bladder) is the standard and most appropriate management. Cesarean section is reserved for complications like fetal distress, failure to progress, or a mento-posterior presentation. Vacuum is inappropriate for face presentation and the station. Conversion is impossible.\n\n5.  **Final Answer Selection:** Option D aligns best with the clinical picture and standard obstetric management.<unused95>Respuesta final:D",
         "medgemma-27b-text-it",
         "D"
        ],
        [
         "33",
         "Mujer de 45 años usuaria crónica de AINES por osteoartritis, acude por hematemesis y melena activa. Examen: PA: 80/50 \nmmHg, FC: 112 X', FR: 22 X'. Palidez marcada de piel y mucosas. Luego de administrar el bolo de omeprazol se decide \ncontinuar con infusión del mismo medicamento. ¿Cuál es la velocidad de infusión del omeprazol en mg/h?",
         "8",
         "6",
         "4",
         "10",
         "A",
         "Ninguna de las anteriores",
         "Prueba A",
         "Year2025",
         "2025",
         "Mujer de 45 años usuaria crónica de AINES por osteoartritis, acude por hematemesis y melena activa. Examen: PA: 80/50 \nmmHg, FC: 112 X', FR: 22 X'. Palidez marcada de piel y mucosas. Luego de administrar el bolo de omeprazol se decide \ncontinuar con infusión del mismo medicamento. ¿Cuál es la velocidad de infusión del omeprazol en mg/h? A) 8 B) 6 C) 4 D) 10 E) Ninguna de las anteriores",
         "<unused94>thought\n1.  **Identify the core question:** The question asks for the infusion rate of omeprazole in mg/h for a patient with upper GI bleeding (hematemesis, melena) and hemodynamic instability (hypotension, tachycardia) who is a chronic NSAID user.\n\n2.  **Analyze the patient's condition:**\n    *   45-year-old female.\n    *   Chronic NSAID use (risk factor for peptic ulcer disease and bleeding).\n    *   Symptoms: Hematemesis (vomiting blood) and melena (black, tarry stools) - indicate upper GI bleeding.\n    *   Signs: Hypotension (PA 80/50 mmHg), tachycardia (FC 112 X'), tachypnea (FR 22 X'), pallor - indicate significant blood loss and hemodynamic instability (shock).\n    *   Initial treatment: IV bolus of omeprazole.\n    *   Next step: Continuous IV infusion of omeprazole.\n\n3.  **Recall/Research standard protocols for managing upper GI bleeding:**\n    *   Upper GI bleeding, especially with hemodynamic instability, is a medical emergency.\n    *   Initial management includes resuscitation (fluids, blood transfusion if needed), endoscopic evaluation, and pharmacotherapy.\n    *   Proton pump inhibitors (PPIs) like omeprazole are crucial. They reduce gastric acid secretion, promote clot stability, and decrease rebleeding risk.\n    *   Standard protocols often involve an initial IV bolus followed by a continuous infusion.\n\n4.  **Focus on the omeprazole infusion rate:**\n    *   What is the standard IV infusion rate for omeprazole in the context of acute upper GI bleeding?\n    *   Common protocols (e.g., based on guidelines from gastroenterology societies, hospital formularies) recommend a specific infusion rate.\n    *   Search for standard IV omeprazole infusion rates for acute upper GI bleed.\n    *   Sources (like UpToDate, hospital protocols, pharmacology references) typically state the standard IV infusion rate for omeprazole in acute upper GI bleeding is 4 mg/h.\n    *   The initial bolus is usually 80 mg IV over 20-30 minutes.\n    *   The continuous infusion is then typically 4 mg/h for 72 hours after the bolus, followed by oral therapy.\n\n5.  **Compare the standard rate with the options:**\n    *   A) 8 mg/h\n    *   B) 6 mg/h\n    *   C) 4 mg/h\n    *   D) 10 mg/h\n    *   E) Ninguna de las anteriores\n\n6.  **Select the correct option:** The standard infusion rate is 4 mg/h, which matches option C.\n\n7.  **Format the final answer:** The instruction requires only the letter of the correct option.<unused95>Respuesta final:C",
         "medgemma-27b-text-it",
         "C"
        ],
        [
         "34",
         "¿Cuál es la hormona responsable de aumentar la producción hepática de glucosa durante un ayuno prolongado de 24 \nhoras?",
         "Glucagon",
         "Insulina",
         "Leptina",
         "Somatostatina",
         "A",
         "Ninguna de las anteriores",
         "Prueba A",
         "Year2025",
         "2025",
         "¿Cuál es la hormona responsable de aumentar la producción hepática de glucosa durante un ayuno prolongado de 24 \nhoras? A) Glucagon B) Insulina C) Leptina D) Somatostatina E) Ninguna de las anteriores",
         "<unused94>thought\n1.  **Analyze the question:** The question asks for the hormone responsible for increasing hepatic glucose production during a prolonged fast (24 hours). This implies a state of low blood glucose and the body's response to maintain it.\n\n2.  **Recall relevant physiology:**\n    *   **Fasting state:** During fasting, blood glucose levels decrease.\n    *   **Hepatic glucose production:** The liver produces glucose primarily through glycogenolysis (breakdown of stored glycogen) and gluconeogenesis (synthesis of glucose from non-carbohydrate precursors).\n    *   **Hormonal regulation of glucose:** Several hormones regulate blood glucose.\n        *   **Insulin:** Secreted by pancreatic beta cells in response to high blood glucose. It *decreases* hepatic glucose production and promotes glucose uptake by tissues.\n        *   **Glucagon:** Secreted by pancreatic alpha cells in response to low blood glucose. It *increases* hepatic glucose production (glycogenolysis and gluconeogenesis).\n        *   **Leptin:** Secreted by adipose tissue. Primarily involved in appetite regulation and energy balance. It generally *inhibits* hepatic glucose production.\n        *   **Somatostatin:** Secreted by pancreatic delta cells, hypothalamus, etc. It has inhibitory effects on various hormones, including insulin and glucagon, but its primary role in *increasing* hepatic glucose production during fasting is not established. It tends to *decrease* both insulin and glucagon secretion.\n        *   **Other hormones:** Cortisol and growth hormone also increase hepatic glucose production during prolonged fasting, but glucagon is the primary counter-regulatory hormone released immediately in response to falling glucose levels.\n\n3.  **Evaluate the options:**\n    *   **A) Glucagon:** This hormone is secreted when blood glucose is low (like during fasting) and directly stimulates the liver to produce glucose. This fits the description.\n    *   **B) Insulin:** This hormone is secreted when blood glucose is high and *inhibits* hepatic glucose production. This is the opposite of what's needed during fasting.\n    *   **C) Leptin:** This hormone is related to satiety and energy stores. It generally *inhibits* glucose production.\n    *   **D) Somatostatin:** This hormone generally inhibits hormone secretion, including both insulin and glucagon. It doesn't directly stimulate hepatic glucose production in this context.\n    *   **E) Ninguna de las anteriores:** Since Glucagon (A) is a strong candidate, this option is unlikely.\n\n4.  **Confirm the best fit:** Glucagon is the principal hormone that counteracts the effects of insulin and raises blood glucose levels by stimulating hepatic glucose production (glycogenolysis and gluconeogenesis) during fasting. A 24-hour fast is a significant period where glucagon's role becomes prominent.\n\n5.  **Formulate the final answer:** Based on the analysis, Glucagon is the correct hormone. The corresponding option is A.<unused95>Respuesta final:A",
         "medgemma-27b-text-it",
         "A"
        ],
        [
         "35",
         "Mujer de 47 años, hipertensa mal controlada, acude por que hace 20 minutos presenta dolor precordial opresivo con \nirradiación a brazo izquierdo. EKG muestra supradesnivel del ST en todas las derivadas precordiales. En un escenario \nideal. ¿Cuál es el tratamiento de elección?",
         "Oxigenoterapia",
         "Fibrinolisis",
         "Doble antiagregación",
         "Intervención coronaria",
         "D",
         "Ninguna de las anteriores",
         "Prueba A",
         "Year2025",
         "2025",
         "Mujer de 47 años, hipertensa mal controlada, acude por que hace 20 minutos presenta dolor precordial opresivo con \nirradiación a brazo izquierdo. EKG muestra supradesnivel del ST en todas las derivadas precordiales. En un escenario \nideal. ¿Cuál es el tratamiento de elección? A) Oxigenoterapia B) Fibrinolisis C) Doble antiagregación D) Intervención coronaria E) Ninguna de las anteriores",
         "<unused94>thought\n1.  **Analyze the Request:** The user wants me to act as an expert medical assistant trained in Peru and answer a multiple-choice medical question. I need to provide a step-by-step internal thought process, summarize the information, and then give *only* the final letter answer.\n\n2.  **Summarize the Case:**\n    *   Patient: 47-year-old female.\n    *   History: Poorly controlled hypertension.\n    *   Presentation: Acute onset (20 minutes ago) of oppressive precordial chest pain radiating to the left arm.\n    *   EKG Findings: ST-segment elevation in all precordial leads (V1-V6).\n    *   Scenario: Ideal setting.\n    *   Question: What is the treatment of choice?\n\n3.  **Interpret the Findings:**\n    *   The symptoms (acute chest pain, radiation) are classic for acute myocardial infarction (AMI).\n    *   The EKG findings (ST elevation in V1-V6) indicate an extensive anterior ST-segment elevation myocardial infarction (STEMI).\n    *   The patient is relatively young (47 years old).\n    *   The scenario is \"ideal,\" implying access to optimal resources.\n\n4.  **Evaluate the Options:**\n    *   **A) Oxigenoterapia (Oxygen therapy):** Important supportive care for AMI, especially if hypoxic, but not the definitive *treatment* to restore coronary flow.\n    *   **B) Fibrinolisis (Fibrinolysis):** A reperfusion strategy used when primary PCI is not readily available within the recommended timeframe (e.g., <90-120 minutes). It dissolves the clot causing the occlusion.\n    *   **C) Doble antiagregación (Dual antiplatelet therapy):** Crucial part of AMI management (aspirin + P2Y12 inhibitor), but it prevents further clot formation/extension, it doesn't actively dissolve the existing occlusive thrombus or mechanically open the artery.\n    *   **D) Intervención coronaria (Coronary intervention):** Refers to primary percutaneous coronary intervention (PCI), specifically angioplasty with or without stenting. This is the preferred method for reperfusion in STEMI when available promptly in an ideal setting, as it directly opens the occluded artery.\n    *   **E) Ninguna de las anteriores (None of the above):** Unlikely, as there are established treatments.\n\n5.  **Determine the Best Choice (Ideal Scenario):**\n    *   The patient has a STEMI.\n    *   The goal in STEMI is rapid reperfusion to salvage myocardium.\n    *   Primary PCI (coronary intervention) is the gold standard and preferred reperfusion strategy for STEMI when it can be performed in a timely manner (door-to-balloon time <90 minutes in a PCI-capable hospital, or <120 minutes if transfer is needed).\n    *   The question specifies an \"ideal scenario,\" which strongly implies access to timely primary PCI.\n    *   Fibrinolysis is an alternative if PCI is delayed.\n    *   Oxygen and dual antiplatelet therapy are essential adjuncts but not the primary reperfusion strategy.\n\n6.  **Formulate the Final Answer:** Based on the analysis, coronary intervention (primary PCI) is the treatment of choice in an ideal setting for STEMI. This corresponds to option D.\n\n7.  **Final Check:** Ensure the output format matches the request (internal reasoning, then *only* the letter).<unused95>Respuesta final:D",
         "medgemma-27b-text-it",
         "D"
        ],
        [
         "36",
         "Mujer de 32 años que presenta ataxia y temblor de manos. Antecedente: epilepsia tratada con fármaco que aumenta los \nniveles de GABA e inhibe los canales de calcio tipo T. Examen: petequias. Laboratorio: hiperamonemia. ¿Qué \nmedicamento se ha utilizado?",
         "Etosuximida",
         "Gabapentina",
         "Fenitoína",
         "Valproato",
         "D",
         "Ninguna de las anteriores",
         "Prueba A",
         "Year2025",
         "2025",
         "Mujer de 32 años que presenta ataxia y temblor de manos. Antecedente: epilepsia tratada con fármaco que aumenta los \nniveles de GABA e inhibe los canales de calcio tipo T. Examen: petequias. Laboratorio: hiperamonemia. ¿Qué \nmedicamento se ha utilizado? A) Etosuximida B) Gabapentina C) Fenitoína D) Valproato E) Ninguna de las anteriores",
         "<unused94>thought\n1.  **Analyze the Request:** The user wants me to act as an expert medical assistant trained in Peru and answer a multiple-choice medical question. I need to provide a step-by-step internal thought process, summarize the information, and then output *only* the final letter answer.\n\n2.  **Summarize the Information:**\n    *   Patient: 32-year-old female.\n    *   Symptoms: Ataxia, hand tremor, petechiae.\n    *   History: Epilepsy.\n    *   Medication: A drug that increases GABA levels and inhibits T-type calcium channels.\n    *   Lab finding: Hyperammonemia.\n    *   Question: Identify the medication used.\n    *   Options: A) Ethosuximide, B) Gabapentin, C) Phenytoin, D) Valproate, E) None of the above.\n\n3.  **Evaluate Each Option based on the Information:**\n\n    *   **A) Ethosuximide:**\n        *   Mechanism: Primarily inhibits T-type calcium channels.\n        *   Use: Primarily for absence seizures.\n        *   Side effects: GI upset, CNS effects (drowsiness, headache), rarely blood dyscrasias, *not* typically associated with hyperammonemia or significant GABA increase.\n        *   Match: Partially matches mechanism (T-type Ca++ channels), but doesn't fit the GABA increase, hyperammonemia, or petechiae well.\n\n    *   **B) Gabapentin:**\n        *   Mechanism: Binds to alpha-2-delta subunit of voltage-gated calcium channels. *Not* a primary GABA agonist or inhibitor of T-type calcium channels in the way described.\n        *   Use: Epilepsy (adjunctive), neuropathic pain.\n        *   Side effects: Drowsiness, dizziness, ataxia. *Not* typically associated with hyperammonemia or petechiae.\n        *   Match: Doesn't fit the described mechanism or the hyperammonemia/petechiae.\n\n    *   **C) Phenytoin:**\n        *   Mechanism: Blocks voltage-gated sodium channels.\n        *   Use: Focal and generalized tonic-clonic seizures.\n        *   Side effects: Gingival hyperplasia, hirsutism, ataxia, nystagmus, rash (including Stevens-Johnson), blood dyscrasias (rarely). *Not* associated with GABA increase, T-type Ca++ inhibition, or hyperammonemia.\n        *   Match: Doesn't fit the described mechanism or the hyperammonemia.\n\n    *   **D) Valproate (Valproic Acid):**\n        *   Mechanism: Multiple mechanisms - increases GABA levels (inhibits GABA transaminase, increases GABA synthesis), blocks voltage-gated sodium channels, and inhibits T-type calcium channels.\n        *   Use: Broad-spectrum anti-epileptic (absence, myoclonic, tonic-clonic, focal).\n        *   Side effects: Hepatotoxicity, pancreatitis, *hyperammonemia*, thrombocytopenia (leading to petechiae/bruising), weight gain, hair loss, tremor, ataxia.\n        *   Match: Fits *all* the key pieces of information:\n            *   Mechanism: Increases GABA, inhibits T-type Ca++ channels.\n            *   Symptoms/Signs: Ataxia, tremor (common side effects), petechiae (due to thrombocytopenia).\n            *   Lab: Hyperammonemia (known side effect).\n            *   History: Epilepsy (common indication).\n\n    *   **E) None of the above:** Since Valproate fits well, this is unlikely.\n\n4.  **Synthesize and Conclude:** Valproate is the only drug among the options that matches the described mechanism of action (increasing GABA and inhibiting T-type calcium channels) and the clinical presentation (ataxia, tremor, petechiae) and laboratory finding (hyperammonemia).\n\n5.  **Format the Output:** Provide only the final letter answer as requested.<unused95>Respuesta final:D",
         "medgemma-27b-text-it",
         "D"
        ],
        [
         "37",
         "Varón de 39 años, obeso, acude por anorexia, constipación, poliuria y dolores oseos difusos. Examen: PA: 130/80 mmHg, \nFC: 84X'. Laboratorio: calcio: 11.6 mg/dL. ¿Cuál es el diagnóstico presuntivo?",
         "Consumo de tiazidas",
         "Hiperparatiroidismo primario",
         "Neoplasia metastásica",
         "Hiperparatoridismo secundario",
         "B",
         "Ninguna de las anteriores",
         "Prueba A",
         "Year2025",
         "2025",
         "Varón de 39 años, obeso, acude por anorexia, constipación, poliuria y dolores oseos difusos. Examen: PA: 130/80 mmHg, \nFC: 84X'. Laboratorio: calcio: 11.6 mg/dL. ¿Cuál es el diagnóstico presuntivo? A) Consumo de tiazidas B) Hiperparatiroidismo primario C) Neoplasia metastásica D) Hiperparatoridismo secundario E) Ninguna de las anteriores",
         "<unused94>thought\n1.  **Analyze the Request:** The user wants me to act as an expert medical assistant trained in Peru and answer a multiple-choice medical question. I need to provide a step-by-step internal thought process, summarize the information, and then output *only* the final letter answer.\n\n2.  **Summarize the Case:**\n    *   Patient: 39-year-old male.\n    *   Relevant History: Obese.\n    *   Symptoms: Anorexia, constipation, polyuria, diffuse bone pain.\n    *   Vitals: BP 130/80 mmHg, HR 84 bpm (within normal limits, slightly elevated BP but not severely hypertensive).\n    *   Lab Result: Calcium 11.6 mg/dL (Normal range typically ~8.5-10.2 mg/dL, so this is elevated - hypercalcemia).\n\n3.  **Analyze the Symptoms and Lab Result:**\n    *   **Hypercalcemia (Ca 11.6 mg/dL):** This is the key finding.\n    *   **Symptoms related to hypercalcemia:**\n        *   Anorexia (loss of appetite)\n        *   Constipation\n        *   Polyuria (due to nephrogenic diabetes insipidus caused by hypercalcemia)\n        *   Bone pain (can be caused by hypercalcemia itself or underlying bone disease)\n    *   **Other factors:** Obesity is noted but doesn't directly point to a specific cause of hypercalcemia in this context. Age (39) is relatively young for some causes but possible for others.\n\n4.  **Evaluate the Options:**\n    *   **A) Consumo de tiazidas (Thiazide use):** Thiazide diuretics can cause mild hypercalcemia by increasing renal calcium reabsorption. However, they usually don't cause such significant symptoms like diffuse bone pain, and the calcium level might not be this high. The patient's history doesn't mention thiazide use. Less likely to be the primary cause given the constellation of symptoms.\n    *   **B) Hiperparatiroidismo primario (Primary hyperparathyroidism):** This is a common cause of hypercalcemia, especially in adults. It's caused by excessive PTH secretion (usually from a parathyroid adenoma). Symptoms often include \"stones, bones, abdominal groans, thrones, and psychiatric overtones.\" The patient's symptoms (bone pain, constipation, polyuria - \"thrones\", anorexia - \"groans\") fit well. Hypercalcemia is the hallmark. This is a strong possibility.\n    *   **C) Neoplasia metastásica (Metastatic neoplasia):** Malignancy is another major cause of hypercalcemia, often more severe and rapid in onset than primary hyperparathyroidism. Bone metastases (e.g., from breast, lung, prostate cancer) can cause bone pain and hypercalcemia through osteolysis or secretion of PTHrP (parathyroid hormone-related peptide). While possible, primary hyperparathyroidism is statistically more common as a cause of hypercalcemia in an outpatient setting with these symptoms. The age (39) makes widespread metastases slightly less common than primary hyperparathyroidism, although not impossible.\n    *   **D) Hiperparatiroidismo secundario (Secondary hyperparathyroidism):** This occurs in response to chronic hypocalcemia (e.g., chronic kidney disease, vitamin D deficiency). PTH levels are high, but *calcium levels are typically low or normal*, not high. This option is inconsistent with the patient's hypercalcemia.\n    *   **E) Ninguna de las anteriores (None of the above):** Given that primary hyperparathyroidism (B) fits the clinical picture well, this is less likely.\n\n5.  **Compare Strongest Options (B vs. C):**\n    *   Primary hyperparathyroidism (B) is the most common cause of hypercalcemia in the outpatient setting. The symptoms (bone pain, constipation, polyuria, anorexia) are classic, albeit non-specific, for hypercalcemia and fit well with this diagnosis.\n    *   Metastatic neoplasia (C) is a significant cause, especially in hospitalized patients or those with known cancer. While possible, the presentation is very typical for primary hyperparathyroidism. Without more information suggesting malignancy (e.g., weight loss, history of cancer), primary hyperparathyroidism is the more likely *presumptive* diagnosis.\n\n6.  **Conclusion:** Based on the classic symptoms of hypercalcemia (anorexia, constipation, polyuria) combined with bone pain and a significantly elevated calcium level (11.6 mg/dL) in a 39-year-old male, primary hyperparathyroidism is the most likely presumptive diagnosis among the choices provided.\n\n7.  **Final Answer Format:** Select the letter corresponding to the chosen diagnosis.<unused95>Respuesta final:B",
         "medgemma-27b-text-it",
         "B"
        ],
        [
         "38",
         "En pacientes con acromegalia secundarios a adenomas que secretan GH. ¿Cuál es el tratamiento inicial?",
         "Pegvisomant",
         "Cabergolina",
         "Octeótride",
         "Ablación quirúrgica",
         "D",
         "Ninguna de las anteriores",
         "Prueba A",
         "Year2025",
         "2025",
         "En pacientes con acromegalia secundarios a adenomas que secretan GH. ¿Cuál es el tratamiento inicial? A) Pegvisomant B) Cabergolina C) Octeótride D) Ablación quirúrgica E) Ninguna de las anteriores",
         "<unused94>thought\n1.  **Identify the core question:** The question asks for the *initial* treatment for acromegaly caused by GH-secreting pituitary adenomas.\n\n2.  **Analyze the condition:** Acromegaly is caused by excessive Growth Hormone (GH), usually from a pituitary adenoma. The goal of treatment is to normalize GH and IGF-1 levels and reduce tumor size if possible.\n\n3.  **Evaluate the options:**\n    *   **A) Pegvisomant:** This is a GH receptor antagonist. It blocks the action of GH but doesn't reduce tumor size. It's typically used when surgery or somatostatin analogs fail or are contraindicated. Not usually the *initial* treatment.\n    *   **B) Cabergolina:** This is a dopamine agonist. It can sometimes lower GH levels, especially in tumors that co-secrete prolactin, but it's not the primary or most effective treatment for pure GH-secreting adenomas. Not the standard *initial* treatment.\n    *   **C) Octeótride:** This is a somatostatin analog. It inhibits GH secretion from the pituitary adenoma and can also reduce tumor size in some cases. It's a common medical treatment option.\n    *   **D) Ablación quirúrgica (Surgical ablation/Transsphenoidal surgery):** This is the removal of the pituitary adenoma. It's considered the *first-line* and most definitive treatment for most patients with GH-secreting adenomas, aiming to cure the disease by removing the source of excess GH.\n    *   **E) Ninguna de las anteriores (None of the above):** Given that surgery is a standard initial treatment, this is unlikely.\n\n4.  **Determine the *initial* treatment:** Standard medical guidelines (including those relevant in Peru, which generally follow international standards) recommend transsphenoidal surgery as the primary and initial treatment for most patients with acromegaly due to pituitary adenomas. Medical therapy (like somatostatin analogs or pegvisomant) is usually reserved for patients who are not surgical candidates, have residual disease after surgery, or cannot tolerate surgery.\n\n5.  **Select the best option:** Based on the standard of care, surgical ablation (transsphenoidal surgery) is the preferred initial treatment.\n\n6.  **Format the answer:** The final answer should be just the letter corresponding to the chosen option.<unused95>Respuesta final:D",
         "medgemma-27b-text-it",
         "D"
        ],
        [
         "39",
         "Primigesta de 41 semanas, acude a control prenatal por que aún no ha iniciado trabajo de parto. Examen: PA: 100/60 \nmmHg, FC: 72 X', AU: 32 cm, SPP: LCI, LCF: 132 X'. Tacto vaginal: D: 0 B: 50% AP -2. Ecografía: ponderado fetal 3700 \ng y oligohidramnios. Test no estresante normal. ¿Cuál es la conducta más adecuada?",
         "Inducción de trabajo de parto",
         "Cesárea a las 42 semanas",
         "Vigilancia fetal cada 72 horas",
         "Cesárea de emergencia",
         "A",
         "Ninguna de las anteriores",
         "Prueba A",
         "Year2025",
         "2025",
         "Primigesta de 41 semanas, acude a control prenatal por que aún no ha iniciado trabajo de parto. Examen: PA: 100/60 \nmmHg, FC: 72 X', AU: 32 cm, SPP: LCI, LCF: 132 X'. Tacto vaginal: D: 0 B: 50% AP -2. Ecografía: ponderado fetal 3700 \ng y oligohidramnios. Test no estresante normal. ¿Cuál es la conducta más adecuada? A) Inducción de trabajo de parto B) Cesárea a las 42 semanas C) Vigilancia fetal cada 72 horas D) Cesárea de emergencia E) Ninguna de las anteriores",
         "<unused94>thought\n1.  **Analyze the Request:** The user wants me to act as an expert medical assistant trained in Peru and answer a multiple-choice medical question. I need to provide a step-by-step internal thought process, summarize the information, and then give *only* the final letter answer.\n\n2.  **Summarize the Patient Information:**\n    *   Patient: Primigesta (first pregnancy).\n    *   Gestational Age: 41 weeks (post-term).\n    *   Reason for visit: No labor onset.\n    *   Vitals: BP 100/60 mmHg (normal), HR 72 bpm (normal).\n    *   Abdominal Exam: AU 32 cm (appropriate for GA), Fetal Presentation: Longitudinal, Cephalic, Fetal Heart Rate (FHR): 132 bpm (normal range).\n    *   Vaginal Exam: Dilation 0 cm, Effacement 50%, Station -2 (unfavorable cervix).\n    *   Ultrasound: Estimated Fetal Weight (EFW) 3700 g (macrosomia risk), Oligohydramnios (low amniotic fluid).\n    *   Non-Stress Test (NST): Normal (reassuring fetal status *at this moment*).\n\n3.  **Identify the Key Issues:**\n    *   **Post-term pregnancy (41 weeks):** Increased risk of placental insufficiency, macrosomia, meconium aspiration, stillbirth.\n    *   **Oligohydramnios:** Associated with placental insufficiency and increased risk of fetal compromise.\n    *   **Macrosomia (EFW 3700g):** Increased risk of shoulder dystocia, birth trauma, C-section.\n    *   **Unfavorable cervix (0/50%/-2):** Induction might be less successful or take longer.\n    *   **Normal NST:** Reassuring *currently*, but doesn't negate the risks associated with post-term pregnancy and oligohydramnios.\n\n4.  **Evaluate the Options:**\n    *   **A) Inducción de trabajo de parto (Induction of labor):** This is a standard management option for post-term pregnancies (typically recommended at 41-42 weeks). Given the oligohydramnios and potential macrosomia, delivery is indicated. Induction is a reasonable first step, although the unfavorable cervix might make it challenging. However, the risks of continuing the pregnancy (placental insufficiency, fetal compromise) outweigh the risks of induction in this scenario.\n    *   **B) Cesárea a las 42 semanas (Cesarean section at 42 weeks):** Waiting until 42 weeks increases the risks significantly, especially with oligohydramnios. This is not the most appropriate immediate action.\n    *   **C) Vigilancia fetal cada 72 horas (Fetal surveillance every 72 hours):** While fetal surveillance (like NSTs, biophysical profiles) is important, it's not sufficient management for a post-term pregnancy with oligohydramnios. The risks are too high to simply wait and monitor every 72 hours. More frequent monitoring (e.g., daily or every other day) and consideration for delivery are needed.\n    *   **D) Cesárea de emergencia (Emergency Cesarean section):** There is no indication for an *emergency* C-section *right now*. The NST is normal, and there are no signs of acute fetal distress or maternal compromise. Induction is usually attempted first unless there are contraindications or fetal distress.\n    *   **E) Ninguna de las anteriores (None of the above):** Option A (Induction) is a standard and appropriate management strategy in this situation.\n\n5.  **Determine the Most Appropriate Conduct:** The patient is post-term (41 weeks) with oligohydramnios and a macrosomic fetus. These factors increase the risk of adverse outcomes if the pregnancy continues. Although the NST is currently normal and the cervix is unfavorable, the risks associated with continuing the pregnancy outweigh the risks of attempting induction. Induction of labor is the standard management for post-term pregnancies, especially when complicated by oligohydramnios. While the unfavorable cervix might necessitate cervical ripening agents or a higher chance of C-section if induction fails, it remains the most appropriate initial step.\n\n6.  **Final Answer Selection:** Based on the analysis, induction of labor (Option A) is the most appropriate management strategy.<unused95>Respuesta final:A",
         "medgemma-27b-text-it",
         "A"
        ],
        [
         "40",
         "Mujer de 30 años que durante una apendicectomía se encuentra una tumoración de menos de 2 cm en la punta del \napéndice. No se observa muestra de extensión abdominal extraapendicular. ¿Cuál es la conducta indicada?",
         "Colectomía ascendente",
         "Ileostomía",
         "Hemicolectomía derecha",
         "Apendicectomía",
         "D",
         "Ninguna de las anteriores",
         "Prueba A",
         "Year2025",
         "2025",
         "Mujer de 30 años que durante una apendicectomía se encuentra una tumoración de menos de 2 cm en la punta del \napéndice. No se observa muestra de extensión abdominal extraapendicular. ¿Cuál es la conducta indicada? A) Colectomía ascendente B) Ileostomía C) Hemicolectomía derecha D) Apendicectomía E) Ninguna de las anteriores",
         "<unused94>thought\n1.  **Analyze the question:** A 30-year-old woman undergoes an appendectomy. A tumor < 2 cm is found at the tip of the appendix. No extra-appendiceal spread is seen. The question asks for the indicated management.\n\n2.  **Identify the key information:**\n    *   Age: 30 years old (young adult)\n    *   Procedure: Appendectomy\n    *   Finding: Tumor < 2 cm at the tip of the appendix\n    *   Extent: No extra-appendiceal spread observed (implies localized disease)\n    *   Goal: Determine the appropriate management.\n\n3.  **Evaluate the options:**\n    *   A) Colectomía ascendente (Ascending colectomy): This is a major surgery involving removal of the cecum, ascending colon, and part of the transverse colon. It's typically reserved for larger tumors or those involving the cecum/ascending colon. Given the small size (< 2 cm) and location limited to the appendix tip with no spread, this seems excessive.\n    *   B) Ileostomía (Ileostomy): This is a surgical procedure creating an opening (stoma) from the ileum to the outside of the body. It's usually done for conditions affecting the colon or rectum, requiring temporary or permanent diversion of stool. It's not a primary treatment for a localized appendiceal tumor.\n    *   C) Hemicolectomía derecha (Right hemicolectomy): This involves removing the cecum, ascending colon, hepatic flexure, and the terminal ileum. It's a standard procedure for cecal or ascending colon cancers, or sometimes for appendiceal cancers with significant involvement or spread. Similar to ascending colectomy, it seems too extensive for a small, localized tumor at the appendix tip.\n    *   D) Apendicectomía (Appendectomy): The patient is already undergoing an appendectomy. If the tumor is small (< 2 cm), located at the tip, and confined to the appendix (no extra-appendiceal spread), a simple appendectomy might be sufficient treatment, especially for certain types of appendiceal tumors like carcinoid tumors of this size.\n    *   E) Ninguna de las anteriores (None of the above): This would be correct if none of the other options are appropriate.\n\n4.  **Consider the pathology:** The description suggests a possible appendiceal neuroendocrine tumor (carcinoid) or potentially a low-grade appendiceal mucinous neoplasm (LAMN) or adenocarcinoma.\n    *   For carcinoid tumors < 1 cm confined to the appendix, simple appendectomy is generally considered curative.\n    *   For carcinoid tumors between 1 and 2 cm, the risk of nodal metastasis increases, and a right hemicolectomy might be considered, especially if there are high-risk features (e.g., invasion of the mesoappendix, positive margins). However, the question states \"no se observa muestra de extensión abdominal extraapendicular,\" which implies the tumor is confined.\n    *   For LAMN or adenocarcinoma, even if small, a right hemicolectomy is often recommended due to the risk of spread and the potential for mucin production.\n\n5.  **Re-evaluate based on typical guidelines (Peruvian context implied, but general principles apply):**\n    *   A tumor < 2 cm at the *tip* of the appendix with *no* extra-appendiceal spread.\n    *   If it's a carcinoid: < 1 cm -> appendectomy. 1-2 cm -> appendectomy *or* right hemicolectomy depending on risk factors (invasion, margins, etc.). Since no spread is noted and it's at the tip, appendectomy is a strong possibility, especially if it's < 1 cm. Even if it's 1-2 cm, appendectomy *can* be considered if margins are clear and no high-risk features are present.\n    *   If it's LAMN or adenocarcinoma: Right hemicolectomy is usually preferred even for small tumors due to the risk of peritoneal spread.\n\n6.  **Critically assess the options again:**\n    *   A, C (Colectomía ascendente, Hemicolectomía derecha): These are major resections. While potentially indicated for certain appendiceal cancers (especially adenocarcinoma or high-risk carcinoids), they might be overtreatment for a small (<2cm), localized tumor at the tip, particularly if it's a low-grade carcinoid.\n    *   B (Ileostomía): Irrelevant for primary treatment.\n    *   D (Apendicectomía): The patient is already having this. If the tumor is small and confined (as described), this *might* be sufficient, especially for carcinoids < 1 cm or even 1-2 cm without adverse features. Given the options, and the description of a small tumor confined to the tip, appendectomy is the *least* invasive option that could potentially be curative in some scenarios (e.g., carcinoid < 1 cm). If the tumor is 1-2 cm, the decision between appendectomy and right hemicolectomy is more complex and depends on histology and risk factors not provided. However, *among the given choices*, appendectomy is the most plausible *initial* or *sufficient* procedure described. The question asks for the *indicated* conduct *given the findings during the appendectomy*. The finding is a small tumor confined to the tip. The most immediate and potentially sufficient procedure *based solely on the information given* is the appendectomy itself. If further pathology suggested a need for wider resection, that would be a subsequent decision, but the *indicated* conduct *at that moment* based on the intraoperative finding is to complete the appendectomy.\n\n7.  **Refine the choice:** The question describes a finding *during* an appendectomy. The tumor is small (<2cm) and localized to the tip without apparent spread. While a right hemicolectomy is often standard for appendiceal adenocarcinoma or high-risk carcinoids, a simple appendectomy is curative for carcinoids <1cm and can be considered for 1-2cm carcinoids without high-risk features. Given the limited information and the options, the appendectomy already in progress is the most appropriate *initial* step and potentially curative procedure based on the description. The other options represent more extensive surgery that might not be necessary based *only* on the intraoperative findings described.\n\n8.  **Final check:** The tumor is small (<2cm), at the tip, and no spread is seen. Appendectomy is the procedure being performed. For certain tumor types (like carcinoid <1cm), appendectomy alone is sufficient. Even for 1-2cm carcinoids, appendectomy might be considered if margins are clear and no high-risk features are present. Therefore, completing the appendectomy is the most reasonable immediate action based on the provided information.<unused95>Respuesta final:D",
         "medgemma-27b-text-it",
         "D"
        ],
        [
         "41",
         "Varón de 18 años sufre caída sobre su hombro izquierdo, acude por limitación en la movilidad del miembro superior \nizquierdo. Examen: hombro en aducción, brazo en rotación interna y codo extendido. ¿Dónde se localiza la lesión?",
         "Tronco inferior del plexo braquial",
         "Nervio cubital y braquial cutáneo medial",
         "Tronco superior del plexo braquial",
         "Tronco medio del plexo braquial",
         "C",
         "Ninguna de las anteriores",
         "Prueba A",
         "Year2025",
         "2025",
         "Varón de 18 años sufre caída sobre su hombro izquierdo, acude por limitación en la movilidad del miembro superior \nizquierdo. Examen: hombro en aducción, brazo en rotación interna y codo extendido. ¿Dónde se localiza la lesión? A) Tronco inferior del plexo braquial B) Nervio cubital y braquial cutáneo medial C) Tronco superior del plexo braquial D) Tronco medio del plexo braquial E) Ninguna de las anteriores",
         "<unused94>thought\n1.  **Analyze the Request:** The user wants me to act as an expert medical assistant trained in Peru and answer a multiple-choice medical question. I need to provide a step-by-step internal thought process, summarize the information, and then output *only* the final letter answer.\n\n2.  **Summarize the Information:**\n    *   Patient: 18-year-old male.\n    *   Mechanism: Fall onto the left shoulder.\n    *   Symptom: Limited mobility of the left upper limb.\n    *   Physical Exam Findings:\n        *   Shoulder: Adducted.\n        *   Arm: Internally rotated.\n        *   Elbow: Extended.\n    *   Question: Location of the lesion causing these findings.\n    *   Options:\n        *   A) Lower trunk of the brachial plexus\n        *   B) Ulnar and medial brachial cutaneous nerves\n        *   C) Upper trunk of the brachial plexus\n        *   D) Middle trunk of the brachial plexus\n        *   E) None of the above\n\n3.  **Internal Step-by-Step Reasoning:**\n    *   **Identify the clinical presentation:** The described posture (shoulder adducted, arm internally rotated, elbow extended) is characteristic of a specific type of brachial plexus injury. This posture is often called the \"waiter's tip\" position.\n    *   **Relate the posture to muscle function:**\n        *   Shoulder adduction implies weakness/paralysis of shoulder abductors (deltoid, supraspinatus).\n        *   Arm internal rotation implies weakness/paralysis of external rotators (infraspinatus, teres minor).\n        *   Elbow extension implies weakness/paralysis of elbow flexors (biceps, brachialis, brachioradialis).\n    *   **Identify the nerves involved:**\n        *   Deltoid (abduction): Axillary nerve (C5, C6).\n        *   Supraspinatus (abduction initiation): Suprascapular nerve (C5, C6).\n        *   Infraspinatus (external rotation): Suprascapular nerve (C5, C6).\n        *   Teres minor (external rotation): Axillary nerve (C5, C6).\n        *   Biceps (elbow flexion, forearm supination): Musculocutaneous nerve (C5, C6, C7).\n        *   Brachialis (elbow flexion): Musculocutaneous nerve (C5, C6, T1).\n        *   Brachioradialis (elbow flexion): Radial nerve (C5, C6, C7).\n    *   **Determine the origin of these nerves:**\n        *   Axillary nerve: Posterior cord (C5, C6).\n        *   Suprascapular nerve: Upper trunk (C5, C6).\n        *   Musculocutaneous nerve: Lateral cord (C5, C6, C7).\n        *   Radial nerve: Posterior cord (C5, C6, C7, C8, T1).\n    *   **Identify the common origin:** The nerves supplying the muscles responsible for the observed weakness (deltoid, supraspinatus, infraspinatus, teres minor, biceps, brachialis, brachioradialis) primarily originate from the C5 and C6 nerve roots. These roots form the *upper trunk* of the brachial plexus.\n    *   **Consider the mechanism:** A fall onto the shoulder can stretch the brachial plexus, particularly the upper trunk, as it passes over the first rib or through the thoracic outlet. This is a common mechanism for Erb's palsy (upper trunk injury).\n    *   **Evaluate the options:**\n        *   A) Lower trunk (C8, T1): Primarily affects intrinsic hand muscles and forearm flexors/pronators. Not consistent with the presentation.\n        *   B) Ulnar and medial brachial cutaneous nerves: Ulnar nerve (C8, T1) affects intrinsic hand muscles, flexor carpi ulnaris, medial half of flexor digitorum profundus. Medial brachial cutaneous nerve (C8, T1) is sensory. Not consistent.\n        *   C) Upper trunk (C5, C6): Affects muscles innervated by C5/C6, leading to the \"waiter's tip\" posture. Consistent with the presentation.\n        *   D) Middle trunk (C7): Primarily affects triceps, wrist/finger extensors. Not consistent.\n        *   E) None of the above: Option C is consistent.\n    *   **Conclusion:** The clinical presentation strongly suggests an injury to the upper trunk of the brachial plexus (Erb's palsy).\n\n4.  **Format the Final Answer:** Output only the letter corresponding to the correct option.<unused95>Respuesta final:C",
         "medgemma-27b-text-it",
         "C"
        ],
        [
         "42",
         "En el sistema de cuantificación POP-Q para prolapso genital. ¿Qué significa cuando el punto D se omite?",
         "Dificultad para cuantificar",
         "Prolapso genital total",
         "Hay presencia de incontinencia",
         "No hay cérvix",
         "D",
         "Ninguna de las anteriores",
         "Prueba A",
         "Year2025",
         "2025",
         "En el sistema de cuantificación POP-Q para prolapso genital. ¿Qué significa cuando el punto D se omite? A) Dificultad para cuantificar B) Prolapso genital total C) Hay presencia de incontinencia D) No hay cérvix E) Ninguna de las anteriores",
         "<unused94>thought\n1.  **Analyze the Request:** The user wants me to act as a medical assistant expert trained in Peru and answer a multiple-choice question about the POP-Q system for pelvic organ prolapse. I need to provide a step-by-step internal thought process, summarize the information, and then give *only* the final letter answer.\n\n2.  **Understand the POP-Q System:** The POP-Q (Pelvic Organ Prolapse Quantification) system is a standardized method for describing and quantifying pelvic organ prolapse. It uses specific anatomical points measured relative to the hymenal ring (or vaginal opening if the hymen is absent). The points are:\n    *   A: Anterior vaginal wall (cystocele)\n    *   B: Vesicourethral pivot point\n    *   C: Urethral meatus\n    *   D: Posterior vaginal wall (rectocele)\n    *   E: Perineal body\n    *   F: Popliteal fossa (used for rectal prolapse)\n    *   Ba: Bladder neck\n    *   Bb: Urethral meatus (at rest)\n    *   Bc: Urethral meatus (straining)\n    *   Bp: Vesicourethral pivot point (straining)\n    *   Qa: Anterior vaginal wall (straining)\n    *   Qb: Vesicourethral pivot point (straining)\n    *   Qc: Urethral meatus (straining)\n    *   Qd: Posterior vaginal wall (straining)\n    *   Qe: Perineal body (straining)\n    *   Sf: Rectal axis (straining)\n\n3.  **Focus on Point D:** Point D specifically refers to the *posterior vaginal wall* (rectocele). It's measured from the hymenal ring to the most distal point of the posterior vaginal wall.\n\n4.  **Interpret \"Point D is omitted\":** If point D is omitted, it means the posterior vaginal wall cannot be measured in its usual way. Why might this happen?\n    *   The posterior wall is completely prolapsed *beyond* the hymenal ring, making the measurement impossible or meaningless in the standard way.\n    *   The posterior wall is *absent* or significantly altered, preventing measurement.\n    *   The *cervix* has prolapsed completely, obscuring the posterior vaginal wall. This is a common reason for omitting D. When the cervix prolapses completely (Stage III or IV prolapse, specifically uterine prolapse), it descends below the hymenal ring, making the measurement of the posterior vaginal wall (D) impossible or irrelevant as the primary prolapse is uterine.\n\n5.  **Evaluate the Options:**\n    *   A) Dificultad para cuantificar: This is too general. Omitting D *is* a difficulty, but the question asks for the *specific meaning* of the omission in the context of POP-Q.\n    *   B) Prolapso genital total: This is a possible outcome of severe prolapse, but omitting D doesn't *automatically* mean total prolapse. It could be just a complete uterine prolapse obscuring D.\n    *   C) Hay presencia de incontinencia: Incontinence is related to pelvic floor function but is not directly indicated by omitting point D.\n    *   D) No hay cérvix: This is incorrect. The omission of D often happens *because* the cervix is present and has prolapsed completely, obscuring the posterior wall. If there were no cervix (e.g., post-hysterectomy), point D would still be measurable (representing the rectocele).\n    *   E) Ninguna de las anteriores: Let's re-evaluate. The most common reason for omitting D is a complete uterine prolapse where the cervix descends below the hymen, making the posterior vaginal wall measurement impossible or irrelevant. None of the options perfectly capture this specific scenario. Option D is definitively wrong. Option A is too vague. Option B might occur, but isn't the direct meaning of omitting D. Option C is unrelated.\n\n6.  **Refine Understanding of Omitting D:** According to POP-Q guidelines (e.g., ACOG Practice Bulletin No. 200), point D is omitted when the cervix is completely prolapsed (below the hymen). The reason is that the measurement of the posterior vaginal wall is no longer relevant or possible in the standard way when the uterus/cervix is the primary prolapsing organ obscuring the view.\n\n7.  **Re-evaluate Options based on Refined Understanding:**\n    *   A) Dificultad para cuantificar: Still too general.\n    *   B) Prolapso genital total: Possible consequence, but not the *meaning* of omitting D.\n    *   C) Hay presencia de incontinencia: Unrelated.\n    *   D) No hay cérvix: Incorrect. Omitting D is often *because* the cervix is present and prolapsed.\n    *   E) Ninguna de las anteriores: This seems the most likely correct answer, as none of the other options accurately describe the specific clinical situation (complete uterine prolapse obscuring the posterior vaginal wall) that leads to omitting point D in the POP-Q system.\n\n8.  **Final Check:** The standard interpretation of omitting D in POP-Q is due to complete uterine prolapse where the cervix descends below the hymenal ring. None of the provided options (A, B, C, D) accurately state this reason. Therefore, E is the correct choice.<unused95>Respuesta final:E",
         "medgemma-27b-text-it",
         "E"
        ],
        [
         "43",
         "Mujer de 65 años, diabética con ERC en terapia dialítica hace 4 años, desde hace un mes presenta dorsalgia y fiebre; en \nla última semana se agrega debilidad en miembros inferiores y dificultad para la micción. ¿Cuál es el diagnóstico más \nprobable?",
         "Metástasis ósea",
         "Osteomielitis vertebral",
         "Espóndiloartrosis",
         "Paraparesia espástica",
         "B",
         "Ninguna de las anteriores",
         "Prueba A",
         "Year2025",
         "2025",
         "Mujer de 65 años, diabética con ERC en terapia dialítica hace 4 años, desde hace un mes presenta dorsalgia y fiebre; en \nla última semana se agrega debilidad en miembros inferiores y dificultad para la micción. ¿Cuál es el diagnóstico más \nprobable? A) Metástasis ósea B) Osteomielitis vertebral C) Espóndiloartrosis D) Paraparesia espástica E) Ninguna de las anteriores",
         "<unused94>thought\nLa usuaria quiere que actúe como un asistente médico experto con entrenamiento en Perú y responda una pregunta de opción múltiple sobre un caso clínico.\n\n**Resumen del caso:**\n*   **Paciente:** Mujer de 65 años.\n*   **Antecedentes:** Diabetes Mellitus, Enfermedad Renal Crónica (ERC) en diálisis hace 4 años.\n*   **Síntomas:**\n    *   Dorsalgia (dolor de espalda) y fiebre desde hace 1 mes.\n    *   Debilidad en miembros inferiores y dificultad para la micción desde hace 1 semana.\n\n**Análisis de las opciones:**\n\n*   **A) Metástasis ósea:** Posible en una paciente de 65 años, pero la fiebre y la rápida progresión de síntomas neurológicos (debilidad, dificultad para micción) en una semana no son tan típicos, aunque pueden ocurrir con compresión medular. No hay información sobre un cáncer primario.\n*   **B) Osteomielitis vertebral:** La fiebre y el dolor de espalda son consistentes. La ERC y la diabetes son factores de riesgo. La compresión medular por un absceso epidural asociado a osteomielitis vertebral podría explicar la debilidad en miembros inferiores y la dificultad para la micción (síndrome de cauda equina o compresión medular). Esta opción encaja bien con el cuadro clínico completo.\n*   **C) Espóndiloartrosis:** Es común en esta edad, causa dorsalgia, pero no explica la fiebre, la debilidad en miembros inferiores ni la dificultad para la micción.\n*   **D) Paraparesia espástica:** Es un síntoma (debilidad en miembros inferiores), no un diagnóstico etiológico. La causa de la paraparesia necesita ser determinada.\n*   **E) Ninguna de las anteriores:** Dado que la osteomielitis vertebral con posible compresión medular parece una explicación plausible, esta opción es menos probable.\n\n**Razonamiento:**\nLa combinación de fiebre, dolor de espalda (dorsalgia) en un paciente con diabetes y ERC en diálisis, junto con el desarrollo rápido de síntomas neurológicos como debilidad en miembros inferiores y disfunción urinaria (dificultad para la micción), sugiere fuertemente una infección vertebral con posible extensión a estructuras adyacentes causando compresión medular o del cono medular/cauda equina. La osteomielitis vertebral, especialmente con formación de absceso epidural, es una causa importante de estos síntomas en pacientes inmunocomprometidos o con comorbilidades como la diabetes y la ERC. Las metástasis óseas son menos probables sin un antecedente de cáncer y la fiebre no es un síntoma primario. La espóndiloartrosis no explica la fiebre ni los síntomas neurológicos agudos. La paraparesia espástica es un hallazgo, no la causa subyacente.\n\n**Conclusión:** La osteomielitis vertebral con posible compresión medular es el diagnóstico más probable que integra todos los síntomas y factores de riesgo de la paciente.\n\n**Respuesta final:** B<unused95>Respuesta final:B",
         "medgemma-27b-text-it",
         "B"
        ],
        [
         "44",
         "Mujer de 75 años es trasladada al servicio de emergencia, porque desde hace 4 días presenta dolor abdominal a \npredominio de fosa iliaca izquierda, vómitos, alza térmica y rectorragia. Antecedente: estreñimiento crónico. Examen: \npálida, PA: 90/60 mmHg, FC: 100X', FR: 30X'. Abdomen: distendido, RHA (-); a la palpación dolor abdominal generalizado, \nrebote(+); TR: dedo de guante con sangre. ¿Cuál es el diagnóstico más probable?",
         "Colitis infecciosa",
         "Apendicitis aguda",
         "Diverticulitis aguda",
         "Enfermedad de Crohn",
         "C",
         "Ninguna de las anteriores",
         "Prueba A",
         "Year2025",
         "2025",
         "Mujer de 75 años es trasladada al servicio de emergencia, porque desde hace 4 días presenta dolor abdominal a \npredominio de fosa iliaca izquierda, vómitos, alza térmica y rectorragia. Antecedente: estreñimiento crónico. Examen: \npálida, PA: 90/60 mmHg, FC: 100X', FR: 30X'. Abdomen: distendido, RHA (-); a la palpación dolor abdominal generalizado, \nrebote(+); TR: dedo de guante con sangre. ¿Cuál es el diagnóstico más probable? A) Colitis infecciosa B) Apendicitis aguda C) Diverticulitis aguda D) Enfermedad de Crohn E) Ninguna de las anteriores",
         "<unused94>thought\n1.  **Analyze the Request:** The user wants me to act as an expert medical assistant trained in Peru and answer a multiple-choice medical question. I need to provide a step-by-step internal thought process (which I won't show in the final output) and then output *only* the letter of the correct answer, preceded by \"Respuesta final:\".\n\n2.  **Summarize the Case Information:**\n    *   **Patient:** 75-year-old female.\n    *   **Presenting Complaint:** 4 days of abdominal pain (predominantly left iliac fossa), vomiting, fever, rectal bleeding.\n    *   **History:** Chronic constipation.\n    *   **Examination Findings:**\n        *   Pale.\n        *   Hypotension (BP 90/60 mmHg).\n        *   Tachycardia (HR 100 bpm).\n        *   Tachypnea (RR 30 breaths/min).\n        *   Abdomen: Distended, absent bowel sounds (RHA -), generalized tenderness, rebound tenderness (+).\n        *   Rectal Exam (TR): Blood on glove.\n\n3.  **Evaluate the Options:**\n    *   **A) Colitis infecciosa (Infectious Colitis):** Can cause abdominal pain, fever, and sometimes rectal bleeding. However, the pain is often more diffuse or lower abdominal, and the localized left iliac fossa pain, combined with the patient's age and history of chronic constipation, makes other diagnoses more likely. The signs of peritonitis (rebound tenderness, absent bowel sounds) are less typical for uncomplicated infectious colitis.\n    *   **B) Apendicitis aguda (Acute Appendicitis):** Typically presents with periumbilical pain migrating to the right iliac fossa. While atypical presentations exist, the predominant *left* iliac fossa pain makes this diagnosis highly unlikely.\n    *   **C) Diverticulitis aguda (Acute Diverticulitis):** This is inflammation/infection of diverticula, most commonly in the sigmoid colon (left iliac fossa). It classically presents with left lower quadrant pain, fever, and changes in bowel habits (constipation or diarrhea). Complications can include perforation, abscess, obstruction, and bleeding. The patient's age (elderly), history of chronic constipation (risk factor for diverticulosis), location of pain (left iliac fossa), fever, vomiting, and signs of peritonitis (distension, absent bowel sounds, rebound tenderness) are highly suggestive of complicated diverticulitis (e.g., perforation with peritonitis). The rectal bleeding could be from diverticular bleeding (common) or related to the inflammation/perforation. This fits the clinical picture well.\n    *   **D) Enfermedad de Crohn (Crohn's Disease):** This is a chronic inflammatory bowel disease. While it can cause abdominal pain, fever, and sometimes bleeding, it usually presents more insidiously or with recurrent flares. Acute presentation with signs of peritonitis like this is less typical, especially as a first presentation in a 75-year-old. Crohn's often affects the terminal ileum (right lower quadrant) or perianal area, although it can affect any part of the GI tract. The acute, severe presentation with peritonitis points away from Crohn's as the *most likely* diagnosis in this scenario.\n    *   **E) Ninguna de las anteriores (None of the above):** Given that diverticulitis fits the clinical picture very well, this option is less likely.\n\n4.  **Synthesize and Conclude:** The patient is elderly with chronic constipation, presenting with acute left iliac fossa pain, fever, vomiting, rectal bleeding, and signs of peritonitis (distension, absent bowel sounds, rebound tenderness). This constellation of symptoms and signs is most characteristic of acute diverticulitis, likely complicated (e.g., perforation leading to peritonitis).\n\n5.  **Format the Final Answer:** The request requires only \"Respuesta final:\" followed by the letter. The most likely diagnosis is Diverticulitis aguda, which corresponds to option C.<unused95>Respuesta final:C",
         "medgemma-27b-text-it",
         "C"
        ],
        [
         "45",
         "¿Qué sustancia facilita la absorción de hierro a nivel intestinal?",
         "Polifenoles",
         "Calcio",
         "Fructosa",
         "Oxalatos",
         "C",
         "Ninguna de las anteriores",
         "Prueba A",
         "Year2025",
         "2025",
         "¿Qué sustancia facilita la absorción de hierro a nivel intestinal? A) Polifenoles B) Calcio C) Fructosa D) Oxalatos E) Ninguna de las anteriores",
         "<unused94>thought\n1.  **Analyze the question:** The question asks which substance *facilitates* (enhances) iron absorption in the intestine.\n\n2.  **Evaluate the options:**\n    *   **A) Polifenoles:** These are found in tea, coffee, and some fruits/vegetables. They are known to *inhibit* iron absorption by forming complexes with iron. So, this is incorrect.\n    *   **B) Calcio:** Calcium competes with iron for absorption pathways in the intestine. High calcium intake can *inhibit* iron absorption. So, this is incorrect.\n    *   **C) Fructosa:** Fructose is a sugar. While some studies suggest certain sugars might slightly influence iron absorption, it's not a primary facilitator. Vitamin C (ascorbic acid) is the most well-known enhancer. Fructose itself isn't typically listed as a major facilitator.\n    *   **D) Oxalatos:** Oxalates, found in spinach, rhubarb, etc., bind to iron and *inhibit* its absorption. So, this is incorrect.\n    *   **E) Ninguna de las anteriores:** Since options A, B, and D are known inhibitors, and C is not a primary facilitator, this option becomes plausible. The most significant facilitator of non-heme iron absorption is Vitamin C (ascorbic acid), which is not listed.\n\n3.  **Confirm knowledge:** Recall or look up factors affecting iron absorption. Key enhancers include Vitamin C (ascorbic acid) and meat/fish/poultry factors (for heme iron). Key inhibitors include phytates, polyphenols (tannins), calcium, oxalates, and certain medications (e.g., antacids).\n\n4.  **Re-evaluate options based on confirmation:**\n    *   Polyphenols: Inhibitor.\n    *   Calcium: Inhibitor.\n    *   Fructosa: Not a primary facilitator.\n    *   Oxalates: Inhibitor.\n    *   None of the above: Correct, as the major facilitator (Vitamin C) is missing, and the listed options are either inhibitors or not significant facilitators.\n\n5.  **Formulate the final answer:** Based on the analysis, none of the listed substances (Polifenoles, Calcio, Fructosa, Oxalatos) facilitate iron absorption; in fact, A, B, and D inhibit it. Therefore, the correct answer is E.<unused95>Respuesta final:E",
         "medgemma-27b-text-it",
         "E"
        ],
        [
         "46",
         "Con el objetivo de disminuir la incidencia de embarazo en adolescentes la Dirección Regional de Salud implementa un \nplan de comunicación educativa dirigido a los escolares de secundaria de su ámbito. ¿Qué tipo de intervención sanitaria \nse está implementando?",
         "Rehabilitación",
         "Prevención",
         "Promoción",
         "Recuperación",
         "C",
         "Ninguna de las anteriores",
         "Prueba A",
         "Year2025",
         "2025",
         "Con el objetivo de disminuir la incidencia de embarazo en adolescentes la Dirección Regional de Salud implementa un \nplan de comunicación educativa dirigido a los escolares de secundaria de su ámbito. ¿Qué tipo de intervención sanitaria \nse está implementando? A) Rehabilitación B) Prevención C) Promoción D) Recuperación E) Ninguna de las anteriores",
         "<unused94>thought\n1.  **Analyze the question:** The question asks to classify a health intervention implemented by a Regional Health Directorate in Peru. The intervention is an educational communication plan aimed at secondary school students to reduce teenage pregnancy.\n\n2.  **Identify the key elements:**\n    *   **Goal:** Decrease the incidence of teenage pregnancy.\n    *   **Target population:** Secondary school students.\n    *   **Method:** Educational communication plan.\n    *   **Context:** Implemented by a health authority (Dirección Regional de Salud).\n\n3.  **Define the options:**\n    *   **A) Rehabilitación (Rehabilitation):** Actions aimed at restoring function or reducing disability after a disease or injury has occurred. Focuses on recovery from an existing condition.\n    *   **B) Prevención (Prevention):** Actions aimed at reducing the risk of disease or injury *before* it occurs. Includes primary (preventing onset), secondary (early detection/intervention), and tertiary (reducing complications).\n    *   **C) Promoción (Promotion):** Actions aimed at enabling people to increase control over and improve their health. Focuses on health education, lifestyle changes, and creating supportive environments *before* disease occurs. Often overlaps with primary prevention but emphasizes empowerment and positive health.\n    *   **D) Recuperación (Recovery):** Similar to rehabilitation, focusing on regaining health or function after illness or injury.\n    *   **E) Ninguna de las anteriores (None of the above):** If none of the other options fit.\n\n4.  **Evaluate the intervention against the definitions:**\n    *   The intervention aims to *decrease the incidence* of teenage pregnancy. This means it's trying to stop it from happening in the first place.\n    *   It targets a population *before* they experience the outcome (teenage pregnancy).\n    *   It uses *education* to influence behavior and knowledge.\n    *   This aligns strongly with the concept of **prevention**, specifically primary prevention, as it aims to prevent the initial occurrence of the unwanted outcome (pregnancy).\n    *   It also has elements of **promotion**, as it involves health education to empower students to make informed decisions about their health. However, the primary goal stated (\"disminuir la incidencia\") points more directly towards prevention.\n    *   Rehabilitation and Recovery are clearly incorrect as they deal with conditions that have already occurred.\n\n5.  **Distinguish between Prevention and Promotion:** While related, prevention often focuses on specific risk reduction (e.g., vaccination, screening), while promotion is broader, focusing on overall health enhancement and empowerment through education and lifestyle changes. In this case, the intervention is specifically targeted at reducing the *incidence* of a particular negative outcome (teenage pregnancy) through education. This fits the definition of prevention, particularly primary prevention. While it *promotes* health by educating, the *objective* stated is prevention. In public health classification, interventions aimed at reducing the *incidence* of a specific health problem are typically categorized under prevention.\n\n6.  **Select the best fit:** Based on the goal of reducing the *incidence* of teenage pregnancy before it occurs, \"Prevención\" (Prevention) is the most accurate classification.\n\n7.  **Final Answer Formulation:** The question asks for the type of health intervention. The intervention aims to reduce the incidence of teenage pregnancy through education. This is a classic example of primary prevention. Therefore, the correct option is B.<unused95>Respuesta final:B",
         "medgemma-27b-text-it",
         "B"
        ],
        [
         "47",
         "Mujer de 32 años, acude por dolor en fosa iliaca derecha desde hace tres días que se ha ido intensificando. Antecedentes \nde hidrosonografía hace 10 días. Examen: T°: 37 °C, FC: 80X'. Tacto vaginal: dolor a la movilización de cérvix, se \nevidencia flujo vaginal con mal olor. Eco TV útero de 7 cm, presencia de líquido en fondo de saco. ¿Cuál es el manejo \nmás adecuado?",
         "Clindamicina + gentamicina",
         "Doxiciclina + ceftriaxona + metronidazol",
         "Doxiciclina + azitromicina",
         "Ceftriaxona + doxiciclina + gentamicina",
         "B",
         "Ninguna de las anteriores",
         "Prueba A",
         "Year2025",
         "2025",
         "Mujer de 32 años, acude por dolor en fosa iliaca derecha desde hace tres días que se ha ido intensificando. Antecedentes \nde hidrosonografía hace 10 días. Examen: T°: 37 °C, FC: 80X'. Tacto vaginal: dolor a la movilización de cérvix, se \nevidencia flujo vaginal con mal olor. Eco TV útero de 7 cm, presencia de líquido en fondo de saco. ¿Cuál es el manejo \nmás adecuado? A) Clindamicina + gentamicina B) Doxiciclina + ceftriaxona + metronidazol C) Doxiciclina + azitromicina D) Ceftriaxona + doxiciclina + gentamicina E) Ninguna de las anteriores",
         "<unused94>thought\n1.  **Analyze the Request:** The user wants me to act as an expert medical assistant trained in Peru and answer a multiple-choice medical question. I need to provide a step-by-step internal thought process, summarize the information, and then give *only* the final letter answer.\n\n2.  **Summarize the Case:**\n    *   **Patient:** 32-year-old female.\n    *   **Presenting Complaint:** Right iliac fossa pain, worsening over 3 days.\n    *   **Relevant History:** Hysterosalpingography (HSG) 10 days ago.\n    *   **Vitals:** Temp 37°C (afebrile), HR 80 bpm (normal).\n    *   **Physical Exam:**\n        *   Vaginal exam: Cervical motion tenderness (CMT).\n        *   Vaginal discharge: Malodorous.\n    *   **Imaging (Transvaginal Ultrasound - TVUS):**\n        *   Uterus: 7 cm (enlarged, normal is ~5-7 cm, but could be within range or slightly enlarged).\n        *   Pouch of Douglas (cul-de-sac): Free fluid.\n\n3.  **Differential Diagnosis based on Symptoms/Signs:**\n    *   **Pelvic Inflammatory Disease (PID):** Right iliac fossa pain, CMT, malodorous discharge, free fluid in the pouch of Douglas. The recent HSG is a significant risk factor (instrumentation can introduce infection). The enlarged uterus could be related to endometritis (part of PID).\n    *   **Appendicitis:** Right iliac fossa pain. However, CMT and malodorous discharge are less typical. Fever is often present but not always.\n    *   **Ectopic Pregnancy:** Right iliac fossa pain, free fluid. However, CMT is less specific, and malodorous discharge is not typical. A pregnancy test would be crucial (not mentioned, but assumed negative or ruled out given the context of PID treatment options).\n    *   **Ovarian Cyst Rupture/Torsion:** Right iliac fossa pain, free fluid. CMT and malodorous discharge are less typical.\n    *   **Endometritis:** Pain, enlarged uterus, free fluid. Often associated with PID.\n    *   **Tubo-ovarian Abscess (TOA):** A complication of PID. Presents with severe pain, often fever, and a palpable mass (not mentioned here).\n\n4.  **Most Likely Diagnosis:** Given the combination of right iliac fossa pain, CMT, malodorous discharge, free fluid, and the recent HSG (a known risk factor for ascending infection), Pelvic Inflammatory Disease (PID) is the most likely diagnosis. The enlarged uterus suggests possible endometritis.\n\n5.  **Evaluate Treatment Options for PID (based on Peruvian/International Guidelines - CDC/WHO):**\n    *   PID is typically polymicrobial, involving *Neisseria gonorrhoeae*, *Chlamydia trachomatis*, anaerobes, and Gram-negative rods.\n    *   Treatment needs to cover these organisms.\n    *   **Outpatient Regimens (for mild-moderate PID):**\n        *   Ceftriaxone (covers *N. gonorrhoeae*) + Doxycycline (covers *C. trachomatis*) +/- Metronidazole (covers anaerobes).\n        *   Cefoxitin or Cefotetan (covers *N. gonorrhoeae*, *C. trachomatis*, and anaerobes) OR Other parenteral 3rd-gen cephalosporin + Doxycycline +/- Metronidazole.\n        *   Azithromycin can sometimes substitute for Doxycycline.\n    *   **Inpatient Regimens (for severe PID, TOA, pregnancy, failure of outpatient therapy):**\n        *   Cefotetan or Cefoxitin PLUS Doxycycline.\n        *   Clindamycin PLUS Gentamicin.\n        *   Ampicillin-Sulbactam PLUS Doxycycline.\n\n6.  **Analyze the Provided Options:**\n    *   **A) Clindamicina + gentamicina:** This is a standard *inpatient* regimen for PID, particularly if TOA is suspected or if there's concern for resistant organisms or allergy to cephalosporins. It covers anaerobes, Gram-negatives, and some Gram-positives.\n    *   **B) Doxiciclina + ceftriaxona + metronidazol:** This is a comprehensive *outpatient* regimen covering *N. gonorrhoeae* (ceftriaxone), *C. trachomatis* (doxycycline), and anaerobes (metronidazole). This is a very common and appropriate regimen for PID.\n    *   **C) Doxiciclina + azitromicina:** This covers *C. trachomatis* (both) and some other atypical organisms. It lacks reliable coverage for *N. gonorrhoeae* and anaerobes. Not a standard PID regimen.\n    *   **D) Ceftriaxona + doxiciclina + gentamicina:** Ceftriaxone + Doxycycline is a standard outpatient regimen. Adding Gentamicin is usually reserved for inpatient, more severe cases or specific situations (like suspected *Pseudomonas* or resistant Gram-negatives), often in combination with Clindamycin. This combination isn't a typical first-line outpatient regimen.\n    *   **E) Ninguna de las anteriores:** Unlikely, as several options represent standard PID treatments.\n\n7.  **Select the Best Option:**\n    *   The patient presents with symptoms suggestive of PID (pain, CMT, discharge, free fluid) following a procedure known to increase risk (HSG).\n    *   The patient is afebrile and hemodynamically stable (T 37°C, FC 80), suggesting mild-to-moderate PID suitable for outpatient management, although the worsening pain and free fluid warrant careful consideration.\n    *   Option B (Doxycycline + Ceftriaxone + Metronidazole) provides broad coverage for the most common pathogens in PID (*N. gonorrhoeae*, *C. trachomatis*, anaerobes) and is a standard outpatient regimen.\n    *   Option A (Clindamycin + Gentamicin) is typically reserved for inpatient management or more severe cases. While potentially effective, it's usually not the first choice for uncomplicated outpatient PID.\n    *   Option D adds Gentamicin to a standard outpatient regimen, which isn't standard practice for initial outpatient treatment.\n    *   Option C lacks adequate coverage for *N. gonorrhoeae* and anaerobes.\n\n8.  **Conclusion:** Option B represents the most appropriate and comprehensive outpatient antibiotic regimen for suspected PID in this clinical scenario, covering the likely pathogens.\n\n9.  **Final Answer Format:** Provide only the letter.<unused95>Respuesta final:B",
         "medgemma-27b-text-it",
         "B"
        ],
        [
         "48",
         "Varón de 32 años, ingresa por pérdida de conciencia de forma brusca acompañado de movimientos tónico clónicos \ngeneralizados; esposo refiere que desde hace 2 días no duerme por problemas familiares y estrés y que nunca ha tenido \nun cuadro similar. Examen: post ictal. Boca: signos de mordedura de lengua. ¿Cuál es la indicación?",
         "Fenitoina",
         "Conducta expectante",
         "Fenobarbital",
         "Valproato de sodio",
         "B",
         "Ninguna de las anteriores",
         "Prueba A",
         "Year2025",
         "2025",
         "Varón de 32 años, ingresa por pérdida de conciencia de forma brusca acompañado de movimientos tónico clónicos \ngeneralizados; esposo refiere que desde hace 2 días no duerme por problemas familiares y estrés y que nunca ha tenido \nun cuadro similar. Examen: post ictal. Boca: signos de mordedura de lengua. ¿Cuál es la indicación? A) Fenitoina B) Conducta expectante C) Fenobarbital D) Valproato de sodio E) Ninguna de las anteriores",
         "<unused94>thought\n1.  **Analyze the Request:** The user wants me to act as an expert medical assistant trained in Peru and answer a multiple-choice medical question. I need to provide a step-by-step internal thought process, summarize the information, and then output *only* the final letter answer.\n\n2.  **Summarize the Case:**\n    *   Patient: 32-year-old male.\n    *   Presentation: Sudden loss of consciousness with generalized tonic-clonic movements.\n    *   History: 2 days of sleep deprivation due to family problems/stress. No prior similar episodes.\n    *   Exam: Post-ictal state. Signs of tongue biting.\n    *   Question: What is the indication (treatment)?\n\n3.  **Identify the Likely Diagnosis:** The clinical presentation (sudden loss of consciousness, generalized tonic-clonic movements, post-ictal state, tongue biting) is highly suggestive of a generalized tonic-clonic seizure (GTCS). The history of sleep deprivation and stress are known triggers for seizures, especially in someone with a potential underlying predisposition or in the context of a first-time seizure. This is likely a *first unprovoked seizure* (although triggered by stress/sleep deprivation, it's the first episode).\n\n4.  **Evaluate the Treatment Options:**\n    *   **A) Fenitoina:** An anticonvulsant commonly used for generalized tonic-clonic seizures and focal seizures. It's a reasonable option for managing seizures.\n    *   **B) Conducta expectante:** This means observation without immediate treatment. While sometimes considered after a *single* unprovoked seizure, especially if the cause is clearly identified and reversible (like here, potentially stress/sleep deprivation), the severity (tonic-clonic, tongue biting) and the potential risk of recurrence often warrant treatment, particularly in the acute setting after a first seizure. However, the question asks for the *indication* (treatment), implying what should be done *now* or shortly after.\n    *   **C) Fenobarbital:** Another anticonvulsant, often used for neonatal seizures or status epilepticus, but less commonly as a first-line agent for a new-onset seizure in an adult compared to others due to side effects (sedation).\n    *   **D) Valproato de sodio:** A broad-spectrum anticonvulsant effective for various seizure types, including generalized tonic-clonic seizures. It's a common first-line option.\n    *   **E) Ninguna de las anteriores:** This is possible if none of the other options are appropriate.\n\n5.  **Determine the Best Indication/Treatment:**\n    *   The patient has had a first generalized tonic-clonic seizure.\n    *   Standard practice after a first unprovoked seizure often involves initiating anticonvulsant therapy to reduce the risk of recurrence, although the decision is individualized based on risk factors (e.g., structural brain lesion, EEG findings, patient preference).\n    *   Given the options, Fenitoina (A) and Valproato de sodio (D) are both appropriate first-line treatments for generalized tonic-clonic seizures.\n    *   Fenobarbital (C) is less commonly used first-line in adults for this presentation.\n    *   Conducta expectante (B) might be considered *long-term* after a single seizure if risk factors are low, but immediate management often involves addressing the acute event and considering prophylaxis. The question asks for the \"indicación,\" which usually implies treatment.\n    *   Between Fenitoina and Valproato, both are valid. However, Fenitoina is a very classic and widely used drug for GTCS. In the context of a multiple-choice question without further differentiating factors, Fenitoina is a strong candidate. Valproato is also a strong candidate.\n    *   Let's re-read the question: \"Cuál es la indicación?\". This implies what treatment is indicated *for this condition* (first GTCS). Both A and D are indicated. Is there a reason to prefer one? Not strongly based on the limited info. However, Fenitoina is a very common choice for GTCS.\n    *   Consider the context of Peru. Both drugs are available and used.\n    *   Let's assume the question is asking for a standard, appropriate treatment for a first GTCS. Both A and D fit. Is there any subtle clue? The presentation is classic GTCS.\n    *   If forced to choose one standard first-line agent for GTCS presented in this way, Fenitoina is a very common and appropriate choice. Valproate is also appropriate, especially if other seizure types were suspected or if the patient was female of childbearing potential (though not relevant here).\n    *   Let's stick with Fenitoina as a highly representative and correct answer for treating a first GTCS.\n\n6.  **Final Answer Selection:** Based on the analysis, Fenitoina (A) is a standard and appropriate indication for treating a first generalized tonic-clonic seizure.<unused95>Respuesta final:A",
         "medgemma-27b-text-it",
         "A"
        ],
        [
         "49",
         "Primigesta de 37 semanas, sin controles prenatales, acude por presentar dolor tipo contracción esporádico. Examen: AU: \n32 cm, SPP: LCI, LCF: 150 X'; Tacto vaginal: D: 0 B: 30% AP: -4. Laboratorio: VIH + y carga viral en 2000 copias/mL. \n¿Cuál es la conducta más adecuada para la vía de parto?",
         "Parto vaginal espontaneo",
         "Cesárea programada",
         "Inducción a las 39 semanas",
         "Parto instrumentado",
         "B",
         "Ninguna de las anteriores",
         "Prueba A",
         "Year2025",
         "2025",
         "Primigesta de 37 semanas, sin controles prenatales, acude por presentar dolor tipo contracción esporádico. Examen: AU: \n32 cm, SPP: LCI, LCF: 150 X'; Tacto vaginal: D: 0 B: 30% AP: -4. Laboratorio: VIH + y carga viral en 2000 copias/mL. \n¿Cuál es la conducta más adecuada para la vía de parto? A) Parto vaginal espontaneo B) Cesárea programada C) Inducción a las 39 semanas D) Parto instrumentado E) Ninguna de las anteriores",
         "<unused94>thought\n1.  **Analyze the Request:** The user wants me to act as an expert medical assistant trained in Peru and answer a multiple-choice medical question. I need to provide a step-by-step internal thought process, summarize the information, and then give *only* the final letter answer.\n\n2.  **Summarize the Case:**\n    *   Patient: Primigesta (first pregnancy).\n    *   Gestational Age: 37 weeks.\n    *   Prenatal Care: None.\n    *   Presenting Symptom: Sporadic contraction-like pain.\n    *   Physical Exam:\n        *   Abdominal Circumference (AU): 32 cm (This seems small for 37 weeks, suggesting possible IUGR or inaccurate dating, but not the primary driver for delivery mode).\n        *   Fetal Presentation (SPP): Longitudinal Cephalic Presentation (LCI).\n        *   Fetal Heart Rate (LCF): 150 bpm (Normal range).\n        *   Vaginal Exam:\n            *   Dilation (D): 0 cm (No dilation).\n            *   Effacement (B): 30% (Some effacement).\n            *   Station (AP): -4 (High station, fetal head is far from the pelvis).\n    *   Laboratory:\n        *   HIV Positive (+).\n        *   Viral Load: 2000 copies/mL (This is a significant viral load).\n\n3.  **Identify the Core Question:** What is the most appropriate mode of delivery for this patient?\n\n4.  **Evaluate the Options based on the Summary:**\n    *   **A) Parto vaginal espontaneo (Spontaneous Vaginal Delivery):** This is generally preferred if no contraindications exist. However, the patient is HIV positive with a significant viral load (2000 copies/mL).\n    *   **B) Cesárea programada (Scheduled Cesarean Section):** Cesarean section is often recommended for HIV-positive pregnant women with a high viral load (typically >1000 copies/mL) near the time of delivery to minimize the risk of vertical transmission to the baby during labor and vaginal delivery. The patient is at 37 weeks, which is near term.\n    *   **C) Inducción a las 39 semanas (Induction at 39 weeks):** Induction might be considered if there were other indications, but the primary concern here is the HIV status and viral load. Delaying delivery to 39 weeks might increase the risk of transmission if the viral load remains high. Also, the patient is already 37 weeks and presenting with symptoms.\n    *   **D) Parto instrumentado (Instrumental Delivery):** This is a type of vaginal delivery (forceps or vacuum) and carries the same risks of vertical transmission as a spontaneous vaginal delivery in this context. It's not the primary mode of delivery planned *before* labor.\n    *   **E) Ninguna de las anteriores (None of the above):** Given the options, one of them is likely appropriate.\n\n5.  **Apply Medical Knowledge (Peruvian Context/General Guidelines):**\n    *   **HIV and Vertical Transmission:** The primary goal is to prevent mother-to-child transmission (MTCT) of HIV.\n    *   **Viral Load Threshold:** A viral load > 1000 copies/mL near delivery significantly increases the risk of MTCT during vaginal delivery.\n    *   **Recommended Management:** For HIV-positive pregnant women with a viral load > 1000 copies/mL at or near term (36-38 weeks), a scheduled cesarean section is generally recommended to reduce MTCT risk, provided the mother is on antiretroviral therapy (ART). Although the case doesn't explicitly state she's on ART, the high viral load suggests either she's not on ART, not adherent, or the ART is not effective. Regardless, the high viral load is the key factor.\n    *   **Gestational Age:** 37 weeks is considered early term. Delivery is often recommended between 38 and 39 weeks for HIV-positive women on effective ART with suppressed viral load, but with a high viral load, delivery might be considered sooner, and cesarean is the preferred mode.\n    *   **Other Factors:** The patient has no dilation, some effacement, and a high station, indicating she is not in active labor. The AU of 32 cm is noted but doesn't change the management regarding the mode of delivery based on HIV status.\n\n6.  **Synthesize and Choose the Best Option:** The patient is HIV positive with a high viral load (2000 copies/mL) at 37 weeks gestation. Standard guidelines recommend a scheduled cesarean section in this situation to minimize the risk of vertical HIV transmission.\n\n7.  **Final Answer Formulation:** Based on the analysis, option B is the most appropriate management. The final output should be just the letter.<unused95>Respuesta final:B",
         "medgemma-27b-text-it",
         "B"
        ]
       ],
       "shape": {
        "columns": 14,
        "rows": 8380
       }
      },
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>questions</th>\n",
       "      <th>option_A</th>\n",
       "      <th>option_B</th>\n",
       "      <th>option_C</th>\n",
       "      <th>option_D</th>\n",
       "      <th>correct_answer</th>\n",
       "      <th>option_E</th>\n",
       "      <th>source_file</th>\n",
       "      <th>source_folder</th>\n",
       "      <th>year</th>\n",
       "      <th>question</th>\n",
       "      <th>answer_llm</th>\n",
       "      <th>model_basename</th>\n",
       "      <th>letra_respuesta</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Varón de 65 años con antecedente de hipertensi...</td>\n",
       "      <td>Labetalol</td>\n",
       "      <td>Hidralazina</td>\n",
       "      <td>Nitroprusiato</td>\n",
       "      <td>Nitroglicerina</td>\n",
       "      <td>C</td>\n",
       "      <td>Ninguna de las anteriores</td>\n",
       "      <td>Prueba A</td>\n",
       "      <td>Year2025</td>\n",
       "      <td>2025</td>\n",
       "      <td>Varón de 65 años con antecedente de hipertensi...</td>\n",
       "      <td>&lt;unused94&gt;thought\\n1.  **Analyze the Request:*...</td>\n",
       "      <td>medgemma-27b-text-it</td>\n",
       "      <td>A</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Mujer de 32 años asintomática que acude por ch...</td>\n",
       "      <td>Solicitar prolactina</td>\n",
       "      <td>Mamografía</td>\n",
       "      <td>Ecografía de mamas</td>\n",
       "      <td>Observación</td>\n",
       "      <td>D</td>\n",
       "      <td>Ninguna de las anteriores</td>\n",
       "      <td>Prueba A</td>\n",
       "      <td>Year2025</td>\n",
       "      <td>2025</td>\n",
       "      <td>Mujer de 32 años asintomática que acude por ch...</td>\n",
       "      <td>&lt;unused94&gt;thought\\n1.  **Analyze the Request:*...</td>\n",
       "      <td>medgemma-27b-text-it</td>\n",
       "      <td>A</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>¿Cuál es el sitio más frecuente de implantació...</td>\n",
       "      <td>Fondo uterino</td>\n",
       "      <td>Segmento inferior del útero</td>\n",
       "      <td>Cérvix uterino</td>\n",
       "      <td>Cuerno uterino</td>\n",
       "      <td>A</td>\n",
       "      <td>Ninguna de las anteriores</td>\n",
       "      <td>Prueba A</td>\n",
       "      <td>Year2025</td>\n",
       "      <td>2025</td>\n",
       "      <td>¿Cuál es el sitio más frecuente de implantació...</td>\n",
       "      <td>&lt;unused94&gt;thought\\n1.  **Identify the core que...</td>\n",
       "      <td>medgemma-27b-text-it</td>\n",
       "      <td>A</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>Varón de 43 años, llevado a urgencias porque s...</td>\n",
       "      <td>Colocación de catéter central</td>\n",
       "      <td>Ventilación no invasiva</td>\n",
       "      <td>Fijación costal quirúrgica</td>\n",
       "      <td>Intubación orotraqueal</td>\n",
       "      <td>D</td>\n",
       "      <td>Ninguna de las anteriores</td>\n",
       "      <td>Prueba A</td>\n",
       "      <td>Year2025</td>\n",
       "      <td>2025</td>\n",
       "      <td>Varón de 43 años, llevado a urgencias porque s...</td>\n",
       "      <td>&lt;unused94&gt;thought\\n1.  **Analyze the Request:*...</td>\n",
       "      <td>medgemma-27b-text-it</td>\n",
       "      <td>D</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>Varón de 27 años, acude a consulta por visión ...</td>\n",
       "      <td>VI</td>\n",
       "      <td>I</td>\n",
       "      <td>III</td>\n",
       "      <td>IV</td>\n",
       "      <td>C</td>\n",
       "      <td>Ninguna de las anteriores</td>\n",
       "      <td>Prueba A</td>\n",
       "      <td>Year2025</td>\n",
       "      <td>2025</td>\n",
       "      <td>Varón de 27 años, acude a consulta por visión ...</td>\n",
       "      <td>&lt;unused94&gt;thought\\n1.  **Analyze the Request:*...</td>\n",
       "      <td>medgemma-27b-text-it</td>\n",
       "      <td>C</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8375</th>\n",
       "      <td>Gestante de 20 años con 10 semanas de embarazo...</td>\n",
       "      <td>Epigastralgia</td>\n",
       "      <td>Meteorismo</td>\n",
       "      <td>Pérdida de peso menor al 5%</td>\n",
       "      <td>Presencia de aliento fétido</td>\n",
       "      <td>E</td>\n",
       "      <td>Alteraciones hidroelectrolíticas</td>\n",
       "      <td>Ginecología y Obstetricia</td>\n",
       "      <td>Year2020</td>\n",
       "      <td>2020</td>\n",
       "      <td>Gestante de 20 años con 10 semanas de embarazo...</td>\n",
       "      <td>&lt;unused94&gt;thought\\n1.  **Analyze the Request:*...</td>\n",
       "      <td>medgemma-27b-text-it</td>\n",
       "      <td>E</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8376</th>\n",
       "      <td>Mujer de 40 años ha tenido 4 partos eutócicos,...</td>\n",
       "      <td>Mola hidatidiforme</td>\n",
       "      <td>Hematometra</td>\n",
       "      <td>Tumor anexial</td>\n",
       "      <td>Miomatosis uterina</td>\n",
       "      <td>A</td>\n",
       "      <td>Embarazo gemelar</td>\n",
       "      <td>Ginecología y Obstetricia</td>\n",
       "      <td>Year2020</td>\n",
       "      <td>2020</td>\n",
       "      <td>Mujer de 40 años ha tenido 4 partos eutócicos,...</td>\n",
       "      <td>&lt;unused94&gt;thought\\nLa usuaria quiere que actúe...</td>\n",
       "      <td>medgemma-27b-text-it</td>\n",
       "      <td>E</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8377</th>\n",
       "      <td>Mujer de 40 años, refiere menstruaciones regul...</td>\n",
       "      <td>Biopsia en sacabocado y curetaje cervical</td>\n",
       "      <td>Histerectomía inmediata y extirpación de</td>\n",
       "      <td>Repetir el frotis de Papanicolaou y control a los</td>\n",
       "      <td>Colposcopía con biopsia</td>\n",
       "      <td>D</td>\n",
       "      <td>Dilatación y legrado fraccionado</td>\n",
       "      <td>Ginecología y Obstetricia</td>\n",
       "      <td>Year2020</td>\n",
       "      <td>2020</td>\n",
       "      <td>Mujer de 40 años, refiere menstruaciones regul...</td>\n",
       "      <td>&lt;unused94&gt;thought\\n1.  **Analyze the Request:*...</td>\n",
       "      <td>medgemma-27b-text-it</td>\n",
       "      <td>D</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8378</th>\n",
       "      <td>De los siguientes exámenes o procedimientos, ¿...</td>\n",
       "      <td>Eco transvaginal</td>\n",
       "      <td>Eco doppler transvaginal</td>\n",
       "      <td>Cultivo de secreción vaginal</td>\n",
       "      <td>Histeroscopía</td>\n",
       "      <td>E</td>\n",
       "      <td>Laparoscopia</td>\n",
       "      <td>Ginecología y Obstetricia</td>\n",
       "      <td>Year2020</td>\n",
       "      <td>2020</td>\n",
       "      <td>De los siguientes exámenes o procedimientos, ¿...</td>\n",
       "      <td>&lt;unused94&gt;thought\\n1.  **Analyze the question:...</td>\n",
       "      <td>medgemma-27b-text-it</td>\n",
       "      <td>E</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8379</th>\n",
       "      <td>Si usted fuera el encargado de determinar que ...</td>\n",
       "      <td>Bloqueo tubárico</td>\n",
       "      <td>DIU</td>\n",
       "      <td>Preservativo</td>\n",
       "      <td>Diafragma</td>\n",
       "      <td>E</td>\n",
       "      <td>Vasectomía</td>\n",
       "      <td>Ginecología y Obstetricia</td>\n",
       "      <td>Year2020</td>\n",
       "      <td>2020</td>\n",
       "      <td>Si usted fuera el encargado de determinar que ...</td>\n",
       "      <td>&lt;unused94&gt;thought\\n1.  **Analyze the Request:*...</td>\n",
       "      <td>medgemma-27b-text-it</td>\n",
       "      <td>E</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>8380 rows × 14 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "                                              questions  \\\n",
       "0     Varón de 65 años con antecedente de hipertensi...   \n",
       "1     Mujer de 32 años asintomática que acude por ch...   \n",
       "2     ¿Cuál es el sitio más frecuente de implantació...   \n",
       "3     Varón de 43 años, llevado a urgencias porque s...   \n",
       "4     Varón de 27 años, acude a consulta por visión ...   \n",
       "...                                                 ...   \n",
       "8375  Gestante de 20 años con 10 semanas de embarazo...   \n",
       "8376  Mujer de 40 años ha tenido 4 partos eutócicos,...   \n",
       "8377  Mujer de 40 años, refiere menstruaciones regul...   \n",
       "8378  De los siguientes exámenes o procedimientos, ¿...   \n",
       "8379  Si usted fuera el encargado de determinar que ...   \n",
       "\n",
       "                                       option_A  \\\n",
       "0                                     Labetalol   \n",
       "1                          Solicitar prolactina   \n",
       "2                                 Fondo uterino   \n",
       "3                 Colocación de catéter central   \n",
       "4                                            VI   \n",
       "...                                         ...   \n",
       "8375                              Epigastralgia   \n",
       "8376                         Mola hidatidiforme   \n",
       "8377  Biopsia en sacabocado y curetaje cervical   \n",
       "8378                           Eco transvaginal   \n",
       "8379                           Bloqueo tubárico   \n",
       "\n",
       "                                      option_B  \\\n",
       "0                                  Hidralazina   \n",
       "1                                   Mamografía   \n",
       "2                  Segmento inferior del útero   \n",
       "3                      Ventilación no invasiva   \n",
       "4                                            I   \n",
       "...                                        ...   \n",
       "8375                                Meteorismo   \n",
       "8376                               Hematometra   \n",
       "8377  Histerectomía inmediata y extirpación de   \n",
       "8378                  Eco doppler transvaginal   \n",
       "8379                                       DIU   \n",
       "\n",
       "                                               option_C  \\\n",
       "0                                         Nitroprusiato   \n",
       "1                                    Ecografía de mamas   \n",
       "2                                        Cérvix uterino   \n",
       "3                            Fijación costal quirúrgica   \n",
       "4                                                   III   \n",
       "...                                                 ...   \n",
       "8375                        Pérdida de peso menor al 5%   \n",
       "8376                                      Tumor anexial   \n",
       "8377  Repetir el frotis de Papanicolaou y control a los   \n",
       "8378                       Cultivo de secreción vaginal   \n",
       "8379                                       Preservativo   \n",
       "\n",
       "                         option_D correct_answer  \\\n",
       "0                  Nitroglicerina              C   \n",
       "1                     Observación              D   \n",
       "2                  Cuerno uterino              A   \n",
       "3          Intubación orotraqueal              D   \n",
       "4                              IV              C   \n",
       "...                           ...            ...   \n",
       "8375  Presencia de aliento fétido              E   \n",
       "8376           Miomatosis uterina              A   \n",
       "8377      Colposcopía con biopsia              D   \n",
       "8378                Histeroscopía              E   \n",
       "8379                    Diafragma              E   \n",
       "\n",
       "                              option_E                 source_file  \\\n",
       "0            Ninguna de las anteriores                    Prueba A   \n",
       "1            Ninguna de las anteriores                    Prueba A   \n",
       "2            Ninguna de las anteriores                    Prueba A   \n",
       "3            Ninguna de las anteriores                    Prueba A   \n",
       "4            Ninguna de las anteriores                    Prueba A   \n",
       "...                                ...                         ...   \n",
       "8375  Alteraciones hidroelectrolíticas  Ginecología y Obstetricia   \n",
       "8376                  Embarazo gemelar  Ginecología y Obstetricia   \n",
       "8377  Dilatación y legrado fraccionado  Ginecología y Obstetricia   \n",
       "8378                      Laparoscopia  Ginecología y Obstetricia   \n",
       "8379                        Vasectomía  Ginecología y Obstetricia   \n",
       "\n",
       "     source_folder  year                                           question  \\\n",
       "0         Year2025  2025  Varón de 65 años con antecedente de hipertensi...   \n",
       "1         Year2025  2025  Mujer de 32 años asintomática que acude por ch...   \n",
       "2         Year2025  2025  ¿Cuál es el sitio más frecuente de implantació...   \n",
       "3         Year2025  2025  Varón de 43 años, llevado a urgencias porque s...   \n",
       "4         Year2025  2025  Varón de 27 años, acude a consulta por visión ...   \n",
       "...            ...   ...                                                ...   \n",
       "8375      Year2020  2020  Gestante de 20 años con 10 semanas de embarazo...   \n",
       "8376      Year2020  2020  Mujer de 40 años ha tenido 4 partos eutócicos,...   \n",
       "8377      Year2020  2020  Mujer de 40 años, refiere menstruaciones regul...   \n",
       "8378      Year2020  2020  De los siguientes exámenes o procedimientos, ¿...   \n",
       "8379      Year2020  2020  Si usted fuera el encargado de determinar que ...   \n",
       "\n",
       "                                             answer_llm        model_basename  \\\n",
       "0     <unused94>thought\\n1.  **Analyze the Request:*...  medgemma-27b-text-it   \n",
       "1     <unused94>thought\\n1.  **Analyze the Request:*...  medgemma-27b-text-it   \n",
       "2     <unused94>thought\\n1.  **Identify the core que...  medgemma-27b-text-it   \n",
       "3     <unused94>thought\\n1.  **Analyze the Request:*...  medgemma-27b-text-it   \n",
       "4     <unused94>thought\\n1.  **Analyze the Request:*...  medgemma-27b-text-it   \n",
       "...                                                 ...                   ...   \n",
       "8375  <unused94>thought\\n1.  **Analyze the Request:*...  medgemma-27b-text-it   \n",
       "8376  <unused94>thought\\nLa usuaria quiere que actúe...  medgemma-27b-text-it   \n",
       "8377  <unused94>thought\\n1.  **Analyze the Request:*...  medgemma-27b-text-it   \n",
       "8378  <unused94>thought\\n1.  **Analyze the question:...  medgemma-27b-text-it   \n",
       "8379  <unused94>thought\\n1.  **Analyze the Request:*...  medgemma-27b-text-it   \n",
       "\n",
       "     letra_respuesta  \n",
       "0                  A  \n",
       "1                  A  \n",
       "2                  A  \n",
       "3                  D  \n",
       "4                  C  \n",
       "...              ...  \n",
       "8375               E  \n",
       "8376               E  \n",
       "8377               D  \n",
       "8378               E  \n",
       "8379               E  \n",
       "\n",
       "[8380 rows x 14 columns]"
      ]
     },
     "execution_count": 3,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# df['letra_respuesta'] = df['answer_llm'].str.extract(r'Respuesta final: ([ABCDE])')\n",
    "# df['letra_respuesta'] = df['answer_llm'].str.extract(r'Respuesta final:\\(?([ABCDE])\\)?')\n",
    "df['letra_respuesta'] = df['answer_llm'].str.extract(r'Respuesta final:\\s?\\(?([ABCDE])\\)?')\n",
    "df"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "id": "3e80e2e4",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "application/vnd.microsoft.datawrangler.viewer.v0+json": {
       "columns": [
        {
         "name": "letra_respuesta",
         "rawType": "object",
         "type": "unknown"
        },
        {
         "name": "count",
         "rawType": "int64",
         "type": "integer"
        }
       ],
       "ref": "561cf8c7-283a-469d-9248-5cad79f4405d",
       "rows": [
        [
         "A",
         "1896"
        ],
        [
         "C",
         "1886"
        ],
        [
         "B",
         "1873"
        ],
        [
         "D",
         "1790"
        ],
        [
         "E",
         "933"
        ],
        [
         null,
         "2"
        ]
       ],
       "shape": {
        "columns": 1,
        "rows": 6
       }
      },
      "text/plain": [
       "letra_respuesta\n",
       "A      1896\n",
       "C      1886\n",
       "B      1873\n",
       "D      1790\n",
       "E       933\n",
       "NaN       2\n",
       "Name: count, dtype: int64"
      ]
     },
     "execution_count": 4,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df['letra_respuesta'].value_counts(dropna = False)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "id": "77ed3ea4",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "application/vnd.microsoft.datawrangler.viewer.v0+json": {
       "columns": [
        {
         "name": "index",
         "rawType": "int64",
         "type": "integer"
        },
        {
         "name": "question",
         "rawType": "object",
         "type": "string"
        },
        {
         "name": "answer_llm",
         "rawType": "object",
         "type": "string"
        },
        {
         "name": "letra_respuesta",
         "rawType": "object",
         "type": "unknown"
        }
       ],
       "ref": "5402ab18-9db2-4f73-8035-463407da09a9",
       "rows": [
        [
         "2404",
         "Gestante de 36 semanas, tiene accidente automovilístico, familiar no refiere antecedentes patológicos. Es llevada a \nemergencia, presentado laceraciones de pierna, pulso filiforme, trauma en tórax y abdomen, palidez marcada, llenado \ncapilar de 4 segundos, FR 24X', FCF 120 X'. ¿Cuál es el puntaje de índice de gravedad del trauma? A) 36 B) 32 C) 30 D) 25 E) 45",
         "<unused94>thought\n1.  **Identify the core task:** Calculate the Trauma Severity Index (TSI) for a pregnant patient involved in a car accident.\n\n2.  **Recall/Look up the TSI scoring system:** The TSI is a scoring system used in trauma assessment, particularly in emergency settings. It assigns points based on various physiological and anatomical parameters. The specific parameters and their points are crucial. I need to find the standard TSI scoring table.\n\n    *   **Physiological Parameters (Vital Signs):**\n        *   Blood Pressure (Systolic):\n            *   >90 mmHg: 0 points\n            *   76-90 mmHg: 1 point\n            *   61-75 mmHg: 2 points\n            *   46-60 mmHg: 3 points\n            *   <46 mmHg: 4 points\n        *   Heart Rate (Pulse):\n            *   <100 bpm: 0 points\n            *   100-120 bpm: 1 point\n            *   121-140 bpm: 2 points\n            *   141-160 bpm: 3 points\n            *   >160 bpm: 4 points\n        *   Respiratory Rate (FR):\n            *   <24 breaths/min: 0 points\n            *   24-34 breaths/min: 1 point\n            *   35-44 breaths/min: 2 points\n            *   45-54 breaths/min: 3 points\n            *   >54 breaths/min: 4 points\n        *   Temperature: (Not provided in the question, so cannot be scored)\n        *   Capillary Refill (Llenado Capilar):\n            *   <2 seconds: 0 points\n            *   2-3 seconds: 1 point\n            *   3-4 seconds: 2 points\n            *   >4 seconds: 3 points\n        *   Glasgow Coma Scale (GCS): (Not provided, assume 15 unless otherwise stated, but not relevant for TSI calculation as it's usually for head injury)\n\n    *   **Anatomical Parameters (Injury Severity):**\n        *   Head: (Not specified, assume 0)\n        *   Neck: (Not specified, assume 0)\n        *   Thorax: (Trauma en tórax mentioned) - Score depends on severity (e.g., simple rib fracture = 1, hemothorax = 2, etc.). The question just says \"trauma en tórax\". Let's assume a moderate injury like a simple fracture or contusion = 1 point.\n        *   Abdomen: (Trauma en abdomen mentioned) - Score depends on severity (e.g., contusion = 1, organ injury = 2, etc.). Let's assume a contusion or minor injury = 1 point.\n        *   Extremities: (Laceraciones de pierna mentioned) - Score depends on severity (e.g., simple laceration = 1, complex fracture = 2, etc.). Let's assume a simple laceration = 1 point.\n        *   Pelvis: (Not specified, assume 0)\n        *   Spine: (Not specified, assume 0)\n\n    *   **Special Considerations (Pregnancy):** The TSI often includes points for pregnancy itself, especially if complications arise. However, the standard TSI might not explicitly add points just for being pregnant unless there's evidence of fetal distress or placental abruption. The FCF (Fetal Cardiac Frequency) is 120 bpm, which is within the normal range (110-160 bpm), suggesting no immediate fetal distress *based on this single value*.\n\n3.  **Apply the scoring to the patient's data:**\n    *   **Systolic BP:** Not given. Assume >90 mmHg (0 points) as the patient is conscious and being transported, but this is a major assumption. *Correction:* The description \"pulso filiforme\" and \"palidez marcada\" strongly suggests shock/hypovolemia, implying low BP. Let's re-evaluate. A filiform pulse usually indicates very low BP. Let's assume Systolic BP is between 61-75 mmHg (2 points) or even lower (3 or 4 points). Given the other signs, 2 points seems a reasonable minimum estimate.\n    *   **Heart Rate (Pulse):** Not given explicitly, but \"pulso filiforme\" implies a rapid, weak pulse. Let's assume it's >120 bpm (2 points).\n    *   **Respiratory Rate (FR):** 24 breaths/min. This falls into the 24-34 range (1 point).\n    *   **Capillary Refill:** 4 seconds. This falls into the >4 seconds range (3 points).\n    *   **Thorax:** Trauma en tórax (1 point - assuming moderate injury).\n    *   **Abdomen:** Trauma en abdomen (1 point - assuming moderate injury).\n    *   **Extremities:** Laceraciones de pierna (1 point - assuming simple laceration).\n\n4.  **Calculate the total TSI score:**\n    *   BP: 2 points (estimated)\n    *   Pulse: 2 points (estimated)\n    *   FR: 1 point\n    *   Capillary Refill: 3 points\n    *   Thorax: 1 point\n    *   Abdomen: 1 point\n    *   Extremities: 1 point\n    *   **Total = 2 + 2 + 1 + 3 + 1 + 1 + 1 = 11 points**\n\n5.  **Re-evaluate assumptions and scoring:** The calculated score (11) is very low compared to the options (30, 32, 36, 45). This suggests my assumptions about the severity of injuries or vital signs might be too conservative, or I'm missing something in the TSI calculation.\n\n    *   **BP:** \"Pulso filiforme\" and \"palidez marcada\" strongly suggest significant shock. A systolic BP < 75 mmHg (2 points) or even < 60 mmHg (3 points) is highly likely. Let's try 3 points for BP.\n    *   **Pulse:** \"Pulso filiforme\" implies tachycardia. Let's assume >140 bpm (3 points).\n    *   **FR:** 24 breaths/min (1 point) - This seems correct.\n    *   **Capillary Refill:** 4 seconds (3 points) - This seems correct.\n    *   **Thorax:** \"Trauma en tórax\" - Could be more severe than a simple fracture. If it's a significant contusion or hemothorax, it could be 2 points. Let's try 2 points.\n    *   **Abdomen:** \"Trauma en abdomen\" - Could be more severe. If there's internal bleeding or organ injury, it could be 2 points. Let's try 2 points.\n    *   **Extremities:** \"Laceraciones de pierna\" - Could be deep or involve underlying structures. Let's keep it at 1 point for now.\n\n6.  **Recalculate with revised assumptions:**\n    *   BP: 3 points\n    *   Pulse: 3 points\n    *   FR: 1 point\n    *   Capillary Refill: 3 points\n    *   Thorax: 2 points\n    *   Abdomen: 2 points\n    *   Extremities: 1 point\n    *   **Total = 3 + 3 + 1 + 3 + 2 + 2 + 1 = 15 points**\n\n7.  **Further Re-evaluation:** Still too low. Let's consider the possibility that the question implies a more severe state than explicitly stated, or that the TSI scoring used in Peru might differ slightly, or that the options provided are based on a different scale or interpretation.\n\n    *   Let's look at the options: 25, 30, 32, 36, 45. These are significantly higher.\n    *   What if the BP was even lower? <46 mmHg (4 points).\n    *   What if the pulse was even higher? >160 bpm (4 points).\n    *   What if the thoracic and abdominal trauma were more severe? (e.g., 2 points each).\n    *   What if the laceration was more severe? (e.g., 2 points).\n\n8.  **Recalculate with maximum plausible severity:**\n    *   BP: 4 points (<46 mmHg)\n    *   Pulse: 4 points (>160 bpm)\n    *   FR: 1 point (24 breaths/min)\n    *   Capillary Refill: 3 points (>4 seconds)\n    *   Thorax: 2 points (Significant injury)\n    *   Abdomen: 2 points (Significant injury)\n    *   Extremities: 1 point (Laceration)\n    *   **Total = 4 + 4 + 1 + 3 + 2 + 2 + 1 = 17 points**\n\n9.  **Consider alternative TSI scales or interpretations:** Some trauma scores combine elements or have different point values. The ATLS (Advanced Trauma Life Support) approach focuses on ABCDEs and resuscitation, but uses scores like GCS, ISS (Injury Severity Score), and RTS (Revised Trauma Score). The TSI is less commonly cited globally than RTS or ISS. Perhaps the question refers to a specific local protocol or a slightly different version of TSI.\n\n10. **Revisit the provided data and options:**\n    *   Patient is clearly in shock (palidez, pulso filiforme, llenado capilar 4 seg).\n    *   Multiple significant traumas (thorax, abdomen, leg).\n    *   Pregnancy adds complexity.\n    *   The options are relatively high (25-45).\n\n11. **Let's try to reach one of the options:**\n    *   To get 25: Need 14 more points.\n    *   To get 30: Need 19 more points.\n    *   To get 32: Need 21 more points.\n    *   To get 36: Need 25 more points.\n    *   To get 45: Need 34 more points.\n\n    *   Let's assume the BP is 76-90 (1 pt), Pulse 121-140 (2 pts), FR 1 pt, Cap Refill 3 pts, Thorax 2 pts, Abdomen 2 pts, Extremity 1 pt. Total = 1+2+1+3+2+2+1 = 12. Still low.\n\n    *   Let's assume the BP is 61-75 (2 pts), Pulse 121-140 (2 pts), FR 1 pt, Cap Refill 3 pts, Thorax 2 pts, Abdomen 2 pts, Extremity 1 pt. Total = 2+2+1+3+2+2+1 = 13. Still low.\n\n    *   Let's assume the BP is 61-75 (2 pts), Pulse 141-160 (3 pts), FR 1 pt, Cap Refill 3 pts, Thorax 2 pts, Abdomen 2 pts, Extremity 1 pt. Total = 2+3+1+3+2+2+1 = 14. Still low.\n\n    *   Let's assume the BP is 61-75 (2 pts), Pulse >160 (4 pts), FR 1 pt, Cap Refill 3 pts, Thorax 2 pts, Abdomen 2 pts, Extremity 1 pt. Total = 2+4+1+3+2+2+1 = 15. Still low.\n\n    *   Let's assume the BP is <60 (3 pts), Pulse >160 (4 pts), FR 1 pt, Cap Refill 3 pts, Thorax 2 pts, Abdomen 2 pts, Extremity 1 pt. Total = 3+4+1+3+2+2+1 = 16. Still low.\n\n    *   Let's assume the BP is <46 (4 pts), Pulse >160 (4 pts), FR 1 pt, Cap Refill 3 pts, Thorax 2 pts, Abdomen 2 pts, Extremity 1 pt. Total = 4+4+1+3+2+2+1 = 17. Still low.\n\n    *   What if the Thorax and Abdomen are *very* severe? (e.g., 3 points each).\n        *   BP: 4 pts, Pulse: 4 pts, FR: 1 pt, Cap Refill: 3 pts, Thorax: 3 pts, Abdomen: 3 pts, Extremity: 1 pt. Total = 4+4+1+3+3+3+1 = 19. Still low.\n\n    *   What if the Extremity is also severe? (e.g., 2 points).\n        *   BP: 4 pts, Pulse: 4 pts, FR: 1 pt, Cap Refill: 3 pts, Thorax: 3 pts, Abdomen: 3 pts, Extremity: 2 pt. Total = 4+4+1+3+3+3+2 = 20. Still low.\n\n    *   There seems to be a discrepancy between the standard TSI scoring and the options provided, given the clinical description. The patient is clearly severely injured and in shock.\n\n    *   Let's reconsider the possibility of a different scoring system or a specific interpretation used in Peru. However, without that specific information, I must rely on the standard TSI.\n\n    *   Could the FCF be relevant? FCF 120 is normal. It doesn't add points.\n\n    *   Let's re-examine the options and the clinical picture. The patient is critically ill. A score of 25 or 30 seems more plausible than 11-20.\n\n    *   Let's try to work backward from the options. If the answer is 30 (Option C), what combination of scores would yield 30?\n        *   BP (4) + Pulse (4) + FR (1) + Cap Refill (3) + Thorax (3) + Abdomen (3) + Extremity (2) = 20.\n        *   BP (4) + Pulse (4) + FR (1) + Cap Refill (3) + Thorax (3) + Abdomen (3) + Extremity (1) = 19.\n        *   BP (4) + Pulse (4) + FR (2) + Cap Refill (3) + Thorax (3) + Abdomen (3) + Extremity (1) = 20.\n        *   BP (4) + Pulse (4) + FR (3) + Cap Refill (3) + Thorax (3) + Abdomen (3) + Extremity (1) = 21.\n        *   BP (4) + Pulse (4) + FR (4) + Cap Refill (3) + Thorax (3) + Abdomen (3) + Extremity (1) = 22.\n        *   BP (4) + Pulse (4) + FR (1) + Cap Refill (3) + Thorax (3) + Abdomen (3) + Extremity (2) = 20.\n        *   BP (4) + Pulse (4) + FR (1) + Cap Refill (3) + Thorax (3) + Abdomen (3) + Extremity (2) = 20.\n\n    *   Let's assume the BP is 61-75 (2 pts), Pulse 141-160 (3 pts), FR 35-44 (2 pts), Cap Refill 3-4 (2 pts), Thorax 2 pts, Abdomen 2 pts, Extremity 1 pt. Total = 2+3+2+2+2+2+1 = 14.\n\n    *   Let's assume the BP is 61-75 (2 pts), Pulse >160 (4 pts), FR 35-44 (2 pts), Cap Refill >4 (3 pts), Thorax 2 pts, Abdomen 2 pts, Extremity 1 pt. Total = 2+4+2+3+2+2+1 = 16.\n\n    *   Let's assume the BP is <60 (3 pts), Pulse >160 (4 pts), FR 35-44 (2 pts), Cap Refill >4 (3 pts), Thorax 2 pts, Abdomen 2 pts, Extremity 1 pt. Total = 3+4+2+3+2+2+1 = 17.\n\n    *   Let's assume the BP is <46 (4 pts), Pulse >160 (4 pts), FR 35-44 (2 pts), Cap Refill >4 (3 pts), Thorax 2 pts, Abdomen 2 pts, Extremity 1 pt. Total = 4+4+2+3+2+2+1 = 18.\n\n    *   Let's assume the BP is <46 (4 pts), Pulse >160 (4 pts), FR 45-54 (3 pts), Cap Refill >4 (3 pts), Thorax 2 pts, Abdomen 2 pts, Extremity 1 pt. Total = 4+4+3+3+2+2+1 = 19.\n\n    *   Let's assume the BP is <46 (4 pts), Pulse >160 (4 pts), FR >54 (4 pts), Cap Refill >4 (3 pts), Thorax 2 pts, Abdomen 2 pts, Extremity 1 pt. Total = 4+4+4+3+2+2+1 = 20.\n\n    *   Let's assume the BP is <46 (4 pts), Pulse >160 (4 pts), FR 35-44 (2 pts), Cap Refill >4 (3 pts), Thorax 3 pts, Abdomen 3 pts, Extremity 1 pt. Total = 4+4+2+3+3+3+1 = 20.\n\n    *   Let's assume the BP is <46 (4 pts), Pulse >160 (4 pts), FR 35-44 (2 pts), Cap Refill >4 (3 pts), Thorax 3 pts, Abdomen 3 pts, Extremity 2 pts. Total = 4+4+2+3+3+3+2 = 21.\n\n    *   Let's assume the BP is <46 (4 pts), Pulse >160 (4 pts), FR 45-54 (3 pts), Cap Refill >4 (3 pts), Thorax 3 pts, Abdomen 3 pts, Extremity 1 pt. Total = 4+4+3+3+3+3+1 = 21.\n\n    *   Let's assume the BP is <46 (4 pts), Pulse >160 (4 pts), FR 45-54 (3 pts), Cap Refill >4 (3 pts), Thorax 3 pts, Abdomen 3 pts, Extremity 2 pts. Total = 4+4+3+3+3+3+2 = 22.\n\n    *   Let's assume the BP is <46 (4 pts), Pulse >160 (4 pts), FR >54 (4 pts), Cap Refill >4 (3 pts), Thorax 3 pts, Abdomen 3 pts, Extremity 1 pt. Total = 4+4+4+3+3+3+1 = 22.\n\n    *   Let's assume the BP is <46 (4 pts), Pulse >160 (4 pts), FR >54 (4 pts), Cap Refill >4 (3 pts), Thorax 3 pts, Abdomen 3 pts, Extremity 2 pts. Total = 4+4+4+3+3+3+2 = 23.\n\n    *   Let's assume the BP is <46 (4 pts), Pulse >160 (4 pts), FR >54 (4 pts), Cap Refill >4 (3 pts), Thorax 3 pts, Abdomen 3 pts, Extremity 2 pts. Total = 4+4+4+3+3+3+2 = 23.\n\n    *   Let's assume the BP is <46 (4 pts), Pulse >160 (4 pts), FR >54 (4 pts), Cap Refill >4 (3 pts), Thorax 3 pts, Abdomen 3 pts, Extremity 2 pts. Total = 4+4+4+3+3+3+2 = 23.\n\n    *   Let's assume the BP is <46 (4 pts), Pulse >160 (4 pts), FR >54 (4 pts), Cap Refill >4 (3 pts), Thorax 3 pts, Abdomen 3 pts, Extremity 2 pts. Total = 4+4+4+3+3+3+2 = 23.\n\n    *   Let's assume the BP is <46 (4 pts), Pulse >160 (4 pts), FR >54 (4 pts), Cap Refill >4 (3 pts), Thorax 3 pts, Abdomen 3 pts, Extremity 2 pts. Total = 4+4+4+3+3+3+2 = 23.\n\n    *   Let's assume the BP is <46 (4 pts), Pulse >160 (4 pts), FR >54 (4 pts), Cap Refill >4 (3 pts), Thorax 3 pts, Abdomen 3 pts, Extremity 2 pts. Total = 4+4+4+3+3+3+2 = 23.\n\n    *   Let's assume the BP is <46 (4 pts), Pulse >160 (4 pts), FR >54 (4 pts), Cap Refill >4 (3 pts), Thorax 3 pts, Abdomen 3 pts, Extremity 2 pts. Total = 4+4+4+3+3+3+2 = 23.\n\n    *   Let's assume the BP is <46 (4 pts), Pulse >160 (4 pts), FR >54 (4 pts), Cap Refill >4 (3 pts), Thorax 3 pts, Abdomen 3 pts, Extremity 2 pts. Total = 4+4+4+3+3+3+2 = 23.\n\n    *   Let's assume the BP is <46 (4 pts), Pulse >160 (4 pts), FR >54 (4 pts), Cap Refill >4 (3 pts), Thorax 3 pts, Abdomen 3 pts, Extremity 2 pts. Total = 4+4+4+3+3+3+2 = 23.\n\n    *   Let's assume the BP is <46 (4 pts), Pulse >160 (4 pts), FR >54 (4 pts), Cap Refill >4 (3 pts), Thorax 3 pts, Abdomen 3 pts, Extremity 2 pts. Total = 4+4+4+3+3+3+2 = 23.\n\n    *   Let's assume the BP is <46 (4 pts), Pulse >160 (4 pts), FR >54 (4 pts), Cap Refill >4 (3 pts), Thorax 3 pts, Abdomen 3 pts, Extremity 2 pts. Total = 4+4+4+3+3+3+2 = 23.\n\n    *   Let's assume the BP is <46 (4 pts), Pulse >160 (4 pts), FR >54 (4 pts), Cap Refill >4 (3 pts), Thorax 3 pts, Abdomen 3 pts, Extremity 2 pts. Total = 4+4+4+3+3+3+2 = 23.\n\n    *   Let's assume the BP is <46 (4 pts), Pulse >160 (4 pts), FR >54 (4 pts), Cap Refill >4 (3 pts), Thorax 3 pts, Abdomen 3 pts, Extremity 2 pts. Total = 4+4+4+3+3+3+2 = 23.\n\n    *   Let's assume the BP is <46 (4 pts), Pulse >160 (4 pts), FR >54 (4 pts), Cap Refill >4 (3 pts), Thorax 3 pts, Abdomen 3 pts, Extremity 2 pts. Total = 4+4+4+3+3+3+2 = 23.\n\n    *   Let's assume the BP is <46 (4 pts), Pulse >160 (4 pts), FR >54 (4 pts), Cap Refill >4 (3 pts), Thorax 3 pts, Abdomen 3 pts, Extremity 2 pts. Total = 4+4+4+3+3+3+2 = 23.\n\n    *   Let's assume the BP is <46 (4 pts), Pulse >160 (4 pts), FR >54 (4 pts), Cap Refill >4 (3 pts), Thorax 3 pts, Abdomen 3 pts, Extremity 2 pts. Total = 4+4+4+3+3+3+2 = 23.\n\n    *   Let's assume the BP is <46 (4 pts), Pulse >160 (4 pts), FR >54 (4 pts), Cap Refill >4 (3 pts), Thorax 3 pts, Abdomen 3 pts, Extremity 2 pts. Total = 4+4+4+3+3+3+2 = 23.\n\n    *   Let's assume the BP is <46 (4 pts), Pulse >160 (4 pts), FR >54 (4 pts), Cap Refill >4 (3 pts), Thorax 3 pts, Abdomen 3 pts, Extremity 2 pts. Total = 4+4+4+3+3+3+2 = 23.\n\n    *   Let's assume the BP is <46 (4 pts), Pulse >160 (4 pts), FR >54 (4 pts), Cap Refill >4 (3 pts), Thorax 3 pts, Abdomen 3 pts, Extremity 2 pts. Total = 4+4+4+3+3+3+2 = 23.\n\n    *   Let's assume the BP is <46 (4 pts), Pulse >160 (4 pts), FR >54 (4 pts), Cap Refill >4 (3 pts), Thorax 3 pts, Abdomen 3 pts, Extremity 2 pts. Total = 4+4+4+3+3+3+2 = 23.\n\n    *   Let's assume the BP is <46 (4 pts), Pulse >160 (4 pts), FR >54 (4 pts), Cap Refill >4 (3 pts), Thorax 3 pts, Abdomen 3 pts, Extremity 2 pts. Total = 4+4+4+3+3+3+2 = 23.\n\n    *   Let's assume the BP is <46 (4 pts), Pulse >160 (4 pts), FR >54 (4 pts), Cap Refill >4 (3 pts), Thorax 3 pts, Abdomen 3 pts, Extremity 2 pts. Total = 4+4+4+3+3+3+2 = 23.\n\n    *   Let's assume the BP is <46 (4 pts), Pulse >160 (4 pts), FR >54 (4 pts), Cap Refill >4 (3 pts), Thorax 3 pts, Abdomen 3 pts, Extremity 2 pts. Total = 4+4+4+3+3+3+2 = 23.\n\n    *   Let's assume the BP is <46 (4 pts), Pulse >160 (4 pts), FR >54 (4 pts), Cap Refill >4 (3 pts), Thorax 3 pts, Abdomen 3 pts, Extremity 2 pts. Total = 4+4+4+3+3+3+2 = 23.\n\n    *   Let's assume the BP is <46 (4 pts), Pulse >160 (4 pts), FR >54 (4 pts), Cap Refill >4 (3 pts), Thorax 3 pts, Abdomen 3 pts, Extremity 2 pts. Total = 4+4+4+3+3+3+2 = 23.\n\n    *   Let's assume the BP is <46 (4 pts), Pulse >160 (4 pts), FR >54 (4 pts), Cap Refill >4 (3 pts), Thorax 3 pts, Abdomen 3 pts, Extremity 2 pts. Total = 4+4+4+3+3+3+2 = 23.\n\n    *   Let's assume the BP is <46 (4 pts), Pulse >160 (4 pts), FR >54 (4 pts), Cap Refill >4 (3 pts), Thorax 3 pts, Abdomen 3 pts, Extremity 2 pts. Total = 4+4+4+3+3+3+2 = 23.\n\n    *   Let's assume the BP is <46 (4 pts), Pulse >160 (4 pts), FR >54 (4 pts), Cap Refill >4 (3 pts), Thorax 3 pts, Abdomen 3 pts, Extremity 2 pts. Total = 4+4+4+3+3+3+2 = 23.\n\n    *   Let's assume the BP is <46 (4 pts), Pulse >160 (4 pts), FR >54 (4 pts), Cap Refill >4 (3 pts), Thorax 3 pts, Abdomen 3 pts, Extremity 2 pts. Total = 4+4+4+3+3+3+2 = 23.\n\n    *   Let's assume the BP is <46 (4 pts), Pulse >160 (4 pts), FR >54 (4 pts), Cap Refill >4 (3 pts), Thorax 3 pts, Abdomen 3 pts, Extremity 2 pts. Total = 4+4+4+3+3+3+2 = 23.\n\n    *   Let's assume the BP is <46 (4 pts), Pulse >160 (4 pts), FR >54 (4 pts), Cap Refill >4 (3 pts), Thorax 3 pts, Abdomen 3 pts, Extremity 2 pts. Total = 4+4+4+3+3+3+2 = 23.\n\n    *   Let's assume the BP is <46 (4 pts), Pulse >160 (4 pts), FR >54 (4 pts), Cap Refill >4 (3 pts), Thorax 3 pts, Abdomen 3 pts, Extremity 2 pts. Total = 4+4+4+3+3+3+2 = 23.\n\n    *   Let's assume the BP is <46 (4 pts), Pulse >160 (4 pts), FR >54 (4 pts), Cap Refill >4 (3 pts), Thorax 3 pts, Abdomen 3 pts, Extremity 2 pts. Total = 4+4+4+3+3+3+2 = 23.\n\n    *   Let's assume the BP is <46 (4 pts), Pulse >160 (4 pts), FR >54 (4 pts), Cap Refill >4 (3 pts), Thorax 3 pts, Abdomen 3 pts, Extremity 2 pts. Total = 4+4+4+3+3+3+2 = 23.\n\n    *   Let's assume the BP is <46 (4 pts), Pulse >160 (4 pts), FR >54 (4 pts), Cap Refill >4 (3 pts), Thorax 3 pts, Abdomen 3 pts, Extremity 2 pts. Total = 4+4+4+3+3+3+2 = 23.\n\n    *   Let's assume the BP is <46 (4 pts), Pulse >160 (4 pts), FR >54 (4 pts), Cap Refill >4 (3 pts), Thorax 3 pts, Abdomen 3 pts, Extremity 2 pts. Total = 4+4+4+3+3+3+2 = 23.\n\n    *   Let's assume the BP is <46 (4 pts), Pulse >160 (4 pts), FR >54 (4 pts), Cap Refill >4 (3 pts), Thorax 3 pts, Abdomen 3 pts, Extremity 2 pts. Total = 4+4+4+3+3+3+2 = 23.\n\n    *   Let's assume the BP is <46 (4 pts), Pulse >160 (4 pts), FR >54 (4 pts), Cap Refill >4 (3 pts), Thorax 3 pts, Abdomen 3 pts, Extremity 2 pts. Total = 4+4+4+3+3+3+2 = 23.\n\n    *   Let's assume the BP is <46 (4 pts), Pulse >160 (4 pts), FR >54 (4 pts), Cap Refill >4 (3 pts), Thorax 3 pts, Abdomen 3 pts, Extremity 2 pts. Total = 4+4+4+3+3+3+2 = 23.\n\n    *   Let's assume the BP is <46 (4 pts), Pulse >160 (4 pts), FR >54 (4 pts), Cap Refill >4 (3 pts), Thorax 3 pts, Abdomen 3 pts, Extremity 2 pts. Total = 4+4+4+3+3+3+2 = 23.\n\n    *   Let's assume the BP is <46 (4 pts), Pulse >160 (4 pts), FR >54 (4 pts), Cap Refill >4 (3 pts), Thorax 3 pts, Abdomen 3 pts, Extremity 2 pts. Total = 4+4+4+3+3+3+2 = 23.\n\n    *   Let's assume the BP is <46 (4 pts), Pulse >160 (4 pts), FR >54 (4 pts), Cap Refill >4 (3 pts), Thorax 3 pts, Abdomen 3 pts, Extremity 2 pts. Total = 4+4+4+3+3+3+2 = 23.\n\n    *   Let's assume the BP is <46 (4 pts), Pulse >160 (4 pts), FR >54 (4 pts), Cap Refill >4 (3 pts), Thorax 3 pts, Abdomen 3 pts, Extremity 2 pts. Total = 4+4+4+3+3+3+2 = 23.\n\n    *   Let's assume the BP is <46 (4 pts), Pulse >160 (4 pts), FR >54 (4 pts), Cap Refill >4 (3 pts), Thorax 3 pts, Abdomen 3 pts, Extremity 2 pts. Total = 4+4+4+3+3+3+2 = 23.\n\n    *   Let's assume the BP is <46 (4 pts), Pulse >160 (4 pts), FR >54 (4 pts), Cap Refill >4 (3 pts), Thorax 3 pts, Abdomen 3 pts, Extremity",
         null
        ],
        [
         "2776",
         "Mujer de 50 años con diagnóstico de NM mucionoso de mama. TC: múltiples nódulos hepáticos hipodensos calcificados, \nhipocaptadores. ¿Cuál es el diagnóstico más probable? A) Granulomas B) Metástasis C) Candidiasis D) Hematoma post traumático E) Ninguna de las anteriores",
         "<unused94>thought\n1.  **Analyze the Request:** The user wants me to act as an expert medical assistant trained in Peru and answer a multiple-choice medical question. I need to provide a step-by-step internal thought process, summarize the information, and then output *only* the final letter answer.\n\n2.  **Summarize the Information:**\n    *   Patient: 50-year-old woman.\n    *   Primary Diagnosis: Mucinous breast cancer (NM mucinoso de mama).\n    *   Imaging Findings (CT): Multiple liver nodules.\n    *   Nodule Characteristics: Hypodense, calcified, hypocaptating (hypocaptadores).\n\n3.  **Evaluate the Options:**\n    *   **A) Granulomas:** Granulomas (e.g., from tuberculosis, fungal infections, sarcoidosis) can appear as liver nodules. They can calcify. However, they are typically *hyper*vascular or show variable enhancement, not consistently *hypo*captating. While possible, the combination of features isn't classic.\n    *   **B) Metástasis:** Liver metastases are common in breast cancer. They can be hypodense. Calcification in metastases is *uncommon* but can occur, especially from certain primary tumors (like mucinous adenocarcinoma, osteosarcoma, chondrosarcoma, treated Ewing sarcoma, treated neuroblastoma, treated medulloblastoma, treated rhabdomyosarcoma, treated osteoid osteoma, treated giant cell tumor, treated chondroblastoma, treated adamantinoma, treated liposarcoma, treated fibrosarcoma, treated malignant fibrous histiocytoma, treated synovial sarcoma, treated malignant peripheral nerve sheath tumor, treated melanoma, treated renal cell carcinoma, treated hepatocellular carcinoma, treated cholangiocarcinoma, treated pancreatic adenocarcinoma, treated gastric adenocarcinoma, treated colorectal adenocarcinoma, treated small cell lung cancer, treated large cell lung cancer, treated squamous cell lung cancer, treated adenocarcinoma of the lung, treated thymoma, treated thyroid carcinoma, treated parathyroid carcinoma, treated pheochromocytoma, treated neuroblastoma, treated medulloblastoma, treated germ cell tumor, treated lymphoma, treated multiple myeloma, treated Hodgkin lymphoma, treated non-Hodgkin lymphoma, treated leukemia, treated Kaposi sarcoma, treated angiosarcoma, treated hemangioendothelioma, treated leiomyosarcoma, treated rhabdomyosarcoma, treated liposarcoma, treated fibrosarcoma, treated malignant fibrous histiocytoma, treated synovial sarcoma, treated malignant peripheral nerve sheath tumor, treated melanoma, treated renal cell carcinoma, treated hepatocellular carcinoma, treated cholangiocarcinoma, treated pancreatic adenocarcinoma, treated gastric adenocarcinoma, treated colorectal adenocarcinoma, treated small cell lung cancer, treated large cell lung cancer, treated squamous cell lung cancer, treated adenocarcinoma of the lung, treated thymoma, treated thyroid carcinoma, treated parathyroid carcinoma, treated pheochromocytoma, treated neuroblastoma, treated medulloblastoma, treated germ cell tumor, treated lymphoma, treated multiple myeloma, treated Hodgkin lymphoma, treated non-Hodgkin lymphoma, treated leukemia, treated Kaposi sarcoma, treated angiosarcoma, treated hemangioendothelioma, treated leiomyosarcoma, treated rhabdomyosarcoma, treated liposarcoma, treated fibrosarcoma, treated malignant fibrous histiocytoma, treated synovial sarcoma, treated malignant peripheral nerve sheath tumor, treated melanoma, treated renal cell carcinoma, treated hepatocellular carcinoma, treated cholangiocarcinoma, treated pancreatic adenocarcinoma, treated gastric adenocarcinoma, treated colorectal adenocarcinoma, treated small cell lung cancer, treated large cell lung cancer, treated squamous cell lung cancer, treated adenocarcinoma of the lung, treated thymoma, treated thyroid carcinoma, treated parathyroid carcinoma, treated pheochromocytoma, treated neuroblastoma, treated medulloblastoma, treated germ cell tumor, treated lymphoma, treated multiple myeloma, treated Hodgkin lymphoma, treated non-Hodgkin lymphoma, treated leukemia, treated Kaposi sarcoma, treated angiosarcoma, treated hemangioendothelioma, treated leiomyosarcoma, treated rhabdomyosarcoma, treated liposarcoma, treated fibrosarcoma, treated malignant fibrous histiocytoma, treated synovial sarcoma, treated malignant peripheral nerve sheath tumor, treated melanoma, treated renal cell carcinoma, treated hepatocellular carcinoma, treated cholangiocarcinoma, treated pancreatic adenocarcinoma, treated gastric adenocarcinoma, treated colorectal adenocarcinoma, treated small cell lung cancer, treated large cell lung cancer, treated squamous cell lung cancer, treated adenocarcinoma of the lung, treated thymoma, treated thyroid carcinoma, treated parathyroid carcinoma, treated pheochromocytoma, treated neuroblastoma, treated medulloblastoma, treated germ cell tumor, treated lymphoma, treated multiple myeloma, treated Hodgkin lymphoma, treated non-Hodgkin lymphoma, treated leukemia, treated Kaposi sarcoma, treated angiosarcoma, treated hemangioendothelioma, treated leiomyosarcoma, treated rhabdomyosarcoma, treated liposarcoma, treated fibrosarcoma, treated malignant fibrous histiocytoma, treated synovial sarcoma, treated malignant peripheral nerve sheath tumor, treated melanoma, treated renal cell carcinoma, treated hepatocellular carcinoma, treated cholangiocarcinoma, treated pancreatic adenocarcinoma, treated gastric adenocarcinoma, treated colorectal adenocarcinoma, treated small cell lung cancer, treated large cell lung cancer, treated squamous cell lung cancer, treated adenocarcinoma of the lung, treated thymoma, treated thyroid carcinoma, treated parathyroid carcinoma, treated pheochromocytoma, treated neuroblastoma, treated medulloblastoma, treated germ cell tumor, treated lymphoma, treated multiple myeloma, treated Hodgkin lymphoma, treated non-Hodgkin lymphoma, treated leukemia, treated Kaposi sarcoma, treated angiosarcoma, treated hemangioendothelioma, treated leiomyosarcoma, treated rhabdomyosarcoma, treated liposarcoma, treated fibrosarcoma, treated malignant fibrous histiocytoma, treated synovial sarcoma, treated malignant peripheral nerve sheath tumor, treated melanoma, treated renal cell carcinoma, treated hepatocellular carcinoma, treated cholangiocarcinoma, treated pancreatic adenocarcinoma, treated gastric adenocarcinoma, treated colorectal adenocarcinoma, treated small cell lung cancer, treated large cell lung cancer, treated squamous cell lung cancer, treated adenocarcinoma of the lung, treated thymoma, treated thyroid carcinoma, treated parathyroid carcinoma, treated pheochromocytoma, treated neuroblastoma, treated medulloblastoma, treated germ cell tumor, treated lymphoma, treated multiple myeloma, treated Hodgkin lymphoma, treated non-Hodgkin lymphoma, treated leukemia, treated Kaposi sarcoma, treated angiosarcoma, treated hemangioendothelioma, treated leiomyosarcoma, treated rhabdomyosarcoma, treated liposarcoma, treated fibrosarcoma, treated malignant fibrous histiocytoma, treated synovial sarcoma, treated malignant peripheral nerve sheath tumor, treated melanoma, treated renal cell carcinoma, treated hepatocellular carcinoma, treated cholangiocarcinoma, treated pancreatic adenocarcinoma, treated gastric adenocarcinoma, treated colorectal adenocarcinoma, treated small cell lung cancer, treated large cell lung cancer, treated squamous cell lung cancer, treated adenocarcinoma of the lung, treated thymoma, treated thyroid carcinoma, treated parathyroid carcinoma, treated pheochromocytoma, treated neuroblastoma, treated medulloblastoma, treated germ cell tumor, treated lymphoma, treated multiple myeloma, treated Hodgkin lymphoma, treated non-Hodgkin lymphoma, treated leukemia, treated Kaposi sarcoma, treated angiosarcoma, treated hemangioendothelioma, treated leiomyosarcoma, treated rhabdomyosarcoma, treated liposarcoma, treated fibrosarcoma, treated malignant fibrous histiocytoma, treated synovial sarcoma, treated malignant peripheral nerve sheath tumor, treated melanoma, treated renal cell carcinoma, treated hepatocellular carcinoma, treated cholangiocarcinoma, treated pancreatic adenocarcinoma, treated gastric adenocarcinoma, treated colorectal adenocarcinoma, treated small cell lung cancer, treated large cell lung cancer, treated squamous cell lung cancer, treated adenocarcinoma of the lung, treated thymoma, treated thyroid carcinoma, treated parathyroid carcinoma, treated pheochromocytoma, treated neuroblastoma, treated medulloblastoma, treated germ cell tumor, treated lymphoma, treated multiple myeloma, treated Hodgkin lymphoma, treated non-Hodgkin lymphoma, treated leukemia, treated Kaposi sarcoma, treated angiosarcoma, treated hemangioendothelioma, treated leiomyosarcoma, treated rhabdomyosarcoma, treated liposarcoma, treated fibrosarcoma, treated malignant fibrous histiocytoma, treated synovial sarcoma, treated malignant peripheral nerve sheath tumor, treated melanoma, treated renal cell carcinoma, treated hepatocellular carcinoma, treated cholangiocarcinoma, treated pancreatic adenocarcinoma, treated gastric adenocarcinoma, treated colorectal adenocarcinoma, treated small cell lung cancer, treated large cell lung cancer, treated squamous cell lung cancer, treated adenocarcinoma of the lung, treated thymoma, treated thyroid carcinoma, treated parathyroid carcinoma, treated pheochromocytoma, treated neuroblastoma, treated medulloblastoma, treated germ cell tumor, treated lymphoma, treated multiple myeloma, treated Hodgkin lymphoma, treated non-Hodgkin lymphoma, treated leukemia, treated Kaposi sarcoma, treated angiosarcoma, treated hemangioendothelioma, treated leiomyosarcoma, treated rhabdomyosarcoma, treated liposarcoma, treated fibrosarcoma, treated malignant fibrous histiocytoma, treated synovial sarcoma, treated malignant peripheral nerve sheath tumor, treated melanoma, treated renal cell carcinoma, treated hepatocellular carcinoma, treated cholangiocarcinoma, treated pancreatic adenocarcinoma, treated gastric adenocarcinoma, treated colorectal adenocarcinoma, treated small cell lung cancer, treated large cell lung cancer, treated squamous cell lung cancer, treated adenocarcinoma of the lung, treated thymoma, treated thyroid carcinoma, treated parathyroid carcinoma, treated pheochromocytoma, treated neuroblastoma, treated medulloblastoma, treated germ cell tumor, treated lymphoma, treated multiple myeloma, treated Hodgkin lymphoma, treated non-Hodgkin lymphoma, treated leukemia, treated Kaposi sarcoma, treated angiosarcoma, treated hemangioendothelioma, treated leiomyosarcoma, treated rhabdomyosarcoma, treated liposarcoma, treated fibrosarcoma, treated malignant fibrous histiocytoma, treated synovial sarcoma, treated malignant peripheral nerve sheath tumor, treated melanoma, treated renal cell carcinoma, treated hepatocellular carcinoma, treated cholangiocarcinoma, treated pancreatic adenocarcinoma, treated gastric adenocarcinoma, treated colorectal adenocarcinoma, treated small cell lung cancer, treated large cell lung cancer, treated squamous cell lung cancer, treated adenocarcinoma of the lung, treated thymoma, treated thyroid carcinoma, treated parathyroid carcinoma, treated pheochromocytoma, treated neuroblastoma, treated medulloblastoma, treated germ cell tumor, treated lymphoma, treated multiple myeloma, treated Hodgkin lymphoma, treated non-Hodgkin lymphoma, treated leukemia, treated Kaposi sarcoma, treated angiosarcoma, treated hemangioendothelioma, treated leiomyosarcoma, treated rhabdomyosarcoma, treated liposarcoma, treated fibrosarcoma, treated malignant fibrous histiocytoma, treated synovial sarcoma, treated malignant peripheral nerve sheath tumor, treated melanoma, treated renal cell carcinoma, treated hepatocellular carcinoma, treated cholangiocarcinoma, treated pancreatic adenocarcinoma, treated gastric adenocarcinoma, treated colorectal adenocarcinoma, treated small cell lung cancer, treated large cell lung cancer, treated squamous cell lung cancer, treated adenocarcinoma of the lung, treated thymoma, treated thyroid carcinoma, treated parathyroid carcinoma, treated pheochromocytoma, treated neuroblastoma, treated medulloblastoma, treated germ cell tumor, treated lymphoma, treated multiple myeloma, treated Hodgkin lymphoma, treated non-Hodgkin lymphoma, treated leukemia, treated Kaposi sarcoma, treated angiosarcoma, treated hemangioendothelioma, treated leiomyosarcoma, treated rhabdomyosarcoma, treated liposarcoma, treated fibrosarcoma, treated malignant fibrous histiocytoma, treated synovial sarcoma, treated malignant peripheral nerve sheath tumor, treated melanoma, treated renal cell carcinoma, treated hepatocellular carcinoma, treated cholangiocarcinoma, treated pancreatic adenocarcinoma, treated gastric adenocarcinoma, treated colorectal adenocarcinoma, treated small cell lung cancer, treated large cell lung cancer, treated squamous cell lung cancer, treated adenocarcinoma of the lung, treated thymoma, treated thyroid carcinoma, treated parathyroid carcinoma, treated pheochromocytoma, treated neuroblastoma, treated medulloblastoma, treated germ cell tumor, treated lymphoma, treated multiple myeloma, treated Hodgkin lymphoma, treated non-Hodgkin lymphoma, treated leukemia, treated Kaposi sarcoma, treated angiosarcoma, treated hemangioendothelioma, treated leiomyosarcoma, treated rhabdomyosarcoma, treated liposarcoma, treated fibrosarcoma, treated malignant fibrous histiocytoma, treated synovial sarcoma, treated malignant peripheral nerve sheath tumor, treated melanoma, treated renal cell carcinoma, treated hepatocellular carcinoma, treated cholangiocarcinoma, treated pancreatic adenocarcinoma, treated gastric adenocarcinoma, treated colorectal adenocarcinoma, treated small cell lung cancer, treated large cell lung cancer, treated squamous cell lung cancer, treated adenocarcinoma of the lung, treated thymoma, treated thyroid carcinoma, treated parathyroid carcinoma, treated pheochromocytoma, treated neuroblastoma, treated medulloblastoma, treated germ cell tumor, treated lymphoma, treated multiple myeloma, treated Hodgkin lymphoma, treated non-Hodgkin lymphoma, treated leukemia, treated Kaposi sarcoma, treated angiosarcoma, treated hemangioendothelioma, treated leiomyosarcoma, treated rhabdomyosarcoma, treated liposarcoma, treated fibrosarcoma, treated malignant fibrous histiocytoma, treated synovial sarcoma, treated malignant peripheral nerve sheath tumor, treated melanoma, treated renal cell carcinoma, treated hepatocellular carcinoma, treated cholangiocarcinoma, treated pancreatic adenocarcinoma, treated gastric adenocarcinoma, treated colorectal adenocarcinoma, treated small cell lung cancer, treated large cell lung cancer, treated squamous cell lung cancer, treated adenocarcinoma of the lung, treated thymoma, treated thyroid carcinoma, treated parathyroid carcinoma, treated pheochromocytoma, treated neuroblastoma, treated medulloblastoma, treated germ cell tumor, treated lymphoma, treated multiple myeloma, treated Hodgkin lymphoma, treated non-Hodgkin lymphoma, treated leukemia, treated Kaposi sarcoma, treated angiosarcoma, treated hemangioendothelioma, treated leiomyosarcoma, treated rhabdomyosarcoma, treated liposarcoma, treated fibrosarcoma, treated malignant fibrous histiocytoma, treated synovial sarcoma, treated malignant peripheral nerve sheath tumor, treated melanoma, treated renal cell carcinoma, treated hepatocellular carcinoma, treated cholangiocarcinoma, treated pancreatic adenocarcinoma, treated gastric adenocarcinoma, treated colorectal adenocarcinoma, treated small cell lung cancer, treated large cell lung cancer, treated squamous cell lung cancer, treated adenocarcinoma of the lung, treated thymoma, treated thyroid carcinoma, treated parathyroid carcinoma, treated pheochromocytoma, treated neuroblastoma, treated medulloblastoma, treated germ cell tumor, treated lymphoma, treated multiple myeloma, treated Hodgkin lymphoma, treated non-Hodgkin lymphoma, treated leukemia, treated Kaposi sarcoma, treated angiosarcoma, treated hemangioendothelioma, treated leiomyosarcoma, treated rhabdomyosarcoma, treated liposarcoma, treated fibrosarcoma, treated malignant fibrous histiocytoma, treated synovial sarcoma, treated malignant peripheral nerve sheath tumor, treated melanoma, treated renal cell carcinoma, treated hepatocellular carcinoma, treated cholangiocarcinoma, treated pancreatic adenocarcinoma, treated gastric adenocarcinoma, treated colorectal adenocarcinoma, treated small cell lung cancer, treated large cell lung cancer, treated squamous cell lung cancer, treated adenocarcinoma of the lung, treated thymoma, treated thyroid carcinoma, treated parathyroid carcinoma, treated pheochromocytoma, treated neuroblastoma, treated medulloblastoma, treated germ cell tumor, treated lymphoma, treated multiple myeloma, treated Hodgkin lymphoma, treated non-Hodgkin lymphoma, treated leukemia, treated Kaposi sarcoma, treated angiosarcoma, treated hemangioendothelioma, treated leiomyosarcoma, treated rhabdomyosarcoma, treated liposarcoma, treated fibrosarcoma, treated malignant fibrous histiocytoma, treated synovial sarcoma, treated malignant peripheral nerve sheath tumor, treated melanoma, treated renal cell carcinoma, treated hepatocellular carcinoma, treated cholangiocarcinoma, treated pancreatic adenocarcinoma, treated gastric adenocarcinoma, treated colorectal adenocarcinoma, treated small cell lung cancer, treated large cell lung cancer, treated squamous cell lung cancer, treated adenocarcinoma of the lung, treated thymoma, treated thyroid carcinoma, treated parathyroid carcinoma, treated pheochromocytoma, treated neuroblastoma, treated medulloblastoma, treated germ cell tumor, treated lymphoma, treated multiple myeloma, treated Hodgkin lymphoma, treated non-Hodgkin lymphoma, treated leukemia, treated Kaposi sarcoma, treated angiosarcoma, treated hemangioendothelioma, treated leiomyosarcoma, treated rhabdomyosarcoma, treated liposarcoma, treated fibrosarcoma, treated malignant fibrous histiocytoma, treated synovial sarcoma, treated malignant peripheral nerve sheath tumor, treated melanoma, treated renal cell carcinoma, treated hepatocellular carcinoma, treated cholangiocarcinoma, treated pancreatic adenocarcinoma, treated gastric adenocarcinoma, treated colorectal adenocarcinoma, treated small cell lung cancer, treated large cell lung cancer, treated squamous cell lung cancer, treated adenocarcinoma of the lung, treated thymoma, treated thyroid carcinoma, treated parathyroid carcinoma, treated pheochromocytoma, treated neuroblastoma, treated medulloblastoma, treated germ cell tumor, treated lymphoma, treated multiple myeloma, treated Hodgkin lymphoma, treated non-Hodgkin lymphoma, treated leukemia, treated Kaposi sarcoma, treated angiosarcoma, treated hemangioendothelioma, treated leiomyosarcoma, treated rhabdomyosarcoma, treated liposarcoma, treated fibrosarcoma, treated malignant fibrous histiocytoma, treated synovial sarcoma, treated malignant peripheral nerve sheath tumor, treated melanoma, treated renal cell carcinoma, treated hepatocellular carcinoma, treated cholangiocarcinoma, treated pancreatic adenocarcinoma, treated gastric adenocarcinoma, treated colorectal adenocarcinoma, treated small cell lung cancer, treated large cell lung cancer, treated squamous cell lung cancer, treated adenocarcinoma of the lung, treated thymoma, treated thyroid carcinoma, treated parathyroid carcinoma, treated pheochromocytoma, treated neuroblastoma, treated medulloblastoma, treated germ cell tumor, treated lymphoma, treated multiple myeloma, treated Hodgkin lymphoma, treated non-Hodgkin lymphoma, treated leukemia, treated Kaposi sarcoma, treated angiosarcoma, treated hemangioendothelioma, treated leiomyosarcoma, treated rhabdomyosarcoma, treated liposarcoma, treated fibrosarcoma, treated malignant fibrous histiocytoma, treated synovial sarcoma, treated malignant peripheral nerve sheath tumor, treated melanoma, treated renal cell carcinoma, treated hepatocellular carcinoma, treated cholangiocarcinoma, treated pancreatic adenocarcinoma, treated gastric adenocarcinoma, treated colorectal adenocarcinoma, treated small cell lung cancer, treated large cell lung cancer, treated squamous cell lung cancer, treated adenocarcinoma of the lung, treated thymoma, treated thyroid carcinoma, treated parathyroid carcinoma, treated pheochromocytoma, treated neuroblastoma, treated medulloblastoma, treated germ cell tumor, treated lymphoma, treated multiple myeloma, treated Hodgkin lymphoma, treated non-Hodgkin lymphoma, treated leukemia, treated Kaposi sarcoma, treated angiosarcoma, treated hemangioendothelioma, treated leiomyosarcoma, treated rhabdomyosarcoma, treated liposarcoma, treated fibrosarcoma, treated malignant fibrous histiocytoma, treated synovial sarcoma, treated malignant peripheral nerve sheath tumor, treated melanoma, treated renal cell carcinoma, treated hepatocellular carcinoma, treated cholangiocarcinoma, treated pancreatic adenocarcinoma, treated gastric adenocarcinoma, treated colorectal adenocarcinoma, treated small cell lung cancer, treated large cell lung cancer, treated squamous cell lung cancer, treated adenocarcinoma of the lung, treated thymoma, treated thyroid carcinoma, treated parathyroid carcinoma, treated pheochromocytoma, treated neuroblastoma, treated medulloblastoma, treated germ cell tumor, treated lymphoma, treated multiple myeloma, treated Hodgkin lymphoma, treated non-Hodgkin lymphoma, treated leukemia, treated Kaposi sarcoma, treated angiosarcoma, treated hemangioendothelioma, treated leiomyosarcoma, treated rhabdomyosarcoma, treated liposarcoma, treated fibrosarcoma, treated malignant fibrous histiocytoma, treated synovial sarcoma, treated malignant peripheral nerve sheath tumor, treated melanoma, treated renal cell carcinoma, treated hepatocellular carcinoma, treated cholangiocarcinoma, treated pancreatic adenocarcinoma, treated gastric adenocarcinoma, treated colorectal adenocarcinoma, treated small cell lung cancer, treated large cell lung cancer, treated squamous cell lung cancer, treated adenocarcinoma of the lung, treated thymoma, treated thyroid carcinoma, treated parathyroid carcinoma, treated pheochromocytoma, treated neuroblastoma, treated medulloblastoma, treated germ cell tumor, treated lymphoma, treated multiple myeloma, treated Hodgkin lymphoma, treated non-Hodgkin lymphoma, treated leukemia, treated Kaposi sarcoma, treated angiosarcoma, treated hemangioendothelioma, treated leiomyosarcoma, treated rhabdomyosarcoma, treated liposarcoma, treated fibrosarcoma, treated malignant fibrous histiocytoma, treated synovial sarcoma, treated malignant peripheral nerve sheath tumor, treated melanoma, treated renal cell carcinoma, treated hepatocellular carcinoma, treated cholangiocarcinoma, treated pancreatic adenocarcinoma, treated gastric adenocarcinoma, treated colorectal adenocarcinoma, treated small cell lung cancer, treated large cell lung cancer, treated squamous cell lung cancer, treated adenocarcinoma of the lung, treated thymoma, treated thyroid carcinoma, treated parathyroid carcinoma, treated pheochromocytoma, treated neuroblastoma, treated medulloblastoma, treated germ cell tumor, treated lymphoma, treated multiple myeloma, treated Hodgkin lymphoma, treated non-Hodgkin lymphoma, treated leukemia, treated Kaposi sarcoma, treated angiosarcoma, treated hemangioendothelioma, treated leiomyosarcoma, treated rhabdomyosarcoma, treated liposarcoma, treated fibrosarcoma, treated malignant fibrous histiocytoma, treated synovial sarcoma, treated malignant peripheral nerve sheath tumor, treated melanoma, treated renal cell carcinoma, treated hepatocellular carcinoma, treated cholangiocarcinoma, treated pancreatic adenocarcinoma, treated gastric adenocarcinoma, treated colorectal adenocarcinoma, treated small cell lung cancer, treated large cell lung cancer, treated squamous cell lung cancer, treated adenocarcinoma of the lung, treated thymoma, treated thyroid carcinoma, treated parathyroid carcinoma, treated pheochromocytoma, treated neuroblastoma, treated medulloblastoma, treated germ cell tumor, treated lymphoma, treated multiple myeloma, treated Hodgkin lymphoma, treated non-Hodgkin lymphoma, treated leukemia, treated Kaposi sarcoma, treated angiosarcoma, treated hemangioendothelioma, treated leiomyosarcoma, treated rhabdomyosarcoma, treated liposarcoma, treated fibrosarcoma, treated malignant fibrous histiocytoma, treated synovial sarcoma, treated malignant peripheral nerve sheath tumor, treated melanoma, treated renal cell carcinoma, treated hepatocellular carcinoma, treated cholangiocarcinoma, treated pancreatic adenocarcinoma, treated gastric adenocarcinoma, treated colorectal adenocarcinoma, treated small cell lung cancer, treated large cell lung cancer, treated squamous cell lung cancer, treated adenocarcinoma of the lung, treated thymoma, treated thyroid carcinoma, treated parathyroid carcinoma, treated pheochromocytoma, treated neuroblastoma, treated medulloblastoma, treated germ cell tumor, treated lymphoma, treated multiple myeloma, treated Hodgkin lymphoma, treated non-Hodgkin lymphoma, treated leukemia, treated Kaposi sarcoma, treated angiosarcoma, treated hemangioendothelioma, treated leiomyosarcoma, treated rhabdomyosarcoma, treated liposarcoma, treated fibrosarcoma, treated malignant fibrous histiocytoma, treated synovial sarcoma, treated malignant peripheral nerve sheath tumor, treated melanoma, treated renal cell carcinoma, treated hepatocellular carcinoma, treated cholangiocarcinoma, treated pancreatic adenocarcinoma, treated gastric adenocarcinoma, treated colorectal adenocarcinoma, treated small cell lung cancer, treated large cell lung cancer, treated squamous cell lung cancer, treated adenocarcinoma of the lung, treated thymoma, treated thyroid carcinoma, treated parathyroid carcinoma, treated pheochromocytoma, treated neuroblastoma, treated medulloblastoma, treated germ cell tumor, treated lymphoma, treated multiple myeloma, treated Hodgkin lymphoma, treated non-Hodgkin lymphoma, treated leukemia, treated Kaposi sarcoma, treated angiosarcoma, treated hemangioendothelioma, treated leiomyosarcoma, treated rhabdomyosarcoma, treated liposarcoma, treated fibrosarcoma, treated malignant fibrous histiocytoma, treated synovial sarcoma, treated malignant peripheral nerve sheath tumor, treated melanoma, treated renal cell carcinoma, treated hepatocellular carcinoma, treated cholangiocarcinoma, treated pancreatic adenocarcinoma, treated gastric adenocarcinoma, treated colorectal adenocarcinoma, treated small cell lung cancer, treated large cell lung cancer, treated squamous cell lung cancer, treated adenocarcinoma of the lung, treated thymoma, treated thyroid carcinoma, treated parathyroid carcinoma, treated pheochromocytoma, treated neuroblastoma, treated medulloblastoma, treated germ cell tumor, treated lymphoma, treated multiple myeloma, treated Hodgkin lymphoma, treated non-Hodgkin lymphoma, treated leukemia, treated Kaposi sarcoma, treated angiosarcoma, treated hemangioendothelioma, treated leiomyosarcoma, treated rhabdomyosarcoma, treated liposarcoma, treated fibrosarcoma, treated malignant fibrous histiocytoma, treated synovial sarcoma, treated malignant peripheral nerve sheath tumor, treated melanoma, treated renal cell carcinoma, treated hepatocellular carcinoma, treated cholangiocarcinoma, treated pancreatic adenocarcinoma, treated gastric adenocarcinoma, treated colorectal adenocarcinoma, treated small cell lung cancer, treated large cell lung cancer, treated squamous cell lung cancer, treated adenocarcinoma of the lung, treated thymoma, treated thyroid carcinoma, treated parathyroid carcinoma, treated pheochromocytoma, treated neuroblastoma, treated medulloblastoma, treated germ cell tumor, treated lymphoma, treated multiple myeloma, treated Hodgkin lymphoma, treated non-Hodgkin lymphoma, treated leukemia, treated Kaposi sarcoma, treated angiosarcoma, treated hemangioendothelioma, treated leiomyosarcoma, treated rhabdomyosarcoma, treated liposarcoma, treated fibrosarcoma, treated malignant fibrous histiocytoma, treated synovial sarcoma, treated malignant peripheral nerve sheath tumor, treated melanoma, treated renal cell carcinoma, treated hepatocellular carcinoma, treated cholangiocarcinoma, treated pancreatic adenocarcinoma, treated gastric adenocarcinoma, treated colorectal adenocarcinoma, treated small cell lung cancer, treated large cell lung cancer, treated squamous cell lung cancer, treated adenocarcinoma of the lung, treated thymoma, treated thyroid carcinoma, treated parathyroid carcinoma, treated pheochromocytoma, treated neuroblastoma, treated medulloblastoma, treated germ cell tumor, treated lymphoma, treated multiple myeloma, treated Hodgkin lymphoma, treated non-Hodgkin lymphoma, treated leukemia, treated Kaposi sarcoma, treated angiosarcoma, treated hemangioendothelioma, treated leiomyosarcoma, treated rhabdomyosarcoma, treated liposarcoma, treated fibrosarcoma, treated malignant fibrous histiocytoma, treated synovial sarcoma, treated malignant peripheral nerve sheath tumor, treated melanoma, treated renal cell carcinoma, treated hepatocellular carcinoma, treated cholangiocarcinoma, treated pancreatic adenocarcinoma, treated gastric adenocarcinoma, treated colorectal adenocarcinoma, treated small cell lung cancer, treated large cell lung cancer, treated squamous cell lung cancer, treated adenocarcinoma of the lung, treated thymoma, treated thyroid carcinoma, treated parathyroid carcinoma, treated pheochromocytoma, treated neuroblastoma, treated medulloblastoma, treated germ cell tumor, treated lymphoma, treated multiple myeloma, treated Hodgkin lymphoma, treated non-Hodgkin lymphoma, treated leukemia, treated Kaposi sarcoma, treated angiosarcoma, treated hemangioendothelioma, treated leiomyosarcoma, treated rhabdomyosarcoma, treated liposarcoma, treated fibrosarcoma, treated malignant fibrous histiocytoma, treated synovial sarcoma, treated malignant peripheral nerve sheath tumor, treated melanoma, treated renal cell carcinoma, treated hepatocellular carcinoma, treated cholangiocarcinoma, treated pancreatic adenocarcinoma, treated gastric adenocarcinoma, treated colorectal adenocarcinoma, treated small cell lung cancer, treated large cell lung cancer, treated squamous cell lung cancer, treated adenocarcinoma of the lung, treated thymoma, treated thyroid carcinoma, treated parathyroid carcinoma, treated pheochromocytoma, treated neuroblastoma, treated medulloblastoma, treated germ cell tumor, treated lymphoma, treated multiple myeloma, treated Hodgkin lymphoma, treated non-Hodgkin lymphoma, treated leukemia, treated Kaposi sarcoma, treated angiosarcoma, treated hemangioendothelioma, treated leiomyosarcoma, treated rhabdomyosarcoma, treated liposarcoma, treated fibrosarcoma, treated malignant fibrous histiocytoma, treated synovial sarcoma, treated malignant peripheral nerve sheath tumor, treated melanoma, treated renal cell carcinoma, treated hepatocellular carcinoma, treated cholangiocarcinoma, treated pancreatic adenocarcinoma, treated gastric adenocarcinoma, treated colorectal adenocarcinoma, treated small cell lung cancer, treated large cell lung cancer, treated squamous cell lung cancer, treated adenocarcinoma of the lung, treated thymoma, treated thyroid carcinoma, treated parathyroid carcinoma, treated pheochromocytoma, treated neuroblastoma, treated medulloblastoma, treated germ cell tumor, treated lymphoma, treated multiple myeloma, treated Hodgkin lymphoma, treated non-Hodgkin lymphoma, treated leukemia, treated Kaposi sarcoma, treated angiosarcoma, treated hemangioendothelioma, treated leiomyosarcoma, treated rhabdomyosarcoma, treated liposarcoma, treated fibrosarcoma, treated malignant fibrous histiocytoma, treated synovial sarcoma, treated malignant peripheral nerve sheath tumor, treated melanoma, treated renal cell carcinoma, treated hepatocellular carcinoma, treated cholangiocarcinoma, treated pancreatic adenocarcinoma, treated gastric adenocarcinoma, treated colorectal adenocarcinoma, treated small cell lung cancer, treated large cell lung cancer, treated squamous cell lung cancer, treated adenocarcinoma of the lung, treated thymoma, treated thyroid carcinoma, treated parathyroid carcinoma, treated pheochromocytoma, treated neuroblastoma, treated medulloblastoma, treated germ cell tumor, treated lymphoma, treated multiple myeloma, treated Hodgkin lymphoma, treated non-Hodgkin lymphoma, treated leukemia, treated Kaposi sarcoma, treated angiosarcoma, treated hemangioendothelioma, treated leiomyosarcoma, treated rhabdomyosarcoma, treated liposarcoma, treated fibrosarcoma, treated malignant fibrous histiocytoma, treated synovial sarcoma, treated malignant peripheral nerve sheath tumor, treated melanoma, treated renal cell carcinoma, treated hepatocellular carcinoma, treated cholangiocarcinoma, treated pancreatic adenocarcinoma, treated gastric adenocarcinoma, treated colorectal adenocarcinoma, treated small cell lung cancer, treated large cell lung cancer, treated squamous cell lung cancer, treated adenocarcinoma of the lung, treated thymoma, treated thyroid carcinoma, treated parathyroid carcinoma, treated pheochromocytoma, treated neuroblastoma, treated medulloblastoma, treated germ cell tumor, treated lymphoma, treated multiple myeloma, treated Hodgkin lymphoma, treated non-Hodgkin lymphoma, treated leukemia, treated Kaposi sarcoma, treated angiosarcoma, treated hemangioendothelioma, treated leiomyosarcoma, treated rhabdomyosarcoma, treated liposarcoma, treated fibrosarcoma, treated malignant fibrous histiocytoma, treated synovial sarcoma, treated malignant peripheral nerve sheath tumor, treated melanoma, treated renal cell carcinoma, treated hepatocellular carcinoma, treated cholangiocarcinoma, treated pancreatic adenocarcinoma, treated gastric adenocarcinoma, treated colorectal adenocarcinoma, treated small cell lung cancer, treated large cell lung cancer, treated squamous cell lung cancer, treated adenocarcinoma of the lung, treated thymoma, treated thyroid carcinoma, treated parathyroid carcinoma, treated pheochromocytoma, treated neuroblastoma, treated medulloblastoma, treated germ cell tumor, treated lymphoma, treated multiple myeloma, treated Hodgkin lymphoma, treated non-Hodgkin lymphoma, treated leukemia, treated Kaposi sarcoma, treated angiosarcoma, treated hemangioendothelioma, treated leiomyosarcoma, treated rhabdomyosarcoma, treated liposarcoma, treated fibrosarcoma, treated malignant fibrous histiocytoma, treated synovial sarcoma, treated malignant peripheral nerve sheath tumor, treated melanoma, treated renal cell carcinoma, treated hepatocellular carcinoma, treated cholangiocarcinoma, treated pancreatic adenocarcinoma, treated gastric adenocarcinoma, treated colorectal adenocarcinoma, treated small cell lung cancer, treated large cell lung cancer, treated squamous cell lung cancer, treated adenocarcinoma of the lung, treated thymoma, treated thyroid carcinoma, treated parathyroid carcinoma, treated pheochromocytoma, treated neuroblastoma, treated medulloblastoma, treated germ cell tumor, treated lymphoma, treated multiple myeloma, treated Hodgkin lymphoma, treated non-Hodgkin lymphoma, treated leukemia, treated Kaposi sarcoma, treated angiosarcoma, treated hemangioendothelioma, treated leiomyosarcoma, treated rhabdomyosarcoma, treated liposarcoma, treated fibrosarcoma, treated malignant fibrous histiocytoma, treated synovial sarcoma, treated malignant peripheral nerve sheath tumor, treated melanoma, treated renal cell carcinoma, treated hepatocellular carcinoma, treated cholangiocarcinoma, treated pancreatic adenocarcinoma, treated gastric adenocarcinoma, treated colorectal adenocarcinoma, treated small cell lung cancer, treated large cell lung cancer, treated squamous cell lung cancer, treated adenocarcinoma of the lung, treated thymoma, treated thyroid carcinoma, treated parathyroid carcinoma, treated pheochromocytoma, treated neuroblastoma, treated medulloblastoma, treated germ cell tumor, treated lymphoma, treated multiple myeloma, treated Hodgkin lymphoma, treated non-Hodgkin lymphoma, treated leukemia, treated Kaposi sarcoma, treated angiosarcoma, treated hemangioendothelioma, treated leiomyosarcoma, treated rhabdomyosarcoma, treated liposarcoma, treated fibrosarcoma, treated malignant fibrous histiocytoma, treated synovial sarcoma, treated malignant peripheral nerve sheath tumor, treated melanoma, treated renal cell carcinoma, treated hepatocellular carcinoma, treated cholangiocarcinoma, treated pancreatic adenocarcinoma, treated gastric adenocarcinoma, treated colorectal adenocarcinoma, treated small cell lung cancer, treated large cell lung cancer, treated squamous cell lung cancer, treated adenocarcinoma of the lung, treated thymoma, treated thyroid carcinoma, treated parathyroid carcinoma, treated pheochromocytoma, treated neuroblastoma, treated medulloblastoma, treated germ cell tumor, treated lymphoma, treated multiple myeloma, treated Hodgkin lymphoma, treated non-Hodgkin lymphoma, treated leukemia, treated Kaposi sarcoma, treated angiosarcoma, treated hemangioendothelioma, treated leiomyosarcoma, treated rhabdomyosarcoma, treated liposarcoma, treated fibrosarcoma, treated malignant fibrous histiocytoma, treated synovial sarcoma, treated malignant peripheral nerve sheath tumor, treated melanoma, treated renal cell carcinoma, treated hepatocellular carcinoma, treated cholangiocarcinoma, treated pancreatic adenocarcinoma, treated gastric adenocarcinoma, treated colorectal adenocarcinoma, treated small cell lung cancer, treated large cell lung cancer, treated squamous cell lung cancer, treated adenocarcinoma of the lung, treated thymoma, treated thyroid carcinoma, treated parathyroid carcinoma, treated pheochromocytoma, treated neuroblastoma, treated medulloblastoma, treated germ cell tumor, treated lymphoma, treated multiple myeloma, treated Hodgkin lymphoma, treated non-Hodgkin lymphoma, treated leukemia, treated Kaposi sarcoma, treated angiosarcoma, treated hemangioendothelioma, treated leiomyosarcoma, treated rhabdomyosarcoma, treated liposarcoma, treated fibrosarcoma, treated malignant fibrous histiocytoma, treated synovial sarcoma, treated malignant peripheral nerve sheath tumor, treated melanoma, treated renal cell carcinoma, treated hepatocellular carcinoma, treated cholangiocarcinoma, treated pancreatic adenocarcinoma, treated gastric adenocarcinoma, treated colorectal adenocarcinoma, treated small cell lung cancer, treated large cell lung cancer, treated squamous cell lung cancer, treated adenocarcinoma of the lung, treated thymoma, treated thyroid carcinoma, treated parathyroid carcinoma, treated pheochromocytoma, treated neuroblastoma, treated medulloblastoma, treated germ cell tumor, treated lymphoma, treated multiple myeloma, treated Hodgkin lymphoma, treated non-Hodgkin lymphoma, treated leukemia, treated Kaposi sarcoma, treated angiosarcoma, treated hemangioendothelioma, treated leiomyosarcoma, treated rhabdomyosarcoma, treated liposarcoma, treated fibrosarcoma, treated malignant fibrous histiocytoma, treated synovial sarcoma, treated malignant peripheral nerve sheath tumor, treated melanoma, treated renal cell carcinoma, treated hepatocellular carcinoma, treated cholangiocarcinoma, treated pancreatic adenocarcinoma, treated gastric adenocarcinoma, treated colorectal adenocarcinoma, treated small cell lung cancer, treated large cell lung cancer, treated squamous cell lung cancer, treated adenocarcinoma of the lung, treated thymoma, treated thyroid carcinoma, treated parathyroid carcinoma, treated pheochromocytoma, treated neuroblastoma, treated medulloblastoma, treated germ cell tumor, treated lymphoma, treated multiple myeloma, treated Hodgkin lymphoma, treated non-Hodgkin lymphoma, treated leukemia, treated Kaposi sarcoma, treated angiosarcoma, treated hemangioendothelioma, treated leiomyosarcoma, treated rhabdomyosarcoma, treated liposarcoma, treated fibrosarcoma, treated malignant fibrous histiocytoma, treated synovial sarcoma, treated malignant peripheral nerve sheath tumor, treated melanoma, treated renal cell carcinoma, treated hepatocellular carcinoma, treated cholangiocarcinoma, treated pancreatic adenocarcinoma, treated gastric adenocarcinoma, treated colorectal adenocarcinoma, treated small cell lung cancer, treated large cell lung cancer, treated squamous cell lung cancer, treated adenocarcinoma of the lung, treated thymoma, treated thyroid carcinoma, treated parathyroid carcinoma, treated pheochromocytoma, treated neuroblastoma, treated medulloblastoma, treated germ cell tumor, treated lymphoma, treated multiple myeloma, treated Hodgkin lymphoma, treated non-Hodgkin lymphoma, treated leukemia, treated Kaposi sarcoma, treated angiosarcoma, treated hemangioendothelioma, treated leiomyosarcoma, treated rhabdomyosarcoma, treated liposarcoma, treated fibrosarcoma, treated malignant fibrous histiocytoma, treated synovial sarcoma, treated malignant peripheral nerve sheath tumor, treated melanoma, treated renal cell carcinoma, treated hepatocellular carcinoma, treated cholangiocarcinoma, treated pancreatic adenocarcinoma, treated gastric adenocarcinoma, treated colorectal adenocarcinoma, treated small cell lung cancer, treated large cell lung cancer, treated squamous cell lung cancer, treated adenocarcinoma of the lung, treated thymoma, treated thyroid carcinoma, treated parathyroid carcinoma, treated pheochromocytoma, treated neuroblastoma, treated medulloblastoma, treated germ cell tumor, treated lymphoma, treated multiple myeloma, treated Hodgkin lymphoma, treated non-Hodgkin lymphoma, treated leukemia, treated Kaposi sarcoma, treated angiosarcoma, treated hemangioendothelioma, treated leiomyosarcoma, treated rhabdomyosarcoma, treated liposarcoma, treated fibrosarcoma, treated malignant fibrous histiocytoma, treated synovial sarcoma, treated malignant peripheral nerve sheath tumor, treated melanoma, treated renal cell carcinoma, treated hepatocellular carcinoma, treated cholangiocarcinoma, treated pancreatic adenocarcinoma, treated gastric adenocarcinoma, treated colorectal adenocarcinoma, treated small cell lung cancer, treated large cell lung cancer, treated squamous cell lung cancer, treated adenocarcinoma of the lung, treated thymoma, treated thyroid carcinoma, treated parathyroid carcinoma, treated pheochromocytoma, treated neuroblastoma, treated medulloblastoma, treated germ cell tumor, treated lymphoma, treated multiple myeloma, treated Hodgkin lymphoma, treated non-Hodgkin lymphoma, treated leukemia, treated Kaposi sarcoma, treated angiosarcoma, treated hemangioendothelioma, treated leiomyosarcoma, treated rhabdomyosarcoma, treated liposarcoma, treated fibrosarcoma, treated malignant fibrous histiocytoma, treated synovial sarcoma, treated malignant peripheral nerve sheath tumor, treated melanoma, treated renal cell carcinoma, treated hepatocellular carcinoma, treated cholangiocarcinoma, treated pancreatic adenocarcinoma, treated gastric adenocarcinoma, treated colorectal adenocarcinoma, treated small cell lung cancer, treated large cell lung cancer, treated squamous cell lung cancer, treated adenocarcinoma of the lung, treated thymoma, treated thyroid carcinoma, treated parathyroid carcinoma, treated pheochromocytoma, treated neuroblastoma, treated medulloblastoma, treated germ cell tumor, treated lymphoma, treated multiple myeloma, treated Hodgkin lymphoma, treated non-Hodgkin lymphoma, treated leukemia, treated Kaposi sarcoma, treated angiosarcoma, treated hemangioendothelioma, treated leiomyosarcoma, treated rhabdomyosarcoma, treated liposarcoma, treated fibrosarcoma, treated malignant fibrous histiocytoma, treated synovial sarcoma, treated malignant peripheral nerve sheath tumor, treated melanoma, treated renal cell carcinoma, treated hepatocellular carcinoma, treated cholangiocarcinoma, treated pancreatic adenocarcinoma, treated gastric adenocarcinoma, treated colorectal adenocarcinoma, treated small cell lung cancer, treated large cell lung cancer, treated squamous cell lung cancer, treated adenocarcinoma of the lung, treated thymoma, treated",
         null
        ]
       ],
       "shape": {
        "columns": 3,
        "rows": 2
       }
      },
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>question</th>\n",
       "      <th>answer_llm</th>\n",
       "      <th>letra_respuesta</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>2404</th>\n",
       "      <td>Gestante de 36 semanas, tiene accidente automo...</td>\n",
       "      <td>&lt;unused94&gt;thought\\n1.  **Identify the core tas...</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2776</th>\n",
       "      <td>Mujer de 50 años con diagnóstico de NM muciono...</td>\n",
       "      <td>&lt;unused94&gt;thought\\n1.  **Analyze the Request:*...</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                               question  \\\n",
       "2404  Gestante de 36 semanas, tiene accidente automo...   \n",
       "2776  Mujer de 50 años con diagnóstico de NM muciono...   \n",
       "\n",
       "                                             answer_llm letra_respuesta  \n",
       "2404  <unused94>thought\\n1.  **Identify the core tas...             NaN  \n",
       "2776  <unused94>thought\\n1.  **Analyze the Request:*...             NaN  "
      ]
     },
     "execution_count": 5,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df[df['letra_respuesta'].isna()][['question', 'answer_llm', 'letra_respuesta']]   # Manually verified that these 09 cases do not contain a valid answer."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "id": "19bf2b79",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "(8378, 14)"
      ]
     },
     "execution_count": 6,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df = df.dropna(subset='letra_respuesta')\n",
    "df = df.reset_index(drop=True)\n",
    "df.shape"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "ca5cf809",
   "metadata": {},
   "source": [
    "########################################################################################################################################################################################################"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "id": "4539ae94",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "application/vnd.microsoft.datawrangler.viewer.v0+json": {
       "columns": [
        {
         "name": "correct_answer",
         "rawType": "object",
         "type": "string"
        },
        {
         "name": "A",
         "rawType": "float64",
         "type": "float"
        },
        {
         "name": "B",
         "rawType": "float64",
         "type": "float"
        },
        {
         "name": "C",
         "rawType": "float64",
         "type": "float"
        },
        {
         "name": "D",
         "rawType": "float64",
         "type": "float"
        },
        {
         "name": "E",
         "rawType": "float64",
         "type": "float"
        }
       ],
       "ref": "bc09e081-444b-4a35-8f00-21edf33d8e23",
       "rows": [
        [
         "A",
         "0.765295358649789",
         "0.053390282968499736",
         "0.048250265111346766",
         "0.045251396648044694",
         "0.05359056806002144"
        ],
        [
         "B",
         "0.06856540084388185",
         "0.808328884143086",
         "0.0408271474019088",
         "0.04581005586592179",
         "0.05359056806002144"
        ],
        [
         "C",
         "0.0669831223628692",
         "0.059263214095034704",
         "0.8345705196182397",
         "0.034636871508379886",
         "0.04287245444801715"
        ],
        [
         "D",
         "0.06540084388185655",
         "0.059263214095034704",
         "0.051961823966065745",
         "0.8564245810055866",
         "0.06109324758842444"
        ],
        [
         "E",
         "0.03375527426160337",
         "0.019754404698344902",
         "0.024390243902439025",
         "0.017877094972067038",
         "0.7888531618435155"
        ]
       ],
       "shape": {
        "columns": 5,
        "rows": 5
       }
      },
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th>letra_respuesta</th>\n",
       "      <th>A</th>\n",
       "      <th>B</th>\n",
       "      <th>C</th>\n",
       "      <th>D</th>\n",
       "      <th>E</th>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>correct_answer</th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>A</th>\n",
       "      <td>0.765295</td>\n",
       "      <td>0.053390</td>\n",
       "      <td>0.048250</td>\n",
       "      <td>0.045251</td>\n",
       "      <td>0.053591</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>B</th>\n",
       "      <td>0.068565</td>\n",
       "      <td>0.808329</td>\n",
       "      <td>0.040827</td>\n",
       "      <td>0.045810</td>\n",
       "      <td>0.053591</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>C</th>\n",
       "      <td>0.066983</td>\n",
       "      <td>0.059263</td>\n",
       "      <td>0.834571</td>\n",
       "      <td>0.034637</td>\n",
       "      <td>0.042872</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>D</th>\n",
       "      <td>0.065401</td>\n",
       "      <td>0.059263</td>\n",
       "      <td>0.051962</td>\n",
       "      <td>0.856425</td>\n",
       "      <td>0.061093</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>E</th>\n",
       "      <td>0.033755</td>\n",
       "      <td>0.019754</td>\n",
       "      <td>0.024390</td>\n",
       "      <td>0.017877</td>\n",
       "      <td>0.788853</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "letra_respuesta         A         B         C         D         E\n",
       "correct_answer                                                   \n",
       "A                0.765295  0.053390  0.048250  0.045251  0.053591\n",
       "B                0.068565  0.808329  0.040827  0.045810  0.053591\n",
       "C                0.066983  0.059263  0.834571  0.034637  0.042872\n",
       "D                0.065401  0.059263  0.051962  0.856425  0.061093\n",
       "E                0.033755  0.019754  0.024390  0.017877  0.788853"
      ]
     },
     "execution_count": 7,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "pd.crosstab(df['correct_answer'], df['letra_respuesta'], normalize='columns')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "id": "3acf4f5b",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "application/vnd.microsoft.datawrangler.viewer.v0+json": {
       "columns": [
        {
         "name": "index",
         "rawType": "int64",
         "type": "integer"
        },
        {
         "name": "source_file",
         "rawType": "object",
         "type": "string"
        },
        {
         "name": "year",
         "rawType": "int64",
         "type": "integer"
        },
        {
         "name": "count_of_matches",
         "rawType": "int64",
         "type": "integer"
        },
        {
         "name": "total_rows",
         "rawType": "int64",
         "type": "integer"
        },
        {
         "name": "percent_correct",
         "rawType": "float64",
         "type": "float"
        }
       ],
       "ref": "69b3b96d-a8aa-4220-a81b-38d3b04af4e4",
       "rows": [
        [
         "0",
         "Anatomía Patológica & Patología",
         "2018",
         "82",
         "100",
         "82.0"
        ],
        [
         "1",
         "Anatomía Patológica & Patología",
         "2019",
         "77",
         "100",
         "77.0"
        ],
        [
         "2",
         "Anatomía Patológica & Patología",
         "2020",
         "88",
         "100",
         "88.0"
        ],
        [
         "3",
         "Anatomía Patológica & Patología",
         "2023",
         "86",
         "100",
         "86.0"
        ],
        [
         "4",
         "Anatomía Patológica & Patología",
         "2024",
         "92",
         "100",
         "92.0"
        ],
        [
         "5",
         "Anatomía Patológica & Patología",
         "2025",
         "85",
         "100",
         "85.0"
        ],
        [
         "6",
         "Anestesiología",
         "2018",
         "85",
         "100",
         "85.0"
        ],
        [
         "7",
         "Anestesiología",
         "2019",
         "83",
         "100",
         "83.0"
        ],
        [
         "8",
         "Anestesiología",
         "2020",
         "76",
         "100",
         "76.0"
        ],
        [
         "9",
         "Anestesiología",
         "2022",
         "76",
         "99",
         "76.77"
        ],
        [
         "10",
         "Anestesiología",
         "2023",
         "77",
         "100",
         "77.0"
        ],
        [
         "11",
         "Anestesiología",
         "2024",
         "84",
         "100",
         "84.0"
        ],
        [
         "12",
         "Anestesiología",
         "2025",
         "84",
         "100",
         "84.0"
        ],
        [
         "13",
         "Cirugía General",
         "2018",
         "74",
         "100",
         "74.0"
        ],
        [
         "14",
         "Cirugía General",
         "2019",
         "77",
         "100",
         "77.0"
        ],
        [
         "15",
         "Cirugía General",
         "2020",
         "81",
         "100",
         "81.0"
        ],
        [
         "16",
         "Cirugía General",
         "2022",
         "83",
         "100",
         "83.0"
        ],
        [
         "17",
         "Cirugía General",
         "2023",
         "80",
         "100",
         "80.0"
        ],
        [
         "18",
         "Cirugía General",
         "2024",
         "74",
         "100",
         "74.0"
        ],
        [
         "19",
         "Cirugía General",
         "2025",
         "79",
         "100",
         "79.0"
        ],
        [
         "20",
         "Cirugía de Tórax y Cardiovascular",
         "2019",
         "60",
         "100",
         "60.0"
        ],
        [
         "21",
         "Cirugía de Tórax y Cardiovascular",
         "2022",
         "79",
         "100",
         "79.0"
        ],
        [
         "22",
         "Cirugía de Tórax y Cardiovascular",
         "2023",
         "82",
         "100",
         "82.0"
        ],
        [
         "23",
         "Cirugía de Tórax y Cardiovascular",
         "2024",
         "81",
         "100",
         "81.0"
        ],
        [
         "24",
         "Cirugía de Tórax y Cardiovascular",
         "2025",
         "158",
         "200",
         "79.0"
        ],
        [
         "25",
         "Ginecología y Obstetricia",
         "2018",
         "77",
         "100",
         "77.0"
        ],
        [
         "26",
         "Ginecología y Obstetricia",
         "2019",
         "83",
         "100",
         "83.0"
        ],
        [
         "27",
         "Ginecología y Obstetricia",
         "2020",
         "82",
         "100",
         "82.0"
        ],
        [
         "28",
         "Ginecología y Obstetricia",
         "2022",
         "80",
         "100",
         "80.0"
        ],
        [
         "29",
         "Ginecología y Obstetricia",
         "2023",
         "79",
         "100",
         "79.0"
        ],
        [
         "30",
         "Ginecología y Obstetricia",
         "2024",
         "80",
         "100",
         "80.0"
        ],
        [
         "31",
         "Ginecología y Obstetricia",
         "2025",
         "83",
         "100",
         "83.0"
        ],
        [
         "32",
         "Neurocirugía",
         "2022",
         "71",
         "100",
         "71.0"
        ],
        [
         "33",
         "Neurocirugía",
         "2023",
         "87",
         "100",
         "87.0"
        ],
        [
         "34",
         "Neurocirugía",
         "2024",
         "83",
         "100",
         "83.0"
        ],
        [
         "35",
         "Neurocirugía",
         "2025",
         "68",
         "100",
         "68.0"
        ],
        [
         "36",
         "Oftalmología",
         "2018",
         "75",
         "100",
         "75.0"
        ],
        [
         "37",
         "Oftalmología",
         "2019",
         "78",
         "100",
         "78.0"
        ],
        [
         "38",
         "Oftalmología",
         "2020",
         "80",
         "100",
         "80.0"
        ],
        [
         "39",
         "Oftalmología",
         "2022",
         "75",
         "100",
         "75.0"
        ],
        [
         "40",
         "Oftalmología",
         "2023",
         "76",
         "100",
         "76.0"
        ],
        [
         "41",
         "Oftalmología",
         "2024",
         "74",
         "100",
         "74.0"
        ],
        [
         "42",
         "Oftalmología",
         "2025",
         "77",
         "100",
         "77.0"
        ],
        [
         "43",
         "Pediatría",
         "2018",
         "78",
         "100",
         "78.0"
        ],
        [
         "44",
         "Pediatría",
         "2019",
         "91",
         "100",
         "91.0"
        ],
        [
         "45",
         "Pediatría",
         "2020",
         "74",
         "100",
         "74.0"
        ],
        [
         "46",
         "Pediatría",
         "2022",
         "85",
         "100",
         "85.0"
        ],
        [
         "47",
         "Pediatría",
         "2023",
         "85",
         "100",
         "85.0"
        ],
        [
         "48",
         "Pediatría",
         "2024",
         "86",
         "100",
         "86.0"
        ],
        [
         "49",
         "Pediatría",
         "2025",
         "75",
         "100",
         "75.0"
        ]
       ],
       "shape": {
        "columns": 5,
        "rows": 83
       }
      },
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>source_file</th>\n",
       "      <th>year</th>\n",
       "      <th>count_of_matches</th>\n",
       "      <th>total_rows</th>\n",
       "      <th>percent_correct</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Anatomía Patológica &amp; Patología</td>\n",
       "      <td>2018</td>\n",
       "      <td>82</td>\n",
       "      <td>100</td>\n",
       "      <td>82.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Anatomía Patológica &amp; Patología</td>\n",
       "      <td>2019</td>\n",
       "      <td>77</td>\n",
       "      <td>100</td>\n",
       "      <td>77.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>Anatomía Patológica &amp; Patología</td>\n",
       "      <td>2020</td>\n",
       "      <td>88</td>\n",
       "      <td>100</td>\n",
       "      <td>88.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>Anatomía Patológica &amp; Patología</td>\n",
       "      <td>2023</td>\n",
       "      <td>86</td>\n",
       "      <td>100</td>\n",
       "      <td>86.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>Anatomía Patológica &amp; Patología</td>\n",
       "      <td>2024</td>\n",
       "      <td>92</td>\n",
       "      <td>100</td>\n",
       "      <td>92.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>78</th>\n",
       "      <td>Urología</td>\n",
       "      <td>2020</td>\n",
       "      <td>78</td>\n",
       "      <td>100</td>\n",
       "      <td>78.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>79</th>\n",
       "      <td>Urología</td>\n",
       "      <td>2022</td>\n",
       "      <td>82</td>\n",
       "      <td>100</td>\n",
       "      <td>82.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>80</th>\n",
       "      <td>Urología</td>\n",
       "      <td>2023</td>\n",
       "      <td>83</td>\n",
       "      <td>100</td>\n",
       "      <td>83.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>81</th>\n",
       "      <td>Urología</td>\n",
       "      <td>2024</td>\n",
       "      <td>72</td>\n",
       "      <td>100</td>\n",
       "      <td>72.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>82</th>\n",
       "      <td>Urología</td>\n",
       "      <td>2025</td>\n",
       "      <td>75</td>\n",
       "      <td>100</td>\n",
       "      <td>75.0</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>83 rows × 5 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "                          source_file  year  count_of_matches  total_rows  \\\n",
       "0   Anatomía Patológica & Patología  2018                82         100   \n",
       "1   Anatomía Patológica & Patología  2019                77         100   \n",
       "2   Anatomía Patológica & Patología  2020                88         100   \n",
       "3   Anatomía Patológica & Patología  2023                86         100   \n",
       "4   Anatomía Patológica & Patología  2024                92         100   \n",
       "..                                ...   ...               ...         ...   \n",
       "78                          Urología  2020                78         100   \n",
       "79                          Urología  2022                82         100   \n",
       "80                          Urología  2023                83         100   \n",
       "81                          Urología  2024                72         100   \n",
       "82                          Urología  2025                75         100   \n",
       "\n",
       "    percent_correct  \n",
       "0              82.0  \n",
       "1              77.0  \n",
       "2              88.0  \n",
       "3              86.0  \n",
       "4              92.0  \n",
       "..              ...  \n",
       "78             78.0  \n",
       "79             82.0  \n",
       "80             83.0  \n",
       "81             72.0  \n",
       "82             75.0  \n",
       "\n",
       "[83 rows x 5 columns]"
      ]
     },
     "execution_count": 8,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df['is_correct'] = df['correct_answer'] == df['letra_respuesta']\n",
    "\n",
    "results = df.groupby(['source_file', 'year']).agg(\n",
    "    count_of_matches=('is_correct', 'sum'),\n",
    "    total_rows=('is_correct', 'size')\n",
    ").reset_index()\n",
    "results['percent_correct'] = (results['count_of_matches'] / results['total_rows']) * 100\n",
    "results['percent_correct'] = results['percent_correct'].round(2)\n",
    "# results['performance'] = (results['percent_correct'] >= 52).astype(int)\n",
    "# results[results['performance'] == 1]\n",
    "results"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "id": "c44e294b",
   "metadata": {},
   "outputs": [],
   "source": [
    "results['model_name'] = 'medgemma-27b-text-it'\n",
    "results.to_pickle('/Users/rodrigocarrillo/Documents/Natural Language Processing Projects/Examen Residentado Peru/02.LLMs Results/06.medgemma-27b-text-it/_Results.pickle')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "7cb4031c",
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "771b5902",
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "dfe8845e",
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "base",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.13.2"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
